Query 037918
Match_columns 361
No_of_seqs 503 out of 3383
Neff 10.0
Searched_HMMs 46136
Date Fri Mar 29 05:42:59 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/037918.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/037918hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 KOG1187 Serine/threonine prote 100.0 7.8E-56 1.7E-60 403.2 24.6 274 82-361 61-340 (361)
2 KOG0595 Serine/threonine-prote 100.0 5.2E-51 1.1E-55 356.1 20.0 202 95-303 9-219 (429)
3 KOG0192 Tyrosine kinase specif 100.0 2.2E-50 4.9E-55 364.9 21.8 240 99-361 44-291 (362)
4 KOG0581 Mitogen-activated prot 100.0 7E-51 1.5E-55 352.2 16.1 245 97-361 80-327 (364)
5 KOG0591 NIMA (never in mitosis 100.0 1.1E-51 2.5E-56 343.6 9.0 246 96-361 19-273 (375)
6 KOG0575 Polo-like serine/threo 100.0 3.3E-50 7.2E-55 367.2 17.8 240 96-361 18-261 (592)
7 KOG0197 Tyrosine kinases [Sign 100.0 9.5E-51 2.1E-55 366.8 14.1 240 98-361 208-449 (468)
8 KOG0598 Ribosomal protein S6 k 100.0 1E-49 2.2E-54 344.8 15.1 243 94-361 23-269 (357)
9 KOG0615 Serine/threonine prote 100.0 1.1E-49 2.3E-54 347.6 13.6 246 94-361 170-429 (475)
10 KOG0593 Predicted protein kina 100.0 1.4E-47 3.1E-52 322.1 17.2 258 96-361 2-276 (396)
11 KOG1026 Nerve growth factor re 100.0 4.1E-48 8.8E-53 366.2 15.2 244 96-361 486-750 (774)
12 KOG3653 Transforming growth fa 100.0 7.4E-46 1.6E-50 328.7 20.3 259 97-361 211-491 (534)
13 KOG0605 NDR and related serine 100.0 4.3E-46 9.3E-51 335.3 18.2 247 94-361 139-434 (550)
14 KOG0592 3-phosphoinositide-dep 100.0 2E-46 4.2E-51 337.5 15.3 246 92-361 69-330 (604)
15 KOG0198 MEKK and related serin 100.0 3.9E-46 8.4E-51 327.6 16.7 245 96-361 17-268 (313)
16 KOG0582 Ste20-like serine/thre 100.0 1.5E-45 3.2E-50 324.7 20.1 255 94-361 24-285 (516)
17 KOG0616 cAMP-dependent protein 100.0 7.9E-46 1.7E-50 310.8 16.8 198 96-302 44-245 (355)
18 KOG0600 Cdc2-related protein k 100.0 7.1E-46 1.5E-50 331.3 16.1 261 95-361 116-392 (560)
19 KOG2052 Activin A type IB rece 100.0 1.4E-44 3.1E-49 318.3 21.8 255 92-360 207-490 (513)
20 KOG0193 Serine/threonine prote 100.0 1.1E-45 2.3E-50 336.6 14.8 252 89-361 385-641 (678)
21 KOG0597 Serine-threonine prote 100.0 6.7E-46 1.4E-50 335.0 12.1 239 96-361 2-243 (808)
22 KOG0661 MAPK related serine/th 100.0 6.8E-46 1.5E-50 329.2 12.0 259 94-361 8-283 (538)
23 KOG0583 Serine/threonine prote 100.0 6.7E-45 1.5E-49 332.2 18.8 243 93-361 14-267 (370)
24 KOG0196 Tyrosine kinase, EPH ( 100.0 3.1E-46 6.7E-51 348.0 9.5 243 97-361 630-879 (996)
25 KOG0578 p21-activated serine/t 100.0 2.4E-45 5.3E-50 332.8 13.8 240 96-361 273-515 (550)
26 KOG0659 Cdk activating kinase 100.0 2E-44 4.3E-49 298.1 17.7 259 96-361 2-273 (318)
27 cd05102 PTKc_VEGFR3 Catalytic 100.0 3E-44 6.5E-49 329.3 20.9 246 95-361 6-322 (338)
28 KOG1095 Protein tyrosine kinas 100.0 4.1E-45 8.8E-50 357.5 14.2 244 96-361 692-949 (1025)
29 KOG1094 Discoidin domain recep 100.0 6.6E-44 1.4E-48 323.0 19.7 251 96-361 538-792 (807)
30 cd05612 STKc_PRKX_like Catalyt 100.0 3.9E-44 8.5E-49 321.7 17.8 237 96-361 1-241 (291)
31 cd05631 STKc_GRK4 Catalytic do 100.0 3.1E-43 6.8E-48 314.9 22.1 243 97-361 1-248 (285)
32 PTZ00263 protein kinase A cata 100.0 5.2E-44 1.1E-48 326.3 17.1 237 96-361 18-258 (329)
33 KOG0694 Serine/threonine prote 100.0 2.6E-44 5.6E-49 332.4 15.1 242 93-361 365-611 (694)
34 cd05571 STKc_PKB Catalytic dom 100.0 1.6E-43 3.4E-48 322.4 18.7 234 102-361 1-238 (323)
35 cd05096 PTKc_DDR1 Catalytic do 100.0 9E-43 2E-47 314.9 23.3 251 96-361 5-293 (304)
36 KOG0201 Serine/threonine prote 100.0 1E-44 2.2E-49 319.1 9.3 241 96-361 13-255 (467)
37 PLN00113 leucine-rich repeat r 100.0 4.3E-42 9.3E-47 355.3 30.4 249 95-361 689-939 (968)
38 KOG4721 Serine/threonine prote 100.0 2.5E-44 5.4E-49 324.9 11.9 238 84-361 119-356 (904)
39 KOG0194 Protein tyrosine kinas 100.0 5.7E-44 1.2E-48 327.6 13.9 243 95-361 156-408 (474)
40 cd05585 STKc_YPK1_like Catalyt 100.0 4.7E-43 1E-47 317.8 19.3 232 104-361 1-236 (312)
41 cd05595 STKc_PKB_beta Catalyti 100.0 5.9E-43 1.3E-47 318.5 19.9 234 102-361 1-238 (323)
42 PHA02988 hypothetical protein; 100.0 8.1E-43 1.8E-47 311.7 20.1 233 101-361 25-267 (283)
43 cd07869 STKc_PFTAIRE1 Catalyti 100.0 8E-43 1.7E-47 315.0 20.3 201 95-301 4-207 (303)
44 PTZ00426 cAMP-dependent protei 100.0 2.8E-43 6E-48 322.4 16.9 238 95-361 29-271 (340)
45 KOG0611 Predicted serine/threo 100.0 7.9E-44 1.7E-48 310.3 12.4 238 95-360 52-294 (668)
46 cd05104 PTKc_Kit Catalytic dom 100.0 1.1E-42 2.3E-47 322.8 20.8 246 95-361 34-362 (375)
47 cd05593 STKc_PKB_gamma Catalyt 100.0 9.7E-43 2.1E-47 317.7 19.7 234 102-361 1-238 (328)
48 cd05600 STKc_Sid2p_Dbf2p Catal 100.0 8.9E-43 1.9E-47 318.8 19.4 245 96-361 1-249 (333)
49 cd06649 PKc_MEK2 Catalytic dom 100.0 4E-42 8.7E-47 314.2 23.3 199 95-301 4-205 (331)
50 cd05584 STKc_p70S6K Catalytic 100.0 1.3E-42 2.8E-47 316.4 19.5 234 102-361 2-243 (323)
51 cd07848 STKc_CDKL5 Catalytic d 100.0 3.4E-42 7.4E-47 308.5 22.0 201 96-301 1-204 (287)
52 cd05106 PTKc_CSF-1R Catalytic 100.0 2E-42 4.3E-47 320.8 21.0 247 94-361 36-360 (374)
53 cd05064 PTKc_EphR_A10 Catalyti 100.0 1.2E-42 2.5E-47 308.2 18.6 244 95-361 4-253 (266)
54 KOG0580 Serine/threonine prote 100.0 2.6E-43 5.6E-48 287.4 12.9 241 94-361 20-265 (281)
55 PTZ00267 NIMA-related protein 100.0 1E-42 2.2E-47 332.4 19.3 243 97-361 68-315 (478)
56 cd07871 STKc_PCTAIRE3 Catalyti 100.0 2.1E-42 4.6E-47 310.0 20.1 200 96-301 5-207 (288)
57 KOG0585 Ca2+/calmodulin-depend 100.0 3.8E-43 8.2E-48 311.5 14.8 247 93-361 94-364 (576)
58 cd05587 STKc_cPKC Catalytic do 100.0 2.1E-42 4.6E-47 315.1 19.8 239 97-361 1-244 (324)
59 cd05108 PTKc_EGFR Catalytic do 100.0 2.1E-42 4.5E-47 314.2 19.3 243 96-361 7-256 (316)
60 cd05589 STKc_PKN Catalytic dom 100.0 1.4E-42 3.1E-47 316.3 18.2 237 98-361 1-244 (324)
61 KOG0610 Putative serine/threon 100.0 1.4E-42 3E-47 303.5 17.0 245 96-361 77-380 (459)
62 PF07714 Pkinase_Tyr: Protein 100.0 4.6E-43 1E-47 309.4 14.3 239 101-361 4-250 (259)
63 cd05599 STKc_NDR_like Catalyti 100.0 1.2E-42 2.6E-47 321.9 17.4 202 96-301 1-242 (364)
64 KOG2345 Serine/threonine prote 100.0 3.3E-43 7.3E-48 288.1 11.8 251 94-361 19-288 (302)
65 KOG0588 Serine/threonine prote 100.0 3.1E-43 6.8E-48 323.2 13.0 239 96-361 12-255 (786)
66 cd05616 STKc_cPKC_beta Catalyt 100.0 3.4E-42 7.3E-47 313.7 19.5 239 97-361 1-244 (323)
67 cd05590 STKc_nPKC_eta Catalyti 100.0 2.8E-42 6E-47 313.7 18.9 234 102-361 1-239 (320)
68 cd05614 STKc_MSK2_N N-terminal 100.0 6.7E-42 1.4E-46 313.0 21.5 244 97-361 1-254 (332)
69 cd05048 PTKc_Ror Catalytic Dom 100.0 4.5E-42 9.7E-47 307.0 19.7 244 96-361 5-271 (283)
70 cd05618 STKc_aPKC_iota Catalyt 100.0 4.4E-42 9.6E-47 313.5 20.1 240 102-361 1-248 (329)
71 cd05588 STKc_aPKC Catalytic do 100.0 6.5E-42 1.4E-46 312.4 20.7 240 102-361 1-248 (329)
72 cd05591 STKc_nPKC_epsilon Cata 100.0 3.4E-42 7.4E-47 313.4 18.4 234 102-361 1-239 (321)
73 cd05608 STKc_GRK1 Catalytic do 100.0 1.5E-41 3.3E-46 303.2 22.3 237 104-361 1-244 (280)
74 cd05628 STKc_NDR1 Catalytic do 100.0 5.5E-42 1.2E-46 317.2 20.1 202 96-301 1-239 (363)
75 cd05594 STKc_PKB_alpha Catalyt 100.0 3.9E-42 8.5E-47 313.5 18.8 234 102-361 1-239 (325)
76 cd05592 STKc_nPKC_theta_delta 100.0 5.2E-42 1.1E-46 311.4 19.4 234 102-361 1-239 (316)
77 KOG0589 Serine/threonine prote 100.0 1E-42 2.2E-47 313.7 14.4 242 96-361 4-250 (426)
78 cd05625 STKc_LATS1 Catalytic d 100.0 3.2E-42 6.9E-47 321.0 18.3 201 97-301 2-251 (382)
79 cd06650 PKc_MEK1 Catalytic dom 100.0 1.1E-41 2.3E-46 311.5 21.2 199 95-301 4-205 (333)
80 KOG1989 ARK protein kinase fam 100.0 2.9E-42 6.2E-47 327.9 17.8 245 94-361 35-299 (738)
81 cd05629 STKc_NDR_like_fungal C 100.0 3.2E-42 6.8E-47 320.4 17.8 202 96-301 1-251 (377)
82 cd05105 PTKc_PDGFR_alpha Catal 100.0 1.5E-41 3.3E-46 316.4 22.4 247 94-361 35-385 (400)
83 cd05049 PTKc_Trk Catalytic dom 100.0 6E-42 1.3E-46 305.7 18.9 244 96-361 5-269 (280)
84 cd05573 STKc_ROCK_NDR_like Cat 100.0 1.5E-42 3.2E-47 319.7 15.4 245 96-361 1-276 (350)
85 cd05033 PTKc_EphR Catalytic do 100.0 1.3E-41 2.8E-46 301.4 20.8 245 95-361 3-253 (266)
86 KOG0663 Protein kinase PITSLRE 100.0 2.2E-42 4.7E-47 294.5 14.8 200 96-301 76-281 (419)
87 cd05620 STKc_nPKC_delta Cataly 100.0 1.9E-41 4.1E-46 307.7 22.0 234 102-361 1-239 (316)
88 cd05582 STKc_RSK_N N-terminal 100.0 1.9E-42 4E-47 314.7 15.4 234 102-361 2-241 (318)
89 cd05114 PTKc_Tec_Rlk Catalytic 100.0 1.7E-41 3.6E-46 299.0 21.0 242 96-361 4-246 (256)
90 cd05626 STKc_LATS2 Catalytic d 100.0 7.9E-42 1.7E-46 318.0 19.9 201 97-301 2-251 (381)
91 cd05601 STKc_CRIK Catalytic do 100.0 2E-42 4.4E-47 316.1 15.3 245 96-361 1-255 (330)
92 cd05084 PTKc_Fes Catalytic dom 100.0 1.6E-41 3.4E-46 298.3 20.3 238 102-361 1-241 (252)
93 cd05093 PTKc_TrkB Catalytic do 100.0 8.9E-42 1.9E-46 306.0 19.1 244 96-361 5-267 (288)
94 PTZ00283 serine/threonine prot 100.0 4.1E-42 8.8E-47 328.6 17.9 249 91-361 27-289 (496)
95 cd07859 STKc_TDY_MAPK_plant Ca 100.0 1.2E-41 2.6E-46 312.0 20.3 200 97-301 1-211 (338)
96 cd05575 STKc_SGK Catalytic dom 100.0 6.4E-42 1.4E-46 311.8 18.1 234 102-361 1-239 (323)
97 KOG0660 Mitogen-activated prot 100.0 5.5E-42 1.2E-46 295.8 16.4 205 92-301 18-231 (359)
98 cd05615 STKc_cPKC_alpha Cataly 100.0 8.8E-42 1.9E-46 310.8 18.7 239 97-361 1-244 (323)
99 cd05598 STKc_LATS Catalytic do 100.0 3.1E-42 6.6E-47 320.5 15.8 202 96-301 1-247 (376)
100 cd05619 STKc_nPKC_theta Cataly 100.0 3.3E-41 7.2E-46 306.0 21.9 234 102-361 1-239 (316)
101 cd05617 STKc_aPKC_zeta Catalyt 100.0 3.9E-41 8.4E-46 307.1 22.4 240 102-361 1-246 (327)
102 cd05570 STKc_PKC Catalytic dom 100.0 1.9E-41 4E-46 308.1 20.2 234 102-361 1-239 (318)
103 PHA03212 serine/threonine kina 100.0 4.8E-41 1E-45 312.8 23.2 194 95-300 91-285 (391)
104 cd05603 STKc_SGK2 Catalytic do 100.0 1.8E-41 3.8E-46 308.7 19.9 234 102-361 1-239 (321)
105 cd05605 STKc_GRK4_like Catalyt 100.0 3.5E-41 7.5E-46 301.7 21.5 243 97-361 1-248 (285)
106 cd05111 PTK_HER3 Pseudokinase 100.0 2.3E-41 4.9E-46 302.0 20.2 243 96-361 7-256 (279)
107 cd05113 PTKc_Btk_Bmx Catalytic 100.0 1.2E-41 2.6E-46 299.9 18.1 242 96-361 4-246 (256)
108 PRK13184 pknD serine/threonine 100.0 1.7E-41 3.6E-46 334.2 20.8 246 96-361 2-277 (932)
109 cd05068 PTKc_Frk_like Catalyti 100.0 2E-41 4.4E-46 299.3 19.2 243 95-361 5-249 (261)
110 cd08529 STKc_FA2-like Catalyti 100.0 4.1E-41 8.8E-46 296.2 21.0 241 97-361 1-245 (256)
111 KOG0594 Protein kinase PCTAIRE 100.0 1.3E-41 2.9E-46 294.2 17.4 201 96-302 11-225 (323)
112 cd05607 STKc_GRK7 Catalytic do 100.0 8.8E-41 1.9E-45 297.8 23.4 237 104-361 1-242 (277)
113 cd05072 PTKc_Lyn Catalytic dom 100.0 1.8E-41 3.9E-46 299.6 18.8 243 95-361 5-249 (261)
114 PLN00034 mitogen-activated pro 100.0 2.4E-41 5.3E-46 311.7 20.3 240 96-361 74-320 (353)
115 cd07862 STKc_CDK6 Catalytic do 100.0 3.6E-41 7.9E-46 302.3 20.8 258 96-361 1-279 (290)
116 cd05090 PTKc_Ror1 Catalytic do 100.0 2.6E-41 5.7E-46 302.1 19.8 244 96-361 5-271 (283)
117 cd06644 STKc_STK10_LOK Catalyt 100.0 3.9E-41 8.5E-46 302.4 20.9 244 96-361 12-261 (292)
118 cd05062 PTKc_IGF-1R Catalytic 100.0 2.1E-41 4.6E-46 301.8 18.8 246 94-361 4-266 (277)
119 cd06646 STKc_MAP4K5 Catalytic 100.0 3.3E-41 7.2E-46 298.9 20.0 245 96-361 9-257 (267)
120 cd05059 PTKc_Tec_like Catalyti 100.0 2.2E-41 4.7E-46 298.3 18.5 242 96-361 4-246 (256)
121 cd05627 STKc_NDR2 Catalytic do 100.0 7.6E-42 1.6E-46 315.9 16.3 202 96-301 1-239 (360)
122 cd05148 PTKc_Srm_Brk Catalytic 100.0 1.1E-41 2.3E-46 300.9 16.5 244 94-361 4-249 (261)
123 cd05094 PTKc_TrkC Catalytic do 100.0 2.8E-41 6.1E-46 303.2 19.3 244 96-361 5-270 (291)
124 cd06643 STKc_SLK Catalytic dom 100.0 3.5E-41 7.6E-46 301.2 19.8 242 98-361 7-254 (282)
125 cd05604 STKc_SGK3 Catalytic do 100.0 1.3E-41 2.8E-46 310.1 17.2 234 102-361 1-239 (325)
126 cd05602 STKc_SGK1 Catalytic do 100.0 2.1E-41 4.5E-46 308.7 18.5 234 102-361 1-239 (325)
127 cd06611 STKc_SLK_like Catalyti 100.0 2.5E-41 5.4E-46 301.8 18.0 245 95-361 4-254 (280)
128 cd05054 PTKc_VEGFR Catalytic d 100.0 5.7E-41 1.2E-45 307.0 20.8 246 95-361 6-321 (337)
129 cd05622 STKc_ROCK1 Catalytic d 100.0 2.3E-41 5E-46 313.4 18.3 206 89-300 36-249 (371)
130 cd05596 STKc_ROCK Catalytic do 100.0 1.8E-41 4E-46 314.0 17.7 202 94-301 41-250 (370)
131 cd05109 PTKc_HER2 Catalytic do 100.0 5.5E-41 1.2E-45 299.5 20.1 244 95-361 6-256 (279)
132 cd06625 STKc_MEKK3_like Cataly 100.0 2.3E-40 5E-45 292.7 23.9 244 96-361 2-252 (263)
133 cd05092 PTKc_TrkA Catalytic do 100.0 3.8E-41 8.1E-46 300.7 19.1 244 96-361 5-269 (280)
134 cd05621 STKc_ROCK2 Catalytic d 100.0 2.1E-41 4.5E-46 313.4 17.8 202 94-301 41-250 (370)
135 cd05080 PTKc_Tyk2_rpt2 Catalyt 100.0 5.4E-41 1.2E-45 300.1 19.8 254 98-361 6-269 (283)
136 cd06612 STKc_MST1_2 Catalytic 100.0 1E-40 2.2E-45 293.6 21.0 242 96-361 3-245 (256)
137 cd06654 STKc_PAK1 Catalytic do 100.0 9.5E-41 2.1E-45 300.5 20.7 242 96-361 20-262 (296)
138 cd05045 PTKc_RET Catalytic dom 100.0 8.2E-41 1.8E-45 300.0 20.1 243 97-361 1-274 (290)
139 cd05052 PTKc_Abl Catalytic dom 100.0 6.5E-41 1.4E-45 296.4 19.1 242 96-361 6-250 (263)
140 cd05036 PTKc_ALK_LTK Catalytic 100.0 6.1E-41 1.3E-45 298.9 19.0 246 94-361 4-266 (277)
141 cd08228 STKc_Nek6 Catalytic do 100.0 2.6E-40 5.5E-45 293.1 22.3 245 96-361 2-253 (267)
142 cd05085 PTKc_Fer Catalytic dom 100.0 1.7E-40 3.7E-45 291.4 20.9 237 102-361 1-239 (250)
143 cd05081 PTKc_Jak2_Jak3_rpt2 Ca 100.0 9.6E-41 2.1E-45 298.6 19.4 255 96-361 4-271 (284)
144 cd05091 PTKc_Ror2 Catalytic do 100.0 4.8E-41 1E-45 300.4 17.4 243 97-361 6-271 (283)
145 cd05115 PTKc_Zap-70 Catalytic 100.0 1.7E-40 3.8E-45 292.7 20.7 236 103-361 2-243 (257)
146 cd07872 STKc_PCTAIRE2 Catalyti 100.0 9.4E-41 2E-45 302.4 19.5 200 96-301 6-208 (309)
147 cd06645 STKc_MAP4K3 Catalytic 100.0 9.8E-41 2.1E-45 295.8 19.1 245 96-361 9-257 (267)
148 cd05053 PTKc_FGFR Catalytic do 100.0 5.4E-41 1.2E-45 301.6 17.6 247 93-361 9-279 (293)
149 KOG0574 STE20-like serine/thre 100.0 2.4E-43 5.3E-48 296.6 2.0 239 98-360 35-274 (502)
150 cd06656 STKc_PAK3 Catalytic do 100.0 1.2E-40 2.6E-45 299.9 19.7 243 95-361 18-261 (297)
151 cd06615 PKc_MEK Catalytic doma 100.0 4.6E-40 1E-44 297.7 23.3 197 96-300 1-200 (308)
152 cd06613 STKc_MAP4K3_like Catal 100.0 2.4E-40 5.1E-45 292.4 20.9 246 96-361 3-252 (262)
153 cd06624 STKc_ASK Catalytic dom 100.0 3.8E-40 8.3E-45 292.2 22.3 248 92-361 4-257 (268)
154 cd05116 PTKc_Syk Catalytic dom 100.0 2E-40 4.4E-45 292.3 20.3 235 103-361 2-243 (257)
155 cd06619 PKc_MKK5 Catalytic dom 100.0 1.4E-40 3.1E-45 296.8 19.6 241 96-361 1-245 (279)
156 cd05071 PTKc_Src Catalytic dom 100.0 1.4E-40 3E-45 294.2 19.3 242 95-361 5-248 (262)
157 cd05097 PTKc_DDR_like Catalyti 100.0 3.9E-40 8.5E-45 296.4 22.4 251 96-361 5-284 (295)
158 cd05035 PTKc_Axl_like Catalyti 100.0 2.5E-40 5.3E-45 294.0 20.9 242 98-361 1-260 (273)
159 cd05077 PTK_Jak1_rpt1 Pseudoki 100.0 4.2E-40 9.1E-45 291.1 21.9 230 102-361 1-252 (262)
160 cd06631 STKc_YSK4 Catalytic do 100.0 6.1E-40 1.3E-44 290.4 22.9 244 97-361 1-254 (265)
161 cd05070 PTKc_Fyn_Yrk Catalytic 100.0 1.7E-40 3.6E-45 293.2 19.2 241 96-361 6-248 (260)
162 cd05632 STKc_GRK5 Catalytic do 100.0 3.7E-40 8.1E-45 295.0 21.5 242 98-361 2-248 (285)
163 cd05055 PTKc_PDGFR Catalytic d 100.0 4.3E-40 9.4E-45 297.0 21.9 247 94-361 33-289 (302)
164 cd05597 STKc_DMPK_like Catalyt 100.0 6.2E-40 1.3E-44 299.7 23.0 201 96-300 1-210 (331)
165 cd05075 PTKc_Axl Catalytic dom 100.0 3.4E-40 7.5E-45 293.1 20.7 242 98-361 1-259 (272)
166 cd00192 PTKc Catalytic domain 100.0 3.6E-40 7.9E-45 290.7 20.7 238 102-361 1-252 (262)
167 cd05065 PTKc_EphR_B Catalytic 100.0 1.7E-40 3.7E-45 294.7 18.6 244 96-361 4-256 (269)
168 cd05063 PTKc_EphR_A2 Catalytic 100.0 2.7E-40 5.8E-45 293.2 19.7 245 95-361 4-255 (268)
169 cd05098 PTKc_FGFR1 Catalytic d 100.0 1.6E-40 3.5E-45 300.6 18.6 244 96-361 18-287 (307)
170 cd08229 STKc_Nek7 Catalytic do 100.0 5.7E-40 1.2E-44 290.9 21.7 245 96-361 2-253 (267)
171 cd05101 PTKc_FGFR2 Catalytic d 100.0 2.2E-40 4.7E-45 299.3 19.3 245 95-361 14-284 (304)
172 cd05089 PTKc_Tie1 Catalytic do 100.0 2.8E-40 6.2E-45 297.5 19.9 241 96-361 2-263 (297)
173 cd05624 STKc_MRCK_beta Catalyt 100.0 4.7E-40 1E-44 300.5 21.5 201 96-300 1-210 (331)
174 cd06655 STKc_PAK2 Catalytic do 100.0 1.3E-40 2.7E-45 299.6 17.5 242 96-361 19-261 (296)
175 KOG0658 Glycogen synthase kina 100.0 9.8E-42 2.1E-46 294.7 9.8 253 97-361 25-298 (364)
176 cd05032 PTKc_InsR_like Catalyt 100.0 2.2E-40 4.8E-45 295.1 18.9 245 95-361 5-266 (277)
177 cd08224 STKc_Nek6_Nek7 Catalyt 100.0 1.6E-39 3.4E-44 287.9 24.3 245 96-361 2-253 (267)
178 PF00069 Pkinase: Protein kina 100.0 1.5E-40 3.3E-45 293.2 17.5 245 98-361 1-249 (260)
179 cd05061 PTKc_InsR Catalytic do 100.0 2E-40 4.3E-45 297.3 18.5 246 94-361 4-266 (288)
180 cd05043 PTK_Ryk Pseudokinase d 100.0 1.9E-40 4.1E-45 296.1 18.3 246 94-361 4-264 (280)
181 cd07853 STKc_NLK Catalytic dom 100.0 5E-40 1.1E-44 305.1 21.8 199 97-301 1-208 (372)
182 cd05630 STKc_GRK6 Catalytic do 100.0 6.9E-40 1.5E-44 293.3 21.9 242 98-361 2-248 (285)
183 cd05041 PTKc_Fes_like Catalyti 100.0 5.5E-40 1.2E-44 288.3 20.9 238 102-361 1-240 (251)
184 PHA03207 serine/threonine kina 100.0 2.7E-40 5.8E-45 308.7 19.9 197 95-301 91-290 (392)
185 cd05067 PTKc_Lck_Blk Catalytic 100.0 3.2E-40 7E-45 291.4 19.2 242 95-361 5-248 (260)
186 KOG0033 Ca2+/calmodulin-depend 100.0 6.2E-43 1.3E-47 286.1 1.6 243 95-361 10-259 (355)
187 cd06609 STKc_MST3_like Catalyt 100.0 3.7E-40 8E-45 293.3 19.6 241 96-361 1-243 (274)
188 cd05107 PTKc_PDGFR_beta Cataly 100.0 3.3E-40 7.1E-45 307.3 20.0 247 94-361 35-387 (401)
189 cd07873 STKc_PCTAIRE1 Catalyti 100.0 3.2E-40 7E-45 297.8 19.3 200 96-301 6-208 (301)
190 cd05051 PTKc_DDR Catalytic dom 100.0 1.5E-39 3.3E-44 292.6 23.5 252 95-361 4-285 (296)
191 cd05034 PTKc_Src_like Catalyti 100.0 3.3E-40 7.1E-45 291.4 18.8 243 95-361 5-249 (261)
192 cd05040 PTKc_Ack_like Catalyti 100.0 2.8E-40 6.2E-45 291.2 18.3 238 102-361 1-246 (257)
193 PTZ00036 glycogen synthase kin 100.0 3.2E-40 6.9E-45 311.9 19.8 197 94-301 64-274 (440)
194 KOG0032 Ca2+/calmodulin-depend 100.0 5.6E-40 1.2E-44 299.7 20.6 244 94-361 33-285 (382)
195 cd05099 PTKc_FGFR4 Catalytic d 100.0 4.1E-40 8.8E-45 298.9 19.6 245 95-361 11-281 (314)
196 KOG1025 Epidermal growth facto 100.0 9.5E-41 2.1E-45 312.7 15.7 240 99-361 699-945 (1177)
197 cd05586 STKc_Sck1_like Catalyt 100.0 1.3E-40 2.7E-45 304.3 16.1 233 104-361 1-241 (330)
198 KOG4257 Focal adhesion tyrosin 100.0 1.1E-40 2.5E-45 304.1 15.5 239 99-361 392-637 (974)
199 cd07876 STKc_JNK2 Catalytic do 100.0 6.2E-40 1.3E-44 303.1 20.8 198 94-301 19-225 (359)
200 KOG0596 Dual specificity; seri 100.0 1E-40 2.2E-45 300.9 14.9 247 94-361 359-619 (677)
201 cd06640 STKc_MST4 Catalytic do 100.0 1.9E-39 4.2E-44 289.2 23.1 240 96-361 4-245 (277)
202 cd05066 PTKc_EphR_A Catalytic 100.0 5.6E-40 1.2E-44 291.0 19.6 244 96-361 4-254 (267)
203 cd08219 STKc_Nek3 Catalytic do 100.0 8.9E-40 1.9E-44 287.7 20.6 241 97-361 1-244 (255)
204 cd05609 STKc_MAST Catalytic do 100.0 5.9E-40 1.3E-44 296.6 20.0 245 96-361 1-262 (305)
205 cd05623 STKc_MRCK_alpha Cataly 100.0 1.3E-39 2.9E-44 297.6 22.5 201 96-300 1-210 (332)
206 cd05095 PTKc_DDR2 Catalytic do 100.0 1.5E-39 3.2E-44 292.7 22.3 251 96-361 5-285 (296)
207 cd05057 PTKc_EGFR_like Catalyt 100.0 6.6E-40 1.4E-44 292.5 19.9 243 96-361 7-256 (279)
208 cd05039 PTKc_Csk_like Catalyti 100.0 9.8E-40 2.1E-44 287.6 20.4 238 95-361 5-244 (256)
209 cd05079 PTKc_Jak1_rpt2 Catalyt 100.0 1E-39 2.3E-44 292.0 20.9 249 96-361 4-271 (284)
210 cd08221 STKc_Nek9 Catalytic do 100.0 1.1E-39 2.4E-44 287.2 20.7 241 97-361 1-245 (256)
211 cd06605 PKc_MAPKK Catalytic do 100.0 1.1E-39 2.4E-44 288.7 20.7 246 96-361 1-249 (265)
212 cd05076 PTK_Tyk2_rpt1 Pseudoki 100.0 1E-39 2.2E-44 290.5 20.5 229 103-361 2-264 (274)
213 cd05069 PTKc_Yes Catalytic dom 100.0 8E-40 1.7E-44 288.9 19.7 241 96-361 6-248 (260)
214 cd05050 PTKc_Musk Catalytic do 100.0 5.9E-40 1.3E-44 294.1 19.0 245 95-361 4-277 (288)
215 cd07878 STKc_p38beta_MAPK11 Ca 100.0 8.3E-40 1.8E-44 300.5 20.3 198 92-300 11-218 (343)
216 cd05056 PTKc_FAK Catalytic dom 100.0 9.4E-40 2E-44 290.1 20.0 242 96-361 6-253 (270)
217 cd06622 PKc_MAPKK_PBS2_like Ca 100.0 8.9E-40 1.9E-44 292.7 19.9 244 96-361 1-254 (286)
218 cd06637 STKc_TNIK Catalytic do 100.0 7.8E-40 1.7E-44 290.8 19.4 245 93-361 3-261 (272)
219 cd05103 PTKc_VEGFR2 Catalytic 100.0 1.2E-39 2.6E-44 299.3 21.2 246 95-361 6-327 (343)
220 cd05088 PTKc_Tie2 Catalytic do 100.0 5E-40 1.1E-44 296.7 18.3 241 96-361 7-268 (303)
221 cd07861 STKc_CDK1_euk Catalyti 100.0 1.6E-39 3.5E-44 290.7 21.3 198 97-300 1-204 (285)
222 cd06628 STKc_MAPKKK_Byr2_like 100.0 2.1E-39 4.5E-44 287.3 21.6 242 97-361 1-256 (267)
223 cd05112 PTKc_Itk Catalytic dom 100.0 6.6E-40 1.4E-44 288.7 18.3 242 96-361 4-246 (256)
224 PHA03211 serine/threonine kina 100.0 5.1E-40 1.1E-44 309.8 18.7 193 96-298 169-362 (461)
225 cd07847 STKc_CDKL1_4 Catalytic 100.0 2.4E-39 5.2E-44 289.7 22.0 200 96-301 1-204 (286)
226 KOG4279 Serine/threonine prote 100.0 7.7E-41 1.7E-45 308.4 12.3 237 103-361 582-824 (1226)
227 cd05060 PTKc_Syk_like Catalyti 100.0 1.8E-39 3.8E-44 286.2 20.6 236 102-361 1-243 (257)
228 cd06642 STKc_STK25-YSK1 Cataly 100.0 7E-40 1.5E-44 292.0 18.2 238 98-361 6-245 (277)
229 cd05580 STKc_PKA Catalytic dom 100.0 1.4E-39 3E-44 292.1 20.2 237 96-361 1-241 (290)
230 cd06647 STKc_PAK_I Catalytic d 100.0 1.4E-39 3E-44 292.5 20.1 243 95-361 18-261 (293)
231 cd05038 PTKc_Jak_rpt2 Catalyti 100.0 1.2E-39 2.6E-44 291.2 19.7 255 96-361 4-271 (284)
232 cd05082 PTKc_Csk Catalytic dom 100.0 1.1E-39 2.5E-44 287.2 19.0 236 96-361 6-244 (256)
233 cd07863 STKc_CDK4 Catalytic do 100.0 1.3E-39 2.8E-44 291.9 19.5 198 97-301 1-210 (288)
234 cd05087 PTKc_Aatyk1_Aatyk3 Cat 100.0 7.3E-39 1.6E-43 284.2 24.0 242 102-361 1-258 (269)
235 cd07875 STKc_JNK1 Catalytic do 100.0 1.7E-39 3.6E-44 300.8 20.7 198 94-301 22-228 (364)
236 cd05073 PTKc_Hck Catalytic dom 100.0 1.8E-39 3.8E-44 286.8 19.9 242 95-361 5-248 (260)
237 KOG0599 Phosphorylase kinase g 100.0 1.2E-40 2.5E-45 276.9 11.4 248 91-361 12-275 (411)
238 cd06638 STKc_myosinIIIA Cataly 100.0 8.5E-40 1.8E-44 292.8 17.9 253 86-361 8-275 (286)
239 KOG0667 Dual-specificity tyros 100.0 6.7E-40 1.5E-44 302.7 17.6 194 97-300 187-390 (586)
240 cd05042 PTKc_Aatyk Catalytic d 100.0 6.2E-39 1.3E-43 284.6 23.3 242 102-361 1-258 (269)
241 cd06632 STKc_MEKK1_plant Catal 100.0 4.6E-39 9.9E-44 283.4 22.2 240 97-361 1-247 (258)
242 cd08227 PK_STRAD_alpha Pseudok 100.0 3.4E-39 7.4E-44 294.4 22.0 199 100-301 2-213 (327)
243 cd06639 STKc_myosinIIIB Cataly 100.0 1.1E-39 2.4E-44 292.8 18.5 253 86-361 12-279 (291)
244 cd07874 STKc_JNK3 Catalytic do 100.0 1E-39 2.2E-44 301.2 18.7 198 94-301 15-221 (355)
245 cd07868 STKc_CDK8 Catalytic do 100.0 2.5E-39 5.4E-44 294.1 20.9 195 101-301 6-219 (317)
246 cd06651 STKc_MEKK3 Catalytic d 100.0 7E-39 1.5E-43 283.9 23.3 202 96-301 2-212 (266)
247 PTZ00266 NIMA-related protein 100.0 1.2E-39 2.5E-44 322.5 20.1 248 92-361 9-287 (1021)
248 cd06610 STKc_OSR1_SPAK Catalyt 100.0 2.3E-39 5E-44 286.8 20.1 249 96-361 1-256 (267)
249 cd06620 PKc_MAPKK_Byr1_like Ca 100.0 2.2E-39 4.7E-44 289.9 20.0 246 96-361 5-258 (284)
250 cd05100 PTKc_FGFR3 Catalytic d 100.0 1.6E-39 3.5E-44 297.5 19.5 244 96-361 12-281 (334)
251 cd07870 STKc_PFTAIRE2 Catalyti 100.0 2.1E-39 4.5E-44 291.0 19.9 203 94-302 3-208 (291)
252 cd05110 PTKc_HER4 Catalytic do 100.0 1.3E-39 2.7E-44 294.1 18.6 243 96-361 7-256 (303)
253 cd05037 PTK_Jak_rpt1 Pseudokin 100.0 3.4E-39 7.4E-44 284.5 20.8 228 102-361 1-249 (259)
254 cd06636 STKc_MAP4K4_6 Catalyti 100.0 1.8E-39 4E-44 290.0 19.3 252 86-361 6-271 (282)
255 cd06629 STKc_MAPKKK_Bck1_like 100.0 8.6E-39 1.9E-43 284.2 23.4 247 97-361 2-261 (272)
256 cd08223 STKc_Nek4 Catalytic do 100.0 8.8E-39 1.9E-43 281.6 23.1 241 97-361 1-246 (257)
257 cd05058 PTKc_Met_Ron Catalytic 100.0 2.7E-39 5.9E-44 285.7 19.7 238 102-361 1-247 (262)
258 cd06658 STKc_PAK5 Catalytic do 100.0 8.1E-40 1.7E-44 293.8 16.6 240 98-361 24-264 (292)
259 cd07832 STKc_CCRK Catalytic do 100.0 3.3E-39 7.1E-44 288.9 20.4 199 97-300 1-203 (286)
260 cd05044 PTKc_c-ros Catalytic d 100.0 2E-39 4.3E-44 287.7 18.8 238 102-361 1-258 (269)
261 PTZ00284 protein kinase; Provi 100.0 2.8E-39 6.1E-44 308.4 21.1 201 90-301 123-348 (467)
262 KOG4278 Protein tyrosine kinas 100.0 1.6E-40 3.6E-45 303.0 11.8 247 91-361 262-511 (1157)
263 cd07839 STKc_CDK5 Catalytic do 100.0 1.6E-39 3.5E-44 290.7 18.0 198 97-300 1-202 (284)
264 cd06608 STKc_myosinIII_like Ca 100.0 1.7E-39 3.7E-44 288.8 18.1 246 93-361 3-264 (275)
265 cd05047 PTKc_Tie Catalytic dom 100.0 3.9E-39 8.4E-44 286.2 20.3 235 102-361 1-256 (270)
266 PHA03209 serine/threonine kina 100.0 2.7E-39 5.8E-44 298.3 19.8 193 93-298 63-256 (357)
267 cd06659 STKc_PAK6 Catalytic do 100.0 1E-39 2.2E-44 293.9 16.5 238 100-361 25-263 (297)
268 KOG0584 Serine/threonine prote 100.0 2.2E-40 4.9E-45 303.5 12.3 236 101-361 45-288 (632)
269 cd08218 STKc_Nek1 Catalytic do 100.0 3.1E-39 6.7E-44 284.4 19.1 241 97-361 1-245 (256)
270 smart00219 TyrKc Tyrosine kina 100.0 3.7E-39 7.9E-44 283.9 19.6 241 98-361 1-249 (258)
271 KOG0199 ACK and related non-re 100.0 3.5E-40 7.5E-45 304.3 13.0 240 99-361 113-360 (1039)
272 cd05578 STKc_Yank1 Catalytic d 100.0 4.6E-39 1E-43 283.7 19.8 241 97-361 1-245 (258)
273 cd06614 STKc_PAK Catalytic dom 100.0 4.7E-39 1E-43 288.0 20.1 246 93-361 16-262 (286)
274 cd05078 PTK_Jak2_Jak3_rpt1 Pse 100.0 1.4E-39 3E-44 287.1 16.4 230 102-361 1-248 (258)
275 cd05046 PTK_CCK4 Pseudokinase 100.0 9.4E-39 2E-43 284.4 21.7 244 96-361 5-264 (275)
276 cd07841 STKc_CDK7 Catalytic do 100.0 6.8E-39 1.5E-43 288.6 20.8 258 97-361 1-274 (298)
277 cd05574 STKc_phototropin_like 100.0 5.7E-39 1.2E-43 291.6 20.4 245 96-361 1-277 (316)
278 KOG0579 Ste20-like serine/thre 100.0 6.4E-41 1.4E-45 306.2 7.4 242 98-361 34-281 (1187)
279 cd05083 PTKc_Chk Catalytic dom 100.0 2.9E-39 6.3E-44 284.3 17.8 235 96-361 6-242 (254)
280 cd05122 PKc_STE Catalytic doma 100.0 8.7E-39 1.9E-43 280.2 20.7 242 97-361 1-243 (253)
281 cd07846 STKc_CDKL2_3 Catalytic 100.0 3.4E-39 7.4E-44 288.8 18.4 199 96-300 1-203 (286)
282 cd06623 PKc_MAPKK_plant_like C 100.0 2.4E-38 5.2E-43 279.8 23.6 245 96-361 1-248 (264)
283 cd07844 STKc_PCTAIRE_like Cata 100.0 5.5E-39 1.2E-43 288.3 19.8 200 96-301 5-207 (291)
284 cd06626 STKc_MEKK4 Catalytic d 100.0 6.1E-39 1.3E-43 283.7 19.6 245 97-361 1-253 (264)
285 cd06648 STKc_PAK_II Catalytic 100.0 6.8E-39 1.5E-43 286.9 19.9 240 98-361 21-261 (285)
286 cd05086 PTKc_Aatyk2 Catalytic 100.0 1.9E-38 4.2E-43 281.4 22.6 242 102-361 1-257 (268)
287 cd07867 STKc_CDC2L6 Catalytic 100.0 1.7E-38 3.7E-43 288.5 22.7 194 102-301 7-219 (317)
288 KOG0577 Serine/threonine prote 100.0 1.1E-40 2.3E-45 302.6 8.1 236 98-361 28-270 (948)
289 cd08528 STKc_Nek10 Catalytic d 100.0 2.5E-38 5.4E-43 280.7 23.0 242 97-361 1-258 (269)
290 cd06630 STKc_MEKK1 Catalytic d 100.0 2.3E-38 5E-43 280.7 22.7 246 97-361 1-256 (268)
291 cd06652 STKc_MEKK2 Catalytic d 100.0 1.5E-38 3.2E-43 281.6 21.5 202 96-301 2-212 (265)
292 cd06617 PKc_MKK3_6 Catalytic d 100.0 1.5E-38 3.2E-43 284.3 21.4 242 96-361 1-253 (283)
293 cd06607 STKc_TAO Catalytic dom 100.0 1.2E-38 2.6E-43 288.3 21.1 238 96-361 15-259 (307)
294 cd06917 STKc_NAK1_like Catalyt 100.0 8.7E-39 1.9E-43 284.9 19.8 240 97-361 2-247 (277)
295 cd06621 PKc_MAPKK_Pek1_like Ca 100.0 3.4E-38 7.4E-43 282.6 23.2 248 96-361 1-258 (287)
296 cd05633 STKc_GRK3 Catalytic do 100.0 2.5E-38 5.5E-43 282.3 21.7 234 103-361 1-242 (279)
297 cd06641 STKc_MST3 Catalytic do 100.0 2.4E-38 5.1E-43 282.2 21.5 239 97-361 5-245 (277)
298 cd08217 STKc_Nek2 Catalytic do 100.0 4.5E-38 9.8E-43 277.9 22.8 244 97-361 1-254 (265)
299 cd08220 STKc_Nek8 Catalytic do 100.0 4E-38 8.7E-43 277.1 21.9 240 97-361 1-245 (256)
300 PHA03390 pk1 serine/threonine- 100.0 7E-38 1.5E-42 277.6 23.3 243 88-361 6-253 (267)
301 cd07843 STKc_CDC2L1 Catalytic 100.0 2.4E-38 5.3E-43 284.4 20.2 200 96-301 5-210 (293)
302 cd06606 STKc_MAPKKK Catalytic 100.0 5.4E-38 1.2E-42 276.3 22.0 244 97-361 1-249 (260)
303 cd05572 STKc_cGK_PKG Catalytic 100.0 4.8E-38 1E-42 277.8 21.5 235 104-361 1-239 (262)
304 cd07833 STKc_CDKL Catalytic do 100.0 2.7E-38 5.8E-43 283.2 20.0 201 96-301 1-205 (288)
305 cd07860 STKc_CDK2_3 Catalytic 100.0 3.4E-38 7.3E-43 282.1 20.4 198 97-300 1-203 (284)
306 KOG0986 G protein-coupled rece 100.0 1.1E-39 2.4E-44 287.9 10.0 245 95-361 184-433 (591)
307 cd05118 STKc_CMGC Catalytic do 100.0 7.1E-38 1.5E-42 279.7 21.7 256 98-361 1-272 (283)
308 KOG4717 Serine/threonine prote 100.0 1.3E-38 2.7E-43 285.2 16.5 241 95-361 17-262 (864)
309 cd05577 STKc_GRK Catalytic dom 100.0 7.3E-38 1.6E-42 279.0 21.4 236 104-361 1-241 (277)
310 cd05074 PTKc_Tyro3 Catalytic d 100.0 3.4E-38 7.4E-43 280.4 19.1 242 98-361 1-260 (273)
311 cd07842 STKc_CDK8_like Catalyt 100.0 6E-38 1.3E-42 284.8 20.5 202 97-302 1-220 (316)
312 cd07831 STKc_MOK Catalytic dom 100.0 8.4E-38 1.8E-42 279.1 21.1 254 98-361 1-271 (282)
313 cd06657 STKc_PAK4 Catalytic do 100.0 2.4E-38 5.2E-43 284.2 17.3 236 102-361 26-262 (292)
314 cd06635 STKc_TAO1 Catalytic do 100.0 1.8E-37 3.8E-42 281.9 23.1 236 98-361 27-269 (317)
315 cd05579 STKc_MAST_like Catalyt 100.0 3.3E-38 7.2E-43 278.8 17.7 236 104-361 1-246 (265)
316 cd07836 STKc_Pho85 Catalytic d 100.0 8.8E-38 1.9E-42 279.4 20.3 199 97-301 1-204 (284)
317 cd07865 STKc_CDK9 Catalytic do 100.0 7.8E-38 1.7E-42 283.2 20.1 203 95-301 11-227 (310)
318 cd05611 STKc_Rim15_like Cataly 100.0 6.6E-38 1.4E-42 276.6 19.1 234 102-361 2-240 (260)
319 cd06616 PKc_MKK4 Catalytic dom 100.0 1.4E-37 3.1E-42 278.7 21.5 245 97-361 5-259 (288)
320 cd05606 STKc_beta_ARK Catalyti 100.0 2.5E-37 5.5E-42 275.7 22.8 234 103-361 1-242 (278)
321 KOG0983 Mitogen-activated prot 100.0 2.8E-39 6.1E-44 268.6 9.3 242 98-361 94-341 (391)
322 cd06618 PKc_MKK7 Catalytic dom 100.0 1.1E-37 2.3E-42 280.7 20.3 243 96-361 15-265 (296)
323 cd07864 STKc_CDK12 Catalytic d 100.0 7.2E-38 1.6E-42 282.5 19.3 263 93-361 4-291 (302)
324 cd06653 STKc_MEKK3_like_1 Cata 100.0 2.4E-37 5.3E-42 273.7 22.2 202 96-301 2-212 (264)
325 cd07840 STKc_CDK9_like Catalyt 100.0 1.1E-37 2.4E-42 278.9 20.1 199 98-301 1-205 (287)
326 cd07849 STKc_ERK1_2_like Catal 100.0 5.4E-38 1.2E-42 287.6 18.4 200 95-300 4-212 (336)
327 cd07845 STKc_CDK10 Catalytic d 100.0 6.6E-38 1.4E-42 283.7 18.7 201 95-301 6-212 (309)
328 cd08225 STKc_Nek5 Catalytic do 100.0 1.1E-37 2.4E-42 274.5 19.6 241 97-361 1-246 (257)
329 cd05613 STKc_MSK1_N N-terminal 100.0 1.2E-37 2.6E-42 279.5 19.9 244 97-361 1-255 (290)
330 cd08530 STKc_CNK2-like Catalyt 100.0 1.2E-37 2.5E-42 274.1 19.4 239 97-361 1-245 (256)
331 cd07835 STKc_CDK1_like Catalyt 100.0 1.8E-37 3.8E-42 277.3 20.8 198 98-301 1-203 (283)
332 cd08215 STKc_Nek Catalytic dom 100.0 9.7E-38 2.1E-42 274.6 18.9 241 97-361 1-247 (258)
333 cd06627 STKc_Cdc7_like Catalyt 100.0 3.8E-37 8.3E-42 270.4 22.5 240 97-361 1-243 (254)
334 cd07850 STKc_JNK Catalytic dom 100.0 1.4E-37 3E-42 286.8 20.3 198 94-301 14-220 (353)
335 PHA03210 serine/threonine kina 100.0 9.2E-38 2E-42 299.4 19.8 200 93-298 145-368 (501)
336 KOG0586 Serine/threonine prote 100.0 5.4E-38 1.2E-42 287.5 17.0 242 93-361 53-298 (596)
337 cd07852 STKc_MAPK15 Catalytic 100.0 2E-37 4.4E-42 284.0 20.9 202 94-301 5-216 (337)
338 cd07837 STKc_CdkB_plant Cataly 100.0 1.8E-37 4E-42 278.9 19.9 199 96-300 1-214 (295)
339 KOG0690 Serine/threonine prote 100.0 5.5E-39 1.2E-43 272.9 8.6 202 94-301 166-371 (516)
340 PLN00009 cyclin-dependent kina 100.0 3.9E-37 8.5E-42 276.7 21.2 200 96-301 2-207 (294)
341 cd07855 STKc_ERK5 Catalytic do 100.0 1.6E-37 3.5E-42 284.3 18.7 202 95-301 4-215 (334)
342 cd05581 STKc_PDK1 Catalytic do 100.0 3E-37 6.4E-42 275.2 20.0 242 96-361 1-265 (280)
343 cd08216 PK_STRAD Pseudokinase 100.0 6.6E-37 1.4E-41 277.8 22.3 197 101-301 7-213 (314)
344 KOG1035 eIF-2alpha kinase GCN2 100.0 3.5E-38 7.6E-43 306.8 14.7 249 92-361 475-863 (1351)
345 PHA02882 putative serine/threo 100.0 2.3E-37 4.9E-42 278.2 18.9 250 95-361 11-284 (294)
346 KOG4250 TANK binding protein k 100.0 2.8E-38 6.1E-43 293.2 13.2 200 98-303 15-229 (732)
347 cd07838 STKc_CDK4_6_like Catal 100.0 1.1E-36 2.3E-41 272.6 22.8 256 98-361 1-276 (287)
348 cd06633 STKc_TAO3 Catalytic do 100.0 1.2E-36 2.7E-41 275.9 23.4 236 98-361 23-265 (313)
349 cd07858 STKc_TEY_MAPK_plant Ca 100.0 1.3E-37 2.8E-42 285.2 16.9 199 95-300 4-211 (337)
350 cd06634 STKc_TAO2 Catalytic do 100.0 2.1E-37 4.6E-42 280.3 17.9 237 97-361 16-259 (308)
351 cd07877 STKc_p38alpha_MAPK14 C 100.0 6.2E-37 1.3E-41 281.5 21.2 203 87-300 8-220 (345)
352 KOG0607 MAP kinase-interacting 100.0 1.4E-37 3.1E-42 263.6 15.5 207 88-303 75-296 (463)
353 cd07856 STKc_Sty1_Hog1 Catalyt 100.0 2.9E-37 6.3E-42 281.6 18.8 200 91-301 5-209 (328)
354 cd07880 STKc_p38gamma_MAPK12 C 100.0 4.4E-37 9.6E-42 282.2 19.7 200 91-301 10-219 (343)
355 cd08226 PK_STRAD_beta Pseudoki 100.0 1.1E-36 2.4E-41 278.0 21.9 198 102-302 4-214 (328)
356 cd07834 STKc_MAPK Catalytic do 100.0 4E-37 8.8E-42 281.2 18.7 201 97-302 1-211 (330)
357 cd07830 STKc_MAK_like Catalyti 100.0 8.5E-37 1.9E-41 272.8 20.1 197 98-301 1-202 (283)
358 cd05583 STKc_MSK_N N-terminal 100.0 8.3E-37 1.8E-41 273.8 19.8 244 97-361 1-255 (288)
359 cd07866 STKc_BUR1 Catalytic do 100.0 4E-37 8.7E-42 278.6 17.6 203 95-301 7-230 (311)
360 KOG0200 Fibroblast/platelet-de 100.0 2.3E-37 5.1E-42 301.3 17.1 247 94-361 294-567 (609)
361 KOG4645 MAPKKK (MAP kinase kin 100.0 3.1E-39 6.6E-44 315.7 3.6 244 95-360 1234-1485(1509)
362 cd07829 STKc_CDK_like Catalyti 100.0 9.6E-37 2.1E-41 272.2 18.9 197 98-300 1-201 (282)
363 cd07854 STKc_MAPK4_6 Catalytic 100.0 4.5E-37 9.7E-42 282.1 17.0 201 95-301 4-222 (342)
364 PTZ00024 cyclin-dependent prot 100.0 2.1E-36 4.6E-41 277.0 21.2 201 96-301 8-237 (335)
365 cd05123 STKc_AGC Catalytic dom 100.0 3.2E-36 7E-41 264.1 21.5 232 104-361 1-236 (250)
366 cd07879 STKc_p38delta_MAPK13 C 100.0 1.6E-36 3.5E-41 278.5 19.2 194 95-300 14-217 (342)
367 cd07851 STKc_p38 Catalytic dom 100.0 1E-36 2.2E-41 279.9 16.5 198 93-301 12-219 (343)
368 KOG0612 Rho-associated, coiled 100.0 1.2E-37 2.7E-42 300.9 10.7 207 89-300 68-283 (1317)
369 KOG0696 Serine/threonine prote 100.0 1.4E-37 3.1E-42 271.8 10.0 241 95-361 348-593 (683)
370 cd07857 STKc_MPK1 Catalytic do 100.0 4.9E-36 1.1E-40 274.2 19.3 200 97-301 1-213 (332)
371 cd08222 STKc_Nek11 Catalytic d 100.0 2.6E-36 5.7E-41 266.4 16.9 240 97-361 1-249 (260)
372 cd05576 STKc_RPK118_like Catal 100.0 5.1E-36 1.1E-40 261.0 18.3 217 107-361 4-221 (237)
373 KOG0666 Cyclin C-dependent kin 100.0 3E-37 6.5E-42 260.8 9.2 202 95-300 23-242 (438)
374 cd05610 STKc_MASTL Catalytic d 100.0 8.1E-36 1.8E-40 294.5 19.5 145 96-244 4-152 (669)
375 KOG0604 MAP kinase-activated p 100.0 2E-36 4.3E-41 254.6 12.3 245 94-361 59-314 (400)
376 KOG4236 Serine/threonine prote 100.0 4.4E-37 9.6E-42 275.9 8.2 194 101-300 569-768 (888)
377 KOG1024 Receptor-like protein 100.0 3.1E-36 6.7E-41 261.8 12.3 251 89-361 277-543 (563)
378 KOG0608 Warts/lats-like serine 100.0 4.6E-36 1E-40 274.4 13.5 208 96-307 629-880 (1034)
379 KOG0671 LAMMER dual specificit 100.0 3.2E-36 6.9E-41 261.3 11.3 199 94-302 87-313 (415)
380 KOG0614 cGMP-dependent protein 100.0 3.7E-37 8.1E-42 275.2 5.5 241 96-361 420-664 (732)
381 KOG0662 Cyclin-dependent kinas 100.0 1.5E-35 3.2E-40 232.3 13.8 198 97-300 3-205 (292)
382 KOG1006 Mitogen-activated prot 100.0 2.7E-37 6E-42 255.8 4.0 242 101-361 69-319 (361)
383 KOG0603 Ribosomal protein S6 k 100.0 1.5E-35 3.2E-40 272.8 14.8 233 94-361 320-555 (612)
384 KOG0587 Traf2- and Nck-interac 100.0 2.6E-35 5.6E-40 278.7 16.1 251 88-361 11-274 (953)
385 KOG1151 Tousled-like protein k 100.0 2.5E-36 5.3E-41 266.3 8.5 205 96-302 463-688 (775)
386 KOG0695 Serine/threonine prote 100.0 2.1E-35 4.5E-40 252.3 12.8 247 95-361 249-502 (593)
387 smart00220 S_TKc Serine/Threon 100.0 3.7E-34 8E-39 249.1 16.8 231 108-361 1-233 (244)
388 KOG0669 Cyclin T-dependent kin 100.0 2.7E-36 5.9E-41 248.2 2.2 262 96-361 17-307 (376)
389 PLN03225 Serine/threonine-prot 100.0 3E-34 6.4E-39 277.0 16.5 198 94-299 130-380 (566)
390 KOG0984 Mitogen-activated prot 100.0 4.1E-34 9E-39 228.8 11.4 207 92-304 42-258 (282)
391 PLN03224 probable serine/threo 100.0 5.4E-33 1.2E-37 262.1 19.1 203 94-300 143-435 (507)
392 KOG1027 Serine/threonine prote 100.0 6.4E-34 1.4E-38 268.1 8.2 237 98-361 511-759 (903)
393 KOG1152 Signal transduction se 100.0 2.1E-33 4.6E-38 254.8 9.5 196 96-299 561-770 (772)
394 smart00221 STYKc Protein kinas 100.0 4.8E-31 1E-35 227.2 20.1 199 98-300 1-202 (225)
395 KOG0668 Casein kinase II, alph 100.0 1.4E-32 3E-37 223.4 9.0 197 93-302 35-237 (338)
396 cd00180 PKc Catalytic domain o 100.0 1.3E-30 2.7E-35 221.6 21.4 202 104-361 1-206 (215)
397 KOG1345 Serine/threonine kinas 100.0 3.6E-32 7.7E-37 226.1 8.3 243 95-360 23-275 (378)
398 KOG0664 Nemo-like MAPK-related 100.0 1.4E-32 2.9E-37 229.0 2.3 197 99-301 56-261 (449)
399 KOG0670 U4/U6-associated splic 100.0 1.8E-31 4E-36 239.5 8.2 200 94-302 430-639 (752)
400 KOG1290 Serine/threonine prote 100.0 9E-30 1.9E-34 227.2 16.0 131 95-229 77-221 (590)
401 KOG0576 Mitogen-activated prot 100.0 8.8E-32 1.9E-36 247.9 2.4 246 95-361 14-263 (829)
402 KOG0665 Jun-N-terminal kinase 100.0 1.4E-30 3E-35 221.4 8.8 195 95-300 16-219 (369)
403 KOG1167 Serine/threonine prote 100.0 2.5E-28 5.4E-33 214.9 10.6 209 91-308 31-288 (418)
404 PLN00181 protein SPA1-RELATED; 100.0 1E-28 2.2E-33 249.7 9.0 188 149-361 29-257 (793)
405 smart00750 KIND kinase non-cat 99.9 1.9E-27 4.2E-32 197.3 12.6 157 177-361 1-157 (176)
406 PRK09188 serine/threonine prot 99.9 8E-27 1.7E-31 211.5 15.4 166 92-272 14-194 (365)
407 KOG1164 Casein kinase (serine/ 99.9 8.6E-25 1.9E-29 198.5 18.8 202 97-302 19-241 (322)
408 KOG0195 Integrin-linked kinase 99.9 4.6E-26 9.9E-31 190.1 6.3 236 99-361 193-434 (448)
409 COG0515 SPS1 Serine/threonine 99.9 1.2E-23 2.6E-28 191.0 22.1 199 98-301 2-214 (384)
410 KOG1165 Casein kinase (serine/ 99.9 1.8E-24 3.8E-29 185.2 14.4 203 96-304 28-242 (449)
411 KOG1163 Casein kinase (serine/ 99.9 3.2E-25 7E-30 181.9 8.8 204 94-303 13-226 (341)
412 PRK10359 lipopolysaccharide co 99.9 1.1E-24 2.3E-29 184.2 9.1 171 94-292 29-216 (232)
413 cd05147 RIO1_euk RIO kinase fa 99.9 7.3E-24 1.6E-28 177.1 12.4 139 101-246 2-167 (190)
414 KOG0590 Checkpoint kinase and 99.9 1.9E-24 4.1E-29 208.5 7.7 246 100-361 322-577 (601)
415 cd05145 RIO1_like RIO kinase f 99.9 1.3E-22 2.8E-27 170.1 15.7 139 101-247 2-168 (190)
416 PRK12274 serine/threonine prot 99.9 4E-22 8.7E-27 165.0 14.5 186 99-300 5-209 (218)
417 KOG1023 Natriuretic peptide re 99.9 1.5E-22 3.3E-27 187.0 10.8 202 146-361 1-212 (484)
418 PF14531 Kinase-like: Kinase-l 99.9 1.1E-22 2.5E-27 176.9 9.4 229 99-360 15-288 (288)
419 KOG1166 Mitotic checkpoint ser 99.9 1.6E-22 3.5E-27 199.2 9.0 201 90-297 692-902 (974)
420 PRK10345 hypothetical protein; 99.9 4.5E-21 9.8E-26 161.7 14.6 136 99-243 5-156 (210)
421 KOG0603 Ribosomal protein S6 k 99.9 2.3E-23 4.9E-28 192.7 0.3 186 103-300 1-193 (612)
422 KOG1240 Protein kinase contain 99.9 2.8E-22 6E-27 194.8 5.5 239 97-361 24-283 (1431)
423 smart00090 RIO RIO-like kinase 99.8 2.6E-20 5.7E-25 160.8 12.6 147 92-247 24-199 (237)
424 PRK14879 serine/threonine prot 99.8 1.1E-19 2.5E-24 155.1 15.3 134 102-245 2-143 (211)
425 KOG4158 BRPK/PTEN-induced prot 99.8 4.6E-20 1E-24 161.9 12.4 188 150-361 274-502 (598)
426 cd05144 RIO2_C RIO kinase fami 99.8 1.7E-19 3.6E-24 152.4 14.4 144 90-247 9-176 (198)
427 PRK09605 bifunctional UGMP fam 99.8 4.3E-19 9.3E-24 171.8 18.0 140 93-246 330-477 (535)
428 TIGR03724 arch_bud32 Kae1-asso 99.8 3.7E-19 7.9E-24 150.6 14.0 130 103-245 1-138 (199)
429 KOG1033 eIF-2alpha kinase PEK/ 99.8 2.8E-20 6E-25 169.2 2.4 168 166-361 330-504 (516)
430 KOG0606 Microtubule-associated 99.8 2.8E-19 6E-24 173.9 4.4 168 95-303 82-263 (1205)
431 cd05119 RIO RIO kinase family, 99.8 1.3E-17 2.8E-22 139.6 12.7 136 101-247 2-165 (187)
432 cd05120 APH_ChoK_like Aminogly 99.7 3.2E-17 7E-22 131.9 12.7 135 100-245 2-138 (155)
433 PRK01723 3-deoxy-D-manno-octul 99.7 9.5E-17 2.1E-21 139.0 14.4 134 102-245 37-191 (239)
434 KOG0590 Checkpoint kinase and 99.7 1.6E-18 3.4E-23 167.6 0.1 215 95-311 19-243 (601)
435 TIGR01982 UbiB 2-polyprenylphe 99.7 1.1E-15 2.4E-20 143.5 12.9 145 97-248 119-309 (437)
436 KOG1243 Protein kinase [Genera 99.6 4.7E-14 1E-18 132.5 13.7 167 117-295 34-200 (690)
437 KOG1266 Protein kinase [Signal 99.6 8.8E-15 1.9E-19 126.1 7.7 153 143-297 118-281 (458)
438 PRK04750 ubiB putative ubiquin 99.5 4.8E-14 1E-18 134.1 11.7 143 95-248 119-316 (537)
439 cd05151 ChoK Choline Kinase (C 99.5 9.5E-14 2E-18 114.2 9.4 128 101-245 3-136 (170)
440 cd05146 RIO3_euk RIO kinase fa 99.5 1.3E-12 2.8E-17 108.4 15.5 137 101-247 2-175 (197)
441 KOG0601 Cyclin-dependent kinas 99.5 5.1E-14 1.1E-18 130.9 6.6 199 96-299 114-328 (524)
442 COG3642 Mn2+-dependent serine/ 99.4 5.4E-12 1.2E-16 101.2 13.4 131 102-245 2-140 (204)
443 KOG3087 Serine/threonine prote 99.4 6.6E-12 1.4E-16 100.3 13.0 142 100-245 11-165 (229)
444 cd05154 ACAD10_11_like Acyl-Co 99.4 5.8E-12 1.3E-16 108.2 11.7 142 102-245 4-206 (223)
445 KOG0601 Cyclin-dependent kinas 99.3 1.1E-12 2.3E-17 122.2 5.2 197 92-297 261-465 (524)
446 KOG0606 Microtubule-associated 99.3 3.2E-13 6.9E-18 132.3 -0.0 205 94-302 802-1039(1205)
447 PF01163 RIO1: RIO1 family; I 99.3 6.9E-11 1.5E-15 97.7 12.2 125 111-246 1-156 (188)
448 PRK15123 lipopolysaccharide co 99.2 8.6E-10 1.9E-14 96.7 15.9 139 103-245 29-194 (268)
449 COG0478 RIO-like serine/threon 99.1 5.6E-10 1.2E-14 95.1 11.7 136 98-246 93-252 (304)
450 KOG3741 Poly(A) ribonuclease s 99.1 8.6E-10 1.9E-14 101.3 12.7 167 109-297 289-475 (655)
451 COG0661 AarF Predicted unusual 99.1 1.1E-09 2.3E-14 103.9 12.5 147 96-248 126-317 (517)
452 PF06293 Kdo: Lipopolysacchari 98.9 1.2E-08 2.7E-13 86.4 12.0 106 137-246 56-171 (206)
453 PRK09902 hypothetical protein; 98.9 5.6E-08 1.2E-12 81.0 14.0 137 104-245 26-179 (216)
454 COG4248 Uncharacterized protei 98.9 3.6E-08 7.8E-13 88.7 13.5 192 100-302 15-226 (637)
455 KOG2137 Protein kinase [Signal 98.8 9.8E-10 2.1E-14 104.2 2.0 97 199-297 105-208 (700)
456 KOG1235 Predicted unusual prot 98.8 5E-08 1.1E-12 92.4 12.4 139 102-247 167-356 (538)
457 TIGR02172 Fb_sc_TIGR02172 Fibr 98.8 1.1E-07 2.3E-12 81.7 13.2 132 102-244 7-181 (226)
458 PF06176 WaaY: Lipopolysacchar 98.8 1.1E-07 2.3E-12 79.7 11.5 137 94-244 29-182 (229)
459 COG1718 RIO1 Serine/threonine 98.8 2.1E-07 4.5E-12 78.8 13.1 155 84-247 33-217 (268)
460 PF01636 APH: Phosphotransfera 98.7 4.1E-07 8.9E-12 78.6 12.9 140 102-244 3-196 (239)
461 cd05150 APH Aminoglycoside 3'- 98.6 9.4E-07 2E-11 77.1 13.0 138 103-244 5-192 (244)
462 PF10707 YrbL-PhoP_reg: PhoP r 98.6 2E-06 4.4E-11 71.8 14.3 128 101-239 6-165 (199)
463 KOG0576 Mitogen-activated prot 98.5 1.2E-08 2.6E-13 96.1 -1.7 186 98-299 244-431 (829)
464 COG2112 Predicted Ser/Thr prot 98.5 2.1E-06 4.6E-11 68.9 10.5 129 99-245 25-155 (201)
465 PF12260 PIP49_C: Protein-kina 98.4 1.4E-06 3.1E-11 72.4 8.9 102 140-246 7-112 (188)
466 PLN02876 acyl-CoA dehydrogenas 98.4 3.8E-06 8.2E-11 85.9 13.0 78 101-178 43-130 (822)
467 cd05155 APH_ChoK_like_1 Unchar 98.4 5.3E-06 1.1E-10 71.9 11.5 73 102-180 3-82 (235)
468 PRK10593 hypothetical protein; 98.3 1.7E-05 3.6E-10 71.2 13.7 77 100-179 18-100 (297)
469 PF13095 FTA2: Kinetochore Sim 98.2 4.1E-05 9E-10 63.5 13.0 125 96-243 37-206 (207)
470 cd05157 ETNK_euk Ethanolamine 98.2 2.7E-05 5.9E-10 67.4 11.6 73 102-179 4-79 (235)
471 TIGR02721 ycfN_thiK thiamine k 98.2 1.4E-05 3.1E-10 70.2 9.7 137 103-245 3-175 (256)
472 PRK05231 homoserine kinase; Pr 98.1 0.00022 4.7E-09 64.9 17.0 157 85-245 6-217 (319)
473 PRK09550 mtnK methylthioribose 98.1 0.00012 2.6E-09 67.8 14.8 75 102-178 32-117 (401)
474 cd05153 HomoserineK_II Homoser 98.0 7.3E-05 1.6E-09 67.2 12.0 141 101-245 19-205 (296)
475 TIGR00938 thrB_alt homoserine 97.9 0.0007 1.5E-08 61.2 16.2 141 101-244 27-216 (307)
476 KOG2268 Serine/threonine prote 97.9 2.8E-05 6E-10 68.5 6.1 147 85-245 78-251 (465)
477 KOG2270 Serine/threonine prote 97.9 0.00022 4.7E-09 64.1 11.7 142 99-246 147-314 (520)
478 cd05156 ChoK_euk Choline Kinas 97.9 0.00011 2.5E-09 66.1 10.1 138 102-244 4-212 (302)
479 KOG1035 eIF-2alpha kinase GCN2 97.8 0.00018 3.9E-09 73.1 10.2 155 136-297 226-391 (1351)
480 COG3173 Predicted aminoglycosi 97.7 0.00055 1.2E-08 61.3 11.8 138 101-246 30-229 (321)
481 PLN02236 choline kinase 97.6 0.00058 1.3E-08 62.6 10.9 139 102-245 42-231 (344)
482 PF03881 Fructosamin_kin: Fruc 97.5 0.0011 2.3E-08 59.0 10.9 73 101-177 22-97 (288)
483 cd05152 MPH2' Macrolide 2'-Pho 97.5 0.0015 3.2E-08 58.0 11.8 31 215-245 185-216 (276)
484 TIGR01767 MTRK 5-methylthiorib 97.4 0.0028 6.1E-08 57.7 11.9 80 103-184 2-93 (370)
485 PLN02756 S-methyl-5-thioribose 97.3 0.007 1.5E-07 56.2 13.5 80 101-183 37-128 (418)
486 TIGR02904 spore_ysxE spore coa 97.3 0.0043 9.2E-08 56.1 11.9 32 214-245 195-226 (309)
487 TIGR02906 spore_CotS spore coa 97.1 0.018 3.9E-07 52.0 14.2 30 214-244 186-215 (313)
488 PLN02421 phosphotransferase, a 97.0 0.0044 9.5E-08 56.6 9.6 139 102-245 20-213 (330)
489 COG2334 Putative homoserine ki 96.8 0.015 3.3E-07 52.6 11.1 134 108-244 37-227 (331)
490 PF01633 Choline_kinase: Choli 96.8 0.0023 4.9E-08 54.4 5.5 31 215-245 143-174 (211)
491 PF07387 Seadorna_VP7: Seadorn 96.8 0.0062 1.3E-07 51.2 7.7 151 108-295 74-225 (308)
492 KOG1093 Predicted protein kina 96.8 0.0034 7.3E-08 59.1 6.4 50 137-187 27-77 (725)
493 KOG1826 Ras GTPase activating 96.8 0.00077 1.7E-08 70.6 2.5 159 139-299 1276-1441(2724)
494 COG3001 Uncharacterized protei 96.6 0.11 2.4E-06 44.1 13.5 75 102-180 22-99 (286)
495 PRK12396 5-methylribose kinase 96.5 0.016 3.5E-07 53.6 9.0 81 101-183 34-125 (409)
496 PRK11768 serine/threonine prot 96.5 0.12 2.6E-06 47.0 14.8 71 107-178 36-113 (325)
497 COG5072 ALK1 Serine/threonine 96.4 0.011 2.4E-07 53.4 6.8 73 164-245 298-370 (488)
498 KOG1236 Predicted unusual prot 96.4 0.016 3.4E-07 53.2 7.8 60 167-230 320-379 (565)
499 PF08693 SKG6: Transmembrane a 96.3 0.0016 3.5E-08 38.2 0.9 33 33-65 7-39 (40)
500 PRK06148 hypothetical protein; 96.3 0.058 1.3E-06 56.7 12.7 140 102-245 31-236 (1013)
No 1
>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=7.8e-56 Score=403.20 Aligned_cols=274 Identities=44% Similarity=0.711 Sum_probs=237.5
Q ss_pred cccccCHHHHHHhhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeee
Q 037918 82 TWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSC 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 161 (361)
..+.|++.|+..+|++|...+.||+|+||.||+|..++|+.||||++.........+|.+|++++.+++|||+++++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56789999999999999999999999999999999999999999988765432135599999999999999999999999
Q ss_pred ecCC-eeEEEEEecCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEe
Q 037918 162 SNVD-FKALVLEFMPNGSLEKWLYSHNY-FLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSD 239 (361)
Q Consensus 162 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 239 (361)
.+.+ ..+||+||+++|+|.++|..... .++|..+++|+.++|+||+|||+.+...|+||||||+|||+|+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 59999999999999999997765 799999999999999999999998888999999999999999999999999
Q ss_pred ccCccccCCCCcceeeecc-cccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccc-cccccHHHHHhhhcC
Q 037918 240 FGISKLLGDGENFETRTMT-MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFF-AGEMSLKNWVKESLP 317 (361)
Q Consensus 240 fg~a~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~-~~~~~~~~~~~~~~~ 317 (361)
||+|+...... ...... .||.+|+|||+...+..+.++||||||++|.||+||+.|.+... .++..+.+|....+.
T Consensus 221 FGLa~~~~~~~--~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 221 FGLAKLGPEGD--TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred ccCcccCCccc--cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 99996654311 111112 79999999999999999999999999999999999999987654 345568888876664
Q ss_pred C-Ccccccccccc-CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 318 H-GLTNVVDENLL-LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 318 ~-~l~~~~~~~l~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
. .+.+++|+.+. ..++.. +++..+..++.+|++.+|.+||
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~----~~~~~~~~~a~~C~~~~~~~RP 340 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDE----KEVKKLAELALRCLRPDPKERP 340 (361)
T ss_pred CcchhheeCCCccCCCCChH----HHHHHHHHHHHHHcCcCCCcCc
Confidence 4 78999999987 444322 4566799999999999999998
No 2
>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=5.2e-51 Score=356.07 Aligned_cols=202 Identities=32% Similarity=0.516 Sum_probs=182.9
Q ss_pred hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
..+|...+.||+|+|++||+|+++ ++..||||.+... ..+..+.+..|+.+|+.++|||||++++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 467888899999999999999965 6899999999876 4566677899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC------CcEEEEeccCccc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN------MVAHVSDFGISKL 245 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~------~~~kl~Dfg~a~~ 245 (361)
|||.||+|.+|++..+. +++..+..++.|+|.||++|| +++||||||||+|||++.. -.+||+|||+|+.
T Consensus 89 EyC~gGDLs~yi~~~~~-l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGR-LPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EeCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 99999999999998765 999999999999999999999 9999999999999999764 4689999999999
Q ss_pred cCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcccc
Q 037918 246 LGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFA 303 (361)
Q Consensus 246 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~ 303 (361)
+..... ....+|++-|||||++..+.|+.|+|+||+|++||++++|+.||+....
T Consensus 165 L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 165 LQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred CCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 875432 3446899999999999999999999999999999999999999986543
No 3
>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]
Probab=100.00 E-value=2.2e-50 Score=364.91 Aligned_cols=240 Identities=32% Similarity=0.507 Sum_probs=197.0
Q ss_pred CCCCccccCCceEEEEEEeCCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC-eeEEEEEecC
Q 037918 99 DECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD-FKALVLEFMP 175 (361)
Q Consensus 99 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~ 175 (361)
...+.||+|+||+||+|.+.....||||++.... ....+.|.+|+.+|.+++|||||+++|+|.+.. ..++||||++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 3345699999999999999644449999998653 222568999999999999999999999999887 7899999999
Q ss_pred CCCHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eeeCCCCCCCEEEcCCC-cEEEEeccCccccCCCCcc
Q 037918 176 NGSLEKWLYS-HNYFLDIQERLNVMIDVGSALEYLHHGYSPS-VVHCDLKPSNILLDENM-VAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 176 ~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~~ 252 (361)
+|+|.+++.. ....+++..++.++.|||+||.||| +.+ ||||||||+|||++.++ ++||+|||+++......
T Consensus 124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-- 198 (362)
T KOG0192|consen 124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-- 198 (362)
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence 9999999988 3566999999999999999999999 777 99999999999999997 99999999998765432
Q ss_pred eeeecccccccccCccccC--CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918 253 ETRTMTMATVGYMAPEYGS--EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~--~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 330 (361)
...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||........ ...+ +......
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~--~~~v-----------~~~~~Rp 265 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV--ASAV-----------VVGGLRP 265 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH--HHHH-----------HhcCCCC
Confidence 2334468999999999999 66899999999999999999999999987654211 1111 1111111
Q ss_pred CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..+. +++..+..++.+||+.||++||
T Consensus 266 ~~p~-----~~~~~l~~l~~~CW~~dp~~RP 291 (362)
T KOG0192|consen 266 PIPK-----ECPPHLSSLMERCWLVDPSRRP 291 (362)
T ss_pred CCCc-----cCCHHHHHHHHHhCCCCCCcCC
Confidence 1111 2455689999999999999998
No 4
>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]
Probab=100.00 E-value=7e-51 Score=352.17 Aligned_cols=245 Identities=24% Similarity=0.319 Sum_probs=202.4
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC-eeEEEEEe
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD-FKALVLEF 173 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~ 173 (361)
+.+.++.||+|..|+||++.++ +++.+|+|.+.... ....+++.+|++++++.+||+||.+||.|..++ ...++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 3445679999999999999976 68889999995543 344578999999999999999999999999998 49999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
|++|+|++++...+. +++...-+++.++++||.|||+ .++|+||||||+|||++..|++||+|||.+..+...
T Consensus 160 MDgGSLd~~~k~~g~-i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRVGR-IPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---- 232 (364)
T ss_pred cCCCCHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence 999999999987644 8999999999999999999994 389999999999999999999999999999987654
Q ss_pred eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP 333 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 333 (361)
......||..|||||.+.+..|+.++||||||++++|+.+|+.||...........+.+ +.......|
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll------------~~Iv~~ppP 300 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELL------------CAIVDEPPP 300 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHH------------HHHhcCCCC
Confidence 33456899999999999999999999999999999999999999976422222222222 222222222
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 334 AFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..+.. .+..++.+++..||+.||.+||
T Consensus 301 ~lP~~-~fS~ef~~FV~~CL~Kdp~~R~ 327 (364)
T KOG0581|consen 301 RLPEG-EFSPEFRSFVSCCLRKDPSERP 327 (364)
T ss_pred CCCcc-cCCHHHHHHHHHHhcCCcccCC
Confidence 22111 3455689999999999999997
No 5
>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.1e-51 Score=343.58 Aligned_cols=246 Identities=26% Similarity=0.373 Sum_probs=199.0
Q ss_pred CCCCCCCccccCCceEEEEEE-eCCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeee-eeecCC-eeEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILS-SCSNVD-FKALV 170 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~-~~~lv 170 (361)
.+|.+.+.||.|.||+||++. ..+|..+|.|.+.... .+..+....|+.+|++|+|||||++++ .+.+++ ..++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 357788899999999999999 5689999999887443 455678899999999999999999999 444444 48999
Q ss_pred EEecCCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918 171 LEFMPNGSLEKWLY---SHNYFLDIQERLNVMIDVGSALEYLHHGYS-PSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246 (361)
Q Consensus 171 ~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 246 (361)
||||.+|+|...++ +.+..+++..+|+++.|++.||..+|.... ..++||||||.||+++.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999887 345669999999999999999999994221 23999999999999999999999999999998
Q ss_pred CCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccc
Q 037918 247 GDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE 326 (361)
Q Consensus 247 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 326 (361)
..... .....+|||.||+||.+.+.+|+.+|||||+||++|||..-++||... ++...-+..-......+.+
T Consensus 179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~KI~qgd~~~~p~- 250 (375)
T KOG0591|consen 179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKKIEQGDYPPLPD- 250 (375)
T ss_pred cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHHHHcCCCCCCcH-
Confidence 65443 345678999999999999999999999999999999999999999763 2222222111111111111
Q ss_pred cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.-....+..|+..|+..||+.||
T Consensus 251 ------------~~YS~~l~~li~~ci~vd~~~RP 273 (375)
T KOG0591|consen 251 ------------EHYSTDLRELINMCIAVDPEQRP 273 (375)
T ss_pred ------------HHhhhHHHHHHHHHccCCcccCC
Confidence 11234588999999999999998
No 6
>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=3.3e-50 Score=367.18 Aligned_cols=240 Identities=25% Similarity=0.349 Sum_probs=202.5
Q ss_pred CCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
.+|...+.||+|||+.+|.++. ..|+.||+|++.+.. ....+...+|+++.++|+|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688999999999999999997 789999999998643 445577899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
|+|+.++|.++++ .++.+++.+++.++.||+.||.||| +.+|+|||||..|+|++++.++||+|||+|..+....
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~- 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG- 172 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCcc-
Confidence 9999999999998 4455999999999999999999999 8999999999999999999999999999999986442
Q ss_pred ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918 252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
+.....+|||.|.|||++.....+..+||||+||+||.|++|++||+...-.+ .+..... .+...+.
T Consensus 173 -Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-ty~~Ik~-------~~Y~~P~---- 239 (592)
T KOG0575|consen 173 -ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-TYNKIKL-------NEYSMPS---- 239 (592)
T ss_pred -cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-HHHHHHh-------cCccccc----
Confidence 24455689999999999999999999999999999999999999998632111 0111100 0111010
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.......+||.++|++||++||
T Consensus 240 --------~ls~~A~dLI~~lL~~~P~~Rp 261 (592)
T KOG0575|consen 240 --------HLSAEAKDLIRKLLRPNPSERP 261 (592)
T ss_pred --------ccCHHHHHHHHHHhcCCcccCC
Confidence 1223368899999999999998
No 7
>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=9.5e-51 Score=366.78 Aligned_cols=240 Identities=31% Similarity=0.545 Sum_probs=204.7
Q ss_pred CCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCC
Q 037918 98 FDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNG 177 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 177 (361)
+..++.||+|.||.||.|.++....||+|.++...- ..++|.+|+++|++|+|+|||+++++|..++.++|||||++.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 344678999999999999998778999999986432 2267889999999999999999999999999999999999999
Q ss_pred CHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918 178 SLEKWLYS-HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256 (361)
Q Consensus 178 ~L~~~l~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 256 (361)
+|.+||+. .+..+...+.+.++.|||+|++||+ ++++|||||.++||||+++..+||+|||+|+...++. .....
T Consensus 287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~~~~ 362 (468)
T KOG0197|consen 287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YTASE 362 (468)
T ss_pred cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCc-eeecC
Confidence 99999997 5666999999999999999999999 9999999999999999999999999999999654433 33444
Q ss_pred cccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhH
Q 037918 257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF 335 (361)
Q Consensus 257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~ 335 (361)
...-+..|.|||.+..+.++.||||||||++||||+| |+.||..+...+. .+.+++......|.
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev--------------~~~le~GyRlp~P~- 427 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV--------------LELLERGYRLPRPE- 427 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH--------------HHHHhccCcCCCCC-
Confidence 5566888999999999999999999999999999999 8888876543221 23334444444443
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 336 AAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 336 ~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.|+..+.+++..||+.+|++||
T Consensus 428 ----~CP~~vY~lM~~CW~~~P~~RP 449 (468)
T KOG0197|consen 428 ----GCPDEVYELMKSCWHEDPEDRP 449 (468)
T ss_pred ----CCCHHHHHHHHHHhhCCcccCC
Confidence 5788899999999999999999
No 8
>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]
Probab=100.00 E-value=1e-49 Score=344.80 Aligned_cols=243 Identities=28% Similarity=0.359 Sum_probs=201.8
Q ss_pred hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL 169 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (361)
..++|+++++||+|+||+||.++.. +++.+|+|++++.. ....+...+|..+|.+++||.||+++..|++.+.+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3567999999999999999999954 68899999998654 3345778899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918 170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 249 (361)
|+||+.||.|..+|++++. +++..+..++.+|+.||.||| +++|+||||||+|||+|.+|+++|+|||+++.....
T Consensus 103 Vld~~~GGeLf~hL~~eg~-F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGR-FSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EEeccCCccHHHHHHhcCC-cchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 9999999999999997766 889999999999999999999 999999999999999999999999999999865433
Q ss_pred CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL 329 (361)
Q Consensus 250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 329 (361)
.. .....+||+.|||||++.+..|+.++|.||||+++|||++|.+||.... ...+.+.....+ +.
T Consensus 179 ~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-----~~~~~~~I~~~k--------~~ 243 (357)
T KOG0598|consen 179 GD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-----VKKMYDKILKGK--------LP 243 (357)
T ss_pred CC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-----HHHHHHHHhcCc--------CC
Confidence 22 3344689999999999999999999999999999999999999997532 222222222221 11
Q ss_pred CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
... .. ......+++...+..||++|.
T Consensus 244 ~~p-~~-----ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 244 LPP-GY-----LSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCC-cc-----CCHHHHHHHHHHhccCHHHhc
Confidence 111 10 012258889999999999983
No 9
>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.1e-49 Score=347.64 Aligned_cols=246 Identities=28% Similarity=0.398 Sum_probs=198.3
Q ss_pred hhCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHH-------HHHHHHHHHHHHHhcCCCceeeeeeeeecCC
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLER-------AFRSFDSECEVLRSIRHRNLVKILSSCSNVD 165 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 165 (361)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||+++..... ......+|+++|++++|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 456688899999999999999994 57999999999754311 1234679999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC---CcEEEEeccC
Q 037918 166 FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN---MVAHVSDFGI 242 (361)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~ 242 (361)
..|+||||++||+|.+.+-.++. +.+.....++.|++.|+.||| +.||+||||||+|||+..+ -.+||+|||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccch
Confidence 99999999999999999987765 788888999999999999999 9999999999999999766 6799999999
Q ss_pred ccccCCCCcceeeecccccccccCccccCCCCC---CcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCC
Q 037918 243 SKLLGDGENFETRTMTMATVGYMAPEYGSEGIV---SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHG 319 (361)
Q Consensus 243 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (361)
|+..+... .+...+||+.|.|||++.+... ..+.|+||+||+||-+++|.+||.+..... ++.+++
T Consensus 326 AK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-sl~eQI------- 394 (475)
T KOG0615|consen 326 AKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-SLKEQI------- 394 (475)
T ss_pred hhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-cHHHHH-------
Confidence 99886433 4455789999999999876553 347899999999999999999998754322 222221
Q ss_pred ccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 320 LTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 320 l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
...++...++. ..+...+..++|.++|..||++||
T Consensus 395 ----~~G~y~f~p~~---w~~Iseea~dlI~~mL~VdP~~R~ 429 (475)
T KOG0615|consen 395 ----LKGRYAFGPLQ---WDRISEEALDLINWMLVVDPENRP 429 (475)
T ss_pred ----hcCcccccChh---hhhhhHHHHHHHHHhhEeCcccCc
Confidence 11111111111 123344578999999999999997
No 10
>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]
Probab=100.00 E-value=1.4e-47 Score=322.09 Aligned_cols=258 Identities=22% Similarity=0.261 Sum_probs=200.9
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE 172 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (361)
+.|+.+.++|+|+||.||+++.+ +|+.||||++.... ....+-.++|+++|++++|+|+|.++++|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45788899999999999999976 59999999996543 2334567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
||+. ++.+-|......++.+.+.+++.|++.|+.|+| +.+++||||||+|||++.+|.+||||||+|+.+....
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg-- 155 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG-- 155 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCc--
Confidence 9976 565666666666999999999999999999999 9999999999999999999999999999999986422
Q ss_pred eeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHh---hhcCCCcccc-----
Q 037918 253 ETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK---ESLPHGLTNV----- 323 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~l~~~----- 323 (361)
...+..+.|.+|+|||.+-+ .+|+...||||+||++.||++|.+-|.+..+ .+....+. +.+..+..++
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD--iDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD--IDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch--HHHHHHHHHHHcccCHHHHHHhccCC
Confidence 34466789999999998776 7799999999999999999999999876432 11111111 1111111111
Q ss_pred -----ccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 324 -----VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 324 -----~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.-+......+-+........-+++++..|++.||++|+
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~ 276 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRL 276 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccc
Confidence 11111111122222233344589999999999999996
No 11
>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]
Probab=100.00 E-value=4.1e-48 Score=366.21 Aligned_cols=244 Identities=30% Similarity=0.494 Sum_probs=207.4
Q ss_pred CCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhhHH-HHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQLER-AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (361)
.+....+.||+|+||+||+|+.. +.+.||||.++...+. ..++|++|++++..++|||||+++|+|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 44556789999999999999843 3467999999877655 7789999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcE
Q 037918 169 LVLEFMPNGSLEKWLYSHN-------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235 (361)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 235 (361)
+|+|||..|||.+||.... ..++..+.+.|+.|||.|+.||- +..+|||||..+|+||.++..+
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEE
Confidence 9999999999999997431 22788999999999999999999 8899999999999999999999
Q ss_pred EEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhh
Q 037918 236 HVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKE 314 (361)
Q Consensus 236 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 314 (361)
||+|||+++..-..+.........-+.+|||||.+..+.+|.+||||||||+|||++| |+.||.+....+. .+.+
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV--Ie~i-- 718 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV--IECI-- 718 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH--HHHH--
Confidence 9999999998877776665555667899999999999999999999999999999998 9999887644322 1111
Q ss_pred hcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 315 SLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 315 ~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
-+..+ ... ..+|+.++.+|+..||+.+|++||
T Consensus 719 ---------~~g~l-L~~-----Pe~CP~~vY~LM~~CW~~~P~~RP 750 (774)
T KOG1026|consen 719 ---------RAGQL-LSC-----PENCPTEVYSLMLECWNENPKRRP 750 (774)
T ss_pred ---------HcCCc-ccC-----CCCCCHHHHHHHHHHhhcCcccCC
Confidence 11112 222 237888999999999999999998
No 12
>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=7.4e-46 Score=328.66 Aligned_cols=259 Identities=25% Similarity=0.358 Sum_probs=193.6
Q ss_pred CCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHh--cCCCceeeeeeeeecCC----eeEEE
Q 037918 97 GFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRS--IRHRNLVKILSSCSNVD----FKALV 170 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~~~lv 170 (361)
.....++||+|+||.||+|.+. ++.||||++.... .+.|.+|-++++. ++|+||+++++.-.... .++||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 3455678999999999999994 6999999998653 3567788888775 48999999999876555 78999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918 171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG------YSPSVVHCDLKPSNILLDENMVAHVSDFGISK 244 (361)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~------~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 244 (361)
++|.+.|+|.+||..+. ++|....+++..+++||+|||+. .+++|+|||||.+|||+..|++..|+|||+|.
T Consensus 287 t~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 99999999999999876 89999999999999999999953 46789999999999999999999999999999
Q ss_pred ccCCCCcceeeecccccccccCccccCCCCC------CcccchHHHHHHHHHHHhCCCCCCc--cccccccHHHHHhhhc
Q 037918 245 LLGDGENFETRTMTMATVGYMAPEYGSEGIV------SSKCDVYSYGVLLMETFTRKKPTDE--FFAGEMSLKNWVKESL 316 (361)
Q Consensus 245 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~------~~~~Dv~slG~il~elltg~~p~~~--~~~~~~~~~~~~~~~~ 316 (361)
.+............+||.+|||||++.+... -.+.||||+|.+||||+++-.-+.. ..+.+..+..-+....
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 9876655555556789999999999876442 2379999999999999997654421 1111112211111100
Q ss_pred --CCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 317 --PHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 317 --~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+-..-++.++.....++.-.....+..+.+.+..||+.||+-|.
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARL 491 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARL 491 (534)
T ss_pred CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhh
Confidence 000011122222222222222223456689999999999999883
No 13
>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]
Probab=100.00 E-value=4.3e-46 Score=335.30 Aligned_cols=247 Identities=24% Similarity=0.358 Sum_probs=200.6
Q ss_pred hhCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL 169 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (361)
..++|++++.||+|+||.||+|+- ++|..+|+|++++.. ......+..|-.+|...++|+||+++..|++.+++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 456899999999999999999995 469999999998764 4456778899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918 170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 249 (361)
||||++||++..+|...+. +++..+..++.+++.|+..|| +.|++||||||+|+|||..|++||+|||++.-+...
T Consensus 219 iMEylPGGD~mTLL~~~~~-L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDT-LTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEecCCccHHHHHHhcCc-CchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 9999999999999997765 999999999999999999999 999999999999999999999999999998533210
Q ss_pred ---------------------Ccce-----e-------------------eecccccccccCccccCCCCCCcccchHHH
Q 037918 250 ---------------------ENFE-----T-------------------RTMTMATVGYMAPEYGSEGIVSSKCDVYSY 284 (361)
Q Consensus 250 ---------------------~~~~-----~-------------------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~sl 284 (361)
.... . .....|||.|+|||++.+..|+..+|.|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0000 0 012469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 285 GVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 285 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
|||+||||.|.+||....+.+. | ..++........|... ++..+..+||.+|+. ||++|.
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T----~---------rkI~nwr~~l~fP~~~---~~s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQET----Y---------RKIVNWRETLKFPEEV---DLSDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHH----H---------HHHHHHhhhccCCCcC---cccHHHHHHHHHHhc-CHHHhc
Confidence 9999999999999986443322 1 1222222112222211 112346899999998 999984
No 14
>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]
Probab=100.00 E-value=2e-46 Score=337.49 Aligned_cols=246 Identities=25% Similarity=0.391 Sum_probs=202.2
Q ss_pred HHhhCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCe
Q 037918 92 QRATNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDF 166 (361)
Q Consensus 92 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 166 (361)
.....+|...+.||+|+|++|++|+. ..++.+|||++.+.. +...+-+..|-..|.+| .||.|++++..|++...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 45667899999999999999999995 469999999997643 22334567788999999 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918 167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246 (361)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 246 (361)
+|+|+||+++|+|.++|++.+. +++...+.++.+|+.||+||| +.|||||||||+|||+|+|++++|+|||.|+.+
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gs-fde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGS-FDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCc-chHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999999998765 899999999999999999999 999999999999999999999999999999987
Q ss_pred CCCCcc---------e--eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhh
Q 037918 247 GDGENF---------E--TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKES 315 (361)
Q Consensus 247 ~~~~~~---------~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 315 (361)
...... . .....+||..|.+||++.....++.+|+|+|||+||+|+.|++||..... -.-+...+.
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-yliFqkI~~-- 301 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-YLIFQKIQA-- 301 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-HHHHHHHHH--
Confidence 543221 1 12457899999999999999999999999999999999999999986421 111111111
Q ss_pred cCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 316 LPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 316 ~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
++-.+.... +....+|+.+.|..||.+|+
T Consensus 302 --------l~y~fp~~f---------p~~a~dLv~KLLv~dp~~Rl 330 (604)
T KOG0592|consen 302 --------LDYEFPEGF---------PEDARDLIKKLLVRDPSDRL 330 (604)
T ss_pred --------hcccCCCCC---------CHHHHHHHHHHHccCccccc
Confidence 011111112 12368899999999999996
No 15
>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=3.9e-46 Score=327.63 Aligned_cols=245 Identities=31% Similarity=0.475 Sum_probs=194.3
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC--eeEEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD--FKALVLE 172 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e 172 (361)
.++...+.||+|+||.||++... +|...|||..........+.+.+|+.+|.+++|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 44667789999999999999965 48999999988764333677899999999999999999999854444 6899999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC-CCcEEEEeccCccccCC-CC
Q 037918 173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE-NMVAHVSDFGISKLLGD-GE 250 (361)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~-~~ 250 (361)
|+++|+|.+++...+..+++..+..++.|+++||+||| +++|+||||||+|||++. ++.+||+|||++..... ..
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 99999999999987646999999999999999999999 999999999999999999 79999999999987753 11
Q ss_pred cceeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCcc-ccccccHHHHHhhhcCCCccccccccc
Q 037918 251 NFETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEF-FAGEMSLKNWVKESLPHGLTNVVDENL 328 (361)
Q Consensus 251 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~l~~~~~~~l 328 (361)
.........||+.|||||++.++ ....++|||||||++.||+||++||... ...+..+........| .+
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P---------~i 244 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP---------EI 244 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC---------CC
Confidence 12233456899999999998853 3345999999999999999999999874 1111111111111111 11
Q ss_pred cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+. .......+++..|+..||++||
T Consensus 245 ----p~-----~ls~~a~~Fl~~C~~~~p~~Rp 268 (313)
T KOG0198|consen 245 ----PD-----SLSDEAKDFLRKCFKRDPEKRP 268 (313)
T ss_pred ----Cc-----ccCHHHHHHHHHHhhcCcccCc
Confidence 00 1123468999999999999998
No 16
>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.5e-45 Score=324.69 Aligned_cols=255 Identities=25% Similarity=0.327 Sum_probs=205.2
Q ss_pred hhCCCCCCCccccCCceEEEEEE-eCCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
....|++...||.|..++||+|+ .+.+..||||++..+. ....+.+.+|+..++.++||||++++..|..+..+++||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 34679999999999999999999 4568999999998765 334688999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918 172 EFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE 250 (361)
Q Consensus 172 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 250 (361)
.||.+|++.++++.. ...+++..+..|++++++||.||| .+|.||||||+.||||+++|.+||+|||.+..+....
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999999853 444899999999999999999999 8999999999999999999999999999877665433
Q ss_pred cc-eee-ecccccccccCccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccc
Q 037918 251 NF-ETR-TMTMATVGYMAPEYGSE--GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE 326 (361)
Q Consensus 251 ~~-~~~-~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 326 (361)
.. ... ....|++.|||||++.. ..|+.|+||||||++..||.+|..||..+.+-.+ +..-++...|.......+
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv-Ll~tLqn~pp~~~t~~~~- 258 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV-LLLTLQNDPPTLLTSGLD- 258 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH-HHHHhcCCCCCcccccCC-
Confidence 21 122 44579999999998543 4589999999999999999999999987654322 222222222221111111
Q ss_pred cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..+.......+.+++..||..||++||
T Consensus 259 --------~d~~k~~~ksf~e~i~~CL~kDP~kRp 285 (516)
T KOG0582|consen 259 --------KDEDKKFSKSFREMIALCLVKDPSKRP 285 (516)
T ss_pred --------hHHhhhhcHHHHHHHHHHhhcCcccCC
Confidence 112222344689999999999999998
No 17
>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]
Probab=100.00 E-value=7.9e-46 Score=310.79 Aligned_cols=198 Identities=28% Similarity=0.392 Sum_probs=181.1
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
++|+.++.||.|+||+|.+++.+ +|..+|+|+++... -+..+...+|..+|+.+.||+++++++.|.+.+..++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 56888999999999999999965 68899999998764 345567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
||++||.|..++++.+. +++..++.++.||+.||+||| +.+|++|||||+|||+|.+|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~--- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG--- 196 (355)
T ss_pred eccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecC---
Confidence 99999999999997665 899999999999999999999 99999999999999999999999999999998743
Q ss_pred ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccc
Q 037918 252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFF 302 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~ 302 (361)
.....+|||.|+|||.+...+++.++|.||||+++|||+.|.+||....
T Consensus 197 --rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~ 245 (355)
T KOG0616|consen 197 --RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN 245 (355)
T ss_pred --cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence 2345689999999999999999999999999999999999999997643
No 18
>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=7.1e-46 Score=331.26 Aligned_cols=261 Identities=25% Similarity=0.303 Sum_probs=201.5
Q ss_pred hCCCCCCCccccCCceEEEEEE-eCCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC--CeeEE
Q 037918 95 TNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV--DFKAL 169 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 169 (361)
.+.|+.+++||+|.||.||+|+ ..+|+.||+|++..+. +.......+|+.+|++|+||||+++.+...+. ...||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 4568888999999999999999 4579999999988665 33445667899999999999999999998776 68999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918 170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 249 (361)
|+|||+. +|..++....-.+++.++..++.|++.||+|+| +++|+|||||.+|||||.+|.+||+|||+|+++...
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999965 999999887767999999999999999999999 999999999999999999999999999999988654
Q ss_pred CcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHH--hhhc-CCCcc----
Q 037918 250 ENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWV--KESL-PHGLT---- 321 (361)
Q Consensus 250 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~--~~~~-~~~l~---- 321 (361)
.. ...+..+-|.+|.|||++.+ ..|+.+.|+||.||||.||++|++.|.....- .++.... .... +.-|.
T Consensus 272 ~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv-eQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 272 GS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV-EQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH-HHHHHHHHHhCCCChhccccccC
Confidence 43 23566788999999998766 55999999999999999999999998764321 1111111 1111 11111
Q ss_pred ---ccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 322 ---NVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 322 ---~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
....+.-.....-.+.........++|+..+|..||.+|.
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~ 392 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRG 392 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccc
Confidence 1111111001111111222345578999999999999994
No 19
>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-44 Score=318.33 Aligned_cols=255 Identities=26% Similarity=0.410 Sum_probs=201.1
Q ss_pred HHhhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhc--CCCceeeeeeeeecCC----
Q 037918 92 QRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI--RHRNLVKILSSCSNVD---- 165 (361)
Q Consensus 92 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~~---- 165 (361)
....+...+.+.||+|.||.||+|.+ .|+.||||++....+ +.+.+|.++++.+ +|+||+.+++.-..++
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred HhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 34456677889999999999999999 489999999976543 4677788888764 9999999998864443
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeeeCCCCCCCEEEcCCCcEEEEec
Q 037918 166 FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH-----GYSPSVVHCDLKPSNILLDENMVAHVSDF 240 (361)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~-----~~~~~ivH~dlk~~Nill~~~~~~kl~Df 240 (361)
.++||++|.+.|||.|||..+. ++....++++..+|.||++||. +.++.|.|||||+.|||+..++...|+|+
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~t--v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRNT--VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEEEeeecccCCcHHHHHhhcc--CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 6789999999999999998754 8999999999999999999993 34778999999999999999999999999
Q ss_pred cCccccCCCCc--ceeeecccccccccCccccCCCC------CCcccchHHHHHHHHHHHhC----------CCCCCccc
Q 037918 241 GISKLLGDGEN--FETRTMTMATVGYMAPEYGSEGI------VSSKCDVYSYGVLLMETFTR----------KKPTDEFF 302 (361)
Q Consensus 241 g~a~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~------~~~~~Dv~slG~il~elltg----------~~p~~~~~ 302 (361)
|+|........ .......+||.+|||||++.... .-..+||||||.++||+.-+ +.||.+..
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 99987654422 22334568999999999876533 12369999999999999763 47888777
Q ss_pred cccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCC
Q 037918 303 AGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360 (361)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 360 (361)
+.+.++.+..+-.. .+++....|..-...+++..+.+++..||..||+-|
T Consensus 441 p~DPs~eeMrkVVC--------v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aR 490 (513)
T KOG2052|consen 441 PSDPSFEEMRKVVC--------VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAAR 490 (513)
T ss_pred CCCCCHHHHhccee--------ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhh
Confidence 76666655533222 222333333333344677889999999999999987
No 20
>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-45 Score=336.60 Aligned_cols=252 Identities=24% Similarity=0.439 Sum_probs=202.7
Q ss_pred HHHHHhhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCe
Q 037918 89 LEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF 166 (361)
Q Consensus 89 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 166 (361)
.++....+.+.+...||+|.||+||+|.+. -.||||+++... ....+.|++|+..+++-+|.||+-+.|+|..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 445555566777889999999999999985 359999997543 4577899999999999999999999999999887
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918 167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246 (361)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 246 (361)
.+|+.+|+|-+|+.+++.....++..+.+.|+.|+++|+.||| .++|+|||||..|||+.+++++||+|||++..-
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeee
Confidence 9999999999999999977777999999999999999999999 999999999999999999999999999999754
Q ss_pred CCCCcceeeecccccccccCccccCC---CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccc
Q 037918 247 GDGENFETRTMTMATVGYMAPEYGSE---GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNV 323 (361)
Q Consensus 247 ~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~ 323 (361)
..-..........|..-|||||++.. .+|++.+||||||+++|||+||..||.....+.. .-.
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI--------------ifm 604 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI--------------IFM 604 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe--------------EEE
Confidence 32222122233457888999997653 5689999999999999999999999973222111 111
Q ss_pred ccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 324 VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 324 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+-+..... .......+|+.++.+|+..||.++|++||
T Consensus 605 VGrG~l~p-d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP 641 (678)
T KOG0193|consen 605 VGRGYLMP-DLSKIRSNCPKAMKRLLSDCWKFDREERP 641 (678)
T ss_pred ecccccCc-cchhhhccCHHHHHHHHHHHHhcCcccCc
Confidence 11111111 11123347788899999999999999998
No 21
>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]
Probab=100.00 E-value=6.7e-46 Score=334.98 Aligned_cols=239 Identities=29% Similarity=0.440 Sum_probs=201.6
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE 172 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (361)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+.. ++..+.+.+|+++++.++||||+.++++|+...+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46888889999999999999965 68899999987643 5567789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
|+.| +|..++...+. ++++.+..++.++.+||.||| +.+|.|||+||.|||++.++.+|++|||+|+.+..+.
T Consensus 82 ~a~g-~L~~il~~d~~-lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-- 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK-LPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-- 154 (808)
T ss_pred hhhh-hHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccCc--
Confidence 9966 99999987665 999999999999999999999 9999999999999999999999999999999876543
Q ss_pred eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918 253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 332 (361)
...+...|||-|||||+..+++|+..+|+||+||++||+++|++||-.. ++.+.++....+... +
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d~v~----------~ 219 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKDPVK----------P 219 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcCCCC----------C
Confidence 3456678999999999999999999999999999999999999998642 222222222211100 0
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+. .....+..++...|..||.+|.
T Consensus 220 p~-----~~S~~f~nfl~gLL~kdP~~Rl 243 (808)
T KOG0597|consen 220 PS-----TASSSFVNFLQGLLIKDPAQRL 243 (808)
T ss_pred cc-----cccHHHHHHHHHHhhcChhhcc
Confidence 11 2233478889999999999984
No 22
>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=6.8e-46 Score=329.15 Aligned_cols=259 Identities=24% Similarity=0.310 Sum_probs=202.5
Q ss_pred hhCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHH-HHHHHHHHHHhcC-CCceeeeeeeeecCC-eeEE
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFR-SFDSECEVLRSIR-HRNLVKILSSCSNVD-FKAL 169 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~-~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~l 169 (361)
..++|.++++||.|+||.||+|+. .+|..||||.++.......+ --.+|+..|++++ ||||+++.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 346788899999999999999994 46899999998766533222 2368999999998 999999999998888 9999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918 170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 249 (361)
||||| ..+|.++++.+++.+++..+..|+.||++||+|+| .+|+.|||+||+|||+..+..+||+|||+|+.+...
T Consensus 88 VfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccC
Confidence 99999 56999999999888999999999999999999999 999999999999999999999999999999988654
Q ss_pred CcceeeecccccccccCcccc-CCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcC----CCccc--
Q 037918 250 ENFETRTMTMATVGYMAPEYG-SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLP----HGLTN-- 322 (361)
Q Consensus 250 ~~~~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~l~~-- 322 (361)
. ..+..+.|.+|+|||++ ..+.|+.+.||||+||+++|+.+-++-|.+... .+....+.+.+. ..+.+
T Consensus 164 p---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE--~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 164 P---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE--IDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred C---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH--HHHHHHHHHHhCCCccccchhHH
Confidence 4 34667899999999964 567799999999999999999999998876321 111111111110 11111
Q ss_pred cccccccCCchh------HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 323 VVDENLLLEEPA------FAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 323 ~~~~~l~~~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
-+...+....+. ..-...+..+..+++.+|+++||.+||
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRp 283 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRP 283 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCc
Confidence 011111111111 011123566689999999999999998
No 23
>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=6.7e-45 Score=332.18 Aligned_cols=243 Identities=28% Similarity=0.357 Sum_probs=197.2
Q ss_pred HhhCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehh----hH-HHHHHHHHHHHHHHhcC-CCceeeeeeeeecCC
Q 037918 93 RATNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQ----LE-RAFRSFDSECEVLRSIR-HRNLVKILSSCSNVD 165 (361)
Q Consensus 93 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 165 (361)
...++|.+.+.||+|+||.|+.|.. .+|..||+|++... .. ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999999985 46899999987664 11 23456678999999998 999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC-CcEEEEeccCcc
Q 037918 166 FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN-MVAHVSDFGISK 244 (361)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~ 244 (361)
..++||||+.||+|.+++.+ ...+.+..+..++.|+++|++|+| +++|+||||||+|||++.+ +++||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 99999999999999999998 445899999999999999999999 9999999999999999999 999999999999
Q ss_pred ccC-CCCcceeeecccccccccCccccCCCC-CC-cccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcc
Q 037918 245 LLG-DGENFETRTMTMATVGYMAPEYGSEGI-VS-SKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLT 321 (361)
Q Consensus 245 ~~~-~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~ 321 (361)
... .. ......+|++.|+|||++.+.. |+ .++||||+|++||.|++|+.||++... ..........
T Consensus 170 ~~~~~~---~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-----~~l~~ki~~~--- 238 (370)
T KOG0583|consen 170 ISPGED---GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-----PNLYRKIRKG--- 238 (370)
T ss_pred ccCCCC---CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-----HHHHHHHhcC---
Confidence 873 22 2345568999999999998876 65 789999999999999999999987221 1111111100
Q ss_pred ccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 322 NVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 322 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
++.-+.... ...+..++.+|+..||.+|+
T Consensus 239 ~~~~p~~~~-----------S~~~~~Li~~mL~~~P~~R~ 267 (370)
T KOG0583|consen 239 EFKIPSYLL-----------SPEARSLIEKMLVPDPSTRI 267 (370)
T ss_pred CccCCCCcC-----------CHHHHHHHHHHcCCCcccCC
Confidence 000011000 12368999999999999996
No 24
>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]
Probab=100.00 E-value=3.1e-46 Score=347.99 Aligned_cols=243 Identities=27% Similarity=0.459 Sum_probs=206.4
Q ss_pred CCCCCCccccCCceEEEEEEeCC----CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 97 GFDECNLLGKGSFGSVYKGILSD----GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
...+.++||.|.||.|++|+++- ...||||.++... ++...+|+.|+.||.+++||||+++.|+........+|+
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 34567899999999999999752 3569999998764 566678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
|||++|+|+.||+.+...+++-+...++++||.|++||- +.++|||||.++|||++.+...|++|||+++.+.++..
T Consensus 710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 999999999999988877999999999999999999999 99999999999999999999999999999998866542
Q ss_pred -ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918 252 -FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL 329 (361)
Q Consensus 252 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 329 (361)
..+.....-+.+|.|||.+....+|.+|||||||++|||.++ |..||-++...+. ...+++.+.
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV--------------IkaIe~gyR 852 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV--------------IKAIEQGYR 852 (996)
T ss_pred ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH--------------HHHHHhccC
Confidence 112222234678999999999999999999999999999876 9999987643211 222333333
Q ss_pred CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
... .++|+..|.+|++.||+.|=.+||
T Consensus 853 LPp-----PmDCP~aL~qLMldCWqkdR~~RP 879 (996)
T KOG0196|consen 853 LPP-----PMDCPAALYQLMLDCWQKDRNRRP 879 (996)
T ss_pred CCC-----CCCCcHHHHHHHHHHHHHHhhcCC
Confidence 333 348999999999999999999998
No 25
>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.4e-45 Score=332.76 Aligned_cols=240 Identities=24% Similarity=0.380 Sum_probs=202.6
Q ss_pred CCCCCCCccccCCceEEEEEE-eCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918 96 NGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
..|....+||+|+.|.||.+. ..+++.||||++........+-+.+|+.+|+..+|+|||++++.|...+.+++||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 468888899999999999998 4578999999998776555577899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918 175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET 254 (361)
Q Consensus 175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 254 (361)
+||+|.+.+.... +++.++..+++++++||+||| .++|+|||||.+|||++.+|.+||+|||++..+..... .
T Consensus 353 ~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--K 425 (550)
T KOG0578|consen 353 EGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--K 425 (550)
T ss_pred CCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--c
Confidence 9999999997665 899999999999999999999 99999999999999999999999999999998865443 4
Q ss_pred eecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHH-H-hhhcCCCccccccccccCCc
Q 037918 255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNW-V-KESLPHGLTNVVDENLLLEE 332 (361)
Q Consensus 255 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~-~-~~~~~~~l~~~~~~~l~~~~ 332 (361)
+....||+.|||||+.....|+++.||||||++++||+-|++||-. +..+... + ..+- .
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln----E~PlrAlyLIa~ng---------------~ 486 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRALYLIATNG---------------T 486 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC----CChHHHHHHHhhcC---------------C
Confidence 5566899999999999999999999999999999999999999864 1222111 1 1110 1
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+...........+.+++.+||..||++|+
T Consensus 487 P~lk~~~klS~~~kdFL~~cL~~dv~~Ra 515 (550)
T KOG0578|consen 487 PKLKNPEKLSPELKDFLDRCLVVDVEQRA 515 (550)
T ss_pred CCcCCccccCHHHHHHHHHHhhcchhcCC
Confidence 11111112344589999999999999997
No 26
>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]
Probab=100.00 E-value=2e-44 Score=298.13 Aligned_cols=259 Identities=24% Similarity=0.359 Sum_probs=199.6
Q ss_pred CCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhH--HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLE--RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE 172 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (361)
.+|...+.||+|.||.||+|+. .+|+.||||+++.... ..-....+|+..|+.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677889999999999999995 5799999999986532 223467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
|++ .+|...++.+...++..++..++.++++||+||| ++.|+||||||.|+|++++|.+||+|||+|+.++.....
T Consensus 82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 995 5999999999888999999999999999999999 999999999999999999999999999999998765443
Q ss_pred eeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhh---cCCCcccc-----
Q 037918 253 ETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKES---LPHGLTNV----- 323 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~l~~~----- 323 (361)
.+..+.|.+|+|||.+.+ ..|+...||||.||++.||+-|.+-|.+..+ -.++....+.- -++.|.++
T Consensus 158 --~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD-idQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 158 --QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD-IDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred --cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch-HHHHHHHHHHcCCCCcccCcccccccc
Confidence 233378999999997665 5699999999999999999999887654321 11111111100 11122211
Q ss_pred -ccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 324 -VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 324 -~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
++-......+...-...+....++++..++.+||.+|+
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Ri 273 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRI 273 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcc
Confidence 11000000000001123344579999999999999995
No 27
>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V
Probab=100.00 E-value=3e-44 Score=329.31 Aligned_cols=246 Identities=26% Similarity=0.439 Sum_probs=191.7
Q ss_pred hCCCCCCCccccCCceEEEEEEe------CCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecC-C
Q 037918 95 TNGFDECNLLGKGSFGSVYKGIL------SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNV-D 165 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~ 165 (361)
.++|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++.++ +||||+++++++... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46789999999999999999974 235689999987543 33446788999999999 899999999988764 4
Q ss_pred eeEEEEEecCCCCHHHHHhcCC----------------------------------------------------------
Q 037918 166 FKALVLEFMPNGSLEKWLYSHN---------------------------------------------------------- 187 (361)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 187 (361)
..+++|||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 5789999999999999997531
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecccccccc
Q 037918 188 ---YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGY 264 (361)
Q Consensus 188 ---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y 264 (361)
..+++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 23678889999999999999999 889999999999999999999999999999876433222222334467889
Q ss_pred cCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHH
Q 037918 265 MAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCML 343 (361)
Q Consensus 265 ~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~ 343 (361)
+|||++.+..++.++||||||+++|||++ |..||......+. +......... . . .+ ..++.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~~~~~~~~~---~-----~----~~-----~~~~~ 304 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FCQRLKDGTR---M-----R----AP-----ENATP 304 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHHHhcCCC---C-----C----CC-----CCCCH
Confidence 99999988889999999999999999997 9999976432211 1111111000 0 0 00 01233
Q ss_pred HHHHHHhhcCCCCCCCCC
Q 037918 344 SIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 344 ~l~~l~~~cl~~dP~~RP 361 (361)
.+.+++.+||+.||++||
T Consensus 305 ~l~~li~~cl~~dp~~RP 322 (338)
T cd05102 305 EIYRIMLACWQGDPKERP 322 (338)
T ss_pred HHHHHHHHHccCChhhCc
Confidence 478999999999999998
No 28
>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.1e-45 Score=357.52 Aligned_cols=244 Identities=32% Similarity=0.524 Sum_probs=203.9
Q ss_pred CCCCCCCccccCCceEEEEEEeCC--Cc----EEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILSD--GA----EVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~~--~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (361)
.+.+..+.||+|+||.||.|...+ |. .||+|.+.... .+...+|.+|..+|+.++||||++++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 345567899999999999999643 43 38999887653 456678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccC
Q 037918 169 LVLEFMPNGSLEKWLYSH------NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGI 242 (361)
Q Consensus 169 lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 242 (361)
+++|||++|+|..||++. ...++..+.+.++.|||+|+.||+ ++++|||||.++|+|++....+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999976 567999999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcc
Q 037918 243 SKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLT 321 (361)
Q Consensus 243 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~ 321 (361)
|+.+...+.........-...|||||.+..+.+|.|+|||||||+|||++| |..||.....-+. +..+..
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v-~~~~~~-------- 919 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV-LLDVLE-------- 919 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH-HHHHHh--------
Confidence 997766555444443456678999999999999999999999999999999 8899876533211 111211
Q ss_pred ccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 322 NVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 322 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.. ..+. ...|+..+.+++.+||+.+|++||
T Consensus 920 ----gg-RL~~-----P~~CP~~ly~lM~~CW~~~pe~RP 949 (1025)
T KOG1095|consen 920 ----GG-RLDP-----PSYCPEKLYQLMLQCWKHDPEDRP 949 (1025)
T ss_pred ----CC-ccCC-----CCCCChHHHHHHHHHccCChhhCc
Confidence 11 1222 236788899999999999999998
No 29
>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]
Probab=100.00 E-value=6.6e-44 Score=323.00 Aligned_cols=251 Identities=26% Similarity=0.414 Sum_probs=207.5
Q ss_pred CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhH-HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918 96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLE-RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
+...+.++||+|-||.|.++....+..||||.++.... ....+|.+|+++|.+++||||++++|+|..++.+++|+||+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 45667889999999999999998889999999987664 44588999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 175 PNGSLEKWLYSHNYF-LDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 175 ~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
++|+|.+|+..+..+ +......+|+.||++||+||. +.++|||||.++|+|++.++++||+|||+++.+-..+...
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 999999999977432 356677889999999999999 8999999999999999999999999999999887777766
Q ss_pred eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh--CCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT--RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
......-+.+|||||.+..+.+|.+||||+||+++||+++ ...||.+...++. .+-.....+..-..++- .
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v--ven~~~~~~~~~~~~~l----~- 767 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV--VENAGEFFRDQGRQVVL----S- 767 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH--HHhhhhhcCCCCcceec----c-
Confidence 6666677899999999999999999999999999999865 7889887644322 11111222221111111 1
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
...-|+..+.+++++||+.|-++||
T Consensus 768 -----~P~~cp~~lyelml~Cw~~es~~RP 792 (807)
T KOG1094|consen 768 -----RPPACPQGLYELMLRCWRRESEQRP 792 (807)
T ss_pred -----CCCcCcHHHHHHHHHHhchhhhcCC
Confidence 1124566799999999999999998
No 30
>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt
Probab=100.00 E-value=3.9e-44 Score=321.67 Aligned_cols=237 Identities=24% Similarity=0.316 Sum_probs=194.5
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999965 68999999987543 233456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
||+++|+|.+++...+. +++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~- 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGR-FSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT- 155 (291)
T ss_pred eCCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence 99999999999986553 889999999999999999999 8999999999999999999999999999998764321
Q ss_pred ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918 252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
....|++.|+|||++.+..++.++||||||+++|||++|+.||...... ........... .+...
T Consensus 156 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~~------~~~~~ 220 (291)
T cd05612 156 ----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-----GIYEKILAGKL------EFPRH 220 (291)
T ss_pred ----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCCc------CCCcc
Confidence 2346899999999998888999999999999999999999999753211 11111110000 00000
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
....+.+++.+||+.||.+||
T Consensus 221 ---------~~~~~~~li~~~l~~dp~~R~ 241 (291)
T cd05612 221 ---------LDLYAKDLIKKLLVVDRTRRL 241 (291)
T ss_pred ---------CCHHHHHHHHHHcCCCHHHcc
Confidence 122378999999999999997
No 31
>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i
Probab=100.00 E-value=3.1e-43 Score=314.92 Aligned_cols=243 Identities=25% Similarity=0.312 Sum_probs=193.7
Q ss_pred CCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918 97 GFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE 172 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (361)
.|+..+.||+|+||.||++.. .+|+.||+|.+.... ......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367788999999999999996 478999999987543 2223457889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 173 FMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 173 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
|+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 99999999888643 335899999999999999999999 8999999999999999999999999999998754322
Q ss_pred ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918 252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....... ..+.....+...... ...
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~-----~~~- 226 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV--KREEVDRRVKEDQEE-----YSE- 226 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch--hHHHHHHHhhccccc-----CCc-
Confidence 1233468999999999999999999999999999999999999997543211 111111111100000 000
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+....+.+++.+||+.||++||
T Consensus 227 --------~~s~~~~~li~~~l~~~P~~R~ 248 (285)
T cd05631 227 --------KFSEDAKSICRMLLTKNPKERL 248 (285)
T ss_pred --------cCCHHHHHHHHHHhhcCHHHhc
Confidence 1123478999999999999997
No 32
>PTZ00263 protein kinase A catalytic subunit; Provisional
Probab=100.00 E-value=5.2e-44 Score=326.31 Aligned_cols=237 Identities=25% Similarity=0.276 Sum_probs=194.6
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999975 68999999997543 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
||+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 98 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGR-FPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred cCCCCChHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence 99999999999986543 789999999999999999999 8899999999999999999999999999998764322
Q ss_pred ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918 252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...... +........ .+.
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-----~~~~~i~~~--------~~~-- 233 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-----RIYEKILAG--------RLK-- 233 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-----HHHHHHhcC--------CcC--
Confidence 2346899999999999988999999999999999999999999653211 111111111 000
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+. .....+.+++.+||+.||++||
T Consensus 234 ~p~-----~~~~~~~~li~~~L~~dP~~R~ 258 (329)
T PTZ00263 234 FPN-----WFDGRARDLVKGLLQTDHTKRL 258 (329)
T ss_pred CCC-----CCCHHHHHHHHHHhhcCHHHcC
Confidence 000 0112368999999999999996
No 33
>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.6e-44 Score=332.36 Aligned_cols=242 Identities=23% Similarity=0.317 Sum_probs=197.7
Q ss_pred HhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCee
Q 037918 93 RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFK 167 (361)
Q Consensus 93 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 167 (361)
...++|..+++||+|.||+|+++..+ +++.+|||++++.. .+..+..+.|.+++... +||.++.++..|++.++.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34467999999999999999999976 58899999998764 45567788899998877 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918 168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG 247 (361)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 247 (361)
|+||||+.||++..+.+. ..+++..+..++..|+.||+||| +++||+||||.+|||+|.+|.+||+|||+++..-
T Consensus 445 ~fvmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccC
Confidence 999999999995444433 33899999999999999999999 9999999999999999999999999999998653
Q ss_pred CCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccc
Q 037918 248 DGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN 327 (361)
Q Consensus 248 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 327 (361)
... ...+..+||+.|+|||++.+..|+.+.|.|||||+||||+.|+.||.....++. ... ++...
T Consensus 520 ~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~-Fds------------I~~d~ 584 (694)
T KOG0694|consen 520 GQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV-FDS------------IVNDE 584 (694)
T ss_pred CCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHH------------HhcCC
Confidence 222 245567899999999999999999999999999999999999999986332111 111 11100
Q ss_pred ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
. .+|. -+..+..+++.+.+..||++|.
T Consensus 585 ~--~yP~-----~ls~ea~~il~~ll~k~p~kRL 611 (694)
T KOG0694|consen 585 V--RYPR-----FLSKEAIAIMRRLLRKNPEKRL 611 (694)
T ss_pred C--CCCC-----cccHHHHHHHHHHhccCccccc
Confidence 0 0111 2233468899999999999994
No 34
>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be
Probab=100.00 E-value=1.6e-43 Score=322.39 Aligned_cols=234 Identities=26% Similarity=0.277 Sum_probs=189.5
Q ss_pred CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCC
Q 037918 102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNG 177 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 177 (361)
+.||+|+||.||++... +|+.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 68999999998643 233456788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeec
Q 037918 178 SLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTM 257 (361)
Q Consensus 178 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 257 (361)
+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~ 154 (323)
T cd05571 81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT 154 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccccc
Confidence 9999998654 3899999999999999999999 8899999999999999999999999999987542211 12233
Q ss_pred ccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHH
Q 037918 258 TMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAA 337 (361)
Q Consensus 258 ~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 337 (361)
..|++.|+|||++.+..++.++|||||||++|||++|+.||...... ...... .... ..+..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~~---~~~~------~~~p~------- 216 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELI---LMEE------IRFPR------- 216 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--HHHHHH---HcCC------CCCCC-------
Confidence 56999999999999989999999999999999999999999653211 111111 1000 00000
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 338 KMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 338 ~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||+.||++||
T Consensus 217 --~~~~~~~~li~~~L~~dP~~R~ 238 (323)
T cd05571 217 --TLSPEAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred --CCCHHHHHHHHHHccCCHHHcC
Confidence 1123478999999999999997
No 35
>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k
Probab=100.00 E-value=9e-43 Score=314.86 Aligned_cols=251 Identities=26% Similarity=0.420 Sum_probs=193.1
Q ss_pred CCCCCCCccccCCceEEEEEEeCC-----------------CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeee
Q 037918 96 NGFDECNLLGKGSFGSVYKGILSD-----------------GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKI 157 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~ 157 (361)
++|.+.+.||+|+||.||+|.+.+ +..||+|.+.... ......+.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 568889999999999999997532 3469999987643 3345678999999999999999999
Q ss_pred eeeeecCCeeEEEEEecCCCCHHHHHhcCC------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 037918 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHN------------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219 (361)
Q Consensus 158 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 219 (361)
++++.+.+..++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 999999999999999999999999986431 23678889999999999999999 889999
Q ss_pred CCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh--CCCC
Q 037918 220 CDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT--RKKP 297 (361)
Q Consensus 220 ~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~p 297 (361)
|||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999987644333222233446788999999888889999999999999999987 5567
Q ss_pred CCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 298 TDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
|......+ ................ ..... ..++..+.+++.+||+.||++||
T Consensus 242 ~~~~~~~~--~~~~~~~~~~~~~~~~----~~~~~------~~~~~~~~~li~~cl~~~p~~RP 293 (304)
T cd05096 242 YGELTDEQ--VIENAGEFFRDQGRQV----YLFRP------PPCPQGLYELMLQCWSRDCRERP 293 (304)
T ss_pred CCcCCHHH--HHHHHHHHhhhccccc----cccCC------CCCCHHHHHHHHHHccCCchhCc
Confidence 76532211 1111111110000000 00000 02344589999999999999998
No 36
>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1e-44 Score=319.10 Aligned_cols=241 Identities=28% Similarity=0.370 Sum_probs=202.2
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
..|+..+.||+|.||.||+|... .++.||+|++..+. +...+++.+|+.++.+++++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 34677789999999999999954 68899999998764 45567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
+.||++.+.+..... +++..+.-++++++.||.||| ..+.+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus 93 ~~gGsv~~lL~~~~~-~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~-- 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNI-LDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK-- 166 (467)
T ss_pred hcCcchhhhhccCCC-CccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhh--
Confidence 999999999986653 488888889999999999999 88999999999999999999999999999988765433
Q ss_pred eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP 333 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 333 (361)
.....+||+.|||||++.+..|+.|+||||||++.+||.+|.+|+....+... . -.+|.... +.+..
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv--l----flIpk~~P----P~L~~--- 233 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV--L----FLIPKSAP----PRLDG--- 233 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE--E----EeccCCCC----Ccccc---
Confidence 33567899999999999988999999999999999999999999987654211 0 01111111 11111
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 334 AFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+...+.+++..||+.||+.||
T Consensus 234 ------~~S~~~kEFV~~CL~k~P~~Rp 255 (467)
T KOG0201|consen 234 ------DFSPPFKEFVEACLDKNPEFRP 255 (467)
T ss_pred ------ccCHHHHHHHHHHhhcCcccCc
Confidence 3344589999999999999998
No 37
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=100.00 E-value=4.3e-42 Score=355.30 Aligned_cols=249 Identities=27% Similarity=0.459 Sum_probs=199.8
Q ss_pred hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
...|...+.||+|+||.||+|.. .++..||+|.+..... ....|++.+++++||||++++++|.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 35677888999999999999996 4789999998864322 123468899999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
+++|+|.+++.. ++|..+.+++.|+++||+|||+.++++++||||||+||+++.++..++. ||.......
T Consensus 765 ~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----- 834 (968)
T PLN00113 765 IEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----- 834 (968)
T ss_pred CCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence 999999999963 7899999999999999999997777899999999999999999888875 665543321
Q ss_pred eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCC-CccccccccccCCc
Q 037918 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH-GLTNVVDENLLLEE 332 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~~l~~~~ 332 (361)
.....+++.|+|||++.+..++.++|||||||++|||+||+.||+..........+|.+..... .....+++.+....
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913 (968)
T ss_pred -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence 1223578999999999999999999999999999999999999976555555666676554422 23344555443322
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+. ..+++..+.+++.+||+.||++||
T Consensus 914 ~~---~~~~~~~~~~l~~~Cl~~~P~~RP 939 (968)
T PLN00113 914 SV---NQNEIVEVMNLALHCTATDPTARP 939 (968)
T ss_pred Cc---cHHHHHHHHHHHHhhCcCCchhCc
Confidence 11 123455688999999999999998
No 38
>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]
Probab=100.00 E-value=2.5e-44 Score=324.92 Aligned_cols=238 Identities=28% Similarity=0.424 Sum_probs=199.0
Q ss_pred cccCHHHHHHhhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeec
Q 037918 84 RRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163 (361)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 163 (361)
.+++|++|.. ++-||+|+.|.||+|++ .++.||||+++.- -..+++-|++|+||||+.+.|+|..
T Consensus 119 WeiPFe~IsE-------LeWlGSGaQGAVF~Grl-~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtq 183 (904)
T KOG4721|consen 119 WEIPFEEISE-------LEWLGSGAQGAVFLGRL-HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQ 183 (904)
T ss_pred ccCCHHHhhh-------hhhhccCcccceeeeec-cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecC
Confidence 4677777664 56799999999999999 4789999976532 2347889999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCc
Q 037918 164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGIS 243 (361)
Q Consensus 164 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 243 (361)
...+++|||||..|.|.+.|+..+. +.......|..+||.|+.||| ...|||||||.-||||+.+..+||+|||-+
T Consensus 184 sPcyCIiMEfCa~GqL~~VLka~~~-itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS 259 (904)
T KOG4721|consen 184 SPCYCIIMEFCAQGQLYEVLKAGRP-ITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTS 259 (904)
T ss_pred CceeEEeeeccccccHHHHHhccCc-cCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccch
Confidence 9999999999999999999997765 788888999999999999999 889999999999999999999999999999
Q ss_pred cccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccc
Q 037918 244 KLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNV 323 (361)
Q Consensus 244 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~ 323 (361)
+.+.+. .+....+||..|||||++.+.+.++|.|||||||+||||+||..||.+......- .-+
T Consensus 260 ~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII-------------wGV 323 (904)
T KOG4721|consen 260 KELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII-------------WGV 323 (904)
T ss_pred Hhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE-------------Eec
Confidence 877543 3455678999999999999999999999999999999999999999875432211 011
Q ss_pred ccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 324 VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 324 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
=...+...- ...|+.-+.-|+++||+-.|..||
T Consensus 324 GsNsL~Lpv-----PstcP~GfklL~Kqcw~sKpRNRP 356 (904)
T KOG4721|consen 324 GSNSLHLPV-----PSTCPDGFKLLLKQCWNSKPRNRP 356 (904)
T ss_pred cCCcccccC-----cccCchHHHHHHHHHHhcCCCCCc
Confidence 111122222 225677788899999999999998
No 39
>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=5.7e-44 Score=327.60 Aligned_cols=243 Identities=29% Similarity=0.444 Sum_probs=197.4
Q ss_pred hCCCCCCCccccCCceEEEEEEeCC--C---cEEEEEEeehh---hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCe
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILSD--G---AEVAIKIFNLQ---LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF 166 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~~--~---~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 166 (361)
.++....++||+|+||.||+|.+.. + ..||+|..+.. ......++.+|++++++++||||++++|++.....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3445556899999999999999642 2 23899988852 35667899999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918 167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246 (361)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 246 (361)
+++|||+|.||+|.++|++++..++..++..++.+.|.||+||| +++++||||.++|+|++.++.+||+|||+++.-
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 99999999999999999988777999999999999999999999 999999999999999999999999999998764
Q ss_pred CCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHH-hhhcCCCccccc
Q 037918 247 GDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWV-KESLPHGLTNVV 324 (361)
Q Consensus 247 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~-~~~~~~~l~~~~ 324 (361)
.. .........-+..|+|||.+..+.++.++|||||||++||+++ |..||.+.... ....++ ....+..
T Consensus 313 ~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~~~~~r~~----- 383 (474)
T KOG0194|consen 313 SQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIVKNGYRMP----- 383 (474)
T ss_pred cc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHHhcCccCC-----
Confidence 31 1111112346789999999999999999999999999999999 88998875432 222222 1111111
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 325 DENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 325 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+. ..+..+..++.+||..||++||
T Consensus 384 -------~~~-----~~p~~~~~~~~~c~~~~p~~R~ 408 (474)
T KOG0194|consen 384 -------IPS-----KTPKELAKVMKQCWKKDPEDRP 408 (474)
T ss_pred -------CCC-----CCHHHHHHHHHHhccCChhhcc
Confidence 111 2234578888999999999997
No 40
>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl
Probab=100.00 E-value=4.7e-43 Score=317.79 Aligned_cols=232 Identities=26% Similarity=0.273 Sum_probs=188.8
Q ss_pred cccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCH
Q 037918 104 LGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSL 179 (361)
Q Consensus 104 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 179 (361)
||+|+||.||+|... +++.||+|++.... ......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999965 58899999987542 33446678899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeeccc
Q 037918 180 EKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM 259 (361)
Q Consensus 180 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 259 (361)
.+++..... +++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+++....... ......
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~ 154 (312)
T cd05585 81 FHHLQREGR-FDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFC 154 (312)
T ss_pred HHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cccccc
Confidence 999986543 899999999999999999999 89999999999999999999999999999976432221 223456
Q ss_pred ccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHH
Q 037918 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKM 339 (361)
Q Consensus 260 g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 339 (361)
||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............ .+..
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~~~~~~~~~~~~------~~~~--------- 214 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----NEMYRKILQEPL------RFPD--------- 214 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----HHHHHHHHcCCC------CCCC---------
Confidence 89999999999998999999999999999999999999975321 112111111100 0000
Q ss_pred HHHHHHHHHHhhcCCCCCCCCC
Q 037918 340 DCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 340 ~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||+.||++||
T Consensus 215 ~~~~~~~~li~~~L~~dp~~R~ 236 (312)
T cd05585 215 GFDRDAKDLLIGLLSRDPTRRL 236 (312)
T ss_pred cCCHHHHHHHHHHcCCCHHHcC
Confidence 1123478999999999999996
No 41
>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in
Probab=100.00 E-value=5.9e-43 Score=318.51 Aligned_cols=234 Identities=25% Similarity=0.281 Sum_probs=188.8
Q ss_pred CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCC
Q 037918 102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNG 177 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 177 (361)
+.||+|+||.||++... +|+.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999964 68999999997653 234456778999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeec
Q 037918 178 SLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTM 257 (361)
Q Consensus 178 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 257 (361)
+|.+++.... .+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~ 154 (323)
T cd05595 81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT 154 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccccc
Confidence 9999887654 3899999999999999999999 8899999999999999999999999999987532221 12233
Q ss_pred ccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHH
Q 037918 258 TMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAA 337 (361)
Q Consensus 258 ~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 337 (361)
..|++.|+|||++.+..++.++|||||||++|||++|+.||....... .......... .+..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-----~~~~~~~~~~------~~p~------- 216 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----LFELILMEEI------RFPR------- 216 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-----HHHHHhcCCC------CCCC-------
Confidence 468999999999998899999999999999999999999996532211 1111110000 0000
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 338 KMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 338 ~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||+.||++||
T Consensus 217 --~~~~~~~~li~~~L~~dP~~R~ 238 (323)
T cd05595 217 --TLSPEAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred --CCCHHHHHHHHHHccCCHHHhC
Confidence 1123478999999999999996
No 42
>PHA02988 hypothetical protein; Provisional
Probab=100.00 E-value=8.1e-43 Score=311.72 Aligned_cols=233 Identities=24% Similarity=0.354 Sum_probs=187.0
Q ss_pred CCccccCCceEEEEEEeCCCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeec----CCeeEEEEEe
Q 037918 101 CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSN----VDFKALVLEF 173 (361)
Q Consensus 101 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~ 173 (361)
...||+|++|.||+|.+ +|+.||||.+.... ....+.+.+|+.++.+++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999998 68999999987543 2235678899999999999999999999876 3467899999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS-PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
+++|+|.+++.+.. .+++...+.++.+++.||.||| + .+++||||||+||++++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 104 CTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 99999999998654 4889999999999999999999 5 488899999999999999999999999998654321
Q ss_pred eeeecccccccccCccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918 253 ETRTMTMATVGYMAPEYGSE--GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 330 (361)
....++..|+|||++.+ ..++.++||||||+++|||++|+.||...... .....+ ..... ...+
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--~~~~~i---~~~~~----~~~~-- 243 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--EIYDLI---INKNN----SLKL-- 243 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--HHHHHH---HhcCC----CCCC--
Confidence 23457889999999876 67899999999999999999999999764221 111111 00000 0001
Q ss_pred CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+ .+++..+.+++.+||+.||++||
T Consensus 244 --~-----~~~~~~l~~li~~cl~~dp~~Rp 267 (283)
T PHA02988 244 --P-----LDCPLEIKCIVEACTSHDSIKRP 267 (283)
T ss_pred --C-----CcCcHHHHHHHHHHhcCCcccCc
Confidence 0 02344589999999999999998
No 43
>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an
Probab=100.00 E-value=8e-43 Score=315.03 Aligned_cols=201 Identities=23% Similarity=0.374 Sum_probs=172.7
Q ss_pred hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH-HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE-RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE 172 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (361)
.++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999975 689999999875432 222456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
|++ ++|.+++......+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 157 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-- 157 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence 994 6888888776566899999999999999999999 8999999999999999999999999999987543221
Q ss_pred eeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 253 ETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
.......+++.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 12233468899999998755 45788999999999999999999999764
No 44
>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional
Probab=100.00 E-value=2.8e-43 Score=322.40 Aligned_cols=238 Identities=24% Similarity=0.272 Sum_probs=193.2
Q ss_pred hCCCCCCCccccCCceEEEEEEeCC--CcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILSD--GAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL 169 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (361)
.++|++.+.||+|+||.||+|...+ +..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3568899999999999999998543 3689999987543 2334678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918 170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 249 (361)
||||+++|+|.+++..... +++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++......
T Consensus 109 v~Ey~~~g~L~~~i~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKR-FPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 9999999999999986643 899999999999999999999 899999999999999999999999999999876432
Q ss_pred CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL 329 (361)
Q Consensus 250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 329 (361)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... .. .....
T Consensus 185 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~~~~~---i~--------~~~~~ 246 (340)
T PTZ00426 185 -----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--LIYQK---IL--------EGIIY 246 (340)
T ss_pred -----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--HHHHH---Hh--------cCCCC
Confidence 12346899999999998888999999999999999999999999753211 11111 01 00000
Q ss_pred CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+. .....+.+++.+|++.||++|+
T Consensus 247 --~p~-----~~~~~~~~li~~~l~~dp~~R~ 271 (340)
T PTZ00426 247 --FPK-----FLDNNCKHLMKKLLSHDLTKRY 271 (340)
T ss_pred --CCC-----CCCHHHHHHHHHHcccCHHHcC
Confidence 000 0112367899999999999994
No 45
>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=7.9e-44 Score=310.27 Aligned_cols=238 Identities=27% Similarity=0.352 Sum_probs=198.9
Q ss_pred hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918 95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV 170 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (361)
..+|++.+.||+|.||.|-+|.. ..|+.||||.++++. ++..-.+.+|+++|+.|+||||+.+|.+|++.+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35688888999999999999984 689999999987654 45556789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918 171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE 250 (361)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 250 (361)
|||..+|.|.+|+...+. +++.++..+++||.+|+.|+| +++++|||||.+|||+|.|+++||+|||++-.+....
T Consensus 132 MEYaS~GeLYDYiSer~~-LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGS-LSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred EEecCCccHHHHHHHhcc-ccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 999999999999987765 999999999999999999999 9999999999999999999999999999998886654
Q ss_pred cceeeecccccccccCccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918 251 NFETRTMTMATVGYMAPEYGSEGIV-SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL 329 (361)
Q Consensus 251 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 329 (361)
. ....+|++-|.+||++.+.+| ++..|-||||++||.|+.|..||++... ...+++.- .
T Consensus 208 f---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-----k~lvrQIs------------~ 267 (668)
T KOG0611|consen 208 F---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-----KRLVRQIS------------R 267 (668)
T ss_pred H---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-----HHHHHHhh------------c
Confidence 3 345689999999999999887 6789999999999999999999987532 11221111 1
Q ss_pred CCchhHHHHHHHHHHHHHHHhhcCCCCCCCC
Q 037918 330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360 (361)
Q Consensus 330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 360 (361)
+.+.+. +.+....-||.+||..||++|
T Consensus 268 GaYrEP----~~PSdA~gLIRwmLmVNP~RR 294 (668)
T KOG0611|consen 268 GAYREP----ETPSDASGLIRWMLMVNPERR 294 (668)
T ss_pred ccccCC----CCCchHHHHHHHHHhcCcccc
Confidence 111110 011224667889999999988
No 46
>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit. Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce
Probab=100.00 E-value=1.1e-42 Score=322.85 Aligned_cols=246 Identities=25% Similarity=0.389 Sum_probs=194.0
Q ss_pred hCCCCCCCccccCCceEEEEEEe------CCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCe
Q 037918 95 TNGFDECNLLGKGSFGSVYKGIL------SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDF 166 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 166 (361)
.++|++.+.||+|+||.||+|.. .++..||||+++... ....+.+.+|+.++..+ +||||++++++|.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45688899999999999999973 245689999987443 33446788999999999 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCC-----------------------------------------------------------
Q 037918 167 KALVLEFMPNGSLEKWLYSHN----------------------------------------------------------- 187 (361)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------- 187 (361)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999986432
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 188 ---------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 188 ---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
..+++..++.++.|++.||+||| +.+++||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 13688899999999999999999 889999999999999999999999999999876543322
Q ss_pred eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918 253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ............. .
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~------------~ 337 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIKEGYRM------------L 337 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHHHhCccC------------C
Confidence 22222345678999999999899999999999999999998 88998754322 1222222211100 0
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+. ..+..+.+++.+||+.||++||
T Consensus 338 ~~~-----~~~~~l~~li~~cl~~dP~~RP 362 (375)
T cd05104 338 SPE-----CAPSEMYDIMKSCWDADPLKRP 362 (375)
T ss_pred CCC-----CCCHHHHHHHHHHccCChhHCc
Confidence 000 1123478999999999999998
No 47
>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate
Probab=100.00 E-value=9.7e-43 Score=317.69 Aligned_cols=234 Identities=25% Similarity=0.289 Sum_probs=189.1
Q ss_pred CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCC
Q 037918 102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNG 177 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 177 (361)
+.||+|+||.||++... +|+.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 68999999997643 234467788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeec
Q 037918 178 SLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTM 257 (361)
Q Consensus 178 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 257 (361)
+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~ 154 (328)
T cd05593 81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKT 154 (328)
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccccc
Confidence 9999887654 3899999999999999999999 8999999999999999999999999999987543221 12233
Q ss_pred ccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHH
Q 037918 258 TMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAA 337 (361)
Q Consensus 258 ~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~ 337 (361)
..|++.|+|||++.+..++.++|||||||++|||++|+.||...... .......... ..+...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----~~~~~~~~~~------~~~p~~------ 217 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILMED------IKFPRT------ 217 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----HHHHHhccCC------ccCCCC------
Confidence 46899999999998888999999999999999999999999653211 1111111000 001011
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 338 KMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 338 ~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
....+.+++.+||+.||++||
T Consensus 218 ---~~~~~~~li~~~L~~dP~~R~ 238 (328)
T cd05593 218 ---LSADAKSLLSGLLIKDPNKRL 238 (328)
T ss_pred ---CCHHHHHHHHHHcCCCHHHcC
Confidence 123478899999999999996
No 48
>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.
Probab=100.00 E-value=8.9e-43 Score=318.85 Aligned_cols=245 Identities=22% Similarity=0.299 Sum_probs=195.8
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
++|++.+.||+|+||.||+|... +++.||+|++.... ......+..|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46889999999999999999975 58999999998653 233456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
||+++++|.+++..... +++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~~-l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLGV-LSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred eCCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 99999999999976543 889999999999999999999 88999999999999999999999999999986543
Q ss_pred ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918 252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
......|++.|+|||++.+..++.++|||||||++|||++|+.||......+. ...... . ...+......
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~i~~--~----~~~~~~~~~~- 223 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-WENLKY--W----KETLQRPVYD- 223 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-HHHHHh--c----cccccCCCCC-
Confidence 22344689999999999988999999999999999999999999975322111 111100 0 0000000000
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+. ......+.+++.+||..+|++||
T Consensus 224 ~~~----~~~s~~~~~li~~~l~~~~~rr~ 249 (333)
T cd05600 224 DPR----FNLSDEAWDLITKLINDPSRRFG 249 (333)
T ss_pred ccc----cccCHHHHHHHHHHhhChhhhcC
Confidence 000 11233478999999999999986
No 49
>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2. Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=4e-42 Score=314.16 Aligned_cols=199 Identities=27% Similarity=0.328 Sum_probs=175.8
Q ss_pred hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE 172 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (361)
.++|++.+.||+|+||.||++... +|..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367999999999999999999965 68889999987643 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP-SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
|+++++|.+++..... +++..+..++.|++.||.||| +. +|+||||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAKR-IPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred cCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 9999999999986543 899999999999999999999 54 6999999999999999999999999999765432
Q ss_pred ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
......|+..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 123346899999999999888999999999999999999999999653
No 50
>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in
Probab=100.00 E-value=1.3e-42 Score=316.36 Aligned_cols=234 Identities=24% Similarity=0.310 Sum_probs=187.8
Q ss_pred CccccCCceEEEEEEe----CCCcEEEEEEeehhh----HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 102 NLLGKGSFGSVYKGIL----SDGAEVAIKIFNLQL----ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
+.||+|+||.||++.. .+++.||+|++.... ......+..|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 357899999997542 22335677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
+++++|.+++...+. +.+..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 155 (323)
T cd05584 82 LSGGELFMHLEREGI-FMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-- 155 (323)
T ss_pred CCCchHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--
Confidence 999999999976553 788889999999999999999 88999999999999999999999999999875432221
Q ss_pred eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP 333 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 333 (361)
......|++.|+|||++.+..++.++||||||+++|||++|+.||...... .......... ....
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~~~~~~~--------~~~~-- 220 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTIDKILKGK--------LNLP-- 220 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHHHHHcCC--------CCCC--
Confidence 123346899999999998888999999999999999999999999753211 1111111110 0000
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 334 AFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
. .....+.+++.+||+.||++||
T Consensus 221 ~-----~~~~~~~~li~~~l~~~p~~R~ 243 (323)
T cd05584 221 P-----YLTPEARDLLKKLLKRNPSSRL 243 (323)
T ss_pred C-----CCCHHHHHHHHHHcccCHhHcC
Confidence 0 1123478999999999999997
No 51
>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes
Probab=100.00 E-value=3.4e-42 Score=308.46 Aligned_cols=201 Identities=25% Similarity=0.321 Sum_probs=172.7
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE 172 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (361)
++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999975 58899999987542 2334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
|++++.+..+.. ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 155 (287)
T cd07848 81 YVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN- 155 (287)
T ss_pred cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-
Confidence 998876665544 3345899999999999999999999 88999999999999999999999999999987643221
Q ss_pred eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~ 204 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE 204 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence 1122346899999999998888999999999999999999999999753
No 52
>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti
Probab=100.00 E-value=2e-42 Score=320.82 Aligned_cols=247 Identities=25% Similarity=0.435 Sum_probs=193.3
Q ss_pred hhCCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCC
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVD 165 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 165 (361)
..++|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|+++++.+ +|+||++++++|...+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3457899999999999999998842 34579999997543 33456788999999999 8999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhcCC----------------------------------------------------------
Q 037918 166 FKALVLEFMPNGSLEKWLYSHN---------------------------------------------------------- 187 (361)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 187 (361)
..++||||+++|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999999986421
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918 188 -----------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256 (361)
Q Consensus 188 -----------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 256 (361)
..+++..+++++.|++.||+||| +++|+||||||+||++++++.+||+|||+++............
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 23678889999999999999999 8899999999999999999999999999998764433222222
Q ss_pred cccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhH
Q 037918 257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF 335 (361)
Q Consensus 257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~ 335 (361)
...++..|+|||++.+..++.++||||||+++|||++ |+.||....... ..........+ ...+.
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~~------------~~~~~- 338 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGYQ------------MSRPD- 338 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcccC------------ccCCC-
Confidence 2345678999999988889999999999999999997 999997643221 11111111100 00000
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 336 AAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 336 ~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..+..+.+++.+||+.||++||
T Consensus 339 ----~~~~~l~~li~~cl~~dp~~RP 360 (374)
T cd05106 339 ----FAPPEIYSIMKMCWNLEPTERP 360 (374)
T ss_pred ----CCCHHHHHHHHHHcCCChhhCc
Confidence 0123478999999999999998
No 53
>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor
Probab=100.00 E-value=1.2e-42 Score=308.15 Aligned_cols=244 Identities=24% Similarity=0.364 Sum_probs=194.4
Q ss_pred hCCCCCCCccccCCceEEEEEEeC----CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS----DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL 169 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (361)
.++|++.+.||+|+||.||+|.+. .+..||+|.++... ......+.+|+..+.+++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888999999999999999853 36689999987653 3334678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918 170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 249 (361)
||||+++|+|.+++......+++..++.++.|++.||+||| +.+++||||||+||+++.++.++++|||.+......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999876556899999999999999999999 889999999999999999999999999987654322
Q ss_pred CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL 328 (361)
Q Consensus 250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l 328 (361)
.. .......++..|+|||.+.+..++.++||||||+++||+++ |+.||...... ..........
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~------------ 225 (266)
T cd05064 161 AI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAVEDGF------------ 225 (266)
T ss_pred ch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCCC------------
Confidence 11 11112335678999999988899999999999999999875 99999754321 1111111110
Q ss_pred cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
....+ ..++..+.+++.+||+.+|++||
T Consensus 226 ~~~~~-----~~~~~~~~~li~~c~~~~p~~RP 253 (266)
T cd05064 226 RLPAP-----RNCPNLLHQLMLDCWQKERGERP 253 (266)
T ss_pred CCCCC-----CCCCHHHHHHHHHHcCCCchhCC
Confidence 00000 12344589999999999999998
No 54
>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=2.6e-43 Score=287.43 Aligned_cols=241 Identities=26% Similarity=0.312 Sum_probs=199.6
Q ss_pred hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL 169 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (361)
+.++|++.+.||+|.||.||.|+.+ ++-.||+|++.+.. ......+.+|+++-+.|+||||+++|++|.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3467999999999999999999954 67889999987653 2334578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918 170 VLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD 248 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 248 (361)
++||..+|+|...|... ...+++.....++.|+|.||.|+| .++++||||||+|+|++.++.+|++|||.+....
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 99999999999999843 334889999999999999999999 9999999999999999999999999999987643
Q ss_pred CCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918 249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL 328 (361)
Q Consensus 249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l 328 (361)
...+...+||..|.+||+..+...+...|+|++|++.||++.|.+||..... ...+.+..+-.+ .
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-~etYkrI~k~~~-------~---- 240 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-SETYKRIRKVDL-------K---- 240 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-HHHHHHHHHccc-------c----
Confidence 2244556899999999999999999999999999999999999999987542 222222211111 1
Q ss_pred cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.|. .......++|.+|+..+|.+|+
T Consensus 241 ---~p~-----~is~~a~dlI~~ll~~~p~~r~ 265 (281)
T KOG0580|consen 241 ---FPS-----TISGGAADLISRLLVKNPIERL 265 (281)
T ss_pred ---CCc-----ccChhHHHHHHHHhccCccccc
Confidence 111 1122368899999999999985
No 55
>PTZ00267 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=1e-42 Score=332.37 Aligned_cols=243 Identities=24% Similarity=0.276 Sum_probs=196.3
Q ss_pred CCCCCCccccCCceEEEEEEeC-C-CcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-D-GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
.|.+.+.||+|++|.||+|... + ++.||+|.+..........+..|+.+++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888999999999999999854 3 6788999876655555567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 175 PNGSLEKWLYSH---NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 175 ~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988642 335889999999999999999999 88999999999999999999999999999987654332
Q ss_pred ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918 252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .............. .
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~~~~~~~~~~~~-----~--- 291 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REIMQQVLYGKYDP-----F--- 291 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCCC-----C---
Confidence 2233445699999999999988999999999999999999999999965321 11111111110000 0
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+ ......+.+++.+||+.||++||
T Consensus 292 -~-----~~~s~~~~~li~~~L~~dP~~Rp 315 (478)
T PTZ00267 292 -P-----CPVSSGMKALLDPLLSKNPALRP 315 (478)
T ss_pred -C-----ccCCHHHHHHHHHHhccChhhCc
Confidence 0 01123478999999999999998
No 56
>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament
Probab=100.00 E-value=2.1e-42 Score=309.99 Aligned_cols=200 Identities=24% Similarity=0.367 Sum_probs=172.1
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56899999999999999999965 68899999986443 22234677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
++ ++|.+++...+..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-- 158 (288)
T cd07871 85 LD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-- 158 (288)
T ss_pred CC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--
Confidence 96 5999999876666899999999999999999999 89999999999999999999999999999976533221
Q ss_pred eeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 254 TRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
......+++.|+|||.+.+ ..++.++||||+|+++|||+||+.||...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~ 207 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS 207 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2233467899999998765 56899999999999999999999999753
No 57
>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=3.8e-43 Score=311.49 Aligned_cols=247 Identities=28% Similarity=0.389 Sum_probs=191.4
Q ss_pred HhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHH--------------HHHHHHHHHHHHHhcCCCceeee
Q 037918 93 RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLER--------------AFRSFDSECEVLRSIRHRNLVKI 157 (361)
Q Consensus 93 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------------~~~~~~~e~~~l~~l~h~niv~~ 157 (361)
...++|++.+.||+|.||.|-+|+.. +++.||||++.+.... ..+...+|+.+|++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999954 7999999999754311 23578899999999999999999
Q ss_pred eeeeecC--CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcE
Q 037918 158 LSSCSNV--DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235 (361)
Q Consensus 158 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 235 (361)
+++..+. +..|||+|||..|.+...-... ..+++.++++++.++..||.||| .++|+||||||+|+|++++|++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~-~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDK-PELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCCc-ccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcE
Confidence 9999765 5789999999988875533222 22899999999999999999999 8999999999999999999999
Q ss_pred EEEeccCccccCCCC---cceeeecccccccccCccccCCCC----CCcccchHHHHHHHHHHHhCCCCCCccccccccH
Q 037918 236 HVSDFGISKLLGDGE---NFETRTMTMATVGYMAPEYGSEGI----VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSL 308 (361)
Q Consensus 236 kl~Dfg~a~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~ 308 (361)
||+|||.+....... .........|||.|+|||...++. .+.+.||||+||+||.|+.|+.||.+.+. ..+
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~--~~l 327 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE--LEL 327 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--HHH
Confidence 999999998663221 111223368999999999766522 46689999999999999999999975321 111
Q ss_pred HHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 309 KNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
. ..+++..+... ... +.-..+.+|++++|+.||++|+
T Consensus 328 ---~--------~KIvn~pL~fP--~~p---e~~e~~kDli~~lL~KdP~~Ri 364 (576)
T KOG0585|consen 328 ---F--------DKIVNDPLEFP--ENP---EINEDLKDLIKRLLEKDPEQRI 364 (576)
T ss_pred ---H--------HHHhcCcccCC--Ccc---cccHHHHHHHHHHhhcChhhee
Confidence 1 22223222211 111 2233478999999999999995
No 58
>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C. Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory
Probab=100.00 E-value=2.1e-42 Score=315.12 Aligned_cols=239 Identities=24% Similarity=0.279 Sum_probs=191.0
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCC-ceeeeeeeeecCCeeEEEE
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHR-NLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~ 171 (361)
+|++.+.||+|+||.||+|... +++.||+|++.... ....+.+..|.+++..+.|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999965 57899999997643 23456678899999999765 6888999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
||+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 81 E~~~~g~L~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVGK-FKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 99999999999976543 789999999999999999999 88999999999999999999999999999875322111
Q ss_pred ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918 252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
......|++.|+|||++.+..++.++|||||||++|||+||+.||...... ........ .. ..+..
T Consensus 157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i~~---~~------~~~~~- 222 (324)
T cd05587 157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELFQSIME---HN------VSYPK- 222 (324)
T ss_pred --ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHc---CC------CCCCC-
Confidence 223456899999999999988999999999999999999999999753221 11111110 00 00000
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||+.||++||
T Consensus 223 --------~~~~~~~~li~~~l~~~P~~R~ 244 (324)
T cd05587 223 --------SLSKEAVSICKGLLTKHPAKRL 244 (324)
T ss_pred --------CCCHHHHHHHHHHhhcCHHHcC
Confidence 1122478899999999999996
No 59
>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor
Probab=100.00 E-value=2.1e-42 Score=314.18 Aligned_cols=243 Identities=29% Similarity=0.475 Sum_probs=193.1
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCc----EEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGA----EVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL 169 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (361)
.+|++.+.||+|+||.||+|.+. ++. .||+|.+.... ....+.+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46899999999999999999853 333 48999986543 34456788999999999999999999999765 5679
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918 170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 249 (361)
++||+++|+|.+++......+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 99999999999999877666899999999999999999999 889999999999999999999999999999877544
Q ss_pred CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL 328 (361)
Q Consensus 250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l 328 (361)
..........++..|+|||++.+..++.++||||||+++|||++ |+.||......+ +........
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~~~~~~~~~------------ 228 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGE------------ 228 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHhCCC------------
Confidence 33222223345678999999999899999999999999999998 999987532211 111111110
Q ss_pred cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
....+ ..+...+.+++.+||+.||++||
T Consensus 229 ~~~~~-----~~~~~~~~~li~~cl~~~p~~Rp 256 (316)
T cd05108 229 RLPQP-----PICTIDVYMIMVKCWMIDADSRP 256 (316)
T ss_pred CCCCC-----CCCCHHHHHHHHHHccCChhhCc
Confidence 00000 01223478999999999999998
No 60
>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N. Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved
Probab=100.00 E-value=1.4e-42 Score=316.27 Aligned_cols=237 Identities=22% Similarity=0.273 Sum_probs=188.3
Q ss_pred CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHH---HhcCCCceeeeeeeeecCCeeEEE
Q 037918 98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVL---RSIRHRNLVKILSSCSNVDFKALV 170 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv 170 (361)
|++.+.||+|+||.||+|... +|+.||||+++... ....+.+..|.+++ +.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999965 68999999997543 22345566676665 456899999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918 171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE 250 (361)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 250 (361)
|||+++++|..++... .+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 9999999999988654 3899999999999999999999 8999999999999999999999999999987532211
Q ss_pred cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918 251 NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330 (361)
Q Consensus 251 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 330 (361)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... +......... .....
T Consensus 156 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-----~~~~~i~~~~------~~~p~ 222 (324)
T cd05589 156 --DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-----EVFDSIVNDE------VRYPR 222 (324)
T ss_pred --CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCC------CCCCC
Confidence 1223456899999999999888999999999999999999999999753221 1111110000 00000
Q ss_pred CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||+.||++||
T Consensus 223 ---------~~~~~~~~li~~~L~~dP~~R~ 244 (324)
T cd05589 223 ---------FLSREAISIMRRLLRRNPERRL 244 (324)
T ss_pred ---------CCCHHHHHHHHHHhhcCHhHcC
Confidence 1123478899999999999997
No 61
>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=1.4e-42 Score=303.52 Aligned_cols=245 Identities=25% Similarity=0.320 Sum_probs=200.1
Q ss_pred CCCCCCCccccCCceEEEEEEeCC-CcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILSD-GAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
+.|+.++.||.|.-|+||++...+ +..+|+|++.+.. .+...+...|-+||+.++||.++.+|..++.+...+++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 457778899999999999999764 6889999998764 345567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918 172 EFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE 250 (361)
Q Consensus 172 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 250 (361)
|||+||+|..+++++ +..+++..++.++.+++-||+||| ..|||+|||||+||||.++|++.|+||.++.......
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999999999865 455899999999999999999999 9999999999999999999999999999874321100
Q ss_pred ---------------------------------c---------------------ceeeecccccccccCccccCCCCCC
Q 037918 251 ---------------------------------N---------------------FETRTMTMATVGYMAPEYGSEGIVS 276 (361)
Q Consensus 251 ---------------------------------~---------------------~~~~~~~~g~~~y~aPE~~~~~~~~ 276 (361)
. .......+||-.|.|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0111234689999999999999999
Q ss_pred cccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCC
Q 037918 277 SKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYS 356 (361)
Q Consensus 277 ~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~d 356 (361)
.++|+|+|||++|||+.|..||.+....+. + .+++-+.+..... ...+..+.+||.+.|..|
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~T-l------------~NIv~~~l~Fp~~-----~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKET-L------------RNIVGQPLKFPEE-----PEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhh-H------------HHHhcCCCcCCCC-----CcchhHHHHHHHHHhccC
Confidence 999999999999999999999987543221 1 3333332222111 123445799999999999
Q ss_pred CCCCC
Q 037918 357 PDQRI 361 (361)
Q Consensus 357 P~~RP 361 (361)
|.+|.
T Consensus 376 P~kRl 380 (459)
T KOG0610|consen 376 PSKRL 380 (459)
T ss_pred hhhhh
Confidence 99994
No 62
>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity. Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....
Probab=100.00 E-value=4.6e-43 Score=309.42 Aligned_cols=239 Identities=35% Similarity=0.582 Sum_probs=188.1
Q ss_pred CCccccCCceEEEEEEeC-----CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918 101 CNLLGKGSFGSVYKGILS-----DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 101 ~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
.+.||.|.||.||+|.+. .+..|+||.++... ....+.+.+|++.+++++||||++++|++...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 468999999999999975 35789999996543 344688999999999999999999999999888899999999
Q ss_pred CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 175 PNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 175 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
++|+|.+++... ...+++..++.++.|+++||+||| +.+++|+||+++||++++++.+||+|||++..........
T Consensus 84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred ccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccc
Confidence 999999999987 556899999999999999999999 8899999999999999999999999999998874433333
Q ss_pred eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 332 (361)
..........|+|||.+.+..++.++||||||+++|||++ |+.||.+... ..+...+.... . ...
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--~~~~~~~~~~~-----------~-~~~ 226 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--EEIIEKLKQGQ-----------R-LPI 226 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--HHHHHHHHTTE-----------E-TTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccc-----------c-cee
Confidence 3344567888999999988889999999999999999999 7899876522 12222211110 0 000
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+. .++..+.+++.+||+.||++||
T Consensus 227 ~~-----~~~~~~~~li~~C~~~~p~~RP 250 (259)
T PF07714_consen 227 PD-----NCPKDIYSLIQQCWSHDPEKRP 250 (259)
T ss_dssp BT-----TSBHHHHHHHHHHT-SSGGGS-
T ss_pred cc-----chhHHHHHHHHHHcCCChhhCc
Confidence 00 1234488999999999999998
No 63
>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica
Probab=100.00 E-value=1.2e-42 Score=321.93 Aligned_cols=202 Identities=24% Similarity=0.382 Sum_probs=175.5
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46889999999999999999965 68999999997543 233456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
||+++|+|.+++...+. +++..+..++.|++.||+||| +.+|+||||||+|||++.++.++|+|||++..+.....
T Consensus 81 E~~~~g~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMKKDT-FTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 99999999999986553 899999999999999999999 88999999999999999999999999999876432110
Q ss_pred ce------------------------------------eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCC
Q 037918 252 FE------------------------------------TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRK 295 (361)
Q Consensus 252 ~~------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~ 295 (361)
.. ......||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 00 001235899999999998888999999999999999999999
Q ss_pred CCCCcc
Q 037918 296 KPTDEF 301 (361)
Q Consensus 296 ~p~~~~ 301 (361)
.||...
T Consensus 237 ~Pf~~~ 242 (364)
T cd05599 237 PPFCSD 242 (364)
T ss_pred CCCCCC
Confidence 999754
No 64
>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]
Probab=100.00 E-value=3.3e-43 Score=288.10 Aligned_cols=251 Identities=21% Similarity=0.286 Sum_probs=199.0
Q ss_pred hhCCCCCCCccccCCceEEEEEE-eCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecC-----Cee
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNV-----DFK 167 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 167 (361)
..++|.+.+.||+|||+-||.++ ..++..+|+|++.....+..+..++|++..++++|||+++++++...+ ...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 45689999999999999999999 567899999999888777788999999999999999999999987443 358
Q ss_pred EEEEEecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918 168 ALVLEFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK 244 (361)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 244 (361)
|++++|...|+|.+.+.. ++..+++.+++.|+.++++||++||.. ..+++||||||.|||+++++.++|.|||.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999999874 355699999999999999999999943 3349999999999999999999999999987
Q ss_pred ccCCCCc-------ceeeecccccccccCccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhh
Q 037918 245 LLGDGEN-------FETRTMTMATVGYMAPEYGS---EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKE 314 (361)
Q Consensus 245 ~~~~~~~-------~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~ 314 (361)
...-.-. .........|..|+|||.+. +...++++|||||||+||+|+.|..||+.......++.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla----- 252 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA----- 252 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE-----
Confidence 6532110 11122335788999999764 45678999999999999999999999986543222211
Q ss_pred hcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 315 SLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 315 ~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..+....+...... .....+.+++.+|++.||.+||
T Consensus 253 ------LAv~n~q~s~P~~~-----~yse~l~~lik~mlqvdP~qRP 288 (302)
T KOG2345|consen 253 ------LAVQNAQISIPNSS-----RYSEALHQLIKSMLQVDPNQRP 288 (302)
T ss_pred ------EeeeccccccCCCC-----CccHHHHHHHHHHhcCCcccCC
Confidence 12222222211111 1234589999999999999999
No 65
>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=3.1e-43 Score=323.25 Aligned_cols=239 Identities=26% Similarity=0.356 Sum_probs=196.6
Q ss_pred CCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
+-|...+.||.|+.|.|-+|++ .+|+.+|||++.... ......+.+|+-+|+.+.|||++++|++|++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3467788999999999999995 579999999997652 233456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
||++||-|.+++-.++. +++.++.++++||+.|+.|+| ..+|+|||+||+|+|+|..+++||+|||+|..-..+..
T Consensus 92 Eyv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL 167 (786)
T ss_pred EecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence 99999999999987765 889999999999999999999 88999999999999999999999999999987554443
Q ss_pred ceeeecccccccccCccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918 252 FETRTMTMATVGYMAPEYGSEGIV-SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 330 (361)
. ...+|++.|.|||++.+.+| +.++||||.|||||.|+||+.||++ .++...+...-.+. -+
T Consensus 168 L---eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-----dNir~LLlKV~~G~-f~-------- 230 (786)
T KOG0588|consen 168 L---ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-----DNIRVLLLKVQRGV-FE-------- 230 (786)
T ss_pred c---cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-----ccHHHHHHHHHcCc-cc--------
Confidence 3 33479999999999999876 5689999999999999999999984 22222221111110 00
Q ss_pred CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.| .+...+..+|+.+|+..||++|.
T Consensus 231 -MP-----s~Is~eaQdLLr~ml~VDp~~Ri 255 (786)
T KOG0588|consen 231 -MP-----SNISSEAQDLLRRMLDVDPSTRI 255 (786)
T ss_pred -CC-----CcCCHHHHHHHHHHhccCccccc
Confidence 01 12233468899999999999995
No 66
>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and
Probab=100.00 E-value=3.4e-42 Score=313.67 Aligned_cols=239 Identities=24% Similarity=0.287 Sum_probs=191.2
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEE
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 171 (361)
+|.+.+.||+|+||.||+|... +++.||+|++.... ......+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999965 57899999998643 22334567788888777 5899999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
||+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++........
T Consensus 81 E~~~~g~L~~~~~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQVGR-FKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred cCCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 99999999999876544 889999999999999999999 88999999999999999999999999999975432211
Q ss_pred ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918 252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
......|++.|+|||++.+..++.++|||||||++|||+||+.||...... .+...... . ...
T Consensus 157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~~~i~~---~--------~~~-- 219 (323)
T cd05616 157 --TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSIME---H--------NVA-- 219 (323)
T ss_pred --ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HHHHHHHh---C--------CCC--
Confidence 223456899999999999999999999999999999999999999754221 11111111 0 000
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+. .....+.+++.+|++.||++|+
T Consensus 220 ~p~-----~~s~~~~~li~~~l~~~p~~R~ 244 (323)
T cd05616 220 YPK-----SMSKEAVAICKGLMTKHPGKRL 244 (323)
T ss_pred CCC-----cCCHHHHHHHHHHcccCHHhcC
Confidence 000 1123478999999999999996
No 67
>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal
Probab=100.00 E-value=2.8e-42 Score=313.70 Aligned_cols=234 Identities=24% Similarity=0.320 Sum_probs=187.9
Q ss_pred CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEEecCC
Q 037918 102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLEFMPN 176 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (361)
+.||+|+||.||+|... +++.||+|++.... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999965 58899999997543 23345677888888876 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918 177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256 (361)
Q Consensus 177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 256 (361)
|+|.+++..... +++..+..++.|++.||+||| +.+++||||||+|||++.++.+||+|||++....... ....
T Consensus 81 g~L~~~i~~~~~-l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSRR-FDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTS 154 (320)
T ss_pred chHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cccc
Confidence 999999876543 899999999999999999999 8999999999999999999999999999987543221 1223
Q ss_pred cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918 257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA 336 (361)
Q Consensus 257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~ 336 (361)
...|++.|+|||++.+..++.++||||||+++|||++|+.||...... .......... .. .+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~i~~~~--------~~--~~~-- 217 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-----DLFEAILNDE--------VV--YPT-- 217 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----HHHHHHhcCC--------CC--CCC--
Confidence 356899999999999888999999999999999999999999753221 1111111100 00 000
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 337 AKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 337 ~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||+.||++||
T Consensus 218 ---~~~~~~~~li~~~L~~dP~~R~ 239 (320)
T cd05590 218 ---WLSQDAVDILKAFMTKNPTMRL 239 (320)
T ss_pred ---CCCHHHHHHHHHHcccCHHHCC
Confidence 0123478999999999999997
No 68
>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=100.00 E-value=6.7e-42 Score=312.98 Aligned_cols=244 Identities=23% Similarity=0.264 Sum_probs=191.6
Q ss_pred CCCCCCccccCCceEEEEEEe----CCCcEEEEEEeehhh----HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCee
Q 037918 97 GFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIFNLQL----ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFK 167 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 167 (361)
+|++.+.||+|+||.||+++. .+++.||+|++.... ....+.+..|+.++.++ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999885 357899999997542 23345678899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918 168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG 247 (361)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 247 (361)
++||||+++|+|.+++..+.. +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDN-FSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 999999999999999976543 899999999999999999999 8899999999999999999999999999998653
Q ss_pred CCCcceeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccc
Q 037918 248 DGENFETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE 326 (361)
Q Consensus 248 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 326 (361)
..... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||........ ........... ++
T Consensus 157 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~------~~ 228 (332)
T cd05614 157 SEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILKC------DP 228 (332)
T ss_pred ccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhcC------CC
Confidence 32221 22234689999999988765 478899999999999999999999964322111 11111111100 01
Q ss_pred cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+... ....+.+++.+||+.||++||
T Consensus 229 ~~~~~---------~~~~~~~li~~~l~~dp~~R~ 254 (332)
T cd05614 229 PFPSF---------IGPEAQDLLHKLLRKDPKKRL 254 (332)
T ss_pred CCCCC---------CCHHHHHHHHHHcCCCHHHcC
Confidence 11111 123478899999999999997
No 69
>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer
Probab=100.00 E-value=4.5e-42 Score=307.03 Aligned_cols=244 Identities=28% Similarity=0.515 Sum_probs=195.4
Q ss_pred CCCCCCCccccCCceEEEEEEeCC------CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILSD------GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (361)
++|++.+.||+|+||.||+|.... ...||+|.+.... ......+.+|++++.+++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468889999999999999998542 2579999887543 334567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC
Q 037918 169 LVLEFMPNGSLEKWLYSHN---------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM 233 (361)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~ 233 (361)
++|||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence 9999999999999997531 34788999999999999999999 88999999999999999999
Q ss_pred cEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHH
Q 037918 234 VAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWV 312 (361)
Q Consensus 234 ~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~ 312 (361)
.++|+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||......+ ....+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--~~~~i 239 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--VIEMI 239 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH
Confidence 999999999986543332222233456788999999888889999999999999999998 999987543221 11111
Q ss_pred hhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 313 KESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 313 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.... .. .. ..+++..+.+++.+||+.||++||
T Consensus 240 ~~~~---~~---------~~-----~~~~~~~~~~l~~~c~~~~p~~Rp 271 (283)
T cd05048 240 RSRQ---LL---------PC-----PEDCPARVYALMIECWNEIPARRP 271 (283)
T ss_pred HcCC---cC---------CC-----cccCCHHHHHHHHHHccCChhhCc
Confidence 1110 00 00 113345689999999999999998
No 70
>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o
Probab=100.00 E-value=4.4e-42 Score=313.48 Aligned_cols=240 Identities=21% Similarity=0.289 Sum_probs=188.8
Q ss_pred CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEEecCC
Q 037918 102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLEFMPN 176 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (361)
+.||+|+||.||++... +++.||+|++.... ......+..|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 68899999998642 23445677888888877 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918 177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256 (361)
Q Consensus 177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 256 (361)
|+|..++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTS 154 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cccc
Confidence 99999887654 3899999999999999999999 8899999999999999999999999999987542211 1223
Q ss_pred cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcccccc---ccHHHHHhhhcCCCccccccccccCCch
Q 037918 257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE---MSLKNWVKESLPHGLTNVVDENLLLEEP 333 (361)
Q Consensus 257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 333 (361)
...|++.|+|||++.+..++.++||||||+++|||++|+.||....... .....+....+.. .... .+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~-------~~~~--~p 225 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-------KQIR--IP 225 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc-------CCCC--CC
Confidence 3568999999999999999999999999999999999999996422111 1112222111100 0000 00
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 334 AFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
. .....+.+++.+||+.||++||
T Consensus 226 ~-----~~~~~~~~ll~~~L~~dP~~R~ 248 (329)
T cd05618 226 R-----SLSVKAASVLKSFLNKDPKERL 248 (329)
T ss_pred C-----CCCHHHHHHHHHHhcCCHHHcC
Confidence 0 1123478999999999999997
No 71
>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl
Probab=100.00 E-value=6.5e-42 Score=312.45 Aligned_cols=240 Identities=21% Similarity=0.295 Sum_probs=189.6
Q ss_pred CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEEecCC
Q 037918 102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLEFMPN 176 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (361)
+.||+|+||.||++... +++.||+|+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999965 68899999998643 23345678899999988 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918 177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256 (361)
Q Consensus 177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 256 (361)
|+|.+++...+ .+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++....... ....
T Consensus 81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTS 154 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC--Cccc
Confidence 99999887654 3899999999999999999999 8999999999999999999999999999987532211 1223
Q ss_pred cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcccccc---ccHHHHHhhhcCCCccccccccccCCch
Q 037918 257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE---MSLKNWVKESLPHGLTNVVDENLLLEEP 333 (361)
Q Consensus 257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 333 (361)
...|++.|+|||++.+..++.++|+||||+++|||++|+.||......+ ....++....+.. ..... +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~--p 225 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE-------KQIRI--P 225 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc-------CCCCC--C
Confidence 3568999999999999899999999999999999999999996432111 1112222111111 00000 0
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 334 AFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
. .....+.+++.+||+.||++||
T Consensus 226 ~-----~~~~~~~~li~~~L~~dP~~R~ 248 (329)
T cd05588 226 R-----SLSVKASSVLKGFLNKDPKERL 248 (329)
T ss_pred C-----CCCHHHHHHHHHHhccCHHHcC
Confidence 0 1123478999999999999996
No 72
>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to
Probab=100.00 E-value=3.4e-42 Score=313.36 Aligned_cols=234 Identities=25% Similarity=0.295 Sum_probs=187.6
Q ss_pred CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEEecCC
Q 037918 102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLEFMPN 176 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (361)
+.||+|+||.||+|... +++.||+|++.... ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 57899999997643 23345677888888876 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918 177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256 (361)
Q Consensus 177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 256 (361)
++|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~ 154 (321)
T cd05591 81 GDLMFQIQRSRK-FDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTT 154 (321)
T ss_pred CcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--ccc
Confidence 999999876543 889999999999999999999 88999999999999999999999999999876432221 223
Q ss_pred cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918 257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA 336 (361)
Q Consensus 257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~ 336 (361)
...|++.|+|||++.+..++.++||||||+++|||++|+.||......+ ......... .. .+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-----~~~~i~~~~--------~~--~p~-- 217 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-----LFESILHDD--------VL--YPV-- 217 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH-----HHHHHHcCC--------CC--CCC--
Confidence 3468999999999998889999999999999999999999997542211 111111100 00 000
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 337 AKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 337 ~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||+.||++||
T Consensus 218 ---~~~~~~~~ll~~~L~~dp~~R~ 239 (321)
T cd05591 218 ---WLSKEAVSILKAFMTKNPNKRL 239 (321)
T ss_pred ---CCCHHHHHHHHHHhccCHHHcC
Confidence 0123478999999999999997
No 73
>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g
Probab=100.00 E-value=1.5e-41 Score=303.23 Aligned_cols=237 Identities=24% Similarity=0.302 Sum_probs=188.1
Q ss_pred cccCCceEEEEEEeC-CCcEEEEEEeehhhH---HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCH
Q 037918 104 LGKGSFGSVYKGILS-DGAEVAIKIFNLQLE---RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSL 179 (361)
Q Consensus 104 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 179 (361)
||+|+||+||++... +|+.+|+|.+..... ...+.+..|+++++.++||||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999964 688999999875432 2345678899999999999999999999999999999999999999
Q ss_pred HHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918 180 EKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256 (361)
Q Consensus 180 ~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 256 (361)
.+++.. ....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 988753 2345899999999999999999999 88999999999999999999999999999976643322 122
Q ss_pred cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918 257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA 336 (361)
Q Consensus 257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~ 336 (361)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ............ ... .+
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~--------~~~--~~--- 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRILND--------SVT--YP--- 221 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHhhccc--------CCC--Cc---
Confidence 3468999999999999999999999999999999999999997532111 111111111100 000 00
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 337 AKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 337 ~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
......+.+++.+||+.||++||
T Consensus 222 --~~~~~~~~~li~~~l~~~P~~R~ 244 (280)
T cd05608 222 --DKFSPASKSFCEALLAKDPEKRL 244 (280)
T ss_pred --ccCCHHHHHHHHHHhcCCHHHhc
Confidence 01233478999999999999997
No 74
>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus
Probab=100.00 E-value=5.5e-42 Score=317.15 Aligned_cols=202 Identities=25% Similarity=0.367 Sum_probs=175.6
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
++|++.+.||+|+||+||++... +++.||+|++.... ......+..|+.++.+++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46889999999999999999864 68999999997543 233456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 9999999999998654 3899999999999999999999 89999999999999999999999999999876532110
Q ss_pred c---------------------------------eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCC
Q 037918 252 F---------------------------------ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPT 298 (361)
Q Consensus 252 ~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~ 298 (361)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0 0012346999999999999889999999999999999999999999
Q ss_pred Ccc
Q 037918 299 DEF 301 (361)
Q Consensus 299 ~~~ 301 (361)
...
T Consensus 237 ~~~ 239 (363)
T cd05628 237 CSE 239 (363)
T ss_pred CCC
Confidence 753
No 75
>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien
Probab=100.00 E-value=3.9e-42 Score=313.49 Aligned_cols=234 Identities=26% Similarity=0.282 Sum_probs=187.9
Q ss_pred CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCC
Q 037918 102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNG 177 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 177 (361)
+.||+|+||.||++... +|+.||+|++.... ......+..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 68999999997643 233456778999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918 178 SLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS-PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256 (361)
Q Consensus 178 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 256 (361)
+|.+++.... .+++..+..++.|++.||+||| + .+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~ 154 (325)
T cd05594 81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMK 154 (325)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccc
Confidence 9999887654 3899999999999999999999 6 7999999999999999999999999999875432211 122
Q ss_pred cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918 257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA 336 (361)
Q Consensus 257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~ 336 (361)
...|++.|+|||++.+..++.++||||||+++|||+||+.||....... ..... .... ..+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--~~~~i---~~~~------~~~p~~----- 218 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELI---LMEE------IRFPRT----- 218 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH--HHHHH---hcCC------CCCCCC-----
Confidence 3468999999999988889999999999999999999999996532211 11111 0000 000001
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 337 AKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 337 ~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
....+.+++.+||+.||++|+
T Consensus 219 ----~~~~~~~li~~~L~~dP~~R~ 239 (325)
T cd05594 219 ----LSPEAKSLLSGLLKKDPKQRL 239 (325)
T ss_pred ----CCHHHHHHHHHHhhcCHHHhC
Confidence 122478899999999999995
No 76
>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp
Probab=100.00 E-value=5.2e-42 Score=311.37 Aligned_cols=234 Identities=24% Similarity=0.298 Sum_probs=185.5
Q ss_pred CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEEecCC
Q 037918 102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLEFMPN 176 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (361)
+.||+|+||.||+|... +++.||+|+++... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999965 57899999997643 22334556677777654 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918 177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256 (361)
Q Consensus 177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 256 (361)
|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 g~L~~~~~~~~~-~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSGR-FDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS 154 (316)
T ss_pred CcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence 999999976543 899999999999999999999 8899999999999999999999999999997643322 1223
Q ss_pred cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918 257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA 336 (361)
Q Consensus 257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~ 336 (361)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+.... +.+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~--~~~~i~~~~---------~~~~~------ 217 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE--LFDSILNDR---------PHFPR------ 217 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHcCC---------CCCCC------
Confidence 4568999999999998889999999999999999999999997532211 111111000 00000
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 337 AKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 337 ~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||+.||++||
T Consensus 218 ---~~~~~~~~ll~~~l~~~P~~R~ 239 (316)
T cd05592 218 ---WISKEAKDCLSKLFERDPTKRL 239 (316)
T ss_pred ---CCCHHHHHHHHHHccCCHHHcC
Confidence 0122368899999999999997
No 77
>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=1e-42 Score=313.71 Aligned_cols=242 Identities=24% Similarity=0.314 Sum_probs=202.2
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCe-eEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF-KALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~ 171 (361)
++|..++++|+|+||.++..+.+ ++..+++|.+.... ....+...+|+.++++++|||||.+.+.|..++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999999865 67899999887543 4444578899999999999999999999998888 99999
Q ss_pred EecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918 172 EFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE 250 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 250 (361)
+|++||+|.+.+...+ ..++++.+..|+.|++.|+.||| +..|+|||||+.|||++.++.++|+|||+|+.+....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999998654 66899999999999999999999 8899999999999999999999999999999987654
Q ss_pred cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918 251 NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330 (361)
Q Consensus 251 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 330 (361)
. ......||+.|++||++.+.+|..|+|||||||++|||++-+++|......+ .+....+.. .. .+..
T Consensus 161 ~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~-----Li~ki~~~~----~~-Plp~ 228 (426)
T KOG0589|consen 161 S--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE-----LILKINRGL----YS-PLPS 228 (426)
T ss_pred h--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH-----HHHHHhhcc----CC-CCCc
Confidence 2 3345689999999999999999999999999999999999999998643221 111111111 00 1111
Q ss_pred CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
....++..++..|++.+|+.||
T Consensus 229 ---------~ys~el~~lv~~~l~~~P~~RP 250 (426)
T KOG0589|consen 229 ---------MYSSELRSLVKSMLRKNPEHRP 250 (426)
T ss_pred ---------cccHHHHHHHHHHhhcCCccCC
Confidence 1234588999999999999998
No 78
>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an
Probab=100.00 E-value=3.2e-42 Score=320.96 Aligned_cols=201 Identities=23% Similarity=0.317 Sum_probs=173.3
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE 172 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (361)
.|+.++.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999964 68899999997543 3345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc-
Q 037918 173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN- 251 (361)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~- 251 (361)
|+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 999999999997654 3789999999999999999999 88999999999999999999999999999753311000
Q ss_pred --------------------------------------------ceeeecccccccccCccccCCCCCCcccchHHHHHH
Q 037918 252 --------------------------------------------FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVL 287 (361)
Q Consensus 252 --------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~i 287 (361)
........||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000112368999999999998899999999999999
Q ss_pred HHHHHhCCCCCCcc
Q 037918 288 LMETFTRKKPTDEF 301 (361)
Q Consensus 288 l~elltg~~p~~~~ 301 (361)
+|||++|+.||...
T Consensus 238 l~elltG~~Pf~~~ 251 (382)
T cd05625 238 LYEMLVGQPPFLAQ 251 (382)
T ss_pred HHHHHhCCCCCCCC
Confidence 99999999999754
No 79
>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1. Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=1.1e-41 Score=311.49 Aligned_cols=199 Identities=27% Similarity=0.343 Sum_probs=175.0
Q ss_pred hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE 172 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (361)
.++|++.+.||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 467999999999999999999975 68889999887543 3344678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS-PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
|+++++|.+++...+. +++..+..++.|++.||.||| + .+++|+||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred cCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 9999999999986543 889999999999999999999 5 47999999999999999999999999998765332
Q ss_pred ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 122346899999999998888999999999999999999999999753
No 80
>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]
Probab=100.00 E-value=2.9e-42 Score=327.87 Aligned_cols=245 Identities=23% Similarity=0.309 Sum_probs=197.9
Q ss_pred hhCCCCCCCccccCCceEEEEEEeCCC-cEEEEEEeehhhHHHHHHHHHHHHHHHhcC-CCceeeeeeee-ec------C
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILSDG-AEVAIKIFNLQLERAFRSFDSECEVLRSIR-HRNLVKILSSC-SN------V 164 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~-~~------~ 164 (361)
...++++.+.|.+|||+.||.|....+ ..+|+|++-...+...+.+.+|+++|++|+ |+|||.+++.. .. .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345577889999999999999997665 999999998778888899999999999996 99999999932 11 1
Q ss_pred CeeEEEEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCc
Q 037918 165 DFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGIS 243 (361)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 243 (361)
-..+|.||||.||.|-++++.+ ...+++.++++|+.|+++|+++||.. +.+|||||||-+||||+.+++.||||||.|
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 2567999999999999999854 23399999999999999999999955 778999999999999999999999999998
Q ss_pred cccCCCCc-cee------eecccccccccCccc---cCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHh
Q 037918 244 KLLGDGEN-FET------RTMTMATVGYMAPEY---GSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313 (361)
Q Consensus 244 ~~~~~~~~-~~~------~~~~~g~~~y~aPE~---~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~ 313 (361)
........ ... .-...-|+.|+|||+ ..+..+++|+|||||||+||-|+....||++...
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---------- 263 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---------- 263 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------
Confidence 75432221 000 011246899999996 4678899999999999999999999999986421
Q ss_pred hhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 314 ESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 314 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..+++.++..... . .....+.+||..||++||++||
T Consensus 264 -------laIlng~Y~~P~~--p---~ys~~l~~LI~~mL~~nP~~RP 299 (738)
T KOG1989|consen 264 -------LAILNGNYSFPPF--P---NYSDRLKDLIRTMLQPNPDERP 299 (738)
T ss_pred -------eeEEeccccCCCC--c---cHHHHHHHHHHHHhccCcccCC
Confidence 3444444433321 1 2344589999999999999998
No 81
>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of
Probab=100.00 E-value=3.2e-42 Score=320.44 Aligned_cols=202 Identities=25% Similarity=0.360 Sum_probs=173.9
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
++|.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46889999999999999999864 68999999987542 334567888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 9999999999998654 3889999999999999999999 89999999999999999999999999999964321100
Q ss_pred c------------e---------------------------------eeecccccccccCccccCCCCCCcccchHHHHH
Q 037918 252 F------------E---------------------------------TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGV 286 (361)
Q Consensus 252 ~------------~---------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~ 286 (361)
. . ......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 0 001246899999999998888999999999999
Q ss_pred HHHHHHhCCCCCCcc
Q 037918 287 LLMETFTRKKPTDEF 301 (361)
Q Consensus 287 il~elltg~~p~~~~ 301 (361)
++|||++|..||...
T Consensus 237 il~elltG~~Pf~~~ 251 (377)
T cd05629 237 IMFECLIGWPPFCSE 251 (377)
T ss_pred hhhhhhcCCCCCCCC
Confidence 999999999999753
No 82
>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-
Probab=100.00 E-value=1.5e-41 Score=316.39 Aligned_cols=247 Identities=25% Similarity=0.438 Sum_probs=194.0
Q ss_pred hhCCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcC-CCceeeeeeeeecCC
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIR-HRNLVKILSSCSNVD 165 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 165 (361)
..++|.+.+.||+|+||.||+|... .+..||||++.... ....+.+.+|+++++++. ||||+++++++.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3567889999999999999999852 13469999997543 334467899999999996 999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhcCC----------------------------------------------------------
Q 037918 166 FKALVLEFMPNGSLEKWLYSHN---------------------------------------------------------- 187 (361)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 187 (361)
..++||||+++|+|.+++..+.
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999999886421
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc
Q 037918 188 -------------------------------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD 230 (361)
Q Consensus 188 -------------------------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~ 230 (361)
..+++..+..++.|++.||+||| +.+++|+||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEe
Confidence 13677888999999999999999 88999999999999999
Q ss_pred CCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHH
Q 037918 231 ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLK 309 (361)
Q Consensus 231 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~ 309 (361)
.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||........ ..
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-~~ 350 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-FY 350 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-HH
Confidence 999999999999987644332222233456788999999988889999999999999999997 9999875432211 11
Q ss_pred HHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 310 NWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
....... ....+ ..++..+.+++.+||+.||++||
T Consensus 351 ~~~~~~~------------~~~~~-----~~~~~~l~~li~~cl~~dP~~RP 385 (400)
T cd05105 351 NKIKSGY------------RMAKP-----DHATQEVYDIMVKCWNSEPEKRP 385 (400)
T ss_pred HHHhcCC------------CCCCC-----ccCCHHHHHHHHHHCccCHhHCc
Confidence 1111100 00000 12334589999999999999998
No 83
>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt
Probab=100.00 E-value=6e-42 Score=305.68 Aligned_cols=244 Identities=30% Similarity=0.498 Sum_probs=195.4
Q ss_pred CCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhhHH-HHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQLER-AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (361)
++|.+.+.||+|+||.||+|... ++..||+|.+...... ..+.+.+|+++++.++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 46888899999999999999853 2478999998765433 4578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcE
Q 037918 169 LVLEFMPNGSLEKWLYSHN-------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235 (361)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 235 (361)
++|||+++++|.+++...+ ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence 9999999999999997542 23788899999999999999999 8899999999999999999999
Q ss_pred EEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhh
Q 037918 236 HVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKE 314 (361)
Q Consensus 236 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 314 (361)
+|+|||++................+++.|+|||++.+..++.++||||||+++|||++ |..||......+ ..+....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~~~~~~ 239 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VIECITQ 239 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHc
Confidence 9999999986543322222233346788999999999999999999999999999998 999986543211 1111111
Q ss_pred hcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 315 SLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 315 ~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..... .+ ...+..+.+++.+||+.||++||
T Consensus 240 ---~~~~~---------~~-----~~~~~~~~~li~~~l~~~p~~Rp 269 (280)
T cd05049 240 ---GRLLQ---------RP-----RTCPSEVYDIMLGCWKRDPQQRI 269 (280)
T ss_pred ---CCcCC---------CC-----CCCCHHHHHHHHHHcCCCcccCC
Confidence 00000 00 01233489999999999999998
No 84
>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the
Probab=100.00 E-value=1.5e-42 Score=319.67 Aligned_cols=245 Identities=22% Similarity=0.347 Sum_probs=195.9
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
++|.+.+.||+|+||.||+|... +|+.||+|++.... ......+..|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999965 68999999997643 134467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC-
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE- 250 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~- 250 (361)
||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999999876 34899999999999999999999 8999999999999999999999999999998764432
Q ss_pred --------------------------cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccc
Q 037918 251 --------------------------NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAG 304 (361)
Q Consensus 251 --------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~ 304 (361)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 001123346899999999999989999999999999999999999999754321
Q ss_pred cccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 305 EMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+ ....... .... . .+.... .....+.+++.+|+. ||++||
T Consensus 237 ~-~~~~i~~--~~~~---~---~~p~~~-------~~~~~~~~li~~ll~-dp~~R~ 276 (350)
T cd05573 237 E-TYNKIIN--WKES---L---RFPPDP-------PVSPEAIDLICRLLC-DPEDRL 276 (350)
T ss_pred H-HHHHHhc--cCCc---c---cCCCCC-------CCCHHHHHHHHHHcc-ChhhcC
Confidence 1 1111100 0000 0 000000 023347889999997 999997
No 85
>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment
Probab=100.00 E-value=1.3e-41 Score=301.36 Aligned_cols=245 Identities=27% Similarity=0.439 Sum_probs=196.7
Q ss_pred hCCCCCCCccccCCceEEEEEEeCC----CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILSD----GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL 169 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (361)
.++|++.+.||+|+||.||+|.+.. ...||+|.+.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578899999999999999999642 4579999887543 3344678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918 170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 249 (361)
+|||+++++|.+++......+++..++.++.|++.||+||| +.+|+|+||+|+||++++++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999876556899999999999999999999 899999999999999999999999999999887532
Q ss_pred CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL 328 (361)
Q Consensus 250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l 328 (361)
..........++..|+|||...+..++.++||||||+++|+|++ |..||...... ...+........
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~---------- 227 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAVEDGYRL---------- 227 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCCC----------
Confidence 22222222345678999999988889999999999999999998 99998653221 111221111000
Q ss_pred cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..+ .+++..+.+++.+||+.+|++||
T Consensus 228 --~~~-----~~~~~~l~~li~~cl~~~p~~Rp 253 (266)
T cd05033 228 --PPP-----MDCPSALYQLMLDCWQKDRNERP 253 (266)
T ss_pred --CCC-----CCCCHHHHHHHHHHcCCCcccCc
Confidence 000 12234588999999999999998
No 86
>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]
Probab=100.00 E-value=2.2e-42 Score=294.49 Aligned_cols=200 Identities=26% Similarity=0.359 Sum_probs=174.3
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHH--HHHHHHHHHHHHhcCCCceeeeeeeee--cCCeeEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERA--FRSFDSECEVLRSIRHRNLVKILSSCS--NVDFKALV 170 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv 170 (361)
++|+.++.|++|+||.||+|+++ +++.||+|+++.+.+.. --...+|+.+|.+.+|||||.+-.+.. +-+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45888899999999999999965 68999999998654321 123568999999999999999988764 44679999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918 171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE 250 (361)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 250 (361)
||||+. +|..++.+.+..+...++..++.|+++|++||| +..|+|||||++|+|++..|.+||+|||+|+.++...
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 999965 999999988877999999999999999999999 8899999999999999999999999999999987653
Q ss_pred cceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 251 NFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 251 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
...+..+-|.+|+|||.+.+ ..|+.+.|+||+|||+.||+++++-|.+.
T Consensus 232 --k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~ 281 (419)
T KOG0663|consen 232 --KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK 281 (419)
T ss_pred --ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC
Confidence 34566678999999997665 55999999999999999999999988763
No 87
>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I
Probab=100.00 E-value=1.9e-41 Score=307.70 Aligned_cols=234 Identities=23% Similarity=0.286 Sum_probs=186.7
Q ss_pred CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEEecCC
Q 037918 102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLEFMPN 176 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (361)
+.||+|+||.||+|... +|+.||+|+++... .........|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999975 68899999998653 22345567788888765 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918 177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256 (361)
Q Consensus 177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 256 (361)
|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||+++...... ....
T Consensus 81 g~L~~~i~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (316)
T cd05620 81 GDLMFHIQDKGR-FDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAS 154 (316)
T ss_pred CcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Ccee
Confidence 999999876543 889999999999999999999 8899999999999999999999999999987532211 1223
Q ss_pred cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918 257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA 336 (361)
Q Consensus 257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~ 336 (361)
...|++.|+|||++.+..++.++||||||+++|||++|+.||..... ..+.+...... +.+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~~~~~~~~~~~---------~~~~~------ 217 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--DELFESIRVDT---------PHYPR------ 217 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCC---------CCCCC------
Confidence 45689999999999998999999999999999999999999975321 11111111100 00000
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 337 AKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 337 ~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||+.||++||
T Consensus 218 ---~~~~~~~~li~~~l~~dP~~R~ 239 (316)
T cd05620 218 ---WITKESKDILEKLFERDPTRRL 239 (316)
T ss_pred ---CCCHHHHHHHHHHccCCHHHcC
Confidence 0122478899999999999997
No 88
>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate
Probab=100.00 E-value=1.9e-42 Score=314.74 Aligned_cols=234 Identities=28% Similarity=0.320 Sum_probs=188.9
Q ss_pred CccccCCceEEEEEEe----CCCcEEEEEEeehhhH--HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918 102 NLLGKGSFGSVYKGIL----SDGAEVAIKIFNLQLE--RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 175 (361)
+.||+|+||.||++.. .+|+.||+|++..... .....+..|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3588999999986532 233457789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee
Q 037918 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR 255 (361)
Q Consensus 176 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 255 (361)
+|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........ ..
T Consensus 82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~ 155 (318)
T cd05582 82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KA 155 (318)
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--ce
Confidence 999999997654 3899999999999999999999 88999999999999999999999999999986543221 22
Q ss_pred ecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhH
Q 037918 256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF 335 (361)
Q Consensus 256 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~ 335 (361)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .......... .. .+.
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-----~~~~~i~~~~--------~~--~p~- 219 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-----ETMTMILKAK--------LG--MPQ- 219 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-----HHHHHHHcCC--------CC--CCC-
Confidence 3456899999999998888899999999999999999999999753211 1111111100 00 000
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 336 AAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 336 ~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||+.||++||
T Consensus 220 ----~~~~~~~~li~~~l~~~P~~R~ 241 (318)
T cd05582 220 ----FLSPEAQSLLRALFKRNPANRL 241 (318)
T ss_pred ----CCCHHHHHHHHHHhhcCHhHcC
Confidence 1123478899999999999997
No 89
>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h
Probab=100.00 E-value=1.7e-41 Score=298.97 Aligned_cols=242 Identities=28% Similarity=0.389 Sum_probs=194.0
Q ss_pred CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918 96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 175 (361)
++|++.+.||+|+||.||++...++..+|+|.+..... ....+.+|++++++++||||+++++++.+.+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 45788899999999999999988888999998764432 23568889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee
Q 037918 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR 255 (361)
Q Consensus 176 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 255 (361)
+|+|.+++......+++..++.++.|++.||+||| +.+++|+||+|+||++++++.++|+|||.++....... ...
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ecc
Confidence 99999999865555899999999999999999999 88999999999999999999999999999986543222 122
Q ss_pred ecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918 256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334 (361)
Q Consensus 256 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 334 (361)
....++..|+|||...+..++.++|+||||+++|||++ |+.||..... ......+..... ...+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i~~~~~-----~~~~~------- 224 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMISRGFR-----LYRPK------- 224 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCC-----CCCCC-------
Confidence 22345668999999988889999999999999999999 8999865321 111111111100 00000
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 335 FAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||+.||++||
T Consensus 225 -----~~~~~~~~li~~c~~~~p~~Rp 246 (256)
T cd05114 225 -----LASMTVYEVMYSCWHEKPEGRP 246 (256)
T ss_pred -----CCCHHHHHHHHHHccCCcccCc
Confidence 0123479999999999999998
No 90
>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po
Probab=100.00 E-value=7.9e-42 Score=318.04 Aligned_cols=201 Identities=24% Similarity=0.309 Sum_probs=173.6
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE 172 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (361)
.|..++.||+|+||+||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999864 68899999997543 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
|+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++..+......
T Consensus 82 ~~~gg~L~~~l~~~~~-~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 9999999999986543 889999999999999999999 889999999999999999999999999997643210000
Q ss_pred ---------------------------------------------eeeecccccccccCccccCCCCCCcccchHHHHHH
Q 037918 253 ---------------------------------------------ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVL 287 (361)
Q Consensus 253 ---------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~i 287 (361)
.......||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00112469999999999988889999999999999
Q ss_pred HHHHHhCCCCCCcc
Q 037918 288 LMETFTRKKPTDEF 301 (361)
Q Consensus 288 l~elltg~~p~~~~ 301 (361)
+|||+||+.||...
T Consensus 238 l~elltG~~Pf~~~ 251 (381)
T cd05626 238 LFEMLVGQPPFLAP 251 (381)
T ss_pred HHHHHhCCCCCcCC
Confidence 99999999999754
No 91
>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase. Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor
Probab=100.00 E-value=2e-42 Score=316.13 Aligned_cols=245 Identities=23% Similarity=0.332 Sum_probs=194.8
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
++|.+.+.||+|+||.||++... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999965 68999999998653 234456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
||+++|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++..+.....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999999876556899999999999999999999 89999999999999999999999999999987654332
Q ss_pred ceeeecccccccccCccccC------CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccc
Q 037918 252 FETRTMTMATVGYMAPEYGS------EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVD 325 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 325 (361)
. ......|++.|+|||++. ...++.++|||||||++|||++|+.||....... .+...... ..
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-~~~~i~~~---~~------ 226 (330)
T cd05601 158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-TYNNIMNF---QR------ 226 (330)
T ss_pred e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-HHHHHHcC---CC------
Confidence 2 223346899999999876 4567899999999999999999999997532211 11111000 00
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 326 ENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 326 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+ ..+.. ......+.+++..|++ ||++||
T Consensus 227 -~~--~~~~~---~~~~~~~~~li~~ll~-~p~~R~ 255 (330)
T cd05601 227 -FL--KFPED---PKVSSDFLDLIQSLLC-GQKERL 255 (330)
T ss_pred -cc--CCCCC---CCCCHHHHHHHHHHcc-ChhhCC
Confidence 00 00000 0112347888999998 999997
No 92
>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes. Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular
Probab=100.00 E-value=1.6e-41 Score=298.34 Aligned_cols=238 Identities=29% Similarity=0.480 Sum_probs=188.5
Q ss_pred CccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCH
Q 037918 102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSL 179 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 179 (361)
+.||+|+||.||+|... +++.+|+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999964 78999999876433 33446789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeeccc
Q 037918 180 EKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM 259 (361)
Q Consensus 180 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 259 (361)
.+++......+++..++.++.|++.||+||| +.+++||||+|+||+++.++.+||+|||++................
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999866556899999999999999999999 8899999999999999999999999999987654321111111122
Q ss_pred ccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHH
Q 037918 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAK 338 (361)
Q Consensus 260 g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 338 (361)
.+..|+|||.+.+..++.++||||||+++|||++ |..||....... .........+. ..+.
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~~~~~~~~~~~------------~~~~---- 219 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--TREAIEQGVRL------------PCPE---- 219 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--HHHHHHcCCCC------------CCcc----
Confidence 3457999999988889999999999999999998 888886532211 11111111100 0000
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCC
Q 037918 339 MDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 339 ~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.++..+.+++.+|++.||++||
T Consensus 220 -~~~~~~~~li~~~l~~~p~~Rp 241 (252)
T cd05084 220 -LCPDAVYRLMERCWEYDPGQRP 241 (252)
T ss_pred -cCCHHHHHHHHHHcCCChhhCc
Confidence 1233588999999999999998
No 93
>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly
Probab=100.00 E-value=8.9e-42 Score=305.99 Aligned_cols=244 Identities=28% Similarity=0.448 Sum_probs=195.2
Q ss_pred CCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL 169 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (361)
++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 56888999999999999999842 345689999876655566789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEE
Q 037918 170 VLEFMPNGSLEKWLYSHN------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHV 237 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 237 (361)
+|||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+||++++++.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence 999999999999997432 24899999999999999999999 889999999999999999999999
Q ss_pred EeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhc
Q 037918 238 SDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESL 316 (361)
Q Consensus 238 ~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 316 (361)
+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||......+ .......
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~~~~i~~-- 237 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIECITQ-- 237 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHc--
Confidence 99999986643322222223345778999999988889999999999999999998 999986543211 1111111
Q ss_pred CCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 317 PHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 317 ~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..... ... ..+..+.+++.+||+.||.+||
T Consensus 238 -~~~~~-----~~~---------~~~~~l~~li~~~l~~~p~~Rp 267 (288)
T cd05093 238 -GRVLQ-----RPR---------TCPKEVYDLMLGCWQREPHMRL 267 (288)
T ss_pred -CCcCC-----CCC---------CCCHHHHHHHHHHccCChhhCC
Confidence 11000 000 1123489999999999999998
No 94
>PTZ00283 serine/threonine protein kinase; Provisional
Probab=100.00 E-value=4.1e-42 Score=328.61 Aligned_cols=249 Identities=26% Similarity=0.317 Sum_probs=197.5
Q ss_pred HHHhhCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC--
Q 037918 91 IQRATNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD-- 165 (361)
Q Consensus 91 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-- 165 (361)
.....++|.+.+.||+|+||.||+|.. .+|+.||||++... .......+.+|+.++..++|+|++++++.+...+
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 344557899999999999999999985 47899999998654 2344567889999999999999999988764332
Q ss_pred ------eeEEEEEecCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEE
Q 037918 166 ------FKALVLEFMPNGSLEKWLYSH---NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAH 236 (361)
Q Consensus 166 ------~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 236 (361)
..++||||+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEE
Confidence 367999999999999999743 345889999999999999999999 88999999999999999999999
Q ss_pred EEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhc
Q 037918 237 VSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESL 316 (361)
Q Consensus 237 l~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 316 (361)
|+|||+++.+.............||+.|+|||++.+..++.++||||||+++|||++|+.||.... ..+.+....
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----~~~~~~~~~ 258 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----MEEVMHKTL 258 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHh
Confidence 999999987654322222334569999999999999999999999999999999999999997532 122222211
Q ss_pred CCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 317 PHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 317 ~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
...... +.. .....+.+++.+||+.||++||
T Consensus 259 ~~~~~~-----~~~---------~~~~~l~~li~~~L~~dP~~RP 289 (496)
T PTZ00283 259 AGRYDP-----LPP---------SISPEMQEIVTALLSSDPKRRP 289 (496)
T ss_pred cCCCCC-----CCC---------CCCHHHHHHHHHHcccChhhCc
Confidence 111100 000 1233478999999999999998
No 95
>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos
Probab=100.00 E-value=1.2e-41 Score=312.05 Aligned_cols=200 Identities=27% Similarity=0.361 Sum_probs=168.0
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC-----CeeE
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV-----DFKA 168 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~ 168 (361)
+|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999964 68999999987432 23345688999999999999999999987543 3579
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918 169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD 248 (361)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 248 (361)
+||||+ +++|.+++..... +++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 lv~e~~-~~~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELM-ESDLHQVIKANDD-LTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecC-CCCHHHHHHhccc-CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 999999 4799999876543 899999999999999999999 88999999999999999999999999999986532
Q ss_pred CCc-ceeeecccccccccCccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 249 GEN-FETRTMTMATVGYMAPEYGSE--GIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 249 ~~~-~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
... ........|++.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~ 211 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 211 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 221 111233468999999998765 57899999999999999999999999653
No 96
>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr
Probab=100.00 E-value=6.4e-42 Score=311.84 Aligned_cols=234 Identities=26% Similarity=0.323 Sum_probs=185.2
Q ss_pred CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHH-HHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918 102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECE-VLRSIRHRNLVKILSSCSNVDFKALVLEFMPN 176 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (361)
+.||+|+||+||+|... +|+.||+|++.... ......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999965 68999999997543 122334455544 56788999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918 177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256 (361)
Q Consensus 177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 256 (361)
|+|.+++..+. .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++....... ....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (323)
T cd05575 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTS 154 (323)
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cccc
Confidence 99999998654 3889999999999999999999 8899999999999999999999999999987542221 1223
Q ss_pred cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918 257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA 336 (361)
Q Consensus 257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~ 336 (361)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..... .+........ ......
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~--------~~~~~~---- 217 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----AEMYDNILNK--------PLRLKP---- 217 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----HHHHHHHHcC--------CCCCCC----
Confidence 44689999999999998999999999999999999999999975321 1111111111 000000
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 337 AKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 337 ~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||+.||++||
T Consensus 218 ---~~~~~~~~li~~~l~~~p~~R~ 239 (323)
T cd05575 218 ---NISVSARHLLEGLLQKDRTKRL 239 (323)
T ss_pred ---CCCHHHHHHHHHHhhcCHHhCC
Confidence 0123478999999999999997
No 97
>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=5.5e-42 Score=295.76 Aligned_cols=205 Identities=27% Similarity=0.339 Sum_probs=177.6
Q ss_pred HHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeeh--hhHHHHHHHHHHHHHHHhcCCCceeeeeeeeec-----
Q 037918 92 QRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNLVKILSSCSN----- 163 (361)
Q Consensus 92 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----- 163 (361)
......|...+.||+|+||.|+.+... +|+.||||++.. ......++..+|+.+|+.++|+||+.+.+.+..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 344556777899999999999999964 789999999873 334556788999999999999999999998855
Q ss_pred CCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCc
Q 037918 164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGIS 243 (361)
Q Consensus 164 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 243 (361)
-+..|+|+|+| +.+|...++.+.. ++...+..++.|+++||.|+| +.+++||||||+|++++.+..+||+|||+|
T Consensus 98 f~DvYiV~elM-etDL~~iik~~~~-L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQQD-LTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcCcc-ccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccce
Confidence 35789999999 6799999987654 899999999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCcceeeecccccccccCcccc-CCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 244 KLLGDGENFETRTMTMATVGYMAPEYG-SEGIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 244 ~~~~~~~~~~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
+...........+....|.+|.|||++ ....||.+.||||.|||+.||++|++-|.+.
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~ 231 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGK 231 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCC
Confidence 988654333445677899999999965 5577999999999999999999999998753
No 98
>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a
Probab=100.00 E-value=8.8e-42 Score=310.82 Aligned_cols=239 Identities=24% Similarity=0.295 Sum_probs=190.5
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcC-CCceeeeeeeeecCCeeEEEE
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIR-HRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 171 (361)
+|+..+.||+|+||.||+|... +|+.||+|++.... ....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677889999999999999965 68999999997643 233456778888988885 577888999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
||+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 Ey~~~g~L~~~i~~~~~-l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred cCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 99999999999976543 899999999999999999999 88999999999999999999999999999875432221
Q ss_pred ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918 252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
......|++.|+|||++.+..++.++||||||+++|||++|+.||...... ...... .... . .
T Consensus 157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i---~~~~--------~--~ 219 (323)
T cd05615 157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--ELFQSI---MEHN--------V--S 219 (323)
T ss_pred --cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHH---HhCC--------C--C
Confidence 223346899999999998888999999999999999999999999754321 111111 1000 0 0
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+. .....+.+++.+||+.||++|+
T Consensus 220 ~p~-----~~~~~~~~li~~~l~~~p~~R~ 244 (323)
T cd05615 220 YPK-----SLSKEAVSICKGLMTKHPSKRL 244 (323)
T ss_pred CCc-----cCCHHHHHHHHHHcccCHhhCC
Confidence 000 1123468899999999999996
No 99
>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.
Probab=100.00 E-value=3.1e-42 Score=320.48 Aligned_cols=202 Identities=23% Similarity=0.305 Sum_probs=173.6
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
++|++++.||+|+||.||++... +++.||+|++.... ......+.+|++++++++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 46899999999999999999964 68999999987543 223456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
||+++|+|.+++...+. +++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 E~~~~g~L~~~i~~~~~-~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 81 DYIPGGDMMSLLIRLGI-FEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred eCCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 99999999999986543 788999999999999999999 88999999999999999999999999999753310000
Q ss_pred -----------------------------------------ceeeecccccccccCccccCCCCCCcccchHHHHHHHHH
Q 037918 252 -----------------------------------------FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLME 290 (361)
Q Consensus 252 -----------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~e 290 (361)
........||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000112468999999999999999999999999999999
Q ss_pred HHhCCCCCCcc
Q 037918 291 TFTRKKPTDEF 301 (361)
Q Consensus 291 lltg~~p~~~~ 301 (361)
|++|+.||...
T Consensus 237 ll~G~~Pf~~~ 247 (376)
T cd05598 237 MLVGQPPFLAD 247 (376)
T ss_pred hhhCCCCCCCC
Confidence 99999999764
No 100
>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in
Probab=100.00 E-value=3.3e-41 Score=305.99 Aligned_cols=234 Identities=24% Similarity=0.308 Sum_probs=186.2
Q ss_pred CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEEecCC
Q 037918 102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLEFMPN 176 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (361)
+.||+|+||.||+|... +++.||+|+++... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 57899999998653 23345566788888764 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918 177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256 (361)
Q Consensus 177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 256 (361)
|+|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++........ ...
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (316)
T cd05619 81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTC 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--cee
Confidence 99999997653 3889999999999999999999 88999999999999999999999999999875422211 223
Q ss_pred cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918 257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA 336 (361)
Q Consensus 257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~ 336 (361)
...|++.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+.+.... +....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~i~~~~---------~~~~~------ 217 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQSIRMDN---------PCYPR------ 217 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCC---------CCCCc------
Confidence 346899999999999888999999999999999999999999753221 1111111100 00000
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 337 AKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 337 ~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||+.||++||
T Consensus 218 ---~~~~~~~~li~~~l~~~P~~R~ 239 (316)
T cd05619 218 ---WLTREAKDILVKLFVREPERRL 239 (316)
T ss_pred ---cCCHHHHHHHHHHhccCHhhcC
Confidence 0122368899999999999997
No 101
>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways
Probab=100.00 E-value=3.9e-41 Score=307.09 Aligned_cols=240 Identities=21% Similarity=0.300 Sum_probs=189.6
Q ss_pred CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEEecCC
Q 037918 102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLEFMPN 176 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (361)
+.||+|+||.||+|... +++.||+|++.... ....+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 67899999998643 23445678899999888 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918 177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256 (361)
Q Consensus 177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 256 (361)
|+|.+++...+. +++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~~L~~~~~~~~~-l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQRK-LPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTS 154 (327)
T ss_pred CcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Ccee
Confidence 999998876543 899999999999999999999 8899999999999999999999999999987532211 1223
Q ss_pred cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccc-cccHHHHHhhhcCCCccccccccccCCchhH
Q 037918 257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAG-EMSLKNWVKESLPHGLTNVVDENLLLEEPAF 335 (361)
Q Consensus 257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~ 335 (361)
...|++.|+|||++.+..++.++||||||+++|||++|+.||...... .....++....+.. .... .+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~~~--~p~- 224 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE-------KPIR--IPR- 224 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh-------CCCC--CCC-
Confidence 456899999999999989999999999999999999999999643221 11112222111100 0000 000
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 336 AAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 336 ~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||+.||++||
T Consensus 225 ----~~~~~~~~li~~~L~~dP~~R~ 246 (327)
T cd05617 225 ----FLSVKASHVLKGFLNKDPKERL 246 (327)
T ss_pred ----CCCHHHHHHHHHHhccCHHHcC
Confidence 0122368899999999999996
No 102
>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C. Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re
Probab=100.00 E-value=1.9e-41 Score=308.06 Aligned_cols=234 Identities=24% Similarity=0.293 Sum_probs=187.9
Q ss_pred CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEEecCC
Q 037918 102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLEFMPN 176 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (361)
+.||+|+||.||+|... +++.||+|++.... ......+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 57899999998653 23345677888999888 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918 177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256 (361)
Q Consensus 177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 256 (361)
|+|.+++.... .+++..+..++.|++.||+||| +.+++||||||+||++++++.++|+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTS 154 (318)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--ccc
Confidence 99999987664 3899999999999999999999 89999999999999999999999999999875322111 122
Q ss_pred cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918 257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA 336 (361)
Q Consensus 257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~ 336 (361)
...|++.|+|||++.+..++.++|||||||++|+|++|+.||...... ...... ... ... .+.
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--~~~~~i---~~~--------~~~--~~~-- 217 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--ELFQSI---LED--------EVR--YPR-- 217 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--HHHHHH---HcC--------CCC--CCC--
Confidence 346899999999999999999999999999999999999999753211 111111 100 000 000
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 337 AKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 337 ~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||+.||++||
T Consensus 218 ---~~~~~~~~li~~~l~~dP~~R~ 239 (318)
T cd05570 218 ---WLSKEAKSILKSFLTKNPEKRL 239 (318)
T ss_pred ---cCCHHHHHHHHHHccCCHHHcC
Confidence 1123478999999999999997
No 103
>PHA03212 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=4.8e-41 Score=312.77 Aligned_cols=194 Identities=23% Similarity=0.305 Sum_probs=168.6
Q ss_pred hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
.++|.+.+.||+|+||.||++... +++.||+|.... ..+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357999999999999999999964 688999996532 3467899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
+ +++|.+++.... .+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........ .
T Consensus 165 ~-~~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~ 238 (391)
T PHA03212 165 Y-KTDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-N 238 (391)
T ss_pred C-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-c
Confidence 9 478998887654 3899999999999999999999 88999999999999999999999999999975432211 1
Q ss_pred eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDE 300 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~ 300 (361)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 22345699999999999988999999999999999999999988643
No 104
>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.
Probab=100.00 E-value=1.8e-41 Score=308.74 Aligned_cols=234 Identities=26% Similarity=0.317 Sum_probs=184.4
Q ss_pred CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHH-HHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918 102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECE-VLRSIRHRNLVKILSSCSNVDFKALVLEFMPN 176 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (361)
+.||+|+||.||+|... +++.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 68899999987543 222344555554 57888999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918 177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256 (361)
Q Consensus 177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 256 (361)
++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (321)
T cd05603 81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTS 154 (321)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cccc
Confidence 99999887654 3788899999999999999999 8899999999999999999999999999987532221 1223
Q ss_pred cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918 257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA 336 (361)
Q Consensus 257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~ 336 (361)
...|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ......... ..+....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~--------~~~~~~~---- 217 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----SQMYDNILH--------KPLQLPG---- 217 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----HHHHHHHhc--------CCCCCCC----
Confidence 45689999999999888899999999999999999999999975321 111111111 1111000
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 337 AKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 337 ~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||+.||++||
T Consensus 218 ---~~~~~~~~li~~~l~~~p~~R~ 239 (321)
T cd05603 218 ---GKTVAACDLLVGLLHKDQRRRL 239 (321)
T ss_pred ---CCCHHHHHHHHHHccCCHhhcC
Confidence 0122478999999999999996
No 105
>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,
Probab=100.00 E-value=3.5e-41 Score=301.67 Aligned_cols=243 Identities=26% Similarity=0.316 Sum_probs=193.2
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH---HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE---RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE 172 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (361)
+|++.+.||+|+||.||++... +++.||+|++..... .....+.+|+++++.++||||+++++.+.+.+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999964 689999999875431 223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 173 FMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 173 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
|+++|+|.+++... ...+++..+..++.|++.||.||| +.+++||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999999988653 335899999999999999999999 88999999999999999999999999999987543221
Q ss_pred ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918 252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
.....|+..|+|||++.+..++.++||||+|+++|||++|+.||...... ... +.+...+.... ..
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~-~~~~~~~~~~~---------~~ 223 (285)
T cd05605 158 ---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKR-EEVERRVKEDQ---------EE 223 (285)
T ss_pred ---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHH-HHHHHHhhhcc---------cc
Confidence 12346899999999998888999999999999999999999999753211 111 11111110000 00
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+. .....+.+++.+||+.||++||
T Consensus 224 ~~~-----~~~~~~~~li~~~l~~~P~~R~ 248 (285)
T cd05605 224 YSE-----KFSEAARSICRQLLTKDPGFRL 248 (285)
T ss_pred cCc-----ccCHHHHHHHHHHccCCHHHhc
Confidence 000 1223478999999999999997
No 106
>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3. Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r
Probab=100.00 E-value=2.3e-41 Score=301.95 Aligned_cols=243 Identities=26% Similarity=0.417 Sum_probs=190.9
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCc----EEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGA----EVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL 169 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (361)
++|++.+.||+|+||.||+|.+. +++ .+++|.+.... .....++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46788899999999999999964 344 47888876433 2344677888889999999999999998864 45789
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918 170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 249 (361)
++||+++|+|.+++......+++..+..++.|++.||+||| +.+++|+||||+||++++++.+||+|||+++.....
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999999999876666899999999999999999999 889999999999999999999999999999876443
Q ss_pred CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL 328 (361)
Q Consensus 250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l 328 (361)
..........++..|+|||...+..++.++||||||+++|||++ |+.||...... ...+......... .+.
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~-----~~~- 234 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVPDLLEKGERLA-----QPQ- 234 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCCcCC-----CCC-
Confidence 32222233456778999999988889999999999999999998 99998754321 1222221111000 000
Q ss_pred cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+...+.+++.+||..||++||
T Consensus 235 -----------~~~~~~~~li~~c~~~~p~~Rp 256 (279)
T cd05111 235 -----------ICTIDVYMVMVKCWMIDENVRP 256 (279)
T ss_pred -----------CCCHHHHHHHHHHcCCCcccCc
Confidence 1223468899999999999998
No 107
>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome. Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds
Probab=100.00 E-value=1.2e-41 Score=299.92 Aligned_cols=242 Identities=28% Similarity=0.396 Sum_probs=194.3
Q ss_pred CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918 96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 175 (361)
++|++.+.||+|++|.||+|...++..+|+|.+..... ..+.+.+|+.++++++||||+++++++.+.+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 45788899999999999999987777899998875432 23568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee
Q 037918 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR 255 (361)
Q Consensus 176 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 255 (361)
+++|.+++......+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.+||+|||.++....... ...
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSS 158 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-eec
Confidence 99999999875556899999999999999999999 88999999999999999999999999999886643321 122
Q ss_pred ecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918 256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334 (361)
Q Consensus 256 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 334 (361)
....++..|+|||...+..++.++||||||+++|+|++ |..||......+ ........... ..+.
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~------------~~~~ 224 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVEKVSQGLRL------------YRPH 224 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHhcCCCC------------CCCC
Confidence 22345678999999988889999999999999999999 999987543211 11111111000 0000
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 335 FAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||+.||++||
T Consensus 225 -----~~~~~~~~li~~cl~~~p~~Rp 246 (256)
T cd05113 225 -----LASEKVYAIMYSCWHEKAEERP 246 (256)
T ss_pred -----CCCHHHHHHHHHHcCCCcccCC
Confidence 0123479999999999999998
No 108
>PRK13184 pknD serine/threonine-protein kinase; Reviewed
Probab=100.00 E-value=1.7e-41 Score=334.16 Aligned_cols=246 Identities=24% Similarity=0.319 Sum_probs=193.7
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
++|++.+.||+|+||.||+|... +|+.||+|++.... ....+++.+|++++++++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999965 58999999986532 334467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEecc
Q 037918 172 EFMPNGSLEKWLYSH----------NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFG 241 (361)
Q Consensus 172 e~~~~g~L~~~l~~~----------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 241 (361)
||++|++|.+++... ....++..++.++.|+++||+||| +.+|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998642 123567788999999999999999 8899999999999999999999999999
Q ss_pred CccccCCCCc----------------ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcccccc
Q 037918 242 ISKLLGDGEN----------------FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305 (361)
Q Consensus 242 ~a~~~~~~~~----------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~ 305 (361)
++........ ........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987621110 001112468999999999999999999999999999999999999997532211
Q ss_pred ccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 306 MSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.... ..... + .......+.+..+.+++.+|++.||++||
T Consensus 239 i~~~----~~i~~-------P------~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ 277 (932)
T PRK13184 239 ISYR----DVILS-------P------IEVAPYREIPPFLSQIAMKALAVDPAERY 277 (932)
T ss_pred hhhh----hhccC-------h------hhccccccCCHHHHHHHHHHccCChhhCc
Confidence 1110 00000 0 00000112334578999999999999996
No 109
>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a
Probab=100.00 E-value=2e-41 Score=299.28 Aligned_cols=243 Identities=26% Similarity=0.468 Sum_probs=194.9
Q ss_pred hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
.++|++.+.||+|++|.||+|...+++.||+|.+..... ..+.+.+|++++++++||||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 456888999999999999999987788899999875432 2356888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 175 PNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 175 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
++++|.+++.... ..+++..+..++.|++.||.||| +.+++||||||+||++++++.++|+|||++........ .
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~ 159 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-E 159 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-c
Confidence 9999999997643 45899999999999999999999 88999999999999999999999999999987653221 1
Q ss_pred eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 332 (361)
.......+..|+|||...+..++.++|+||||+++|||+| |+.||...... ........... ...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~------------~~~ 225 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--EVLQQVDQGYR------------MPC 225 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCC------------CCC
Confidence 1112223467999999988889999999999999999999 99998753211 11111111100 000
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+ ..++..+.+++.+|++.+|++||
T Consensus 226 ~-----~~~~~~~~~li~~~l~~~P~~Rp 249 (261)
T cd05068 226 P-----PGCPKELYDIMLDCWKEDPDDRP 249 (261)
T ss_pred C-----CcCCHHHHHHHHHHhhcCcccCC
Confidence 0 01234589999999999999998
No 110
>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc
Probab=100.00 E-value=4.1e-41 Score=296.23 Aligned_cols=241 Identities=27% Similarity=0.351 Sum_probs=196.1
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
+|++.+.||+|++|.||+|... +++.|++|.+... .......+.+|++++++++|||++++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777889999999999999965 6899999998743 234556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 174 MPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 174 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
+++++|.+++... ...+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 9999999999864 455899999999999999999999 88999999999999999999999999999987654322
Q ss_pred eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918 253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 332 (361)
......+++.|+|||+..+..++.++|+||||+++|+|++|+.||..... ....... ....... .
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~---~~~~~~~-----~---- 221 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--GALILKI---IRGVFPP-----V---- 221 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH---HcCCCCC-----C----
Confidence 12234578899999999988899999999999999999999999975431 1111111 1000000 0
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+. .....+.+++.+||+.+|++||
T Consensus 222 ~~-----~~~~~~~~~i~~~l~~~p~~Rp 245 (256)
T cd08529 222 SQ-----MYSQQLAQLIDQCLTKDYRQRP 245 (256)
T ss_pred cc-----ccCHHHHHHHHHHccCCcccCc
Confidence 00 1233589999999999999998
No 111
>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]
Probab=100.00 E-value=1.3e-41 Score=294.19 Aligned_cols=201 Identities=28% Similarity=0.406 Sum_probs=173.3
Q ss_pred CCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHH--HHHHHHHHHHHHHhcCCCc-eeeeeeeeecCC------
Q 037918 96 NGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLER--AFRSFDSECEVLRSIRHRN-LVKILSSCSNVD------ 165 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~------ 165 (361)
..|..+++||+|+||+||+|+. .+|+.||+|++....+. .-....+|+.+++.++|+| |+++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 3466677899999999999995 47899999999866432 2345678999999999999 999999998877
Q ss_pred eeEEEEEecCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccC
Q 037918 166 FKALVLEFMPNGSLEKWLYSHN---YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGI 242 (361)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 242 (361)
..++|+||+ .-+|..++.... ..++...+..++.||+.||+||| +++|+||||||.|||++++|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccch
Confidence 889999999 569999998765 35788899999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCcceeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccc
Q 037918 243 SKLLGDGENFETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEFF 302 (361)
Q Consensus 243 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~ 302 (361)
|+...-.. ...+...+|..|+|||++.+. .|+...||||+||++.||+++++-|....
T Consensus 167 Ara~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s 225 (323)
T KOG0594|consen 167 ARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS 225 (323)
T ss_pred HHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc
Confidence 99765322 234556789999999987775 69999999999999999999999887643
No 112
>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr
Probab=100.00 E-value=8.8e-41 Score=297.84 Aligned_cols=237 Identities=24% Similarity=0.334 Sum_probs=187.2
Q ss_pred cccCCceEEEEEEeC-CCcEEEEEEeehhhH---HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCH
Q 037918 104 LGKGSFGSVYKGILS-DGAEVAIKIFNLQLE---RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSL 179 (361)
Q Consensus 104 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 179 (361)
||+|+||.||++... +|+.+|+|.+..... .....+..|++++++++||||+++++++.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999964 689999999865321 1234456799999999999999999999999999999999999999
Q ss_pred HHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecc
Q 037918 180 EKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258 (361)
Q Consensus 180 ~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 258 (361)
.+++... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence 9888643 334889999999999999999999 8999999999999999999999999999998764322 22334
Q ss_pred cccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHH
Q 037918 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAK 338 (361)
Q Consensus 259 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 338 (361)
.|+..|+|||++.+..++.++|||||||++|||++|+.||...... .............. ......
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~--------~~~~~~----- 220 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKRRTLEDE--------VKFEHQ----- 220 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHHHhhccc--------cccccc-----
Confidence 6899999999998888999999999999999999999999753221 11111111111111 000000
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCC
Q 037918 339 MDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 339 ~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||+.||++||
T Consensus 221 -~~~~~~~~li~~~L~~~P~~R~ 242 (277)
T cd05607 221 -NFTEESKDICRLFLAKKPEDRL 242 (277)
T ss_pred -cCCHHHHHHHHHHhccCHhhCC
Confidence 1123478999999999999997
No 113
>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn. Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa
Probab=100.00 E-value=1.8e-41 Score=299.57 Aligned_cols=243 Identities=22% Similarity=0.422 Sum_probs=195.8
Q ss_pred hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
.++|++.++||+|++|.||+|...++..||+|.+..... ..+.+.+|+.+++.++|+||+++++.+...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 356888999999999999999988888999998865432 3467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 175 PNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 175 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
++++|.+++... ...+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 159 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-T 159 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce-e
Confidence 999999999753 345889999999999999999999 88999999999999999999999999999987654322 1
Q ss_pred eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 332 (361)
......++..|+|||+..+..++.++||||||+++|+|+| |+.||...... ..........+ .....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~--------~~~~~-- 227 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQRGYR--------MPRME-- 227 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCC--------CCCCC--
Confidence 1222345678999999988889999999999999999998 99998653221 11111111110 00000
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..+..+.+++.+|++.+|++||
T Consensus 228 -------~~~~~~~~li~~~l~~~p~~Rp 249 (261)
T cd05072 228 -------NCPDELYDIMKTCWKEKAEERP 249 (261)
T ss_pred -------CCCHHHHHHHHHHccCCcccCc
Confidence 1223478999999999999998
No 114
>PLN00034 mitogen-activated protein kinase kinase; Provisional
Probab=100.00 E-value=2.4e-41 Score=311.72 Aligned_cols=240 Identities=27% Similarity=0.372 Sum_probs=185.9
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
.+|+..+.||+|+||.||+|... +++.||||++.... ......+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34667789999999999999965 68999999986543 33446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
+++++|.+.. ..++..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||++..+.....
T Consensus 154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-- 223 (353)
T PLN00034 154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-- 223 (353)
T ss_pred CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--
Confidence 9999986532 2567788899999999999999 88999999999999999999999999999987643221
Q ss_pred eeecccccccccCccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918 254 TRTMTMATVGYMAPEYGSE-----GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL 328 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l 328 (361)
......|+..|+|||++.. ...+.++|||||||++|||++|+.||...... .+........... ....
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~~~-----~~~~ 296 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASLMCAICMSQ-----PPEA 296 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHHHHhccC-----CCCC
Confidence 1233468999999998643 33456899999999999999999999732211 1111111100000 0000
Q ss_pred cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
. ..+...+.+++.+||+.||++||
T Consensus 297 ~---------~~~~~~l~~li~~~l~~~P~~Rp 320 (353)
T PLN00034 297 P---------ATASREFRHFISCCLQREPAKRW 320 (353)
T ss_pred C---------CccCHHHHHHHHHHccCChhhCc
Confidence 0 01233489999999999999998
No 115
>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla
Probab=100.00 E-value=3.6e-41 Score=302.27 Aligned_cols=258 Identities=25% Similarity=0.321 Sum_probs=188.4
Q ss_pred CCCCCCCccccCCceEEEEEEeC--CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhc---CCCceeeeeeeee-----c
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS--DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSI---RHRNLVKILSSCS-----N 163 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~-----~ 163 (361)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999863 46889999886432 11223455677777665 6999999999885 3
Q ss_pred CCeeEEEEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccC
Q 037918 164 VDFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGI 242 (361)
Q Consensus 164 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 242 (361)
....++||||++ ++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999995 6999998754 334899999999999999999999 88999999999999999999999999999
Q ss_pred ccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhh---cCCC
Q 037918 243 SKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKES---LPHG 319 (361)
Q Consensus 243 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~ 319 (361)
+....... ......|++.|+|||.+.+..++.++||||||+++|||++|++||......+ .+....... .+..
T Consensus 157 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 157 ARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEED 232 (290)
T ss_pred eEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhh
Confidence 98764321 2234468999999999988889999999999999999999999997643211 111111110 0111
Q ss_pred cccc---ccccccCCch--hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 320 LTNV---VDENLLLEEP--AFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 320 l~~~---~~~~l~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+... ....+..... ......+....+.+++.+||+.||++||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 279 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 279 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcC
Confidence 1100 0000000000 0000112334578999999999999998
No 116
>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=2.6e-41 Score=302.15 Aligned_cols=244 Identities=27% Similarity=0.453 Sum_probs=192.8
Q ss_pred CCCCCCCccccCCceEEEEEEe-----CCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGIL-----SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL 169 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (361)
.+|++.+.||+|+||.||+|.. .++..+++|.+.... ......+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577889999999999999984 246789999987433 3444678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC
Q 037918 170 VLEFMPNGSLEKWLYSH----------------NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM 233 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~ 233 (361)
+|||+++++|.+++... ...+++..++.++.|++.||+||| +.+++|+||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence 99999999999998532 123788899999999999999999 88999999999999999999
Q ss_pred cEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHH
Q 037918 234 VAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWV 312 (361)
Q Consensus 234 ~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~ 312 (361)
.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||..... ....+.+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~~~ 239 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIEMV 239 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH
Confidence 999999999987644332222233345678999999988889999999999999999998 9999865321 1112221
Q ss_pred hhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 313 KESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 313 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.... ... ... .++..+.+++.+||+.||++||
T Consensus 240 ~~~~---~~~-----~~~---------~~~~~~~~li~~cl~~~p~~Rp 271 (283)
T cd05090 240 RKRQ---LLP-----CSE---------DCPPRMYSLMTECWQEGPSRRP 271 (283)
T ss_pred HcCC---cCC-----CCC---------CCCHHHHHHHHHHcccCcccCc
Confidence 1110 000 000 1233478899999999999998
No 117
>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase. Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.
Probab=100.00 E-value=3.9e-41 Score=302.39 Aligned_cols=244 Identities=25% Similarity=0.320 Sum_probs=195.7
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
+.|++.+.||.|+||.||+|... +++.+++|.+........+.+.+|+.+++.++|||++++++.+...+..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56889999999999999999965 58999999998766666778899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918 175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET 254 (361)
Q Consensus 175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 254 (361)
++++|..++.+....+++..+..++.|++.+|+||| +.+++||||+|+||+++.++.++|+|||++....... ..
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~ 166 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QR 166 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc--cc
Confidence 999999988765556899999999999999999999 8899999999999999999999999999987643221 12
Q ss_pred eecccccccccCccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918 255 RTMTMATVGYMAPEYGS-----EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL 329 (361)
Q Consensus 255 ~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 329 (361)
.....++..|+|||++. ...++.++|+||||+++|||++|..||....... ....... ..... ..
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~~~~----~~~~~-----~~ 236 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAK----SEPPT-----LS 236 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-HHHHHhc----CCCcc-----CC
Confidence 23345788999999874 3457889999999999999999999986532211 1111100 00000 00
Q ss_pred CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
. .......+.+++.+||+.||++||
T Consensus 237 ~-------~~~~~~~~~~li~~~l~~~p~~Rp 261 (292)
T cd06644 237 Q-------PSKWSMEFRDFLKTALDKHPETRP 261 (292)
T ss_pred C-------CcccCHHHHHHHHHHhcCCcccCc
Confidence 0 001223478899999999999998
No 118
>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh
Probab=100.00 E-value=2.1e-41 Score=301.83 Aligned_cols=246 Identities=26% Similarity=0.462 Sum_probs=193.1
Q ss_pred hhCCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCe
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF 166 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 166 (361)
.+++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4577999999999999999999753 25679999886432 2334568899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEE
Q 037918 167 KALVLEFMPNGSLEKWLYSHN---------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHV 237 (361)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 237 (361)
.++||||+++++|.+++.+.. ..+++..+..++.|++.||.||| +.+++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999997532 23577889999999999999999 889999999999999999999999
Q ss_pred EeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhc
Q 037918 238 SDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESL 316 (361)
Q Consensus 238 ~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 316 (361)
+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...... ........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~~~~~~-- 236 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVLRFVME-- 236 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHc--
Confidence 99999986644332222222345778999999988889999999999999999999 78888653221 11111111
Q ss_pred CCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 317 PHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 317 ~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
...... +. .++..+.+++.+||+.||++||
T Consensus 237 -~~~~~~---------~~-----~~~~~~~~li~~~l~~~p~~Rp 266 (277)
T cd05062 237 -GGLLDK---------PD-----NCPDMLFELMRMCWQYNPKMRP 266 (277)
T ss_pred -CCcCCC---------CC-----CCCHHHHHHHHHHcCCChhhCc
Confidence 110000 00 1233589999999999999998
No 119
>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=3.3e-41 Score=298.86 Aligned_cols=245 Identities=23% Similarity=0.317 Sum_probs=193.5
Q ss_pred CCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918 96 NGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++++++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 5699999999999999999996 468899999997654444567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918 175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET 254 (361)
Q Consensus 175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 254 (361)
++++|.+++.... .+++..+..++.|++.||+||| +.+|+||||+|+||+++.++.++|+|||++........ .
T Consensus 89 ~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~ 162 (267)
T cd06646 89 GGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--K 162 (267)
T ss_pred CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc--c
Confidence 9999999987554 4899999999999999999999 88999999999999999999999999999987643211 1
Q ss_pred eecccccccccCccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918 255 RTMTMATVGYMAPEYGS---EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 255 ~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
.....++..|+|||.+. ...++.++|+||||+++|||++|+.||......+.. ..+..... ..+...
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~~~~~~~~-------~~~~~~-- 232 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMSKSNF-------QPPKLK-- 232 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-eeeecCCC-------CCCCCc--
Confidence 22345888999999874 445788999999999999999999998643221110 00000000 000000
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
........+.+++.+||+.||++||
T Consensus 233 -----~~~~~~~~~~~li~~~l~~~P~~Rp 257 (267)
T cd06646 233 -----DKTKWSSTFHNFVKISLTKNPKKRP 257 (267)
T ss_pred -----cccccCHHHHHHHHHHhhCChhhCc
Confidence 0011234588999999999999998
No 120
>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows
Probab=100.00 E-value=2.2e-41 Score=298.27 Aligned_cols=242 Identities=30% Similarity=0.419 Sum_probs=193.3
Q ss_pred CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918 96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 175 (361)
.+|++.+.||+|+||.||+|...++..+|+|.+..... ....+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 35778899999999999999987777899999864322 22467889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee
Q 037918 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR 255 (361)
Q Consensus 176 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 255 (361)
+++|.+++..+...+++..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||+++........ ..
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~ 158 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SS 158 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccccc-cc
Confidence 99999999876556899999999999999999999 889999999999999999999999999999866432211 11
Q ss_pred ecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918 256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334 (361)
Q Consensus 256 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 334 (361)
....++..|+|||.+.+..++.++|+||||+++|||++ |+.||......+ .......... ...+.
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~~------------~~~~~ 224 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVESVSAGYR------------LYRPK 224 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHHHHHcCCc------------CCCCC
Confidence 12234567999999988889999999999999999999 899987532211 1111111100 00000
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 335 FAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.++..+.+++.+||+.+|++||
T Consensus 225 -----~~~~~~~~li~~cl~~~p~~Rp 246 (256)
T cd05059 225 -----LAPTEVYTIMYSCWHEKPEDRP 246 (256)
T ss_pred -----CCCHHHHHHHHHHhcCChhhCc
Confidence 1234589999999999999998
No 121
>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul
Probab=100.00 E-value=7.6e-42 Score=315.95 Aligned_cols=202 Identities=25% Similarity=0.370 Sum_probs=175.1
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
++|+..+.||+|+||.||++... +++.||+|++.... ......+..|+.++.+++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999965 68999999997543 233467788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
||+++|+|.+++.+.+. +++..+..++.|++.||+||| +.+|+||||||+|||++.++.++|+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMKKDT-LSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 99999999999976543 899999999999999999999 89999999999999999999999999999875432110
Q ss_pred c---------------------------------eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCC
Q 037918 252 F---------------------------------ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPT 298 (361)
Q Consensus 252 ~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~ 298 (361)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0 0011346899999999999999999999999999999999999999
Q ss_pred Ccc
Q 037918 299 DEF 301 (361)
Q Consensus 299 ~~~ 301 (361)
...
T Consensus 237 ~~~ 239 (360)
T cd05627 237 CSE 239 (360)
T ss_pred CCC
Confidence 754
No 122
>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk. Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom
Probab=100.00 E-value=1.1e-41 Score=300.92 Aligned_cols=244 Identities=28% Similarity=0.485 Sum_probs=199.2
Q ss_pred hhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
...+|++.+.||.|+||.||+|...++..+++|.+..........+..|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34568889999999999999999888999999999876655567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 174 MPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 174 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
+++++|.+++... +..+++..++.++.|++.||+||| +.+++|+||+|+||++++++.+||+|||.+........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~- 159 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY- 159 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence 9999999999864 345899999999999999999999 88999999999999999999999999999987643221
Q ss_pred eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918 253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
......++..|+|||...+..++.++||||||+++|+|++ |+.||...... ............ ...
T Consensus 160 -~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~--------~~~-- 226 (261)
T cd05148 160 -LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--EVYDQITAGYRM--------PCP-- 226 (261)
T ss_pred -cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHHhCCcC--------CCC--
Confidence 1123346778999999888889999999999999999998 89998653311 111111111100 000
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..++..+.+++.+||+.||++||
T Consensus 227 -------~~~~~~~~~~i~~~l~~~p~~Rp 249 (261)
T cd05148 227 -------AKCPQEIYKIMLECWAAEPEDRP 249 (261)
T ss_pred -------CCCCHHHHHHHHHHcCCCchhCc
Confidence 02234578999999999999998
No 123
>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n
Probab=100.00 E-value=2.8e-41 Score=303.21 Aligned_cols=244 Identities=28% Similarity=0.448 Sum_probs=195.7
Q ss_pred CCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL 169 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (361)
++|.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45778889999999999999842 355689999876665556778999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCc
Q 037918 170 VLEFMPNGSLEKWLYSHN---------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV 234 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~ 234 (361)
||||+++++|.+++.... ..+++..++.++.|++.||+||| +++++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence 999999999999997532 23789999999999999999999 889999999999999999999
Q ss_pred EEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHh
Q 037918 235 AHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVK 313 (361)
Q Consensus 235 ~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 313 (361)
++|+|||++................++..|+|||.+.+..++.++||||||+++|||+| |+.||......+ ..+...
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~~ 239 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VIECIT 239 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHh
Confidence 99999999986644332222233456788999999988889999999999999999999 999986543211 111111
Q ss_pred hhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 314 ESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 314 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
. ...... .. .++..+.+++.+||+.||++||
T Consensus 240 ~---~~~~~~-----~~---------~~~~~~~~li~~~l~~~P~~Rp 270 (291)
T cd05094 240 Q---GRVLER-----PR---------VCPKEVYDIMLGCWQREPQQRL 270 (291)
T ss_pred C---CCCCCC-----Cc---------cCCHHHHHHHHHHcccChhhCc
Confidence 1 110100 00 1233488999999999999998
No 124
>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase. Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.
Probab=100.00 E-value=3.5e-41 Score=301.18 Aligned_cols=242 Identities=25% Similarity=0.336 Sum_probs=193.3
Q ss_pred CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918 98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPN 176 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (361)
|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|||++++++++...+..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567789999999999999965 5788899998766556667889999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918 177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256 (361)
Q Consensus 177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 256 (361)
++|.+++......+++..+..++.|+++||.||| +.+++||||+|+||+++.++.++|+|||++....... ....
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~ 161 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRD 161 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc--cccc
Confidence 9999988765556899999999999999999999 8899999999999999999999999999987653321 1223
Q ss_pred cccccccccCccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918 257 MTMATVGYMAPEYGS-----EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 257 ~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
...++..|+|||++. +..++.++||||||+++|||++|++||......+. ......... .....+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~~~----~~~~~~----- 231 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-LLKIAKSEP----PTLAQP----- 231 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-HHHHhhcCC----CCCCCc-----
Confidence 346889999999873 44578899999999999999999999875432111 111111000 000000
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
......+.+++.+||+.||++||
T Consensus 232 -------~~~~~~~~~li~~~l~~~p~~Rp 254 (282)
T cd06643 232 -------SRWSSEFKDFLKKCLEKNVDARW 254 (282)
T ss_pred -------cccCHHHHHHHHHHccCChhhCc
Confidence 01123478999999999999998
No 125
>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,
Probab=100.00 E-value=1.3e-41 Score=310.07 Aligned_cols=234 Identities=26% Similarity=0.326 Sum_probs=184.9
Q ss_pred CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHH-HHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918 102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECE-VLRSIRHRNLVKILSSCSNVDFKALVLEFMPN 176 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (361)
+.||+|+||.||+|... +|+.+|+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999964 68999999997542 223344555554 46778999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918 177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256 (361)
Q Consensus 177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 256 (361)
|+|..++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++....... ....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~ 154 (325)
T cd05604 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTT 154 (325)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCcc
Confidence 99999887654 3899999999999999999999 8899999999999999999999999999987542211 1223
Q ss_pred cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918 257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA 336 (361)
Q Consensus 257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~ 336 (361)
...|++.|+|||++.+..++.++|||||||++|||++|+.||...... +....... ..+....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----~~~~~~~~--------~~~~~~~---- 217 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-----EMYDNILH--------KPLVLRP---- 217 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-----HHHHHHHc--------CCccCCC----
Confidence 456899999999999999999999999999999999999999753211 11111111 1110000
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 337 AKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 337 ~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+|++.||++||
T Consensus 218 ---~~~~~~~~ll~~ll~~~p~~R~ 239 (325)
T cd05604 218 ---GASLTAWSILEELLEKDRQRRL 239 (325)
T ss_pred ---CCCHHHHHHHHHHhccCHHhcC
Confidence 0122368899999999999997
No 126
>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt
Probab=100.00 E-value=2.1e-41 Score=308.72 Aligned_cols=234 Identities=26% Similarity=0.305 Sum_probs=183.6
Q ss_pred CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHH-HHHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918 102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSEC-EVLRSIRHRNLVKILSSCSNVDFKALVLEFMPN 176 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (361)
+.||+|+||.||+|... +++.||+|++.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 57889999997543 12223344444 456788999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918 177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256 (361)
Q Consensus 177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 256 (361)
++|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~~-~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~ 154 (325)
T cd05602 81 GELFYHLQRERC-FLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTS 154 (325)
T ss_pred CcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Ccc
Confidence 999999986543 778888899999999999999 89999999999999999999999999999975432211 223
Q ss_pred cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918 257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA 336 (361)
Q Consensus 257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~ 336 (361)
...|++.|+|||++.+..++.++|||||||++|||++|+.||...... +....... .......
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~--------~~~~~~~---- 217 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-----EMYDNILN--------KPLQLKP---- 217 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-----HHHHHHHh--------CCcCCCC----
Confidence 456899999999999989999999999999999999999999753221 11111110 0000000
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 337 AKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 337 ~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+....+.+++.+|++.||.+||
T Consensus 218 ---~~~~~~~~li~~~l~~~p~~R~ 239 (325)
T cd05602 218 ---NITNSARHLLEGLLQKDRTKRL 239 (325)
T ss_pred ---CCCHHHHHHHHHHcccCHHHCC
Confidence 1123478899999999999997
No 127
>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti
Probab=100.00 E-value=2.5e-41 Score=301.79 Aligned_cols=245 Identities=27% Similarity=0.364 Sum_probs=197.3
Q ss_pred hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
.++|++.+.||.|++|.||++... ++..+|+|.+........+.+..|++++++++||||+++++.+...+..++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888999999999999999964 6889999999876666667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
+++++|.+++......+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-- 158 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-- 158 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence 9999999999876666899999999999999999999 88999999999999999999999999999876533221
Q ss_pred eeecccccccccCccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918 254 TRTMTMATVGYMAPEYGS-----EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL 328 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l 328 (361)
......++..|+|||.+. ...++.++|+||||+++|||++|+.||....... ....+.. .... .+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~----~~~~-----~~ 228 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VLLKILK----SEPP-----TL 228 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HHHHHhc----CCCC-----Cc
Confidence 223346888999999864 3457789999999999999999999997542211 1111110 0000 00
Q ss_pred cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
. .+ ......+.+++.+||+.||++||
T Consensus 229 ~--~~-----~~~~~~~~~li~~~l~~~p~~Rp 254 (280)
T cd06611 229 D--QP-----SKWSSSFNDFLKSCLVKDPDDRP 254 (280)
T ss_pred C--Cc-----ccCCHHHHHHHHHHhccChhhCc
Confidence 0 00 01223478899999999999998
No 128
>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto
Probab=100.00 E-value=5.7e-41 Score=306.99 Aligned_cols=246 Identities=26% Similarity=0.445 Sum_probs=191.6
Q ss_pred hCCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecC-C
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNV-D 165 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~ 165 (361)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+..|+.++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357899999999999999999732 35789999987543 33446778899999999 899999999988654 5
Q ss_pred eeEEEEEecCCCCHHHHHhcCC----------------------------------------------------------
Q 037918 166 FKALVLEFMPNGSLEKWLYSHN---------------------------------------------------------- 187 (361)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 187 (361)
..+++|||+++++|.+++....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 6789999999999999986421
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeeccccccccc
Q 037918 188 --YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYM 265 (361)
Q Consensus 188 --~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~ 265 (361)
..+++..+..++.|++.||+||| +.+|+||||||+||++++++.++|+|||++..+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 24789999999999999999999 8899999999999999999999999999998764433222223345677899
Q ss_pred CccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHH
Q 037918 266 APEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLS 344 (361)
Q Consensus 266 aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~ 344 (361)
|||++.+..++.++|||||||++|||++ |..||......+ .+........ .. ..+. .....
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~----~~--------~~~~-----~~~~~ 304 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKEGT----RM--------RAPE-----YATPE 304 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhccC----CC--------CCCc-----cCCHH
Confidence 9999999999999999999999999998 999987532211 1111111110 00 0000 11234
Q ss_pred HHHHHhhcCCCCCCCCC
Q 037918 345 IMHLALDCSMYSPDQRI 361 (361)
Q Consensus 345 l~~l~~~cl~~dP~~RP 361 (361)
+.+++.+||+.+|++||
T Consensus 305 ~~~l~~~cl~~~p~~RP 321 (337)
T cd05054 305 IYSIMLDCWHNNPEDRP 321 (337)
T ss_pred HHHHHHHHccCChhhCc
Confidence 78999999999999998
No 129
>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an
Probab=100.00 E-value=2.3e-41 Score=313.37 Aligned_cols=206 Identities=21% Similarity=0.334 Sum_probs=177.0
Q ss_pred HHHHHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC
Q 037918 89 LEIQRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV 164 (361)
Q Consensus 89 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 164 (361)
.++....++|++.+.||+|+||.||++... +++.+|+|++.... ......+.+|..+++.++||||+++++.+.+.
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344555688999999999999999999965 68899999987532 22335578899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918 165 DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK 244 (361)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 244 (361)
+..++||||+++|+|.+++.... ++...+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++.
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 99999999999999999997654 788999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCcceeeecccccccccCccccCCC----CCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918 245 LLGDGENFETRTMTMATVGYMAPEYGSEG----IVSSKCDVYSYGVLLMETFTRKKPTDE 300 (361)
Q Consensus 245 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~slG~il~elltg~~p~~~ 300 (361)
....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 191 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 191 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred EcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 7643221 122345699999999987653 378899999999999999999999975
No 130
>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in
Probab=100.00 E-value=1.8e-41 Score=314.05 Aligned_cols=202 Identities=23% Similarity=0.339 Sum_probs=173.7
Q ss_pred hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL 169 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (361)
..++|++.+.||+|+||.||++... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3457899999999999999999965 68899999997532 2233457789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918 170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 249 (361)
||||+++|+|.+++.... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++......
T Consensus 121 v~Ey~~gg~L~~~l~~~~--l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 121 VMEYMPGGDLVNLMSNYD--IPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999997653 788899999999999999999 889999999999999999999999999999876432
Q ss_pred CcceeeecccccccccCccccCCC----CCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 250 ENFETRTMTMATVGYMAPEYGSEG----IVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 250 ~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
.. .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 196 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 250 (370)
T cd05596 196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (370)
T ss_pred Cc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence 21 122345699999999987543 4788999999999999999999999753
No 131
>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2. Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve
Probab=100.00 E-value=5.5e-41 Score=299.45 Aligned_cols=244 Identities=26% Similarity=0.430 Sum_probs=192.4
Q ss_pred hCCCCCCCccccCCceEEEEEEeC-CCc----EEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeE
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS-DGA----EVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (361)
.++|++.+.||+|+||.||+|.+. +|+ .||+|++.... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 356888999999999999999853 444 48999986533 34456788999999999999999999998754 468
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918 169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD 248 (361)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 248 (361)
+++||+++|+|.+++..+...+++..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||+++....
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999999876556899999999999999999999 88999999999999999999999999999987654
Q ss_pred CCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccccccc
Q 037918 249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN 327 (361)
Q Consensus 249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 327 (361)
...........++..|+|||...+..++.++||||||+++|||++ |..||..... ..+..+........
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~~~-------- 231 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLEKGERLP-------- 231 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCcCC--------
Confidence 332212222345678999999988889999999999999999998 9999875322 11222222111000
Q ss_pred ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+ ..+...+.+++.+||+.||++||
T Consensus 232 ----~~-----~~~~~~~~~li~~~l~~dp~~Rp 256 (279)
T cd05109 232 ----QP-----PICTIDVYMIMVKCWMIDSECRP 256 (279)
T ss_pred ----CC-----ccCCHHHHHHHHHHcCCChhhCc
Confidence 00 01233478999999999999998
No 132
>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t
Probab=100.00 E-value=2.3e-40 Score=292.71 Aligned_cols=244 Identities=25% Similarity=0.329 Sum_probs=194.2
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-----HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-----ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL 169 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (361)
++|.+.+.||+|++|.||++... +++.+|+|.+.... ......+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999864 68999999886432 2234578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918 170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 249 (361)
++||+++++|.+++..... +++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++......
T Consensus 82 v~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGA-LTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 9999999999999976543 789999999999999999999 889999999999999999999999999999765432
Q ss_pred Cccee-eecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918 250 ENFET-RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL 328 (361)
Q Consensus 250 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l 328 (361)
..... .....++..|+|||++.+..++.++||||||+++|||++|+.||........ .... ..... . ..+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~---~~~~~-~----~~~ 228 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA-IFKI---ATQPT-N----PQL 228 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH-HHHH---hccCC-C----CCC
Confidence 21111 1234578899999999988899999999999999999999999875322111 0110 00000 0 001
Q ss_pred cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.. .....+.+++.+||+.+|++||
T Consensus 229 ~~---------~~~~~~~~li~~~l~~~p~~Rp 252 (263)
T cd06625 229 PS---------HVSPDARNFLRRTFVENAKKRP 252 (263)
T ss_pred Cc---------cCCHHHHHHHHHHhhcCcccCC
Confidence 11 1223478999999999999998
No 133
>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory
Probab=100.00 E-value=3.8e-41 Score=300.70 Aligned_cols=244 Identities=28% Similarity=0.457 Sum_probs=194.1
Q ss_pred CCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL 169 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (361)
++|...+.||+|+||.||++... ++..+++|.+..........+.+|+++++.++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45777889999999999999732 356799998876666666789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcE
Q 037918 170 VLEFMPNGSLEKWLYSHN--------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 235 (361)
+|||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence 999999999999997542 24789999999999999999999 8899999999999999999999
Q ss_pred EEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhh
Q 037918 236 HVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKE 314 (361)
Q Consensus 236 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 314 (361)
+|+|||++................+++.|+|||...+..++.++||||||+++|||++ |.+||......+ .......
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~ 239 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--AIECITQ 239 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--HHHHHHc
Confidence 9999999976543322122223345678999999988889999999999999999998 999986532211 1111110
Q ss_pred hcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 315 SLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 315 ~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..+ ...+. .++..+.+++.+||+.||++||
T Consensus 240 ~~~------------~~~~~-----~~~~~~~~li~~cl~~~P~~Rp 269 (280)
T cd05092 240 GRE------------LERPR-----TCPPEVYAIMQGCWQREPQQRM 269 (280)
T ss_pred Ccc------------CCCCC-----CCCHHHHHHHHHHccCChhhCC
Confidence 000 00000 1233478999999999999998
No 134
>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found
Probab=100.00 E-value=2.1e-41 Score=313.40 Aligned_cols=202 Identities=22% Similarity=0.346 Sum_probs=174.7
Q ss_pred hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL 169 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (361)
..++|++.+.||+|+||.||++... +++.+|+|++.... ......+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 4567999999999999999999965 58899999987532 2233567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918 170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 249 (361)
||||+++|+|.+++.... +++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++......
T Consensus 121 v~Ey~~gg~L~~~l~~~~--~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 121 VMEYMPGGDLVNLMSNYD--VPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 999999999999997653 789999999999999999999 899999999999999999999999999999876432
Q ss_pred CcceeeecccccccccCccccCCC----CCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 250 ENFETRTMTMATVGYMAPEYGSEG----IVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 250 ~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
.. .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 196 ~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred Cc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 22 122345699999999987653 3788999999999999999999999753
No 135
>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign
Probab=100.00 E-value=5.4e-41 Score=300.11 Aligned_cols=254 Identities=26% Similarity=0.408 Sum_probs=191.1
Q ss_pred CCCCCccccCCceEEEEEEe-----CCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC--CeeEE
Q 037918 98 FDECNLLGKGSFGSVYKGIL-----SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV--DFKAL 169 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 169 (361)
|.+.+.||+|+||.||++.. .+++.||+|.+.... ......+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999988653 357889999987543 23446788999999999999999999988653 46789
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918 170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 249 (361)
+|||+++++|.+++.... +++..++.++.|++.||.||| +.+++||||||+||++++++.++|+|||++......
T Consensus 86 v~e~~~~~~l~~~~~~~~--l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 86 IMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EecCCCCCCHHHHHHHcC--CCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 999999999999997654 899999999999999999999 889999999999999999999999999999876543
Q ss_pred Ccce-eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhc-CCCcccccccc
Q 037918 250 ENFE-TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESL-PHGLTNVVDEN 327 (361)
Q Consensus 250 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~ 327 (361)
.... ......++..|+|||...+..++.++||||||+++|||+||..|+.................. ...+.+.++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 2211 112234566799999988888999999999999999999999998653221111111100000 00111111111
Q ss_pred ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+ ..++..+.+++.+||+.||++||
T Consensus 241 ~~~~~~-----~~~~~~~~~li~~cl~~~p~~Rp 269 (283)
T cd05080 241 MRLPCP-----KNCPQEVYILMKNCWETEAKFRP 269 (283)
T ss_pred CCCCCC-----CCCCHHHHHHHHHHhccChhhCC
Confidence 111111 12345689999999999999998
No 136
>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a
Probab=100.00 E-value=1e-40 Score=293.65 Aligned_cols=242 Identities=29% Similarity=0.396 Sum_probs=198.0
Q ss_pred CCCCCCCccccCCceEEEEEEeCC-CcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918 96 NGFDECNLLGKGSFGSVYKGILSD-GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
++|+..+.||+|++|.||+|...+ ++.+++|.+..... .+.+.+|++++++++||||+++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578999999999999999999764 88999999876543 578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918 175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET 254 (361)
Q Consensus 175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 254 (361)
++++|.+++......+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~ 155 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--K 155 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--c
Confidence 999999999876666899999999999999999999 88999999999999999999999999999987644321 2
Q ss_pred eecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918 255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334 (361)
Q Consensus 255 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 334 (361)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||.......... . .... ....+. .
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~--~----~~~~----~~~~~~--~-- 221 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF--M----IPNK----PPPTLS--D-- 221 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh--h----hccC----CCCCCC--c--
Confidence 223457889999999988889999999999999999999999987542211100 0 0000 000000 0
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 335 FAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.......+.+++.+||+.||++||
T Consensus 222 ---~~~~~~~~~~~i~~~l~~~P~~Rp 245 (256)
T cd06612 222 ---PEKWSPEFNDFVKKCLVKDPEERP 245 (256)
T ss_pred ---hhhcCHHHHHHHHHHHhcChhhCc
Confidence 011233478999999999999998
No 137
>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=9.5e-41 Score=300.47 Aligned_cols=242 Identities=26% Similarity=0.352 Sum_probs=195.3
Q ss_pred CCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918 96 NGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
.+|++.+.||+|++|.||+|.. .+++.|++|.+........+.+.+|+.+++.++|||++++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 5788899999999999999995 468899999987655445577889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918 175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET 254 (361)
Q Consensus 175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 254 (361)
++++|.+++.... +++.++..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 100 ~~~~L~~~~~~~~--~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~ 172 (296)
T cd06654 100 AGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K 172 (296)
T ss_pred CCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--c
Confidence 9999999997543 789999999999999999999 88999999999999999999999999999876543221 1
Q ss_pred eecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918 255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334 (361)
Q Consensus 255 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 334 (361)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||....... .+.. ....... .+ ..+.
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~----~~~~-~~~~~~~-----~~--~~~~ 240 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----ALYL-IATNGTP-----EL--QNPE 240 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH----hHHH-HhcCCCC-----CC--CCcc
Confidence 223468889999999988888999999999999999999999996532211 1110 0000000 00 0000
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 335 FAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||..||++||
T Consensus 241 -----~~~~~l~~li~~~l~~~p~~Rp 262 (296)
T cd06654 241 -----KLSAIFRDFLNRCLDMDVEKRG 262 (296)
T ss_pred -----ccCHHHHHHHHHHCcCCcccCc
Confidence 1223478899999999999998
No 138
>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein. Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi
Probab=100.00 E-value=8.2e-41 Score=300.02 Aligned_cols=243 Identities=28% Similarity=0.448 Sum_probs=191.6
Q ss_pred CCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918 97 GFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL 169 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (361)
+|++.+.||+|+||.||+|... ....+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999852 23568999886543 3345678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 037918 170 VLEFMPNGSLEKWLYSHN-----------------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSN 226 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~N 226 (361)
+|||+.+++|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence 999999999999986421 23788999999999999999999 8899999999999
Q ss_pred EEEcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCcccccc
Q 037918 227 ILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGE 305 (361)
Q Consensus 227 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~ 305 (361)
|++++++.++|+|||+++...............++..|+|||...+..++.++||||||+++|||+| |..||......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 9999999999999999986543322222233346778999999888889999999999999999998 99998653221
Q ss_pred ccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 306 MSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+........ ....+. .+...+.+++.+||+.||++||
T Consensus 237 -~~~~~~~~~~------------~~~~~~-----~~~~~~~~~i~~cl~~~P~~Rp 274 (290)
T cd05045 237 -RLFNLLKTGY------------RMERPE-----NCSEEMYNLMLTCWKQEPDKRP 274 (290)
T ss_pred -HHHHHHhCCC------------CCCCCC-----CCCHHHHHHHHHHccCCcccCC
Confidence 1111111111 011111 1233588999999999999998
No 139
>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase. Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays
Probab=100.00 E-value=6.5e-41 Score=296.41 Aligned_cols=242 Identities=27% Similarity=0.441 Sum_probs=193.2
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
.+|.+.+.||+|++|.||+|... .++.||+|.+.... .....+.+|+++++.++||||+++++++...+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35777889999999999999965 58899999987543 33467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 175 PNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 175 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
++++|.+++... ...+++..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||++........ .
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~ 160 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-T 160 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-e
Confidence 999999999754 344899999999999999999999 88999999999999999999999999999987644221 1
Q ss_pred eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 332 (361)
......++..|+|||.+.+..++.++||||||+++|||++ |..||...... .......... ....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~------------~~~~ 226 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKGY------------RMER 226 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCC------------CCCC
Confidence 1112234567999999988889999999999999999998 99998653211 1111111111 0011
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+. .++..+.+++.+||+.||++||
T Consensus 227 ~~-----~~~~~~~~li~~cl~~~p~~Rp 250 (263)
T cd05052 227 PE-----GCPPKVYELMRACWQWNPSDRP 250 (263)
T ss_pred CC-----CCCHHHHHHHHHHccCCcccCC
Confidence 10 1234589999999999999998
No 140
>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase. Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well
Probab=100.00 E-value=6.1e-41 Score=298.87 Aligned_cols=246 Identities=27% Similarity=0.442 Sum_probs=192.1
Q ss_pred hhCCCCCCCccccCCceEEEEEEeCC------CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCe
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILSD------GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF 166 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 166 (361)
.+++|.+.+.||+|++|.||+|...+ +..|++|.+.... ......+..|+.+++.++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678999999999999999999643 5678999886443 3334578899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC---cEEE
Q 037918 167 KALVLEFMPNGSLEKWLYSHN------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM---VAHV 237 (361)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl 237 (361)
.++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++|+||+|+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999997543 24889999999999999999999 88999999999999998654 5999
Q ss_pred EeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhc
Q 037918 238 SDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESL 316 (361)
Q Consensus 238 ~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 316 (361)
+|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||......+ ....+....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~ 238 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VMEFVTGGG 238 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHcCC
Confidence 99999987643222111112234567999999988889999999999999999997 999987533211 111111100
Q ss_pred CCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 317 PHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 317 ~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
....+ ..++..+.+++.+|++.||++||
T Consensus 239 ------------~~~~~-----~~~~~~~~~~i~~cl~~~p~~Rp 266 (277)
T cd05036 239 ------------RLDPP-----KGCPGPVYRIMTDCWQHTPEDRP 266 (277)
T ss_pred ------------cCCCC-----CCCCHHHHHHHHHHcCCCcccCc
Confidence 00000 01234588999999999999998
No 141
>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase
Probab=100.00 E-value=2.6e-40 Score=293.12 Aligned_cols=245 Identities=24% Similarity=0.350 Sum_probs=194.9
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh---hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ---LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+++++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999964 7899999987532 2344467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918 172 EFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD 248 (361)
Q Consensus 172 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 248 (361)
||+++++|.+++.. ....+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988863 2344789999999999999999999 88999999999999999999999999999887643
Q ss_pred CCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918 249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL 328 (361)
Q Consensus 249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l 328 (361)
... ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||.............+... ... ..
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~-----~~ 228 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC---DYP-----PL 228 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC---CCC-----CC
Confidence 221 11234588899999998888889999999999999999999999864322111111111110 000 00
Q ss_pred cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
. .......+.+++.+||+.+|++||
T Consensus 229 ---~-----~~~~~~~~~~li~~cl~~~p~~Rp 253 (267)
T cd08228 229 ---P-----TEHYSEKLRELVSMCIYPDPDQRP 253 (267)
T ss_pred ---C-----hhhcCHHHHHHHHHHCCCCcccCc
Confidence 0 012234588999999999999998
No 142
>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer. Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c
Probab=100.00 E-value=1.7e-40 Score=291.40 Aligned_cols=237 Identities=31% Similarity=0.525 Sum_probs=189.8
Q ss_pred CccccCCceEEEEEEeCCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCHH
Q 037918 102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLE 180 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 180 (361)
+.||+|+||.||+|...+++.+|+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3699999999999998888999999987543 233456889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecccc
Q 037918 181 KWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA 260 (361)
Q Consensus 181 ~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 260 (361)
+++......+++..++.++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||++........ .......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI 156 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence 999866556899999999999999999999 88999999999999999999999999999876433221 11112234
Q ss_pred cccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHH
Q 037918 261 TVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKM 339 (361)
Q Consensus 261 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 339 (361)
+..|+|||+..+..++.++||||||+++|++++ |..||....... .......... ...+.
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~~~~~~~~~------------~~~~~----- 217 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--AREQVEKGYR------------MSCPQ----- 217 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHHcCCC------------CCCCC-----
Confidence 667999999988889999999999999999998 999987542211 1111111100 00000
Q ss_pred HHHHHHHHHHhhcCCCCCCCCC
Q 037918 340 DCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 340 ~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.++..+.+++.+|++.+|++||
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp 239 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRP 239 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCC
Confidence 1234589999999999999998
No 143
>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th
Probab=100.00 E-value=9.6e-41 Score=298.63 Aligned_cols=255 Identities=30% Similarity=0.429 Sum_probs=193.1
Q ss_pred CCCCCCCccccCCceEEEEEEeC-----CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeec--CCeeE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-----DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN--VDFKA 168 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~ 168 (361)
.+|++.+.||+|+||.||++..+ ++..||+|.+........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46888999999999999999742 578999999987666666789999999999999999999998744 34678
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918 169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD 248 (361)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 248 (361)
+||||+++++|.+++......+++..++.++.|++.||+||| +.+++||||||+||++++++.++|+|||++.....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999999999866556899999999999999999999 88999999999999999999999999999987644
Q ss_pred CCcce-eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCC-----Cccc
Q 037918 249 GENFE-TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH-----GLTN 322 (361)
Q Consensus 249 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----~l~~ 322 (361)
..... ......++..|+|||+..+..++.++||||||+++|||++|..|+..... ..........+. .+.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA---EFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch---hhhhhcccccccccchHHHHH
Confidence 32211 11122344569999999888899999999999999999999877543211 000000000000 0001
Q ss_pred cccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 323 VVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 323 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+........ ...++..+.+++.+||+.+|++||
T Consensus 238 ~~~~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp 271 (284)
T cd05081 238 LLKNNGRLPA-----PPGCPAEIYAIMKECWNNDPSQRP 271 (284)
T ss_pred HHhcCCcCCC-----CCCCCHHHHHHHHHHccCChhhCC
Confidence 1111100000 012234589999999999999998
No 144
>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=4.8e-41 Score=300.40 Aligned_cols=243 Identities=23% Similarity=0.389 Sum_probs=191.6
Q ss_pred CCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhhH-HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918 97 GFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQLE-RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL 169 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (361)
+|.+.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++..++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4667789999999999999853 257899999975442 334668899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCc
Q 037918 170 VLEFMPNGSLEKWLYSH---------------NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV 234 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~ 234 (361)
++||+.+++|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence 99999999999998532 123788889999999999999999 889999999999999999999
Q ss_pred EEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHh
Q 037918 235 AHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVK 313 (361)
Q Consensus 235 ~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 313 (361)
+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||...... ...+.+.
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~i~ 240 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVIEMIR 240 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHH
Confidence 99999999887644332222233346788999999888889999999999999999998 88888653221 1111111
Q ss_pred hhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 314 ESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 314 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
. ..... ... +++..+.+++.+||+.+|++||
T Consensus 241 ~---~~~~~-----~~~---------~~~~~~~~li~~cl~~~p~~RP 271 (283)
T cd05091 241 N---RQVLP-----CPD---------DCPAWVYTLMLECWNEFPSRRP 271 (283)
T ss_pred c---CCcCC-----CCC---------CCCHHHHHHHHHHhCCCcccCC
Confidence 1 11000 001 2344588999999999999998
No 145
>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa. Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho
Probab=100.00 E-value=1.7e-40 Score=292.69 Aligned_cols=236 Identities=28% Similarity=0.511 Sum_probs=186.0
Q ss_pred ccccCCceEEEEEEeC---CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCC
Q 037918 103 LLGKGSFGSVYKGILS---DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGS 178 (361)
Q Consensus 103 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 178 (361)
.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. +..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999753 35579999987654 3334678899999999999999999998864 56799999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce-eeec
Q 037918 179 LEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE-TRTM 257 (361)
Q Consensus 179 L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~ 257 (361)
|.+++......+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.......... ....
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99999866666899999999999999999999 8899999999999999999999999999998664433211 1122
Q ss_pred ccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918 258 TMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA 336 (361)
Q Consensus 258 ~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~ 336 (361)
..++..|+|||...+..++.++||||||+++|||++ |..||......+ ....+....+ ...+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~------------~~~~--- 220 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMSFIEQGKR------------LDCP--- 220 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHHCCCC------------CCCC---
Confidence 234578999999888889999999999999999996 999997643211 1111111110 0000
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 337 AKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 337 ~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..++.++.+++.+||..||++||
T Consensus 221 --~~~~~~l~~li~~c~~~~~~~Rp 243 (257)
T cd05115 221 --AECPPEMYALMKDCWIYKWEDRP 243 (257)
T ss_pred --CCCCHHHHHHHHHHcCCChhhCc
Confidence 01234588999999999999998
No 146
>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play
Probab=100.00 E-value=9.4e-41 Score=302.38 Aligned_cols=200 Identities=22% Similarity=0.354 Sum_probs=171.1
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH-HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE-RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
++|.+.+.||+|+||.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999965 678899999875432 2234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
++ ++|.+++...+..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 159 (309)
T cd07872 86 LD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-- 159 (309)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--
Confidence 96 4899988776666899999999999999999999 88999999999999999999999999999976533221
Q ss_pred eeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 254 TRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
......+++.|+|||.+.+ ..++.++||||||+++|||+||+.||...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 208 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS 208 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1223457889999998754 55889999999999999999999999754
No 147
>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=9.8e-41 Score=295.83 Aligned_cols=245 Identities=26% Similarity=0.354 Sum_probs=193.9
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
++|.+.+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..+++|||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777889999999999999864 68899999987665555567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918 175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET 254 (361)
Q Consensus 175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 254 (361)
++++|.+++...+ .+++.+++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++....... ..
T Consensus 89 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~ 162 (267)
T cd06645 89 GGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AK 162 (267)
T ss_pred CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cc
Confidence 9999999987654 3899999999999999999999 8899999999999999999999999999987664322 12
Q ss_pred eecccccccccCccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918 255 RTMTMATVGYMAPEYGS---EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 255 ~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
.....|+..|+|||++. ...++.++|+||||+++|+|++|..||........ .......... .+....
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~~~-------~~~~~~- 233 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMTKSNFQ-------PPKLKD- 233 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhhccCCC-------CCcccc-
Confidence 23446899999999864 45588999999999999999999999865322111 1111011000 000000
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.......+.+++.+|++.||++||
T Consensus 234 ------~~~~~~~~~~li~~~l~~~P~~R~ 257 (267)
T cd06645 234 ------KMKWSNSFHHFVKMALTKNPKKRP 257 (267)
T ss_pred ------cCCCCHHHHHHHHHHccCCchhCc
Confidence 001123478899999999999998
No 148
>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,
Probab=100.00 E-value=5.4e-41 Score=301.60 Aligned_cols=247 Identities=28% Similarity=0.487 Sum_probs=194.6
Q ss_pred HhhCCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecC
Q 037918 93 RATNGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNV 164 (361)
Q Consensus 93 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 164 (361)
...++|++.+.||+|+||.||++... +...+|+|.+.... .+....+.+|++++.++ +|+||+++++++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34567888999999999999999853 23679999887532 34446788999999999 899999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 037918 165 DFKALVLEFMPNGSLEKWLYSH---------------NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL 229 (361)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill 229 (361)
+..+++|||+++|+|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEE
Confidence 9999999999999999999642 234889999999999999999999 8899999999999999
Q ss_pred cCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccH
Q 037918 230 DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSL 308 (361)
Q Consensus 230 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~ 308 (361)
++++.+||+|||+++.+.............++..|+|||...+..++.++||||||+++|||++ |..||......+ .
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~ 243 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--L 243 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--H
Confidence 9999999999999987654332222223345678999999888889999999999999999998 999986532211 1
Q ss_pred HHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 309 KNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
........ ....+ ..+...+.+++.+||+.||++||
T Consensus 244 ~~~~~~~~------------~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp 279 (293)
T cd05053 244 FKLLKEGY------------RMEKP-----QNCTQELYHLMRDCWHEVPSQRP 279 (293)
T ss_pred HHHHHcCC------------cCCCC-----CCCCHHHHHHHHHHcccCcccCc
Confidence 11111100 00000 01233488999999999999998
No 149
>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]
Probab=100.00 E-value=2.4e-43 Score=296.56 Aligned_cols=239 Identities=26% Similarity=0.377 Sum_probs=204.6
Q ss_pred CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918 98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPN 176 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (361)
|+++.+||+|+||.||++.++ .|+.+|||.+..+ ...+++.+|+.++++.+.|++|++||.+.....+++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 667889999999999999965 6999999988654 4568899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918 177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256 (361)
Q Consensus 177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 256 (361)
|++.+.+..+++.++++++..++...++||+||| ...-+|||||+.|||++.+|.+||+|||.|-.+.+. ...+.
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKRN 187 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKRN 187 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhh--HHhhC
Confidence 9999999988888999999999999999999999 778899999999999999999999999999876542 23445
Q ss_pred cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918 257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA 336 (361)
Q Consensus 257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~ 336 (361)
...||+.|||||++..-.|+.++||||||++..||..|++||.+..+... + --.-...+|.+.
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA----------------I-FMIPT~PPPTF~ 250 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA----------------I-FMIPTKPPPTFK 250 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce----------------e-EeccCCCCCCCC
Confidence 56899999999999999999999999999999999999999987543211 0 000112233344
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCC
Q 037918 337 AKMDCMLSIMHLALDCSMYSPDQR 360 (361)
Q Consensus 337 ~~~~~~~~l~~l~~~cl~~dP~~R 360 (361)
........+-+++.+||-.+|++|
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R 274 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEER 274 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHH
Confidence 444566678999999999999998
No 150
>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=1.2e-40 Score=299.90 Aligned_cols=243 Identities=26% Similarity=0.347 Sum_probs=196.1
Q ss_pred hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
..+|++.+.||+|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36789999999999999999995 47999999999765544456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
+++++|.+++.+.. +++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~~~--~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-- 170 (297)
T cd06656 98 LAGGSLTDVVTETC--MDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 170 (297)
T ss_pred cCCCCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--
Confidence 99999999997543 789999999999999999999 88999999999999999999999999999876543321
Q ss_pred eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP 333 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 333 (361)
......+++.|+|||...+..++.++|+||||+++|+|++|..||............+ . .... . ...+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~-~----~~~~-----~--~~~~ 238 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-T----NGTP-----E--LQNP 238 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec-c----CCCC-----C--CCCc
Confidence 1223468889999999988889999999999999999999999996532211100000 0 0000 0 0000
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 334 AFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
......+.+++.+||+.||++||
T Consensus 239 -----~~~~~~~~~li~~~l~~~p~~Rp 261 (297)
T cd06656 239 -----ERLSAVFRDFLNRCLEMDVDRRG 261 (297)
T ss_pred -----cccCHHHHHHHHHHccCChhhCc
Confidence 11233478899999999999998
No 151
>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase. Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down
Probab=100.00 E-value=4.6e-40 Score=297.68 Aligned_cols=197 Identities=26% Similarity=0.336 Sum_probs=172.8
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
++|++.+.||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++||||+++++++.+++..+++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36889999999999999999965 68889999887543 33445688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS-PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
+++++|.+++...+ .+++..+..++.|+++||.||| + .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 99999999998654 3889999999999999999999 5 589999999999999999999999999987653321
Q ss_pred eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918 253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDE 300 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~ 300 (361)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||..
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 2234688999999998888899999999999999999999999864
No 152
>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ
Probab=100.00 E-value=2.4e-40 Score=292.36 Aligned_cols=246 Identities=26% Similarity=0.363 Sum_probs=198.7
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
++|++.+.||+|++|.||+|... +++.+++|.+........+.+.+|++++++++||||+++++++.+.+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888999999999999999964 57889999998765556678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918 175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET 254 (361)
Q Consensus 175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 254 (361)
++++|.+++......+++..+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++....... ..
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~ 157 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AK 157 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh--hc
Confidence 999999999876455899999999999999999999 8899999999999999999999999999998654321 12
Q ss_pred eecccccccccCccccCCC---CCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918 255 RTMTMATVGYMAPEYGSEG---IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 255 ~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
.....++..|+|||...+. .++.++|+||||+++|||+||+.||.......... .......+ ...+.
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~-~~~~~~~~-------~~~~~-- 227 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-LISKSNFP-------PPKLK-- 227 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccCC-------Ccccc--
Confidence 2334678889999998776 78999999999999999999999987543211111 01000000 00000
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
........+.+++.+||..||++||
T Consensus 228 -----~~~~~~~~~~~li~~~l~~~p~~Rp 252 (262)
T cd06613 228 -----DKEKWSPVFHDFIKKCLTKDPKKRP 252 (262)
T ss_pred -----chhhhhHHHHHHHHHHcCCChhhCC
Confidence 0112234588999999999999998
No 153
>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase. Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina
Probab=100.00 E-value=3.8e-40 Score=292.25 Aligned_cols=248 Identities=28% Similarity=0.374 Sum_probs=194.3
Q ss_pred HHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918 92 QRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV 170 (361)
Q Consensus 92 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (361)
+.+++++.....||+|+||.||+|... ++..|++|.+........+.+.+|+.++++++|+||+++++++..++..+++
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 445666666789999999999999954 6788999998776656667899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC-CCcEEEEeccCccccC
Q 037918 171 LEFMPNGSLEKWLYSHNYFL--DIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE-NMVAHVSDFGISKLLG 247 (361)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~ 247 (361)
+||+++++|.+++......+ ++..+..++.|++.||+||| +.+|+||||+|+||+++. ++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 99999999999998654335 88889999999999999999 889999999999999976 6799999999987654
Q ss_pred CCCcceeeecccccccccCccccCCCC--CCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccc
Q 037918 248 DGENFETRTMTMATVGYMAPEYGSEGI--VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVD 325 (361)
Q Consensus 248 ~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 325 (361)
.... ......++..|+|||++.+.. ++.++|+||||+++|+|++|+.||......... .+..... . ..
T Consensus 161 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~--~~~~~~~-~-----~~ 230 (268)
T cd06624 161 GINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA--MFKVGMF-K-----IH 230 (268)
T ss_pred cCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh--Hhhhhhh-c-----cC
Confidence 3221 122335788999999876543 788999999999999999999998653221111 1100000 0 00
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 326 ENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 326 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+.+ +. .....+.+++.+||+.+|++||
T Consensus 231 ~~~----~~-----~~~~~~~~li~~~l~~~p~~Rp 257 (268)
T cd06624 231 PEI----PE-----SLSAEAKNFILRCFEPDPDKRA 257 (268)
T ss_pred CCC----Cc-----ccCHHHHHHHHHHcCCCchhCC
Confidence 001 00 1223478999999999999998
No 154
>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase. Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio
Probab=100.00 E-value=2e-40 Score=292.26 Aligned_cols=235 Identities=30% Similarity=0.469 Sum_probs=185.9
Q ss_pred ccccCCceEEEEEEe---CCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCC
Q 037918 103 LLGKGSFGSVYKGIL---SDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNG 177 (361)
Q Consensus 103 ~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 177 (361)
.||+|+||.||+|.+ .++..+|+|+++... ....+.+..|+.+++.++||||+++++++.. +..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999974 357889999986443 3345678899999999999999999998864 4678999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce-eee
Q 037918 178 SLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE-TRT 256 (361)
Q Consensus 178 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~ 256 (361)
+|.+++.... .+++..+..++.|++.||+||| +++++||||||+||+++.++.++|+|||++.......... ...
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 9999997654 3899999999999999999999 8899999999999999999999999999998765433221 112
Q ss_pred cccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhH
Q 037918 257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF 335 (361)
Q Consensus 257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~ 335 (361)
...++..|+|||.+....++.++|+||||+++|||++ |+.||..... ......+..... ...+.
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~i~~~~~------------~~~~~- 221 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQMIESGER------------MECPQ- 221 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCCCC------------CCCCC-
Confidence 2234578999999888889999999999999999998 9999975422 122222221110 00000
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 336 AAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 336 ~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.++..+.+++.+||+.||++||
T Consensus 222 ----~~~~~l~~li~~~~~~~p~~Rp 243 (257)
T cd05116 222 ----RCPPEMYDLMKLCWTYGVDERP 243 (257)
T ss_pred ----CCCHHHHHHHHHHhccCchhCc
Confidence 1233478999999999999998
No 155
>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5. Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p
Probab=100.00 E-value=1.4e-40 Score=296.79 Aligned_cols=241 Identities=24% Similarity=0.322 Sum_probs=191.0
Q ss_pred CCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 96 NGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
++|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3578889999999999999985 468899999986542 33446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
+++++|..+. .+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---- 148 (279)
T cd06619 81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---- 148 (279)
T ss_pred CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence 9999997653 2688889999999999999999 889999999999999999999999999999765432
Q ss_pred eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccH--HHHHhhhcCCCccccccccccCC
Q 037918 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSL--KNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.......... ........... .+.+...
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 223 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVLPVG 223 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCCCCC
Confidence 2233468999999999988889999999999999999999999997643222111 11111100000 0000000
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+|++.||++||
T Consensus 224 --------~~~~~~~~li~~~l~~~P~~Rp 245 (279)
T cd06619 224 --------QFSEKFVHFITQCMRKQPKERP 245 (279)
T ss_pred --------cCCHHHHHHHHHHhhCChhhCC
Confidence 0122478999999999999998
No 156
>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src. Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo
Probab=100.00 E-value=1.4e-40 Score=294.15 Aligned_cols=242 Identities=29% Similarity=0.472 Sum_probs=191.8
Q ss_pred hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
.++|++.+.||+|+||.||+|...++..||+|++..... ..+.+.+|++++++++||||+++++.+.. +..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 356899999999999999999987777899999875332 23568889999999999999999998754 5579999999
Q ss_pred CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 175 PNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 175 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
++|+|.+++... ...+++..+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||.+..+......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~- 158 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 158 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence 999999999854 334789999999999999999999 889999999999999999999999999999876443321
Q ss_pred eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 332 (361)
......++..|+|||+..+..++.++||||||+++|||+| |..||......+ ......... ....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~--~~~~~~~~~------------~~~~ 224 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGY------------RMPC 224 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH--HHHHHhcCC------------CCCC
Confidence 1123346678999999888889999999999999999999 888886543211 111100000 0000
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..+++..+.+++.+|++.||++||
T Consensus 225 -----~~~~~~~l~~li~~~l~~~p~~Rp 248 (262)
T cd05071 225 -----PPECPESLHDLMCQCWRKEPEERP 248 (262)
T ss_pred -----ccccCHHHHHHHHHHccCCcccCC
Confidence 012345589999999999999998
No 157
>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including
Probab=100.00 E-value=3.9e-40 Score=296.36 Aligned_cols=251 Identities=24% Similarity=0.405 Sum_probs=191.0
Q ss_pred CCCCCCCccccCCceEEEEEEeCC---------------CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeee
Q 037918 96 NGFDECNLLGKGSFGSVYKGILSD---------------GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILS 159 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~ 159 (361)
++|++.+.||+|+||.||++...+ ...||+|.+.... ......+.+|++++++++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578999999999999999987532 2348999987543 334467899999999999999999999
Q ss_pred eeecCCeeEEEEEecCCCCHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEE
Q 037918 160 SCSNVDFKALVLEFMPNGSLEKWLYSHN-----------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNIL 228 (361)
Q Consensus 160 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nil 228 (361)
++...+..++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence 9999999999999999999999986432 13688899999999999999999 889999999999999
Q ss_pred EcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh--CCCCCCccccccc
Q 037918 229 LDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT--RKKPTDEFFAGEM 306 (361)
Q Consensus 229 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~p~~~~~~~~~ 306 (361)
+++++.+||+|||++................++..|+|||...+..++.++||||||+++|+|++ |..||......+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~- 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ- 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence 99999999999999986543322222223345678999999888889999999999999999998 667776532211
Q ss_pred cHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 307 SLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
................ .....+ ..+..+.+++.+||+.||++||
T Consensus 241 -~~~~~~~~~~~~~~~~----~~~~~~------~~~~~l~~li~~~l~~~p~~RP 284 (295)
T cd05097 241 -VIENTGEFFRNQGRQI----YLSQTP------LCPSPVFKLMMRCWSRDIKDRP 284 (295)
T ss_pred -HHHHHHHhhhhccccc----cCCCCC------CCCHHHHHHHHHHcCCCchhCc
Confidence 1111110000000000 000000 1123589999999999999998
No 158
>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu
Probab=100.00 E-value=2.5e-40 Score=294.03 Aligned_cols=242 Identities=28% Similarity=0.487 Sum_probs=189.6
Q ss_pred CCCCCccccCCceEEEEEEeCC----CcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCe-----
Q 037918 98 FDECNLLGKGSFGSVYKGILSD----GAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF----- 166 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 166 (361)
|.+.+.||+|+||.||+|.... +..||+|++.... ......+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998642 3679999987542 3445678999999999999999999998865543
Q ss_pred -eEEEEEecCCCCHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEec
Q 037918 167 -KALVLEFMPNGSLEKWLYSH-----NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDF 240 (361)
Q Consensus 167 -~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 240 (361)
.+++|||+++++|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 78999999999999998542 234899999999999999999999 889999999999999999999999999
Q ss_pred cCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCC
Q 037918 241 GISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHG 319 (361)
Q Consensus 241 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (361)
|+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...... ...+.......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~-- 233 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYLRHGNR-- 233 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC--
Confidence 99987654332222222345678999999988889999999999999999999 88998653221 11122111100
Q ss_pred ccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 320 LTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 320 l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
. ... ..++..+.+++.+||+.||++||
T Consensus 234 -~-----~~~---------~~~~~~~~~li~~~l~~~p~~Rp 260 (273)
T cd05035 234 -L-----KQP---------EDCLDELYDLMYSCWRADPKDRP 260 (273)
T ss_pred -C-----CCC---------cCCCHHHHHHHHHHcCCChhhCc
Confidence 0 000 01234589999999999999998
No 159
>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom
Probab=100.00 E-value=4.2e-40 Score=291.07 Aligned_cols=230 Identities=24% Similarity=0.384 Sum_probs=182.1
Q ss_pred CccccCCceEEEEEEeCC-------------CcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeE
Q 037918 102 NLLGKGSFGSVYKGILSD-------------GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (361)
+.||+|+||.||+|...+ ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2258999887665555667889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCc-------EEEEecc
Q 037918 169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV-------AHVSDFG 241 (361)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~-------~kl~Dfg 241 (361)
++|||+++++|..++......+++..++.++.|+++||+||| +++++||||||+|||++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999998866556899999999999999999999 899999999999999987664 8999999
Q ss_pred CccccCCCCcceeeecccccccccCccccC-CCCCCcccchHHHHHHHHHHH-hCCCCCCccccccccHHHHHhhhcCCC
Q 037918 242 ISKLLGDGENFETRTMTMATVGYMAPEYGS-EGIVSSKCDVYSYGVLLMETF-TRKKPTDEFFAGEMSLKNWVKESLPHG 319 (361)
Q Consensus 242 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (361)
++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|..||......+ .......
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~~----- 224 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--KERFYEG----- 224 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--HHHHHhc-----
Confidence 98755321 2235788899999876 466899999999999999997 5888876432111 1111000
Q ss_pred ccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 320 LTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 320 l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
......+ ....+.+++.+||+.||++||
T Consensus 225 -------~~~~~~~-------~~~~~~~li~~cl~~dp~~Rp 252 (262)
T cd05077 225 -------QCMLVTP-------SCKELADLMTHCMNYDPNQRP 252 (262)
T ss_pred -------CccCCCC-------ChHHHHHHHHHHcCCChhhCc
Confidence 0000011 123478999999999999998
No 160
>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4. Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.
Probab=100.00 E-value=6.1e-40 Score=290.44 Aligned_cols=244 Identities=25% Similarity=0.359 Sum_probs=194.0
Q ss_pred CCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhh------HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918 97 GFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL------ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV 170 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (361)
+|.+.+.||+|+||.||+|...+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998889999999886432 23346688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918 171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE 250 (361)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 250 (361)
|||+++++|.+++.+... +++..+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRFGP-LPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 999999999999976543 789999999999999999999 8899999999999999999999999999987653211
Q ss_pred c----ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccc
Q 037918 251 N----FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE 326 (361)
Q Consensus 251 ~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 326 (361)
. ........++..|+|||...+..++.++|+||||+++|+|++|+.||....... ..... .. .... .+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~~~-~~-~~~~-----~~ 228 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-AMFYI-GA-HRGL-----MP 228 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-HHHHh-hh-ccCC-----CC
Confidence 1 111123458889999999988889999999999999999999999997532111 11000 00 0000 01
Q ss_pred cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+... ....+.+++.+||+.+|++||
T Consensus 229 ~~~~~---------~~~~~~~~i~~~l~~~p~~Rp 254 (265)
T cd06631 229 RLPDS---------FSAAAIDFVTSCLTRDQHERP 254 (265)
T ss_pred CCCCC---------CCHHHHHHHHHHhcCCcccCC
Confidence 11111 123478999999999999998
No 161
>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk. Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r
Probab=100.00 E-value=1.7e-40 Score=293.23 Aligned_cols=241 Identities=27% Similarity=0.491 Sum_probs=191.5
Q ss_pred CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918 96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 175 (361)
++|++.+.||+|++|.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++.. +..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecC
Confidence 46888999999999999999988888899999875432 23568899999999999999999998854 56789999999
Q ss_pred CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918 176 NGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET 254 (361)
Q Consensus 176 ~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 254 (361)
+++|.+++... ...+++..+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++......... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~ 159 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-A 159 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-c
Confidence 99999999754 334899999999999999999999 889999999999999999999999999999876433211 1
Q ss_pred eecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918 255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP 333 (361)
Q Consensus 255 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 333 (361)
.....++..|+|||...+..++.++|+||||+++|+|++ |..||...... ...+......+ ...+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~------------~~~~ 225 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLEQVERGYR------------MPCP 225 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCC------------CCCC
Confidence 122235668999999888889999999999999999999 89998653221 11111111100 0000
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 334 AFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+.+..+.+++.+|++.||++||
T Consensus 226 -----~~~~~~~~~li~~~l~~~p~~Rp 248 (260)
T cd05070 226 -----QDCPISLHELMLQCWKKDPEERP 248 (260)
T ss_pred -----CcCCHHHHHHHHHHcccCcccCc
Confidence 02234589999999999999998
No 162
>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with
Probab=100.00 E-value=3.7e-40 Score=295.01 Aligned_cols=242 Identities=25% Similarity=0.295 Sum_probs=191.9
Q ss_pred CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
|+..+.||+|+||+||+|... +++.+|+|.+.... ......+.+|++++++++|+|++++.+.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999964 68899999987543 22234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 174 MPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 174 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
+++++|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 9999999988653 335899999999999999999999 8899999999999999999999999999997653322
Q ss_pred eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918 253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 332 (361)
......|+..|+|||.+.+..++.++|+||||+++|||++|..||........ . ............ ....
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~-~~~~~~~~~~~~-----~~~~-- 226 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-R-EEVDRRVLETEE-----VYSA-- 226 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-H-HHHHHhhhcccc-----ccCc--
Confidence 11234689999999999888899999999999999999999999975322111 1 111111111000 0101
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++..|++.||++||
T Consensus 227 -------~~~~~~~~li~~~l~~~P~~R~ 248 (285)
T cd05632 227 -------KFSEEAKSICKMLLTKDPKQRL 248 (285)
T ss_pred -------cCCHHHHHHHHHHccCCHhHcC
Confidence 1123468899999999999997
No 163
>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept
Probab=100.00 E-value=4.3e-40 Score=296.97 Aligned_cols=247 Identities=24% Similarity=0.410 Sum_probs=194.7
Q ss_pred hhCCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCC
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVD 165 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 165 (361)
..++|.+.+.||+|+||.||++... .+..||+|.++... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3456899999999999999999741 34579999887543 33446789999999999 7999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918 166 FKALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK 244 (361)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 244 (361)
..+++|||+++|+|.+++.... ..+++.++..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++.
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 9999999999999999997543 34899999999999999999999 8899999999999999999999999999998
Q ss_pred ccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccc
Q 037918 245 LLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNV 323 (361)
Q Consensus 245 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~ 323 (361)
...............++..|+|||.+.+..++.++||||||+++|||++ |..||......+ ..........
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~~~~~~~------- 261 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYKLIKEGY------- 261 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHHHHHcCC-------
Confidence 7644332222223346778999999988889999999999999999998 999987543211 1111111110
Q ss_pred ccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 324 VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 324 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
....+. .....+.+++.+||+.+|++||
T Consensus 262 -----~~~~~~-----~~~~~~~~li~~cl~~~p~~Rp 289 (302)
T cd05055 262 -----RMAQPE-----HAPAEIYDIMKTCWDADPLKRP 289 (302)
T ss_pred -----cCCCCC-----CCCHHHHHHHHHHcCCCchhCc
Confidence 000000 0123478999999999999998
No 164
>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,
Probab=100.00 E-value=6.2e-40 Score=299.68 Aligned_cols=201 Identities=25% Similarity=0.353 Sum_probs=174.0
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46889999999999999999965 58999999997532 223456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
||+++|+|.+++......+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999999999865555899999999999999999999 89999999999999999999999999999876643322
Q ss_pred ceeeecccccccccCccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918 252 FETRTMTMATVGYMAPEYGSE-----GIVSSKCDVYSYGVLLMETFTRKKPTDE 300 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~p~~~ 300 (361)
.......|++.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 158 -VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred -ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 11223468999999998763 4578899999999999999999999965
No 165
>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl. Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor
Probab=100.00 E-value=3.4e-40 Score=293.09 Aligned_cols=242 Identities=28% Similarity=0.515 Sum_probs=186.7
Q ss_pred CCCCCccccCCceEEEEEEeCC-Cc--EEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecC------Ce
Q 037918 98 FDECNLLGKGSFGSVYKGILSD-GA--EVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSNV------DF 166 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 166 (361)
|.+.+.||+|+||.||+|...+ +. .+|+|.++.. .....+.+..|+++++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999754 33 5899988653 234457788999999999999999999987432 25
Q ss_pred eEEEEEecCCCCHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEecc
Q 037918 167 KALVLEFMPNGSLEKWLYS-----HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFG 241 (361)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 241 (361)
.+++|||+++|+|.+++.. ....+++..+..++.|++.||+||| +.+|+||||||+||++++++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999998742 2234789999999999999999999 8899999999999999999999999999
Q ss_pred CccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCc
Q 037918 242 ISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGL 320 (361)
Q Consensus 242 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l 320 (361)
++................+++.|+|||...+..++.++||||||+++|||++ |+.||..... ....+..... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~---~~ 232 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SEIYDYLRQG---NR 232 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHcC---CC
Confidence 9987654332222222346678999999998889999999999999999999 8899865322 1111111110 00
Q ss_pred cccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 321 TNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 321 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
. ...+ .++..+.+++.+||+.||++||
T Consensus 233 ~--------~~~~------~~~~~~~~li~~~l~~~p~~Rp 259 (272)
T cd05075 233 L--------KQPP------DCLDGLYSLMSSCWLLNPKDRP 259 (272)
T ss_pred C--------CCCC------CCCHHHHHHHHHHcCCCcccCc
Confidence 0 0000 1233478999999999999998
No 166
>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan
Probab=100.00 E-value=3.6e-40 Score=290.74 Aligned_cols=238 Identities=33% Similarity=0.572 Sum_probs=194.3
Q ss_pred CccccCCceEEEEEEeCC----CcEEEEEEeehhhHH-HHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918 102 NLLGKGSFGSVYKGILSD----GAEVAIKIFNLQLER-AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPN 176 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (361)
+.||+|+||.||+|.... +..+++|.+...... ..+.+.+|++.++.++|+|++++++++.+....+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999653 788999999865433 357889999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918 177 GSLEKWLYSH--------NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD 248 (361)
Q Consensus 177 g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 248 (361)
++|.+++... ...+++..++.++.|+++||+||| +.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999876 356899999999999999999999 89999999999999999999999999999988755
Q ss_pred CCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccccccc
Q 037918 249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN 327 (361)
Q Consensus 249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 327 (361)
...........++..|+|||......++.++||||||+++|||++ |..||..... ....+......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~~----------- 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEVLEYLRKGY----------- 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCC-----------
Confidence 432223344567889999999888889999999999999999999 6999876521 11111111100
Q ss_pred ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
....+ ..++..+.+++.+||+.||++||
T Consensus 225 -~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp 252 (262)
T cd00192 225 -RLPKP-----EYCPDELYELMLSCWQLDPEDRP 252 (262)
T ss_pred -CCCCC-----ccCChHHHHHHHHHccCCcccCc
Confidence 00000 01234589999999999999998
No 167
>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr
Probab=100.00 E-value=1.7e-40 Score=294.65 Aligned_cols=244 Identities=28% Similarity=0.475 Sum_probs=193.3
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CC---cEEEEEEeehh-hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DG---AEVAIKIFNLQ-LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV 170 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (361)
++|++.+.||+|+||.||+|... ++ ..||+|.+... .......+..|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 34778899999999999999964 23 36999998754 244457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918 171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE 250 (361)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 250 (361)
|||+++++|.+++......+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999876566899999999999999999999 8899999999999999999999999999987664332
Q ss_pred cceeeecc---cccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccc
Q 037918 251 NFETRTMT---MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE 326 (361)
Q Consensus 251 ~~~~~~~~---~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 326 (361)
........ ..+..|+|||.+.+..++.++||||||+++|||++ |..||...... ....++....+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~~~~~--------- 229 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIEQDYR--------- 229 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCCc---------
Confidence 21111111 12457999999988889999999999999999886 99998654321 12222211110
Q ss_pred cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+ ..+ .+++..+.+++.+||+.+|++||
T Consensus 230 -~--~~~-----~~~~~~~~~li~~~l~~~p~~Rp 256 (269)
T cd05065 230 -L--PPP-----MDCPTALHQLMLDCWQKDRNARP 256 (269)
T ss_pred -C--CCc-----ccCCHHHHHHHHHHcCCChhhCc
Confidence 0 000 12334578999999999999998
No 168
>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored
Probab=100.00 E-value=2.7e-40 Score=293.22 Aligned_cols=245 Identities=26% Similarity=0.482 Sum_probs=193.9
Q ss_pred hCCCCCCCccccCCceEEEEEEeC-CC---cEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS-DG---AEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL 169 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (361)
+++|+..+.||+|+||.||+|... ++ ..+++|.+.... ....+.+..|++++++++|||++++.+++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 356788899999999999999964 23 379999887542 3445678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918 170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 249 (361)
||||+++++|.+++......+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999876556899999999999999999999 889999999999999999999999999999876433
Q ss_pred Cccee-eecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccccccc
Q 037918 250 ENFET-RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN 327 (361)
Q Consensus 250 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 327 (361)
..... ......+..|+|||++.+..++.++||||||+++|||++ |+.||...... .........
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~~~~~i~~~------------ 226 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--EVMKAINDG------------ 226 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHHHHhcC------------
Confidence 22111 111223557999999888889999999999999999998 99998653221 111111110
Q ss_pred ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+ .+++..+.+++.+||+.+|++||
T Consensus 227 ~~~~~~-----~~~~~~~~~li~~c~~~~p~~Rp 255 (268)
T cd05063 227 FRLPAP-----MDCPSAVYQLMLQCWQQDRARRP 255 (268)
T ss_pred CCCCCC-----CCCCHHHHHHHHHHcCCCcccCc
Confidence 000000 12234589999999999999998
No 169
>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=1.6e-40 Score=300.57 Aligned_cols=244 Identities=27% Similarity=0.469 Sum_probs=191.3
Q ss_pred CCCCCCCccccCCceEEEEEEeC--------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCC
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS--------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVD 165 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 165 (361)
++|.+.+.||+|+||.||++... ++..+|+|.+.... ......+..|+.+++.+ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56899999999999999999742 23569999987542 34456788899999999 7999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc
Q 037918 166 FKALVLEFMPNGSLEKWLYSHN---------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD 230 (361)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~ 230 (361)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence 9999999999999999997532 24788999999999999999999 88999999999999999
Q ss_pred CCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHH
Q 037918 231 ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLK 309 (361)
Q Consensus 231 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~ 309 (361)
.++.++|+|||.+................++..|+|||.+.+..++.++||||||+++|||++ |..||...... ...
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~--~~~ 252 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--ELF 252 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHH
Confidence 999999999999876543222111222234568999999988889999999999999999998 88888643211 111
Q ss_pred HHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 310 NWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
....... ..+.+. .+...+.+++.+||+.+|++||
T Consensus 253 ~~~~~~~------------~~~~~~-----~~~~~~~~li~~~l~~~p~~Rp 287 (307)
T cd05098 253 KLLKEGH------------RMDKPS-----NCTNELYMMMRDCWHAVPSQRP 287 (307)
T ss_pred HHHHcCC------------CCCCCC-----cCCHHHHHHHHHHcccChhhCc
Confidence 1111100 000000 1233578999999999999998
No 170
>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.
Probab=100.00 E-value=5.7e-40 Score=290.89 Aligned_cols=245 Identities=24% Similarity=0.331 Sum_probs=195.1
Q ss_pred CCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehh---hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQ---LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
++|++.+.||+|++|.||++.. .+++.+|||.+... .......+.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999995 47899999987643 2334467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918 172 EFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD 248 (361)
Q Consensus 172 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 248 (361)
||+++++|.+++.. ....+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998863 2344899999999999999999999 88999999999999999999999999999887643
Q ss_pred CCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918 249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL 328 (361)
Q Consensus 249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l 328 (361)
... ......++..|+|||...+..++.++|+||||+++|+|++|..||.....+......... ....+..
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~ 228 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE--------QCDYPPL 228 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhh--------cCCCCCC
Confidence 322 122345888999999998888999999999999999999999998643221111111111 0000000
Q ss_pred cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.. ......+.+++.+||+.||++||
T Consensus 229 ~~--------~~~~~~~~~li~~~l~~~p~~Rp 253 (267)
T cd08229 229 PS--------DHYSEELRQLVNMCINPDPEKRP 253 (267)
T ss_pred Cc--------ccccHHHHHHHHHhcCCCcccCC
Confidence 00 01234588999999999999998
No 171
>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=2.2e-40 Score=299.32 Aligned_cols=245 Identities=26% Similarity=0.475 Sum_probs=193.2
Q ss_pred hCCCCCCCccccCCceEEEEEEeC--------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecC
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS--------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNV 164 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 164 (361)
..+|.+.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 456888899999999999999731 24579999887543 34456788999999999 899999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 037918 165 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL 229 (361)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill 229 (361)
+..+++|||+++++|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence 99999999999999999997532 24788889999999999999999 8899999999999999
Q ss_pred cCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccH
Q 037918 230 DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSL 308 (361)
Q Consensus 230 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~ 308 (361)
++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .+
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~ 248 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--EL 248 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HH
Confidence 9999999999999987654332222233346678999999988889999999999999999998 78888643211 11
Q ss_pred HHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 309 KNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
........ . ...+ ..++..+.+++.+||+.+|++||
T Consensus 249 ~~~~~~~~----~--------~~~~-----~~~~~~~~~li~~cl~~~p~~Rp 284 (304)
T cd05101 249 FKLLKEGH----R--------MDKP-----ANCTNELYMMMRDCWHAIPSHRP 284 (304)
T ss_pred HHHHHcCC----c--------CCCC-----CCCCHHHHHHHHHHcccChhhCC
Confidence 11111100 0 0000 12344588999999999999998
No 172
>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1. Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.
Probab=100.00 E-value=2.8e-40 Score=297.54 Aligned_cols=241 Identities=29% Similarity=0.484 Sum_probs=188.2
Q ss_pred CCCCCCCccccCCceEEEEEEeCC-Cc--EEEEEEeehh-hHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILSD-GA--EVAIKIFNLQ-LERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALV 170 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 170 (361)
++|++.+.||+|+||.||+|...+ +. .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999998653 33 4788887642 233456788999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcE
Q 037918 171 LEFMPNGSLEKWLYSHN---------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235 (361)
Q Consensus 171 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 235 (361)
|||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 99999999999997532 24788999999999999999999 8899999999999999999999
Q ss_pred EEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhh
Q 037918 236 HVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKE 314 (361)
Q Consensus 236 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 314 (361)
||+|||++...... ........+..|+|||...+..++.++||||||+++|||++ |..||......+ ....
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-----~~~~ 230 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-----LYEK 230 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHH
Confidence 99999998643211 11111233567999999988889999999999999999998 999997543211 1111
Q ss_pred hcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 315 SLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 315 ~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.. .. .....+. .+...+.+++.+||+.||.+||
T Consensus 231 ~~-~~--------~~~~~~~-----~~~~~~~~li~~~l~~~p~~Rp 263 (297)
T cd05089 231 LP-QG--------YRMEKPR-----NCDDEVYELMRQCWRDRPYERP 263 (297)
T ss_pred Hh-cC--------CCCCCCC-----CCCHHHHHHHHHHcCCChhhCc
Confidence 10 00 0000000 1233478999999999999998
No 173
>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.
Probab=100.00 E-value=4.7e-40 Score=300.47 Aligned_cols=201 Identities=23% Similarity=0.345 Sum_probs=174.4
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
++|.+.+.||+|+||.||++... +++.||+|++.... ......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999965 67889999987532 223355788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999999875555899999999999999999999 89999999999999999999999999999987644322
Q ss_pred ceeeecccccccccCccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918 252 FETRTMTMATVGYMAPEYGSE-----GIVSSKCDVYSYGVLLMETFTRKKPTDE 300 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~p~~~ 300 (361)
. ......|++.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 158 V-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred e-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 1 2223469999999998765 4578899999999999999999999965
No 174
>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=1.3e-40 Score=299.64 Aligned_cols=242 Identities=25% Similarity=0.346 Sum_probs=195.7
Q ss_pred CCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918 96 NGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
.+|++.+.||.|++|.||+|.. .+++.|++|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4588899999999999999985 478999999987655444567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918 175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET 254 (361)
Q Consensus 175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 254 (361)
++++|.+++.... +++.++..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 99 ~~~~L~~~~~~~~--l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~ 171 (296)
T cd06655 99 AGGSLTDVVTETC--MDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--K 171 (296)
T ss_pred CCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--c
Confidence 9999999987543 899999999999999999999 88999999999999999999999999999886543321 1
Q ss_pred eecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918 255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334 (361)
Q Consensus 255 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 334 (361)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||........ . .......... +. .+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~-~~~~~~~~~~--------~~--~~- 238 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-L-YLIATNGTPE--------LQ--NP- 238 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H-HHHHhcCCcc--------cC--Cc-
Confidence 2234588899999999888899999999999999999999999975332111 1 1111000000 00 00
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 335 FAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
......+.+++.+||..||++||
T Consensus 239 ----~~~~~~~~~li~~~l~~dp~~Rp 261 (296)
T cd06655 239 ----EKLSPIFRDFLNRCLEMDVEKRG 261 (296)
T ss_pred ----ccCCHHHHHHHHHHhhcChhhCC
Confidence 01223478899999999999998
No 175
>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]
Probab=100.00 E-value=9.8e-42 Score=294.74 Aligned_cols=253 Identities=26% Similarity=0.329 Sum_probs=186.0
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC-----eeEEE
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD-----FKALV 170 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv 170 (361)
.|...+++|+|+||.||+|... +++.||||+.-.+.. --.+|+++|+.++|||||++.-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4667789999999999999964 579999998765432 2246999999999999999998885432 34589
Q ss_pred EEecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC-CcEEEEeccCcccc
Q 037918 171 LEFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN-MVAHVSDFGISKLL 246 (361)
Q Consensus 171 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~ 246 (361)
|||++. +|.++++. .+..++.-.+.-+..||++||+||| +.+|+||||||.|+|+|.+ |.+||+|||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999975 99999884 2444888888999999999999999 8999999999999999966 89999999999998
Q ss_pred CCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCC---Cc--
Q 037918 247 GDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH---GL-- 320 (361)
Q Consensus 247 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~l-- 320 (361)
..++.. .....|..|+|||.+.+ ..|+.+.||||.||++.||+-|++-|.+.. +...+....+---.. .+
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s-~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS-SVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC-HHHHHHHHHHHhCCCCHHHHhh
Confidence 665532 34567889999997766 569999999999999999999999987632 222232222111000 00
Q ss_pred -----cccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 321 -----TNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 321 -----~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+...+.+....-.............+++.+++.++|.+|.
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~ 298 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRL 298 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcC
Confidence 01111111111100001112234579999999999999994
No 176
>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological
Probab=100.00 E-value=2.2e-40 Score=295.10 Aligned_cols=245 Identities=27% Similarity=0.460 Sum_probs=193.9
Q ss_pred hCCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCee
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFK 167 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 167 (361)
.++|.+.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++++...+..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 357888999999999999999864 24689999986543 23345788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEE
Q 037918 168 ALVLEFMPNGSLEKWLYSHN---------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVS 238 (361)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 238 (361)
++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence 99999999999999997432 23678899999999999999999 8999999999999999999999999
Q ss_pred eccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcC
Q 037918 239 DFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLP 317 (361)
Q Consensus 239 Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 317 (361)
|||+++...............++..|+|||...+..++.++||||||+++|||+| |..||...... ....+....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~-- 237 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVLKFVIDG-- 237 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHHHHHhcC--
Confidence 9999987644332222233346788999999888889999999999999999998 99998653221 111221110
Q ss_pred CCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 318 HGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 318 ~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.... ... .++..+.+++.+||+.+|++||
T Consensus 238 -~~~~-----~~~---------~~~~~~~~li~~~l~~~p~~Rp 266 (277)
T cd05032 238 -GHLD-----LPE---------NCPDKLLELMRMCWQYNPKMRP 266 (277)
T ss_pred -CCCC-----CCC---------CCCHHHHHHHHHHcCCChhhCC
Confidence 0000 000 1133588999999999999998
No 177
>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a
Probab=100.00 E-value=1.6e-39 Score=287.89 Aligned_cols=245 Identities=26% Similarity=0.371 Sum_probs=195.9
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh---hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ---LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
++|++.+.||+|++|.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+|++++++++.+.+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999976 7899999988632 2333567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918 172 EFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD 248 (361)
Q Consensus 172 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 248 (361)
||+++++|.+++.. ....+++..++.++.+++.||.||| +.+++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999864 2344789999999999999999999 88999999999999999999999999999886643
Q ss_pred CCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918 249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL 328 (361)
Q Consensus 249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l 328 (361)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.... .+..+............
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~------ 227 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKIEKCDYPP------ 227 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhhhhcCCCCC------
Confidence 221 1223457888999999888889999999999999999999999985422 22222211111000000
Q ss_pred cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+. ......+.+++.+||+.+|++||
T Consensus 228 ---~~~----~~~~~~~~~~i~~cl~~~p~~Rp 253 (267)
T cd08224 228 ---LPA----DHYSEELRDLVSRCINPDPEKRP 253 (267)
T ss_pred ---CCh----hhcCHHHHHHHHHHcCCCcccCC
Confidence 000 02233578999999999999998
No 178
>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity. Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....
Probab=100.00 E-value=1.5e-40 Score=293.16 Aligned_cols=245 Identities=32% Similarity=0.447 Sum_probs=192.1
Q ss_pred CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHH--HHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918 98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAF--RSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
|++.+.||+|+||+||++... +++.+|+|++........ .....|+.++++++||||+++++++.+.+..+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999976 567899999987653322 23456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918 175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET 254 (361)
Q Consensus 175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 254 (361)
++++|.+++.... .+++..+..++.|+++||++|| +.+++|+||||+||++++++.++|+|||.+..... ....
T Consensus 81 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQKNK-PLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNEN 154 (260)
T ss_dssp TTEBHHHHHHHHS-SBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTSE
T ss_pred ccccccccccccc-cccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc--cccc
Confidence 9999999998333 3899999999999999999999 88999999999999999999999999999986422 1223
Q ss_pred eecccccccccCccccC-CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918 255 RTMTMATVGYMAPEYGS-EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP 333 (361)
Q Consensus 255 ~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 333 (361)
.....++..|+|||+.. +..++.++|+||+|+++|+|++|..||..... .+......... ............
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~~~~~~~~~----~~~~~~~~~~~~- 227 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQLEIIEKIL----KRPLPSSSQQSR- 227 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHHHHHHHHHH----HTHHHHHTTSHT-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc--hhhhhhhhhcc----cccccccccccc-
Confidence 44567899999999988 78899999999999999999999999986411 11111111110 000000000000
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 334 AFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||+.||++||
T Consensus 228 ------~~~~~l~~li~~~l~~~p~~R~ 249 (260)
T PF00069_consen 228 ------EKSEELRDLIKKMLSKDPEQRP 249 (260)
T ss_dssp ------TSHHHHHHHHHHHSSSSGGGST
T ss_pred ------hhHHHHHHHHHHHccCChhHCc
Confidence 0014589999999999999998
No 179
>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta
Probab=100.00 E-value=2e-40 Score=297.25 Aligned_cols=246 Identities=24% Similarity=0.414 Sum_probs=191.6
Q ss_pred hhCCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCe
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF 166 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 166 (361)
..++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999743 24579999876443 2333467889999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEE
Q 037918 167 KALVLEFMPNGSLEKWLYSHN---------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHV 237 (361)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 237 (361)
.++||||+++|+|.+++.... ...++..+..++.|++.||.||| +++++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999997421 22467788999999999999999 899999999999999999999999
Q ss_pred EeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhc
Q 037918 238 SDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESL 316 (361)
Q Consensus 238 ~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 316 (361)
+|||+++...............++..|+|||.+.+..++.++|+||||+++|||++ |..||...... +......
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-----~~~~~~~ 235 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-----QVLKFVM 235 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHH
Confidence 99999986543322222222345678999999988889999999999999999998 78888653221 1111111
Q ss_pred CCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 317 PHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 317 ~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
...... ... .++..+.+++.+||+.||++||
T Consensus 236 ~~~~~~-----~~~---------~~~~~~~~li~~~l~~~p~~Rp 266 (288)
T cd05061 236 DGGYLD-----QPD---------NCPERVTDLMRMCWQFNPKMRP 266 (288)
T ss_pred cCCCCC-----CCC---------CCCHHHHHHHHHHcCCChhHCc
Confidence 110000 000 1123589999999999999998
No 180
>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase). Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It
Probab=100.00 E-value=1.9e-40 Score=296.09 Aligned_cols=246 Identities=26% Similarity=0.403 Sum_probs=195.2
Q ss_pred hhCCCCCCCccccCCceEEEEEEeCC-----CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeec-CCe
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILSD-----GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSN-VDF 166 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~ 166 (361)
..++|.+.+.||+|+||.||+|...+ +..|++|.+.... ....+.+.+|+.++++++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 34678889999999999999999755 6889999887542 3445678899999999999999999998765 567
Q ss_pred eEEEEEecCCCCHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEe
Q 037918 167 KALVLEFMPNGSLEKWLYSHN-------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSD 239 (361)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 239 (361)
.++++||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++|+||+|+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECC
Confidence 899999999999999997532 34889999999999999999999 88999999999999999999999999
Q ss_pred ccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCC
Q 037918 240 FGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPH 318 (361)
Q Consensus 240 fg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 318 (361)
||+++.+.............++..|+|||.+.+..++.++||||||+++||+++ |+.||..... ..+..+......
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~- 237 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKDGYR- 237 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHcCCC-
Confidence 999986644332222223346778999999988889999999999999999999 9999975322 122222221110
Q ss_pred CccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 319 GLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 319 ~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
...+ ..++..+.+++.+||+.||++||
T Consensus 238 -----------~~~~-----~~~~~~~~~li~~~l~~~p~~Rp 264 (280)
T cd05043 238 -----------LAQP-----INCPDELFAVMACCWALDPEERP 264 (280)
T ss_pred -----------CCCC-----CcCCHHHHHHHHHHcCCChhhCC
Confidence 0000 01233578999999999999998
No 181
>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase. Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription
Probab=100.00 E-value=5e-40 Score=305.13 Aligned_cols=199 Identities=26% Similarity=0.345 Sum_probs=169.2
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC-----eeE
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD-----FKA 168 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 168 (361)
+|++.+.||+|+||.||++... +|+.||+|++... .....+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999964 7899999988643 2234467889999999999999999999998776 789
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918 169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD 248 (361)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 248 (361)
+||||+. ++|.+++.... .+++..+..++.|++.||+||| +.+++||||||+|||++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999995 68888886554 4899999999999999999999 88999999999999999999999999999986543
Q ss_pred CCcceeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 249 GENFETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 249 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
... .......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 156 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 208 (372)
T cd07853 156 DES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ 208 (372)
T ss_pred Ccc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC
Confidence 221 122334578899999987764 4789999999999999999999999754
No 182
>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as
Probab=100.00 E-value=6.9e-40 Score=293.26 Aligned_cols=242 Identities=25% Similarity=0.316 Sum_probs=191.7
Q ss_pred CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++|+|++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999965 68899999987542 22234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 174 MPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 174 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
+++++|.+++... ...+++..+..++.|++.||.||| +.+++||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 9999999998643 234899999999999999999999 89999999999999999999999999999876543221
Q ss_pred eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918 253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 332 (361)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... ... ....... ... .....
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~-~~~~~~~-~~~----~~~~~-- 226 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KRE-EVERLVK-EVQ----EEYSE-- 226 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHH-HHHhhhh-hhh----hhcCc--
Confidence 123468999999999988889999999999999999999999997532211 000 0000000 000 00001
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||+.||++||
T Consensus 227 -------~~~~~~~~li~~~l~~~p~~R~ 248 (285)
T cd05630 227 -------KFSPDARSLCKMLLCKDPKERL 248 (285)
T ss_pred -------cCCHHHHHHHHHHhhcCHHHcc
Confidence 1123478999999999999997
No 183
>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k
Probab=100.00 E-value=5.5e-40 Score=288.30 Aligned_cols=238 Identities=33% Similarity=0.549 Sum_probs=190.4
Q ss_pred CccccCCceEEEEEEeCCCcEEEEEEeehhhH-HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCHH
Q 037918 102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQLE-RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLE 180 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 180 (361)
+.||+|++|.||++...+++.|++|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999987799999998876443 34567899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecccc
Q 037918 181 KWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA 260 (361)
Q Consensus 181 ~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 260 (361)
+++......+++..+..++.+++.+|+||| +.+++||||+|+||+++.++.++|+|||++.................
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 999765556889999999999999999999 88999999999999999999999999999986543221111122234
Q ss_pred cccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHH
Q 037918 261 TVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKM 339 (361)
Q Consensus 261 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 339 (361)
+..|+|||.+.+..++.++|+||||+++|||+| |..||...... .......... ....+.
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~~~~~~------------~~~~~~----- 218 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRERIESGY------------RMPAPQ----- 218 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHHHhcCC------------CCCCCc-----
Confidence 567999999888889999999999999999999 88888654321 1111111100 000010
Q ss_pred HHHHHHHHHHhhcCCCCCCCCC
Q 037918 340 DCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 340 ~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..+..+.+++.+|+..+|++||
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp 240 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRP 240 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCc
Confidence 1234589999999999999998
No 184
>PHA03207 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=2.7e-40 Score=308.72 Aligned_cols=197 Identities=21% Similarity=0.261 Sum_probs=171.3
Q ss_pred hCCCCCCCccccCCceEEEEEEeC---CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS---DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
..+|.+.+.||+|+||.||++... .+..||+|.+... ....+|++++++++||||+++++++...+..+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999753 3578999988643 23457999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
|++. ++|.+++... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.++|+|||++........
T Consensus 166 e~~~-~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 166 PKYK-CDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred hhcC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 9994 6899988543 34899999999999999999999 88999999999999999999999999999987654433
Q ss_pred ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 22333457999999999999889999999999999999999999998654
No 185
>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk. Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr
Probab=100.00 E-value=3.2e-40 Score=291.44 Aligned_cols=242 Identities=24% Similarity=0.424 Sum_probs=193.1
Q ss_pred hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
.++|++.++||+|+||.||+|...+++.||+|.+..... ....+.+|+.++++++|+||+++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 456888999999999999999988899999999875432 2357889999999999999999999874 45689999999
Q ss_pred CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 175 PNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 175 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
++++|.+++... +..+++..+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++........ .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 158 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-T 158 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-c
Confidence 999999998753 345899999999999999999999 88999999999999999999999999999977643221 1
Q ss_pred eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 332 (361)
......++..|+|||.+....++.++||||||+++|||++ |+.||...... ............ ....
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~--------~~~~-- 226 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EVIQNLERGYRM--------PRPD-- 226 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--HHHHHHHcCCCC--------CCCC--
Confidence 2223345678999999988889999999999999999999 99999754321 111111111100 0000
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..+..+.+++.+|++.+|++||
T Consensus 227 -------~~~~~~~~li~~~l~~~p~~Rp 248 (260)
T cd05067 227 -------NCPEELYELMRLCWKEKPEERP 248 (260)
T ss_pred -------CCCHHHHHHHHHHccCChhhCC
Confidence 1123489999999999999998
No 186
>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=100.00 E-value=6.2e-43 Score=286.11 Aligned_cols=243 Identities=26% Similarity=0.397 Sum_probs=195.1
Q ss_pred hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
++.|++.+.||+|.|+.|+++.. .+|+.+|+|++.... ....+.+.+|+++-+.++||||+++.+.....+..|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45678888999999999999884 479999999886442 345678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC---CCcEEEEeccCccccCC
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE---NMVAHVSDFGISKLLGD 248 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~~~~~ 248 (361)
|++.|++|..-+-.+ ...++..+-.++.||+.+|.|+| .++|||||+||+|+++.. .--+||+|||+|..++.
T Consensus 90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 999999998766554 34788999999999999999999 999999999999999953 34699999999998873
Q ss_pred CCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHH-hhhcCCCcccccccc
Q 037918 249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWV-KESLPHGLTNVVDEN 327 (361)
Q Consensus 249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~l~~~~~~~ 327 (361)
. .......|||+|||||++...+|+..+|||+.|++||-|+.|.+||.+... ..+-+.+ ...+ ++-.+.
T Consensus 166 g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~--~rlye~I~~g~y-----d~~~~~ 235 (355)
T KOG0033|consen 166 G---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYEQIKAGAY-----DYPSPE 235 (355)
T ss_pred c---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH--HHHHHHHhcccc-----CCCCcc
Confidence 2 244567899999999999999999999999999999999999999976321 1121111 1111 111111
Q ss_pred ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+.. ...+..+|+.+||..||++|+
T Consensus 236 w~~----------is~~Ak~LvrrML~~dP~kRI 259 (355)
T KOG0033|consen 236 WDT----------VTPEAKSLIRRMLTVNPKKRI 259 (355)
T ss_pred cCc----------CCHHHHHHHHHHhccChhhhc
Confidence 111 122368899999999999995
No 187
>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)
Probab=100.00 E-value=3.7e-40 Score=293.31 Aligned_cols=241 Identities=26% Similarity=0.326 Sum_probs=196.0
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
++|++.+.||.|++|.||+|... +++.||+|.+.... ......+.+|+++++.++|+|++++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999965 68899999987543 34446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
+++++|.+++... .+++..++.++.|++.||.||| +.+++|+||+|+||++++++.++|+|||+++...... .
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S 153 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence 9999999999865 4899999999999999999999 8899999999999999999999999999998775432 1
Q ss_pred eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP 333 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 333 (361)
......++..|+|||.+.+..++.++||||||+++|+|+||+.||....... ......... . +.+...
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~----~----~~~~~~-- 221 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--VLFLIPKNN----P----PSLEGN-- 221 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--HHHHhhhcC----C----CCCccc--
Confidence 2233467888999999988889999999999999999999999997533211 111111100 0 000000
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 334 AFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||..||++||
T Consensus 222 ------~~~~~~~~~l~~~l~~~p~~Rp 243 (274)
T cd06609 222 ------KFSKPFKDFVSLCLNKDPKERP 243 (274)
T ss_pred ------ccCHHHHHHHHHHhhCChhhCc
Confidence 0123478899999999999998
No 188
>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D
Probab=100.00 E-value=3.3e-40 Score=307.33 Aligned_cols=247 Identities=24% Similarity=0.393 Sum_probs=192.3
Q ss_pred hhCCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcC-CCceeeeeeeeecCC
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIR-HRNLVKILSSCSNVD 165 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 165 (361)
..++|.+.+.||+|+||.||+|++. .+..||+|++.... ....+.+.+|++++.++. ||||+++++++...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3446788899999999999999853 34679999997543 333457889999999997 999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhcCC----------------------------------------------------------
Q 037918 166 FKALVLEFMPNGSLEKWLYSHN---------------------------------------------------------- 187 (361)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 187 (361)
..++||||+++|+|.+++...+
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 9999999999999999996431
Q ss_pred ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEE
Q 037918 188 ---------------------------------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNIL 228 (361)
Q Consensus 188 ---------------------------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nil 228 (361)
..+++..++.++.|++.||+||| +.+++||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEE
Confidence 13567788999999999999999 889999999999999
Q ss_pred EcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCcccccccc
Q 037918 229 LDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMS 307 (361)
Q Consensus 229 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~ 307 (361)
+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......+.
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~- 350 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ- 350 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-
Confidence 99999999999999986543222112223356788999999988889999999999999999998 8999865322111
Q ss_pred HHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 308 LKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 308 ~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
......... ....+. .+...+.+++.+||+.+|++||
T Consensus 351 ~~~~~~~~~------------~~~~p~-----~~~~~l~~li~~cl~~~P~~RP 387 (401)
T cd05107 351 FYNAIKRGY------------RMAKPA-----HASDEIYEIMQKCWEEKFEIRP 387 (401)
T ss_pred HHHHHHcCC------------CCCCCC-----CCCHHHHHHHHHHcCCChhHCc
Confidence 111111100 000110 1233589999999999999998
No 189
>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl
Probab=100.00 E-value=3.2e-40 Score=297.75 Aligned_cols=200 Identities=24% Similarity=0.355 Sum_probs=171.0
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56889999999999999999865 68899999987443 22234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
++ ++|.+++......+++..+..++.|+++||+||| +.+++|+||||+||++++++.++|+|||++........
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-- 159 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-- 159 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--
Confidence 96 6999998876666899999999999999999999 89999999999999999999999999999976533221
Q ss_pred eeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 254 TRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
......+++.|+|||.+.+ ..++.++||||||+++|||+||++||...
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~ 208 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS 208 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1223356889999998755 45788999999999999999999999754
No 190
>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke
Probab=100.00 E-value=1.5e-39 Score=292.60 Aligned_cols=252 Identities=25% Similarity=0.409 Sum_probs=194.9
Q ss_pred hCCCCCCCccccCCceEEEEEEeCC-----------------CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceee
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILSD-----------------GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVK 156 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 156 (361)
.++|++.+.||+|+||.||+|...+ +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578999999999999999988542 2458999987543 344567899999999999999999
Q ss_pred eeeeeecCCeeEEEEEecCCCCHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 037918 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHN----------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSN 226 (361)
Q Consensus 157 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~N 226 (361)
+++++...+..+++|||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence 9999999999999999999999999997543 24899999999999999999999 8899999999999
Q ss_pred EEEcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh--CCCCCCccccc
Q 037918 227 ILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT--RKKPTDEFFAG 304 (361)
Q Consensus 227 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~p~~~~~~~ 304 (361)
|+++.++.++|+|||+++...............++..|+|||...+..++.++||||||+++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999986644332223334456788999999888889999999999999999998 67787643211
Q ss_pred cccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 305 EMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+ ............-... ....+ ..++..+.+++.+||+.||++||
T Consensus 241 ~--~~~~~~~~~~~~~~~~-----~~~~~-----~~~~~~l~~li~~cl~~~p~~Rp 285 (296)
T cd05051 241 Q--VIENAGHFFRDDGRQI-----YLPRP-----PNCPKDIYELMLECWRRDEEDRP 285 (296)
T ss_pred H--HHHHHHhccccccccc-----cCCCc-----cCCCHHHHHHHHHHhccChhcCC
Confidence 1 1111111000000000 00000 01224589999999999999998
No 191
>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t
Probab=100.00 E-value=3.3e-40 Score=291.45 Aligned_cols=243 Identities=28% Similarity=0.499 Sum_probs=195.0
Q ss_pred hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
.++|.+.+.||+|++|.||+|..++++.+|+|.+..... ..+.+.+|+.++++++|+||+++++++......+++|||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 467899999999999999999988888999999875432 2356889999999999999999999999989999999999
Q ss_pred CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 175 PNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 175 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++........ .
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~ 159 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-T 159 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhh-h
Confidence 9999999998643 45899999999999999999999 88999999999999999999999999999987643211 1
Q ss_pred eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 332 (361)
.......+..|+|||...+..++.++|+||||+++|+|++ |+.||...... ..+ ........ ...
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~-~~~~~~~~------------~~~ 225 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVL-EQVERGYR------------MPR 225 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHH-HHHHcCCC------------CCC
Confidence 1112234568999999988889999999999999999999 99998653221 111 11111100 000
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+. +.+..+.+++.+|++.+|++||
T Consensus 226 ~~-----~~~~~~~~~i~~~l~~~p~~Rp 249 (261)
T cd05034 226 PP-----NCPEELYDLMLQCWDKDPEERP 249 (261)
T ss_pred CC-----CCCHHHHHHHHHHcccCcccCC
Confidence 00 1133488999999999999998
No 192
>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase. Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and
Probab=100.00 E-value=2.8e-40 Score=291.16 Aligned_cols=238 Identities=27% Similarity=0.414 Sum_probs=190.2
Q ss_pred CccccCCceEEEEEEeCC--C--cEEEEEEeehhhH-HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918 102 NLLGKGSFGSVYKGILSD--G--AEVAIKIFNLQLE-RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPN 176 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (361)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|++++++++||||+++++.+.. ...+++|||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3689999987654 566789999999999999999999999988 889999999999
Q ss_pred CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc-ee
Q 037918 177 GSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF-ET 254 (361)
Q Consensus 177 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~ 254 (361)
++|.+++.+.. ..+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.+||+|||++..+...... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999998754 45899999999999999999999 889999999999999999999999999999877543221 11
Q ss_pred eecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918 255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP 333 (361)
Q Consensus 255 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 333 (361)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ......... .. . ..+
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~-~~--------~--~~~ 223 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKKIDKEG-ER--------L--ERP 223 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHhcC-Cc--------C--CCC
Confidence 123456788999999988889999999999999999999 999986532211 111111100 00 0 000
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 334 AFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
...+..+.+++.+|++.+|++||
T Consensus 224 -----~~~~~~~~~li~~~l~~~p~~Rp 246 (257)
T cd05040 224 -----EACPQDIYNVMLQCWAHNPADRP 246 (257)
T ss_pred -----ccCCHHHHHHHHHHCCCCcccCC
Confidence 01234588999999999999998
No 193
>PTZ00036 glycogen synthase kinase; Provisional
Probab=100.00 E-value=3.2e-40 Score=311.87 Aligned_cols=197 Identities=26% Similarity=0.381 Sum_probs=162.7
Q ss_pred hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecC--------
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNV-------- 164 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------- 164 (361)
..++|.+.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999964 68899999886432 2335699999999999999999876432
Q ss_pred CeeEEEEEecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC-cEEEEec
Q 037918 165 DFKALVLEFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM-VAHVSDF 240 (361)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Df 240 (361)
...++||||++ ++|.+++.. ....+++..++.++.|++.||+||| +.+|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 24678999996 578777652 3445899999999999999999999 89999999999999998664 7999999
Q ss_pred cCccccCCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 241 GISKLLGDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 241 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
|+++.+..... .....|++.|+|||++.+ ..++.++|||||||++|||++|.+||...
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 274 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99987643221 223468999999998765 46899999999999999999999999754
No 194
>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=100.00 E-value=5.6e-40 Score=299.66 Aligned_cols=244 Identities=25% Similarity=0.340 Sum_probs=201.4
Q ss_pred hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH---HHHHHHHHHHHHHHhcC-CCceeeeeeeeecCCeeE
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE---RAFRSFDSECEVLRSIR-HRNLVKILSSCSNVDFKA 168 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 168 (361)
....|++.+.||.|.||.||++..+ +|+.+|+|.+..... .....+.+|+.+|+++. ||||+.+++++++.+..+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4456888899999999999999966 599999999976543 23468899999999998 999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC----CCcEEEEeccCcc
Q 037918 169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE----NMVAHVSDFGISK 244 (361)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfg~a~ 244 (361)
+|||++.||.|.+.+... . +++..+..++.|++.+++||| +.+++||||||+|+|+.. ++.+|++|||++.
T Consensus 113 lvmEL~~GGeLfd~i~~~-~-~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-H-YSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEEecCCchHHHHHHHc-c-CCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 999999999999999877 3 899999999999999999999 899999999999999963 3579999999999
Q ss_pred ccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccc
Q 037918 245 LLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVV 324 (361)
Q Consensus 245 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~ 324 (361)
.... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.......... ....
T Consensus 188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-~i~~----------- 252 (382)
T KOG0032|consen 188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-AILR----------- 252 (382)
T ss_pred EccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-HHHc-----------
Confidence 8865 234556789999999999999999999999999999999999999998644322211 1111
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 325 DENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 325 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..+....+.. .+......+++..++..||..|+
T Consensus 253 -~~~~f~~~~w---~~is~~akd~i~~ll~~dp~~R~ 285 (382)
T KOG0032|consen 253 -GDFDFTSEPW---DDISESAKDFIRKLLEFDPRKRL 285 (382)
T ss_pred -CCCCCCCCCc---cccCHHHHHHHHHhcccCcccCC
Confidence 1111111111 12233478999999999999996
No 195
>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=4.1e-40 Score=298.86 Aligned_cols=245 Identities=25% Similarity=0.459 Sum_probs=191.3
Q ss_pred hCCCCCCCccccCCceEEEEEEeC--------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecC
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS--------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNV 164 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 164 (361)
.++|.+.+.||+|+||.||++... .+..+|+|.+.... ......+..|+++++++ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 356888999999999999999742 24568999887543 34456788999999999 699999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 037918 165 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL 229 (361)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill 229 (361)
+..+++|||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEE
Confidence 99999999999999999997532 24788999999999999999999 8899999999999999
Q ss_pred cCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccH
Q 037918 230 DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSL 308 (361)
Q Consensus 230 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~ 308 (361)
+.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...... ..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~~ 245 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--EL 245 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--HH
Confidence 9999999999999987643222111122234567999999888889999999999999999999 88998653211 11
Q ss_pred HHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 309 KNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
........ .. ..+ ..++..+.+++.+||+.||++||
T Consensus 246 ~~~~~~~~---~~---------~~~-----~~~~~~l~~li~~cl~~~p~~Rp 281 (314)
T cd05099 246 FKLLREGH---RM---------DKP-----SNCTHELYMLMRECWHAVPTQRP 281 (314)
T ss_pred HHHHHcCC---CC---------CCC-----CCCCHHHHHHHHHHcCCCcccCc
Confidence 11111100 00 000 01233578999999999999998
No 196
>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=9.5e-41 Score=312.70 Aligned_cols=240 Identities=29% Similarity=0.450 Sum_probs=201.3
Q ss_pred CCCCccccCCceEEEEEEe-CCC----cEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918 99 DECNLLGKGSFGSVYKGIL-SDG----AEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE 172 (361)
Q Consensus 99 ~~~~~lg~G~~g~V~~~~~-~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (361)
...++||+|+||+||+|.+ .+| -+||+|++.... .+...++.+|+-+|.+++|||+++++|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3467999999999999995 344 468999886543 445578999999999999999999999998776 789999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
|++.|+|.+|++.++..+..+..+.|..|||+||.||| .+.++||||..+|||+.+-..+|+.|||+++.+..+...
T Consensus 778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 99999999999988888999999999999999999999 889999999999999999999999999999998776655
Q ss_pred eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918 253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
.......-.+.|||-|.+....++.++|||||||++||++| |..|++....++. .++++..-...
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI--------------~dlle~geRLs 920 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI--------------PDLLEKGERLS 920 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh--------------hHHHhccccCC
Confidence 44444456778999999999999999999999999999998 9999987654332 22222211122
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+..-|...+..++.+||..|+..||
T Consensus 921 -----qPpiCtiDVy~~mvkCwmid~~~rp 945 (1177)
T KOG1025|consen 921 -----QPPICTIDVYMVMVKCWMIDADSRP 945 (1177)
T ss_pred -----CCCCccHHHHHHHHHHhccCcccCc
Confidence 2235677789999999999999998
No 197
>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of
Probab=100.00 E-value=1.3e-40 Score=304.26 Aligned_cols=233 Identities=23% Similarity=0.221 Sum_probs=181.3
Q ss_pred cccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc---CCCceeeeeeeeecCCeeEEEEEecCC
Q 037918 104 LGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI---RHRNLVKILSSCSNVDFKALVLEFMPN 176 (361)
Q Consensus 104 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (361)
||+|+||.||+|... +++.||+|++.... .........|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999965 68999999987543 12233455667777655 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918 177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256 (361)
Q Consensus 177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 256 (361)
|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.++|+|||++........ ...
T Consensus 81 g~L~~~l~~~~~-~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~ 154 (330)
T cd05586 81 GELFWHLQKEGR-FSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTN 154 (330)
T ss_pred ChHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--Ccc
Confidence 999999876544 899999999999999999999 88999999999999999999999999999875432221 223
Q ss_pred cccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhH
Q 037918 257 MTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF 335 (361)
Q Consensus 257 ~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~ 335 (361)
...||+.|+|||++.+. .++.++|||||||++|||++|+.||...... +......... .. +...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-----~~~~~i~~~~-~~-----~~~~---- 219 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-----QMYRNIAFGK-VR-----FPKN---- 219 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-----HHHHHHHcCC-CC-----CCCc----
Confidence 45689999999987654 4799999999999999999999999653211 1111111000 00 0000
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 336 AAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 336 ~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||+.||++||
T Consensus 220 ----~~~~~~~~li~~~L~~~P~~R~ 241 (330)
T cd05586 220 ----VLSDEGRQFVKGLLNRNPQHRL 241 (330)
T ss_pred ----cCCHHHHHHHHHHcCCCHHHCC
Confidence 0122368899999999999997
No 198
>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-40 Score=304.06 Aligned_cols=239 Identities=26% Similarity=0.454 Sum_probs=199.4
Q ss_pred CCCCccccCCceEEEEEEeCC---C--cEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918 99 DECNLLGKGSFGSVYKGILSD---G--AEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE 172 (361)
Q Consensus 99 ~~~~~lg~G~~g~V~~~~~~~---~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (361)
...+.||.|-||.||+|.+.+ | -.||||..+.+. ....+.|..|..++++++||||++++|+|.+. ..++|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmE 470 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVME 470 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEe
Confidence 345689999999999999532 3 358999888643 34467899999999999999999999999875 4689999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
.++.|.|.+||+.+...++......++.||+.||+||| +..+|||||..+|||+.....+||+|||+++.+.++...
T Consensus 471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY 547 (974)
T KOG4257|consen 471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY 547 (974)
T ss_pred cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence 99999999999998888999999999999999999999 999999999999999999999999999999999776654
Q ss_pred eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918 253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
.. +...-+..|||||-+.-..+|.+||||.||+.+||+++ |..||......+. +-..-.++
T Consensus 548 ka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-----------------I~~iEnGe 609 (974)
T KOG4257|consen 548 KA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-----------------IGHIENGE 609 (974)
T ss_pred hc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-----------------EEEecCCC
Confidence 33 34556788999999999999999999999999999976 9999987543221 11100111
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..+....|+..|..|+.+||++||.+||
T Consensus 610 --RlP~P~nCPp~LYslmskcWayeP~kRP 637 (974)
T KOG4257|consen 610 --RLPCPPNCPPALYSLMSKCWAYEPSKRP 637 (974)
T ss_pred --CCCCCCCCChHHHHHHHHHhccCcccCC
Confidence 1122336888899999999999999998
No 199
>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=6.2e-40 Score=303.13 Aligned_cols=198 Identities=22% Similarity=0.294 Sum_probs=168.4
Q ss_pred hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC-----
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD----- 165 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 165 (361)
..++|++.+.||+|+||.||++... +|+.||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999964 68999999986432 333466788999999999999999999986543
Q ss_pred -eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918 166 -FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK 244 (361)
Q Consensus 166 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 244 (361)
..++||||++ ++|.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 4789999996 467776643 2788999999999999999999 8899999999999999999999999999997
Q ss_pred ccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 245 LLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 245 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
...... ......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 172 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 172 TACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred ccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 653321 223346899999999999989999999999999999999999999754
No 200
>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1e-40 Score=300.93 Aligned_cols=247 Identities=22% Similarity=0.298 Sum_probs=202.3
Q ss_pred hhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehh--hHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEE
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALV 170 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 170 (361)
....|+++++||+||.+.||++...+.+.+|+|++... .......|.+|+.+|.+| .|.+|+++++|-..++.+|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 34569999999999999999999888888988876533 355678899999999999 599999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918 171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE 250 (361)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 250 (361)
|||- ..+|..+|++....++...+..+..|++.++.++| ..||||.||||.|+|+- .|.+||+|||.|..+..+.
T Consensus 439 mE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred eecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence 9986 56999999987655554488899999999999999 88999999999999995 4689999999999988776
Q ss_pred cceeeecccccccccCccccCCCC-----------CCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCC
Q 037918 251 NFETRTMTMATVGYMAPEYGSEGI-----------VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHG 319 (361)
Q Consensus 251 ~~~~~~~~~g~~~y~aPE~~~~~~-----------~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (361)
........+||+.||+||.+.... .+.+|||||||||||+|+.|++||......- ..
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~------------aK 581 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI------------AK 581 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH------------HH
Confidence 666667788999999999654322 5678999999999999999999998643211 12
Q ss_pred ccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 320 LTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 320 l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+..+.++.-..+++...... ++.++++.||..||.+||
T Consensus 582 l~aI~~P~~~Iefp~~~~~~----~li~~mK~CL~rdPkkR~ 619 (677)
T KOG0596|consen 582 LHAITDPNHEIEFPDIPEND----ELIDVMKCCLARDPKKRW 619 (677)
T ss_pred HHhhcCCCccccccCCCCch----HHHHHHHHHHhcCcccCC
Confidence 34555555544444432221 279999999999999997
No 201
>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter
Probab=100.00 E-value=1.9e-39 Score=289.20 Aligned_cols=240 Identities=26% Similarity=0.376 Sum_probs=195.1
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
..|+..+.||.|+||.||+|... ++..||+|.+.... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 34777889999999999999965 58899999987543 34557788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
+++++|.+++.... +++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~~~--l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06640 84 LGGGSALDLLRAGP--FDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCCCcHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--
Confidence 99999999997543 889999999999999999999 88999999999999999999999999999977643221
Q ss_pred eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP 333 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 333 (361)
......++..|+|||.+.+..++.++|+||||+++|||+||+.||........ ... .+.. . .+
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~----~~~~--------~---~~ 219 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV--LFL----IPKN--------N---PP 219 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH--hhh----hhcC--------C---CC
Confidence 12234578889999999888899999999999999999999999875432111 000 0000 0 00
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 334 AFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
. .....+..+.+++.+||+.+|++||
T Consensus 220 ~--~~~~~~~~~~~li~~~l~~~p~~Rp 245 (277)
T cd06640 220 T--LTGEFSKPFKEFIDACLNKDPSFRP 245 (277)
T ss_pred C--CchhhhHHHHHHHHHHcccCcccCc
Confidence 0 0112345688999999999999998
No 202
>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul
Probab=100.00 E-value=5.6e-40 Score=291.04 Aligned_cols=244 Identities=28% Similarity=0.450 Sum_probs=193.8
Q ss_pred CCCCCCCccccCCceEEEEEEeC-C---CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-D---GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV 170 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (361)
++|++.+.||+|+||.||+|... + +..+|+|.++... ....+.+..|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56888999999999999999853 2 3479999886543 33456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918 171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE 250 (361)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 250 (361)
|||+++++|.+++......+++.+++.++.|++.||+||| +.+++||||||+||+++.++.++|+|||++..+....
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999876656899999999999999999999 8899999999999999999999999999998765432
Q ss_pred cce-eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918 251 NFE-TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL 328 (361)
Q Consensus 251 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l 328 (361)
... ......++..|+|||.+.+..++.++|+||||+++||+++ |..||...... ........... ...
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~~--------~~~ 230 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIEEGYR--------LPA 230 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHhCCCc--------CCC
Confidence 211 1111223567999999988889999999999999999886 99998754321 11111111100 000
Q ss_pred cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
. ..++..+.+++.+|++.+|++||
T Consensus 231 ~---------~~~~~~~~~li~~~l~~~p~~Rp 254 (267)
T cd05066 231 P---------MDCPAALHQLMLDCWQKDRNERP 254 (267)
T ss_pred C---------CCCCHHHHHHHHHHcccCchhCC
Confidence 0 11234578999999999999998
No 203
>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati
Probab=100.00 E-value=8.9e-40 Score=287.73 Aligned_cols=241 Identities=22% Similarity=0.281 Sum_probs=194.0
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh-hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ-LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
+|++.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.+++.++||||+++++.+.+.+..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999965 6889999988643 2344567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 175 PNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 175 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
++++|.+++... ...+++..++.++.|++.||.||| +.+++|+||+|+||++++++.++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-- 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-- 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence 999999988753 344789999999999999999999 89999999999999999999999999999976643221
Q ss_pred eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP 333 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 333 (361)
......++..|+|||+..+..++.++|+||||+++|+|++|..||..... .............. +..
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~-----~~~--- 222 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----KNLILKVCQGSYKP-----LPS--- 222 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----HHHHHHHhcCCCCC-----CCc---
Confidence 12234688899999999888899999999999999999999999975321 11111111110000 000
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 334 AFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||+.||++||
T Consensus 223 ------~~~~~~~~li~~~l~~~P~~Rp 244 (255)
T cd08219 223 ------HYSYELRSLIKQMFKRNPRSRP 244 (255)
T ss_pred ------ccCHHHHHHHHHHHhCCcccCC
Confidence 1123478999999999999998
No 204
>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a
Probab=100.00 E-value=5.9e-40 Score=296.62 Aligned_cols=245 Identities=21% Similarity=0.243 Sum_probs=192.4
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
++|++.+.||+|+||.||++... .++.|++|.+.... ......+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999965 57899999987653 233457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
||+++++|.+++...+ .+++..+..++.|++.||+||| +.+++||||+|+||+++.++.++|+|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 9999999999997664 3899999999999999999999 88999999999999999999999999999864211000
Q ss_pred -------------ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCC
Q 037918 252 -------------FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH 318 (361)
Q Consensus 252 -------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (361)
........++..|+|||.+.+..++.++|+||||+++|||++|..||...... +........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-----~~~~~~~~~ 231 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-----ELFGQVISD 231 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhc
Confidence 00111234778899999988888999999999999999999999998643211 111111100
Q ss_pred CccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 319 GLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 319 ~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
... .+. ... ..+..+.+++.+||+.||++||
T Consensus 232 ~~~---~~~---~~~------~~~~~~~~li~~~l~~~P~~R~ 262 (305)
T cd05609 232 DIE---WPE---GDE------ALPADAQDLISRLLRQNPLERL 262 (305)
T ss_pred ccC---CCC---ccc------cCCHHHHHHHHHHhccChhhcc
Confidence 000 000 000 1233478999999999999997
No 205
>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw
Probab=100.00 E-value=1.3e-39 Score=297.64 Aligned_cols=201 Identities=24% Similarity=0.342 Sum_probs=173.3
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
++|++.+.||+|+||.||++... +++.+|+|++.... ......+..|..++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999965 57889999986532 223345788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999999999875555899999999999999999999 89999999999999999999999999999876533222
Q ss_pred ceeeecccccccccCccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918 252 FETRTMTMATVGYMAPEYGS-----EGIVSSKCDVYSYGVLLMETFTRKKPTDE 300 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~ 300 (361)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 158 -VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred -ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 1223346999999999875 34578999999999999999999999975
No 206
>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit
Probab=100.00 E-value=1.5e-39 Score=292.74 Aligned_cols=251 Identities=24% Similarity=0.403 Sum_probs=191.4
Q ss_pred CCCCCCCccccCCceEEEEEEeC-----------------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeee
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-----------------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKI 157 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~ 157 (361)
++|++.+.||+|+||.||++... ++..+|+|.+.... ......+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56899999999999999998532 23468999987543 3445678999999999999999999
Q ss_pred eeeeecCCeeEEEEEecCCCCHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCE
Q 037918 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHN----------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNI 227 (361)
Q Consensus 158 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Ni 227 (361)
++++...+..+++|||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence 999999999999999999999999997542 23677889999999999999999 88999999999999
Q ss_pred EEcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh--CCCCCCcccccc
Q 037918 228 LLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT--RKKPTDEFFAGE 305 (361)
Q Consensus 228 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~p~~~~~~~~ 305 (361)
+++.++.++|+|||++..+.............++..|+|||...++.++.++|+||||+++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986644332222222334678999998888889999999999999999998 778886532211
Q ss_pred ccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 306 MSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
. ............... . ...+ ..++..+.+++.+||+.||++||
T Consensus 242 ~--~~~~~~~~~~~~~~~----~-~~~~-----~~~~~~~~~li~~cl~~~p~~Rp 285 (296)
T cd05095 242 V--IENTGEFFRDQGRQV----Y-LPKP-----ALCPDSLYKLMLSCWRRNAKERP 285 (296)
T ss_pred H--HHHHHHHHhhccccc----c-CCCC-----CCCCHHHHHHHHHHcCCCcccCC
Confidence 1 000000000000000 0 0000 01234588999999999999998
No 207
>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea
Probab=100.00 E-value=6.6e-40 Score=292.49 Aligned_cols=243 Identities=28% Similarity=0.475 Sum_probs=192.9
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCc----EEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGA----EVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL 169 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (361)
.+|++.+.||+|+||.||+|... +|. .+|+|.+.... ......+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56788899999999999999864 333 58999887554 3445678899999999999999999999987 78899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918 170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 249 (361)
+|||+++|+|.+++......+++..+..++.|++.||+||| +.+++|+||+|+||++++++.+||+|||+++.....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999999876666899999999999999999999 889999999999999999999999999999876543
Q ss_pred CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL 328 (361)
Q Consensus 250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l 328 (361)
..........++..|+|||......++.++|+||||+++||+++ |+.||...... .+...+.....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~----------- 229 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIPDLLEKGER----------- 229 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhCCCC-----------
Confidence 32222222234568999999888889999999999999999999 99998764321 11212111000
Q ss_pred cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
...+. .+...+.+++.+||..||++||
T Consensus 230 -~~~~~-----~~~~~~~~~~~~~l~~~p~~Rp 256 (279)
T cd05057 230 -LPQPP-----ICTIDVYMVLVKCWMIDAESRP 256 (279)
T ss_pred -CCCCC-----CCCHHHHHHHHHHcCCChhhCC
Confidence 00000 1123478899999999999998
No 208
>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk
Probab=100.00 E-value=9.8e-40 Score=287.61 Aligned_cols=238 Identities=31% Similarity=0.507 Sum_probs=194.1
Q ss_pred hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
.++|++.+.||.|++|.||+|... |+.||+|.+..... ..+.+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 356888999999999999999874 78999999986654 4577899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 175 PNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 175 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--- 156 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence 9999999997654 25899999999999999999999 8899999999999999999999999999998763221
Q ss_pred eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 332 (361)
.....+..|+|||.+....++.++||||||+++|||++ |..||...... .+......... ...
T Consensus 157 --~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~------------~~~ 220 (256)
T cd05039 157 --DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPHVEKGYR------------MEA 220 (256)
T ss_pred --ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhcCCC------------CCC
Confidence 12235667999999888889999999999999999997 99998654211 11111111100 000
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+. ..+..+.+++.+||..+|++||
T Consensus 221 ~~-----~~~~~~~~li~~~l~~~p~~Rp 244 (256)
T cd05039 221 PE-----GCPPEVYKVMKDCWELDPAKRP 244 (256)
T ss_pred cc-----CCCHHHHHHHHHHhccChhhCc
Confidence 00 1234588999999999999998
No 209
>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a
Probab=100.00 E-value=1e-39 Score=291.98 Aligned_cols=249 Identities=26% Similarity=0.458 Sum_probs=192.3
Q ss_pred CCCCCCCccccCCceEEEEEEe-----CCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC--Cee
Q 037918 96 NGFDECNLLGKGSFGSVYKGIL-----SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV--DFK 167 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 167 (361)
..|.+++.||+|+||.||++.. .++..||+|.+.... ......+.+|++++++++|||++++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3478889999999999999974 257889999987543 34456789999999999999999999998775 568
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918 168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG 247 (361)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 247 (361)
++||||+++++|.+++......+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||+++.+.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 8999999999999999766555899999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCcce-eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcccc----------ccccHHHHHhhhc
Q 037918 248 DGENFE-TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFA----------GEMSLKNWVKESL 316 (361)
Q Consensus 248 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~----------~~~~~~~~~~~~~ 316 (361)
...... ......++..|+|||.+.+..++.++||||||+++|||+|++.|...... .+.........
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 238 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV-- 238 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH--
Confidence 433211 11234467789999998888899999999999999999998876532111 01111111100
Q ss_pred CCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 317 PHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 317 ~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+........+ ..++..+.+++.+||+.||++||
T Consensus 239 -------~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp 271 (284)
T cd05079 239 -------LEEGKRLPRP-----PNCPEEVYQLMRKCWEFQPSKRT 271 (284)
T ss_pred -------HHcCccCCCC-----CCCCHHHHHHHHHHccCCcccCc
Confidence 0000000000 12344589999999999999998
No 210
>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa
Probab=100.00 E-value=1.1e-39 Score=287.25 Aligned_cols=241 Identities=25% Similarity=0.335 Sum_probs=195.8
Q ss_pred CCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 97 GFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
+|+..+.||.|+||.||.+.. .+++.+++|.+.... ....+.+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478889999999999999985 468899999876542 44456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 174 MPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 174 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
+++++|.+++... ...+++..+..++.|++.+|.||| +.+++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999865 445899999999999999999999 88999999999999999999999999999987644331
Q ss_pred eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918 253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 332 (361)
......+++.|+|||...+..++.++|+||||+++|||++|..||..... .+.........+....
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~~~-------- 222 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----LNLVVKIVQGNYTPVV-------- 222 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHcCCCCCCc--------
Confidence 22334688999999998888889999999999999999999999865321 1111111111111100
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
......+.+++.+||+.+|++||
T Consensus 223 ------~~~~~~~~~~i~~~l~~~p~~R~ 245 (256)
T cd08221 223 ------SVYSSELISLVHSLLQQDPEKRP 245 (256)
T ss_pred ------cccCHHHHHHHHHHcccCcccCC
Confidence 11233478999999999999997
No 211
>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity
Probab=100.00 E-value=1.1e-39 Score=288.68 Aligned_cols=246 Identities=24% Similarity=0.301 Sum_probs=198.0
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
++|+..+.||+|++|.||++... +++.+|+|.+.... ......+.+|++++++++||||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35778889999999999999975 68999999987653 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS-PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
+++++|.+++......+++..+..++.|++.||+||| + .+++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 9999999999876456899999999999999999999 7 8999999999999999999999999999876532211
Q ss_pred eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918 253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 332 (361)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+..+........ .+ .
T Consensus 157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~---~ 225 (265)
T cd06605 157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP-----RL---P 225 (265)
T ss_pred ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC-----CC---C
Confidence 115688899999999888999999999999999999999999975432222222222221111000 00 0
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.. .....+.+++.+||..||++||
T Consensus 226 ~~-----~~~~~~~~li~~~l~~~p~~Rp 249 (265)
T cd06605 226 SG-----KFSPDFQDFVNLCLIKDPRERP 249 (265)
T ss_pred hh-----hcCHHHHHHHHHHcCCCchhCc
Confidence 00 1233478999999999999998
No 212
>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt
Probab=100.00 E-value=1e-39 Score=290.50 Aligned_cols=229 Identities=24% Similarity=0.348 Sum_probs=180.4
Q ss_pred ccccCCceEEEEEEeCC-------------------------CcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeee
Q 037918 103 LLGKGSFGSVYKGILSD-------------------------GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKI 157 (361)
Q Consensus 103 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~ 157 (361)
.||+|+||.||+|.... ...|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13589999876655555678889999999999999999
Q ss_pred eeeeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC----
Q 037918 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM---- 233 (361)
Q Consensus 158 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---- 233 (361)
++++.+.+..++||||+++|+|..++......+++..+..++.|++.||+||| +++|+||||||+||+++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999999765556899999999999999999999 88999999999999997643
Q ss_pred ---cEEEEeccCccccCCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHH-HhCCCCCCccccccccH
Q 037918 234 ---VAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMET-FTRKKPTDEFFAGEMSL 308 (361)
Q Consensus 234 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el-ltg~~p~~~~~~~~~~~ 308 (361)
.++++|||++...... ....++..|+|||.+.+ ..++.++||||||+++||| ++|+.||......+.
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-- 230 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-- 230 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--
Confidence 3799999988644221 12346788999998765 5689999999999999999 579999875432211
Q ss_pred HHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 309 KNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 309 ~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..+..... .+.... ...+.+++.+||+.+|++||
T Consensus 231 ~~~~~~~~----------~~~~~~---------~~~~~~li~~cl~~~p~~Rp 264 (274)
T cd05076 231 ERFYEKKH----------RLPEPS---------CKELATLISQCLTYEPTQRP 264 (274)
T ss_pred HHHHHhcc----------CCCCCC---------ChHHHHHHHHHcccChhhCc
Confidence 11111100 000000 12378899999999999998
No 213
>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes. Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an
Probab=100.00 E-value=8e-40 Score=288.93 Aligned_cols=241 Identities=28% Similarity=0.469 Sum_probs=190.8
Q ss_pred CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918 96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 175 (361)
++|.+.+.||+|++|.||+|...++..+|+|.+..... ..+.+.+|++++++++|||++++++++.. +..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence 45888899999999999999987777899998765432 23568889999999999999999998754 56789999999
Q ss_pred CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918 176 NGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET 254 (361)
Q Consensus 176 ~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 254 (361)
+++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++........ ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~ 159 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TA 159 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cc
Confidence 99999999754 334789999999999999999999 88999999999999999999999999999987643321 11
Q ss_pred eecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918 255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP 333 (361)
Q Consensus 255 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 333 (361)
.....++..|+|||...+..++.++|+||||+++|||+| |+.||......+ ...+.....+. ..+
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~~------------~~~ 225 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVERGYRM------------PCP 225 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCC------------CCC
Confidence 122345678999999888889999999999999999999 999987543211 11111111100 000
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 334 AFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+.+..+.+++.+||+.||++||
T Consensus 226 -----~~~~~~~~~li~~~l~~~p~~Rp 248 (260)
T cd05069 226 -----QGCPESLHELMKLCWKKDPDERP 248 (260)
T ss_pred -----cccCHHHHHHHHHHccCCcccCc
Confidence 01234589999999999999998
No 214
>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase. Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M
Probab=100.00 E-value=5.9e-40 Score=294.13 Aligned_cols=245 Identities=25% Similarity=0.411 Sum_probs=193.1
Q ss_pred hCCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCee
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFK 167 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 167 (361)
.++|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999853 46789999987543 33446788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 037918 168 ALVLEFMPNGSLEKWLYSHN---------------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSN 226 (361)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~N 226 (361)
+++|||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++||||+|+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence 99999999999999997431 23678889999999999999999 8899999999999
Q ss_pred EEEcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCcccccc
Q 037918 227 ILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGE 305 (361)
Q Consensus 227 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~ 305 (361)
|++++++.++|+|||++.................+..|+|||...+..++.++||||||+++|||++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999876543322222222345677999999888889999999999999999998 88888643221
Q ss_pred ccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 306 MSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+........... .... .++..+.+++.+||+.||++||
T Consensus 240 ----~~~~~~~~~~~~--------~~~~------~~~~~l~~li~~~l~~~p~~Rp 277 (288)
T cd05050 240 ----EVIYYVRDGNVL--------SCPD------NCPLELYNLMRLCWSKLPSDRP 277 (288)
T ss_pred ----HHHHHHhcCCCC--------CCCC------CCCHHHHHHHHHHcccCcccCC
Confidence 111111111100 0000 1234589999999999999998
No 215
>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is
Probab=100.00 E-value=8.3e-40 Score=300.49 Aligned_cols=198 Identities=24% Similarity=0.347 Sum_probs=169.3
Q ss_pred HHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC----
Q 037918 92 QRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV---- 164 (361)
Q Consensus 92 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---- 164 (361)
....++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 345678999999999999999999954 68899999987543 22345677899999999999999999987543
Q ss_pred --CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccC
Q 037918 165 --DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGI 242 (361)
Q Consensus 165 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 242 (361)
...+++++++ +++|.+++.... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~~--l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQK--LSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCcc
Confidence 3568999988 789998886543 899999999999999999999 88999999999999999999999999999
Q ss_pred ccccCCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918 243 SKLLGDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDE 300 (361)
Q Consensus 243 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~ 300 (361)
+...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9875432 233468999999998766 5689999999999999999999999965
No 216
>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase. Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions
Probab=100.00 E-value=9.4e-40 Score=290.05 Aligned_cols=242 Identities=25% Similarity=0.428 Sum_probs=191.6
Q ss_pred CCCCCCCccccCCceEEEEEEeCC----CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILSD----GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV 170 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (361)
.+|.+.+.||+|+||.||+|...+ ...|++|...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457888999999999999998643 3468999887654 4455688999999999999999999999876 456899
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918 171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE 250 (361)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 250 (361)
|||+++++|.+++......+++..++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 9999999999999876656899999999999999999999 8899999999999999999999999999998764432
Q ss_pred cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918 251 NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL 329 (361)
Q Consensus 251 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 329 (361)
. ...+...++..|+|||.+....++.++||||||+++|||++ |..||......+ ......... .+ ..
T Consensus 162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~--~~------~~- 229 (270)
T cd05056 162 Y-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIGRIENGE--RL------PM- 229 (270)
T ss_pred c-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHcCC--cC------CC-
Confidence 1 11222345568999999888889999999999999999996 999997543221 111111100 00 00
Q ss_pred CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+ ..++..+.+++.+|+..+|++||
T Consensus 230 ---~-----~~~~~~~~~li~~~l~~~P~~Rp 253 (270)
T cd05056 230 ---P-----PNCPPTLYSLMTKCWAYDPSKRP 253 (270)
T ss_pred ---C-----CCCCHHHHHHHHHHcCCChhhCc
Confidence 0 02234588999999999999998
No 217
>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=8.9e-40 Score=292.68 Aligned_cols=244 Identities=23% Similarity=0.329 Sum_probs=191.6
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
++|++.+.||+|+||.||++... +++.||+|.+.... ......+.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888999999999999999975 68999999887542 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 174 MPNGSLEKWLYSH--NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 174 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
+++++|.+++... ...+++..+..++.|++.||.|||+ +.+++|+||+|+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 9999999998764 2348999999999999999999993 2589999999999999999999999999987653321
Q ss_pred ceeeecccccccccCccccCCC------CCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccc
Q 037918 252 FETRTMTMATVGYMAPEYGSEG------IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVD 325 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 325 (361)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...... ...............
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~---- 228 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA--NIFAQLSAIVDGDPP---- 228 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh--hHHHHHHHHhhcCCC----
Confidence 2233578899999987543 3588999999999999999999999653211 111111111100000
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 326 ENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 326 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+ .+ +....+.+++.+||+.+|++||
T Consensus 229 -~~---~~------~~~~~~~~li~~~l~~~p~~Rp 254 (286)
T cd06622 229 -TL---PS------GYSDDAQDFVAKCLNKIPNRRP 254 (286)
T ss_pred -CC---Cc------ccCHHHHHHHHHHcccCcccCC
Confidence 00 00 1233478899999999999998
No 218
>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase. Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ
Probab=100.00 E-value=7.8e-40 Score=290.80 Aligned_cols=245 Identities=24% Similarity=0.321 Sum_probs=191.0
Q ss_pred HhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecC------
Q 037918 93 RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSNV------ 164 (361)
Q Consensus 93 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~------ 164 (361)
.+++.|++.+.||+|+||.||+|... +++.||+|++..... ....+..|+.++.++ +|||++++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35677888999999999999999964 588999999875432 235678899999998 799999999998653
Q ss_pred CeeEEEEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCc
Q 037918 165 DFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGIS 243 (361)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 243 (361)
...+++|||+++++|.+++... ...+++..+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 4678999999999999999864 345899999999999999999999 889999999999999999999999999999
Q ss_pred cccCCCCcceeeecccccccccCccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCC
Q 037918 244 KLLGDGENFETRTMTMATVGYMAPEYGS-----EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH 318 (361)
Q Consensus 244 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (361)
....... .......|+..|+|||++. +..++.++||||||+++|||++|+.||........ .... ...
T Consensus 159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~----~~~~-~~~ 231 (272)
T cd06637 159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA----LFLI-PRN 231 (272)
T ss_pred eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH----HHHH-hcC
Confidence 8654322 1223356889999999875 34578899999999999999999999965322111 1000 000
Q ss_pred CccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 319 GLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 319 ~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
....... . .++..+.+++.+||..||++||
T Consensus 232 ~~~~~~~----~---------~~~~~~~~li~~~l~~~p~~Rp 261 (272)
T cd06637 232 PAPRLKS----K---------KWSKKFQSFIESCLVKNHSQRP 261 (272)
T ss_pred CCCCCCC----C---------CcCHHHHHHHHHHcCCChhhCC
Confidence 0000000 0 1223478999999999999998
No 219
>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp
Probab=100.00 E-value=1.2e-39 Score=299.28 Aligned_cols=246 Identities=27% Similarity=0.437 Sum_probs=189.1
Q ss_pred hCCCCCCCccccCCceEEEEEEe------CCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecC-C
Q 037918 95 TNGFDECNLLGKGSFGSVYKGIL------SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNV-D 165 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~ 165 (361)
.++|++.+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35799999999999999999973 347889999997543 33456788999999999 689999999988654 4
Q ss_pred eeEEEEEecCCCCHHHHHhcCC----------------------------------------------------------
Q 037918 166 FKALVLEFMPNGSLEKWLYSHN---------------------------------------------------------- 187 (361)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 187 (361)
..+++|||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6789999999999999986431
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeeccc
Q 037918 188 --------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM 259 (361)
Q Consensus 188 --------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 259 (361)
..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 13678888999999999999999 8999999999999999999999999999998754322211222234
Q ss_pred ccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHH
Q 037918 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAK 338 (361)
Q Consensus 260 g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 338 (361)
++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ........... ...+.
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~~------------~~~~~---- 305 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTR------------MRAPD---- 305 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHHHHHhccCC------------CCCCC----
Confidence 5678999999888889999999999999999997 999986532211 11111111000 00000
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCC
Q 037918 339 MDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 339 ~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||+.||++||
T Consensus 306 -~~~~~~~~~~~~cl~~~p~~Rp 327 (343)
T cd05103 306 -YTTPEMYQTMLDCWHGEPSQRP 327 (343)
T ss_pred -CCCHHHHHHHHHHccCChhhCc
Confidence 0112478999999999999998
No 220
>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2. Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A
Probab=100.00 E-value=5e-40 Score=296.74 Aligned_cols=241 Identities=32% Similarity=0.514 Sum_probs=187.7
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCc--EEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGA--EVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALV 170 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 170 (361)
++|++.+.||+|+||.||+|.+. ++. .+++|.+.... ......+.+|++++.++ +||||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 56888899999999999999964 454 45777766432 33456788999999999 899999999999999999999
Q ss_pred EEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcE
Q 037918 171 LEFMPNGSLEKWLYSHN---------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235 (361)
Q Consensus 171 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 235 (361)
|||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+||++++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcE
Confidence 99999999999997432 24789999999999999999999 8999999999999999999999
Q ss_pred EEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhh
Q 037918 236 HVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKE 314 (361)
Q Consensus 236 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 314 (361)
||+|||++...... .......++..|+|||.+.+..++.++||||||+++|||+| |..||......+ ....
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~--- 235 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEK--- 235 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--HHHH---
Confidence 99999998643211 11111234667999999888889999999999999999998 999986532211 1111
Q ss_pred hcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 315 SLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 315 ~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+... ....+. .....+.+++.+||+.+|++||
T Consensus 236 -~~~~~--------~~~~~~-----~~~~~~~~li~~~l~~~p~~Rp 268 (303)
T cd05088 236 -LPQGY--------RLEKPL-----NCDDEVYDLMRQCWREKPYERP 268 (303)
T ss_pred -HhcCC--------cCCCCC-----CCCHHHHHHHHHHcCCChhhCc
Confidence 11110 000000 1123478999999999999998
No 221
>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2
Probab=100.00 E-value=1.6e-39 Score=290.71 Aligned_cols=198 Identities=28% Similarity=0.412 Sum_probs=168.6
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
+|++.+.||+|++|.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999965 68999999886432 22235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 174 MPNGSLEKWLYSHN--YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 174 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
++ ++|.+++.... ..+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 96 68988886432 45899999999999999999999 8899999999999999999999999999997654322
Q ss_pred ceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918 252 FETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDE 300 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~ 300 (361)
.......+++.|+|||.+.+ ..++.++||||||+++|+|+||+.||..
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~ 204 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG 204 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12223356889999998765 4578899999999999999999999975
No 222
>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate
Probab=100.00 E-value=2.1e-39 Score=287.26 Aligned_cols=242 Identities=27% Similarity=0.399 Sum_probs=192.3
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---------HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCe
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---------ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF 166 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 166 (361)
+|.+.+.||+|++|.||+|... +++.+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677889999999999999864 68899999886432 1233568899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918 167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246 (361)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 246 (361)
.+++|||+++++|.+++.... .+++..+..++.|++.||+||| +.+++||||+|+||++++++.++|+|||.++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 999999999999999998654 3789999999999999999999 889999999999999999999999999999876
Q ss_pred CCCCcc----eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccc
Q 037918 247 GDGENF----ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTN 322 (361)
Q Consensus 247 ~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~ 322 (361)
...... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....... ..... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~-~~-------- 226 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AIFKI-GE-------- 226 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-HHHHH-hc--------
Confidence 432111 11122357889999999988889999999999999999999999997532111 11000 00
Q ss_pred cccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 323 VVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 323 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
...+.+.. ..+..+.+++.+||+.||++||
T Consensus 227 ~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rp 256 (267)
T cd06628 227 NASPEIPS---------NISSEAIDFLEKTFEIDHNKRP 256 (267)
T ss_pred cCCCcCCc---------ccCHHHHHHHHHHccCCchhCc
Confidence 00111111 1223478999999999999998
No 223
>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase. Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ
Probab=100.00 E-value=6.6e-40 Score=288.66 Aligned_cols=242 Identities=29% Similarity=0.443 Sum_probs=193.4
Q ss_pred CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918 96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 175 (361)
.+|++.+.||+|+||.||++.+.++..+|+|.+...... ...+.+|++++++++|||++++++++......+++|||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC-HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 467888999999999999999877889999988754321 2468889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee
Q 037918 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR 255 (361)
Q Consensus 176 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 255 (361)
+++|.+++......+++..++.++.|++.+|+||| +.+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~ 158 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcc-ccc
Confidence 99999999876556899999999999999999999 88999999999999999999999999999886543221 111
Q ss_pred ecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918 256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334 (361)
Q Consensus 256 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 334 (361)
....++.+|+|||...+..++.++||||||+++|||++ |..||...... ...+...... . ...+..
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~----~-~~~~~~------ 225 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--EVVETINAGF----R-LYKPRL------ 225 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHhCCC----C-CCCCCC------
Confidence 22335678999999988889999999999999999998 99998753221 1111111000 0 000100
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 335 FAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+..+.+++.+||+.+|++||
T Consensus 226 ------~~~~~~~l~~~~l~~~p~~Rp 246 (256)
T cd05112 226 ------ASQSVYELMQHCWKERPEDRP 246 (256)
T ss_pred ------CCHHHHHHHHHHcccChhhCC
Confidence 123489999999999999998
No 224
>PHA03211 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=5.1e-40 Score=309.79 Aligned_cols=193 Identities=22% Similarity=0.259 Sum_probs=168.4
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
.+|.+.+.||+|+||.||++... .++.||||.... ..+.+|++++++++|+||+++++++...+..++|||++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 36899999999999999999975 578899996432 34567999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918 175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET 254 (361)
Q Consensus 175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 254 (361)
.++|.+++......+++..++.++.|++.||.||| +.+|+||||||+|||++.++.++|+|||+++..........
T Consensus 243 -~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 243 -RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 57999998776556999999999999999999999 88999999999999999999999999999987643322222
Q ss_pred eecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCC
Q 037918 255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPT 298 (361)
Q Consensus 255 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~ 298 (361)
.....||..|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 23456999999999999989999999999999999999988764
No 225
>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio
Probab=100.00 E-value=2.4e-39 Score=289.71 Aligned_cols=200 Identities=24% Similarity=0.304 Sum_probs=171.3
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE 172 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (361)
++|+..+.||+|++|.||+|... +|+.||+|++.... ....+.+.+|++++++++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999975 58999999886432 1223567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
|+++++|..++.... .+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 81 YCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 999988888776543 4899999999999999999999 88999999999999999999999999999987654321
Q ss_pred eeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 253 ETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||...
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~ 204 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK 204 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 1123357788999998765 55788999999999999999999999754
No 226
>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=7.7e-41 Score=308.40 Aligned_cols=237 Identities=27% Similarity=0.393 Sum_probs=194.6
Q ss_pred ccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCHHH
Q 037918 103 LLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEK 181 (361)
Q Consensus 103 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~ 181 (361)
+||+|.||+||.|++. +...+|||.+.....+..+.+..|+.+.++++|.|||+++|.+.+++..-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999965 456799999987777777888999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc-CCCcEEEEeccCccccCCCCcceeeecc
Q 037918 182 WLYSHNYFL--DIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMT 258 (361)
Q Consensus 182 ~l~~~~~~~--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 258 (361)
++.+.-.++ .+.++-.+.+||++||.||| ...|||||||-+|||++ -.|.+||+|||-++.+..-. ......
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TETF 736 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTETF 736 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCC--cccccc
Confidence 999875556 78888899999999999999 88999999999999996 67899999999998774322 233456
Q ss_pred cccccccCccccCCCC--CCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918 259 MATVGYMAPEYGSEGI--VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA 336 (361)
Q Consensus 259 ~g~~~y~aPE~~~~~~--~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~ 336 (361)
.||..|||||++..++ |+.++|||||||++.||.||++||.+..+..... ..-.+....|..+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM---------------FkVGmyKvHP~iP 801 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM---------------FKVGMYKVHPPIP 801 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh---------------hhhcceecCCCCc
Confidence 7999999999987754 8999999999999999999999998764433211 1111111111111
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 337 AKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 337 ~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+.......++++|..+||.+||
T Consensus 802 --eelsaeak~FilrcFepd~~~R~ 824 (1226)
T KOG4279|consen 802 --EELSAEAKNFILRCFEPDPCDRP 824 (1226)
T ss_pred --HHHHHHHHHHHHHHcCCCcccCc
Confidence 12334468899999999999998
No 227
>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi
Probab=100.00 E-value=1.8e-39 Score=286.21 Aligned_cols=236 Identities=32% Similarity=0.514 Sum_probs=186.0
Q ss_pred CccccCCceEEEEEEeC--C--CcEEEEEEeehhhH-HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918 102 NLLGKGSFGSVYKGILS--D--GAEVAIKIFNLQLE-RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPN 176 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~--~--~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (361)
+.||+|+||.||+|... + +..+|+|.+..... ...+.+.+|+++++.+.||||+++++++.. +..+++|||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 46999999999999853 2 36899999875543 344678899999999999999999998764 467999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce-ee
Q 037918 177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE-TR 255 (361)
Q Consensus 177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~ 255 (361)
++|.+++.... .+++..+..++.|++.||+||| ..+++|+||||+||+++.++.+||+|||+++......... ..
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999998665 4899999999999999999999 8899999999999999999999999999998764433211 11
Q ss_pred ecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918 256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334 (361)
Q Consensus 256 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 334 (361)
....++..|+|||...+..++.++||||||+++|||++ |..||..... .....+.....+. ..+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~------------~~~- 220 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGERL------------PRP- 220 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCcC------------CCC-
Confidence 12224567999999988889999999999999999998 9999975432 1222222111100 000
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 335 FAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..++..+.+++.+||..||++||
T Consensus 221 ----~~~~~~l~~li~~cl~~~p~~Rp 243 (257)
T cd05060 221 ----EECPQEIYSIMLSCWKYRPEDRP 243 (257)
T ss_pred ----CCCCHHHHHHHHHHhcCChhhCc
Confidence 01234588999999999999998
No 228
>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1. Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25
Probab=100.00 E-value=7e-40 Score=292.01 Aligned_cols=238 Identities=26% Similarity=0.357 Sum_probs=192.1
Q ss_pred CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918 98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 175 (361)
|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 556678999999999999864 57889999987443 3445678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee
Q 037918 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR 255 (361)
Q Consensus 176 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 255 (361)
+++|.+++... .+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++..+..... ..
T Consensus 86 ~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~ 158 (277)
T cd06642 86 GGSALDLLKPG--PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KR 158 (277)
T ss_pred CCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch--hh
Confidence 99999998754 3889999999999999999999 88999999999999999999999999999987643221 12
Q ss_pred ecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhH
Q 037918 256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF 335 (361)
Q Consensus 256 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~ 335 (361)
....++..|+|||++.+..++.++|+||||+++|||++|+.||........ ........ .+.+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~--------~~~~~~----- 223 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LFLIPKNS--------PPTLEG----- 223 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--HhhhhcCC--------CCCCCc-----
Confidence 223578899999999888899999999999999999999999875432111 11110000 000111
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 336 AAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 336 ~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..+..+.+++.+||+.+|++||
T Consensus 224 ----~~~~~~~~li~~~l~~~p~~Rp 245 (277)
T cd06642 224 ----QYSKPFKEFVEACLNKDPRFRP 245 (277)
T ss_pred ----ccCHHHHHHHHHHccCCcccCc
Confidence 1233478999999999999998
No 229
>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi
Probab=100.00 E-value=1.4e-39 Score=292.05 Aligned_cols=237 Identities=26% Similarity=0.296 Sum_probs=194.1
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
++|++.+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999965 68999999987543 234467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
||+++++|.+++.... .++...+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 9999999999998664 4899999999999999999999 899999999999999999999999999999876443
Q ss_pred ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918 252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
.....+++.|+|||.+.+...+.++|+||||+++|+|++|+.||..... ....... .... ..+...
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~---~~~~------~~~~~~ 220 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--IQIYEKI---LEGK------VRFPSF 220 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH---hcCC------ccCCcc
Confidence 2234588999999998888889999999999999999999999865331 1111110 0000 000000
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
....+.+++.+||..||++||
T Consensus 221 ---------~~~~l~~li~~~l~~~p~~R~ 241 (290)
T cd05580 221 ---------FSPDAKDLIRNLLQVDLTKRL 241 (290)
T ss_pred ---------CCHHHHHHHHHHccCCHHHcc
Confidence 122478999999999999996
No 230
>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi
Probab=100.00 E-value=1.4e-39 Score=292.47 Aligned_cols=243 Identities=26% Similarity=0.338 Sum_probs=195.5
Q ss_pred hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
.++|.+.+.||+|+||.||++... +++.|++|.+........+.+.+|+.++++++|||++++++++...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 367899999999999999999854 6889999998755444556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
+++++|.+++.+.. +++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~~~--l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-- 170 (293)
T cd06647 98 LAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 170 (293)
T ss_pred CCCCcHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence 99999999997643 789999999999999999999 88999999999999999999999999999876543322
Q ss_pred eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP 333 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 333 (361)
......+++.|+|||.+.+..++.++|+||||+++|++++|+.||.......... .... .. .+
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-~~~~-----------~~-----~~ 233 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIAT-----------NG-----TP 233 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-ehhc-----------CC-----CC
Confidence 2223458889999999888888999999999999999999999997532211100 0000 00 00
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 334 AFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
...........+.+++.+||+.+|++||
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp 261 (293)
T cd06647 234 ELQNPEKLSAIFRDFLNRCLEMDVEKRG 261 (293)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCc
Confidence 0000111233478999999999999998
No 231
>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut
Probab=100.00 E-value=1.2e-39 Score=291.23 Aligned_cols=255 Identities=27% Similarity=0.423 Sum_probs=195.4
Q ss_pred CCCCCCCccccCCceEEEEEEeC-----CCcEEEEEEeehhhHH-HHHHHHHHHHHHHhcCCCceeeeeeeeec--CCee
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-----DGAEVAIKIFNLQLER-AFRSFDSECEVLRSIRHRNLVKILSSCSN--VDFK 167 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 167 (361)
+.|++.+.||+|+||.||+|... ++..+|+|.+...... ..+.+.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777889999999999999853 3678999999765443 45789999999999999999999999877 5578
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918 168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG 247 (361)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 247 (361)
+++|||+++++|.+++......+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||.+....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999999999876656899999999999999999999 8899999999999999999999999999998775
Q ss_pred CCCcce-eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcC----CCccc
Q 037918 248 DGENFE-TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLP----HGLTN 322 (361)
Q Consensus 248 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~l~~ 322 (361)
...... ......++..|+|||...+..++.++||||||+++|||+||..|+......... +...... ..+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGIAQGQMIVTRLLE 237 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccccccccccHHHHHH
Confidence 332211 111234556799999988888999999999999999999999998653222111 0000000 00000
Q ss_pred cccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 323 VVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 323 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+........ ...++..+.+++.+||+.||++||
T Consensus 238 ~~~~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp 271 (284)
T cd05038 238 LLKEGERLPR-----PPSCPDEVYDLMKLCWEAEPQDRP 271 (284)
T ss_pred HHHcCCcCCC-----CccCCHHHHHHHHHHhccChhhCC
Confidence 1111000000 012335689999999999999998
No 232
>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re
Probab=100.00 E-value=1.1e-39 Score=287.25 Aligned_cols=236 Identities=30% Similarity=0.442 Sum_probs=188.4
Q ss_pred CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeee-ecCCeeEEEEEec
Q 037918 96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSC-SNVDFKALVLEFM 174 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~ 174 (361)
.+|.+.+.||+|+||.||++... |..+|+|.+..... .+.+.+|+.++++++|+|++++++++ ...+..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCch--HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46888899999999999999874 78899998865432 35788999999999999999999976 4556789999999
Q ss_pred CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 175 PNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 175 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
++++|.+++.+.. ..+++..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 9999999998653 34789999999999999999999 8899999999999999999999999999987653321
Q ss_pred eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 332 (361)
....++..|+|||+..+..++.++||||||+++|||++ |+.||..... ...........+. ..
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~--------~~---- 220 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGYKM--------DA---- 220 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCCCC--------CC----
Confidence 12234568999999988889999999999999999998 9999864321 1111111111100 00
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+ ..++..+.+++.+|++.||++||
T Consensus 221 ~-----~~~~~~~~~li~~~l~~~p~~Rp 244 (256)
T cd05082 221 P-----DGCPPVVYDVMKQCWHLDAATRP 244 (256)
T ss_pred C-----CCCCHHHHHHHHHHhcCChhhCc
Confidence 0 02234588999999999999998
No 233
>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou
Probab=100.00 E-value=1.3e-39 Score=291.90 Aligned_cols=198 Identities=27% Similarity=0.396 Sum_probs=163.9
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH--HHHHHHHHHHHHHHhc---CCCceeeeeeeeec-----CC
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE--RAFRSFDSECEVLRSI---RHRNLVKILSSCSN-----VD 165 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~~ 165 (361)
+|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999965 689999998864321 1123455677766655 79999999998854 34
Q ss_pred eeEEEEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918 166 FKALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK 244 (361)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 244 (361)
..+++|||++ ++|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 5789999996 58998887543 34899999999999999999999 8899999999999999999999999999998
Q ss_pred ccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 245 LLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 245 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
...... ......++..|+|||++.+..++.++|||||||++|||++|++||...
T Consensus 157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 157 IYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred cccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 764322 122345789999999998888999999999999999999999998653
No 234
>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells
Probab=100.00 E-value=7.3e-39 Score=284.21 Aligned_cols=242 Identities=25% Similarity=0.370 Sum_probs=181.7
Q ss_pred CccccCCceEEEEEEeCC---CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCC
Q 037918 102 NLLGKGSFGSVYKGILSD---GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNG 177 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 177 (361)
+.||+|+||.||+|...+ +..+|+|.+.... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998543 4579999886543 233357888999999999999999999999999999999999999
Q ss_pred CHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 178 SLEKWLYSHN----YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 178 ~L~~~l~~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
+|.+++.... ...++..+..++.|++.||+||| +.+++|+||||+||+++.+++++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997532 23567788899999999999999 8899999999999999999999999999997654332222
Q ss_pred eeecccccccccCccccCCC-------CCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccccc
Q 037918 254 TRTMTMATVGYMAPEYGSEG-------IVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVD 325 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~-------~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 325 (361)
......++..|+|||++.+. .++.++|+||||+++|||++ |+.||......+. . ... .........+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~-~~~---~~~~~~~~~~ 232 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-L-TYT---VREQQLKLPK 232 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-H-HHH---hhcccCCCCC
Confidence 22334567889999987542 35789999999999999996 9999975432221 1 110 1011111111
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 326 ENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 326 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+.+.... ...+.+++..|+ .+|++||
T Consensus 233 ~~~~~~~---------~~~~~~l~~~c~-~~P~~Rp 258 (269)
T cd05087 233 PRLKLPL---------SDRWYEVMQFCW-LQPEQRP 258 (269)
T ss_pred CccCCCC---------ChHHHHHHHHHh-cCcccCC
Confidence 2211111 223677889998 6899998
No 235
>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=1.7e-39 Score=300.82 Aligned_cols=198 Identities=22% Similarity=0.294 Sum_probs=169.1
Q ss_pred hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC------
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV------ 164 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 164 (361)
..++|.+.+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999964 68899999987532 33346678899999999999999999987543
Q ss_pred CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918 165 DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK 244 (361)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 244 (361)
...++||||++ ++|.+.+... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHhc---CCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 35799999995 5787777532 788999999999999999999 8899999999999999999999999999998
Q ss_pred ccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 245 LLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 245 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
...... ......++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 175 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 175 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred ccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 654322 123346899999999999989999999999999999999999999753
No 236
>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase. Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa
Probab=100.00 E-value=1.8e-39 Score=286.76 Aligned_cols=242 Identities=24% Similarity=0.443 Sum_probs=193.3
Q ss_pred hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
..+|.+.+.||+|+||.||++...++..+|+|.+.... ...+.+.+|++++++++|+||+++++.+.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 45788899999999999999998778889999887543 234678889999999999999999999887 7789999999
Q ss_pred CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 175 PNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 175 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
++++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 158 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-T 158 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-c
Confidence 999999999764 344788999999999999999999 88999999999999999999999999999986643222 1
Q ss_pred eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 332 (361)
......++..|+|||++....++.++|+||||+++|+++| |+.||..... ............. ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~~~~~~------------~~ 224 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERGYRM------------PR 224 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHhCCCCC------------CC
Confidence 1222345677999999988889999999999999999999 9999875322 1112221111100 00
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+ ...+..+.+++.+|++.||++||
T Consensus 225 ~-----~~~~~~~~~~i~~~l~~~p~~Rp 248 (260)
T cd05073 225 P-----ENCPEELYNIMMRCWKNRPEERP 248 (260)
T ss_pred c-----ccCCHHHHHHHHHHcccCcccCc
Confidence 0 01233488999999999999998
No 237
>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]
Probab=100.00 E-value=1.2e-40 Score=276.86 Aligned_cols=248 Identities=27% Similarity=0.399 Sum_probs=200.1
Q ss_pred HHHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--------HHHHHHHHHHHHHHHhc-CCCceeeeeee
Q 037918 91 IQRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--------ERAFRSFDSECEVLRSI-RHRNLVKILSS 160 (361)
Q Consensus 91 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 160 (361)
-+...+.|...+.||.|..+.|-++..+ +|..+|+|++.... ....+.-.+|+.+|+++ .||+|+.+.++
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 3455677888899999999999988854 68899999886322 23345677899999998 69999999999
Q ss_pred eecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEec
Q 037918 161 CSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDF 240 (361)
Q Consensus 161 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 240 (361)
++.+...++|+|.++.|.|.|+|.+.-. +++....+|++|+..|+.||| .++||||||||+|||++++.++||+||
T Consensus 92 yes~sF~FlVFdl~prGELFDyLts~Vt-lSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLTSKVT-LSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhhhhee-ecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEecc
Confidence 9999999999999999999999987654 899999999999999999999 999999999999999999999999999
Q ss_pred cCccccCCCCcceeeecccccccccCccccC------CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhh
Q 037918 241 GISKLLGDGENFETRTMTMATVGYMAPEYGS------EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKE 314 (361)
Q Consensus 241 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~ 314 (361)
|++..+..+.. ....+|||+|+|||.+. ...|+...|+||.|+++|.|+.|.+||.... ++-..
T Consensus 168 GFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--QmlML----- 237 (411)
T KOG0599|consen 168 GFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--QMLML----- 237 (411)
T ss_pred ceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--HHHHH-----
Confidence 99998876553 34568999999999654 2458889999999999999999999986421 11111
Q ss_pred hcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 315 SLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 315 ~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.-++........++ ..+......+|+.+||+.||.+|.
T Consensus 238 ------R~ImeGkyqF~spe---Wadis~~~KdLIsrlLqVdp~~Ri 275 (411)
T KOG0599|consen 238 ------RMIMEGKYQFRSPE---WADISATVKDLISRLLQVDPTKRI 275 (411)
T ss_pred ------HHHHhcccccCCcc---hhhccccHHHHHHHHHeeCchhcc
Confidence 11122222222222 234445578999999999999984
No 238
>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin. Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear
Probab=100.00 E-value=8.5e-40 Score=292.77 Aligned_cols=253 Identities=22% Similarity=0.317 Sum_probs=194.0
Q ss_pred cCHHHHHHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeee-
Q 037918 86 ISYLEIQRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCS- 162 (361)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~- 162 (361)
+.+..+....++|++.+.||+|+||.||++... +++.+|+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 344556677889999999999999999999864 58899999876432 2235677899999999 6999999999873
Q ss_pred ----cCCeeEEEEEecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcE
Q 037918 163 ----NVDFKALVLEFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235 (361)
Q Consensus 163 ----~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 235 (361)
.++..++||||+++++|.+++.. ....+++..+..++.|++.||.||| +.+++||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCE
Confidence 44578999999999999998763 2344889999999999999999999 8899999999999999999999
Q ss_pred EEEeccCccccCCCCcceeeecccccccccCccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHH
Q 037918 236 HVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS-----EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKN 310 (361)
Q Consensus 236 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~ 310 (361)
+|+|||++........ ......|+..|+|||++. +..++.++||||||+++|||++|+.||....... .
T Consensus 164 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~----~ 237 (286)
T cd06638 164 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR----A 237 (286)
T ss_pred EEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH----H
Confidence 9999999987643221 223346889999999874 3447889999999999999999999987532211 1
Q ss_pred HHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 311 WVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 311 ~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
... ...........+ . .....+.+++.+||+.||++||
T Consensus 238 ~~~-~~~~~~~~~~~~-------~-----~~~~~~~~li~~~l~~~p~~Rp 275 (286)
T cd06638 238 LFK-IPRNPPPTLHQP-------E-----LWSNEFNDFIRKCLTKDYEKRP 275 (286)
T ss_pred Hhh-ccccCCCcccCC-------C-----CcCHHHHHHHHHHccCCcccCC
Confidence 100 000000000000 0 0122478999999999999998
No 239
>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]
Probab=100.00 E-value=6.7e-40 Score=302.72 Aligned_cols=194 Identities=30% Similarity=0.393 Sum_probs=171.0
Q ss_pred CCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC-C-----CceeeeeeeeecCCeeEE
Q 037918 97 GFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-H-----RNLVKILSSCSNVDFKAL 169 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~~l 169 (361)
+|.+.+.||+|+||.|.+|.. .+++.||||+++... ........|+.+|..++ | -|+|+++++|...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 789999999999999999995 469999999998664 34466778999999996 4 389999999999999999
Q ss_pred EEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC--cEEEEeccCcccc
Q 037918 170 VLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM--VAHVSDFGISKLL 246 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~--~~kl~Dfg~a~~~ 246 (361)
|+|.+ .-+|.++++.++ ..++...++.++.||+.||.+|| ..+|||+||||+|||+.+-. .+||+|||.+...
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999 669999999664 34899999999999999999999 89999999999999996543 7999999999986
Q ss_pred CCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918 247 GDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDE 300 (361)
Q Consensus 247 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~ 300 (361)
.... .....+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+
T Consensus 342 ~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 342 SQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred CCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 5432 245678889999999999999999999999999999999888765
No 240
>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina
Probab=100.00 E-value=6.2e-39 Score=284.64 Aligned_cols=242 Identities=24% Similarity=0.352 Sum_probs=179.9
Q ss_pred CccccCCceEEEEEEeCC---CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCC
Q 037918 102 NLLGKGSFGSVYKGILSD---GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNG 177 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 177 (361)
+.||+|+||.||+|...+ ...+++|.+.... ......+.+|++.++.++||||+++++.+.+.+..++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997533 4568888876443 334457889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 178 SLEKWLYSHNY----FLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 178 ~L~~~l~~~~~----~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
+|.+++..... ..++.....++.|++.||+||| +.+|+||||||+||++++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976432 2467788899999999999999 8899999999999999999999999999987543322222
Q ss_pred eeecccccccccCccccC-------CCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccccc
Q 037918 254 TRTMTMATVGYMAPEYGS-------EGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVD 325 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 325 (361)
......++..|+|||+.. ...++.++||||||+++|||++ |..||......+ .+....... ......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~----~~~~~~ 232 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVREQ----DIKLPK 232 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhhcc----CccCCC
Confidence 223334667899999753 3456889999999999999999 788886542211 111111111 111111
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 326 ENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 326 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+.+... ....+.+++..|+ .||++||
T Consensus 233 ~~~~~~---------~~~~~~~~~~~~~-~dp~~Rp 258 (269)
T cd05042 233 PQLDLK---------YSDRWYEVMQFCW-LDPETRP 258 (269)
T ss_pred Cccccc---------CCHHHHHHHHHHh-cCccccc
Confidence 111111 1233677788888 5999998
No 241
>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops
Probab=100.00 E-value=4.6e-39 Score=283.40 Aligned_cols=240 Identities=28% Similarity=0.361 Sum_probs=193.1
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-----HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-----ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV 170 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (361)
+|+..+.||+|++|.||+|... +++.|++|.+.... .+..+.+.+|+++++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999976 78999999886533 33456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918 171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE 250 (361)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 250 (361)
+||+++++|.+++.... .+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 99999999999997654 3889999999999999999999 8899999999999999999999999999988764332
Q ss_pred cceeeecccccccccCccccCCCC-CCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918 251 NFETRTMTMATVGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL 329 (361)
Q Consensus 251 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 329 (361)
......++..|+|||...... ++.++|+||||+++|+|++|+.||....... ........ ..... +.
T Consensus 157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~---~~~~~-----~~ 224 (258)
T cd06632 157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA-AVFKIGRS---KELPP-----IP 224 (258)
T ss_pred ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH-HHHHHHhc---ccCCC-----cC
Confidence 123345888999999877666 8999999999999999999999997643111 01111000 00000 00
Q ss_pred CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
. .....+.+++.+||+.+|++||
T Consensus 225 ~---------~~~~~~~~li~~~l~~~p~~Rp 247 (258)
T cd06632 225 D---------HLSDEAKDFILKCLQRDPSLRP 247 (258)
T ss_pred C---------CcCHHHHHHHHHHhhcCcccCc
Confidence 0 1123478899999999999998
No 242
>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha. Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype
Probab=100.00 E-value=3.4e-39 Score=294.43 Aligned_cols=199 Identities=20% Similarity=0.253 Sum_probs=166.0
Q ss_pred CCCccccC--CceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918 100 ECNLLGKG--SFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 100 ~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
++++||+| +|++||++... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78999999864 78999999987543 334456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc-
Q 037918 175 PNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF- 252 (361)
Q Consensus 175 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~- 252 (361)
++|+|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+||+++.++.++++||+.+.........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999999754 334899999999999999999999 889999999999999999999999999875443211110
Q ss_pred ----eeeecccccccccCccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 253 ----ETRTMTMATVGYMAPEYGSE--GIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 253 ----~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 01122346778999998865 45889999999999999999999999754
No 243
>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin. Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre
Probab=100.00 E-value=1.1e-39 Score=292.83 Aligned_cols=253 Identities=25% Similarity=0.354 Sum_probs=195.1
Q ss_pred cCHHHHHHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeec
Q 037918 86 ISYLEIQRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSN 163 (361)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 163 (361)
+...++..++++|.+.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 344556667889999999999999999999964 68899999986532 2235677899999998 89999999999865
Q ss_pred C-----CeeEEEEEecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcE
Q 037918 164 V-----DFKALVLEFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235 (361)
Q Consensus 164 ~-----~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 235 (361)
. +..++||||+++++|.+++.. ....+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCE
Confidence 3 358999999999999998863 3345899999999999999999999 8899999999999999999999
Q ss_pred EEEeccCccccCCCCcceeeecccccccccCccccCCC-----CCCcccchHHHHHHHHHHHhCCCCCCccccccccHHH
Q 037918 236 HVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG-----IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKN 310 (361)
Q Consensus 236 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~ 310 (361)
+|+|||++........ ......++..|+|||.+... .++.++||||||+++|||++|+.||....... .+..
T Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-~~~~ 244 (291)
T cd06639 168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-TLFK 244 (291)
T ss_pred EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-HHHH
Confidence 9999999887543221 12234578899999987543 36889999999999999999999987542211 1111
Q ss_pred HHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 311 WVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 311 ~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+.... + ..+.+ + .+....+.+++.+||+.||++||
T Consensus 245 ~~~~~-~---~~~~~-------~-----~~~~~~l~~li~~~l~~~p~~Rp 279 (291)
T cd06639 245 IPRNP-P---PTLLH-------P-----EKWCRSFNHFISQCLIKDFEARP 279 (291)
T ss_pred HhcCC-C---CCCCc-------c-----cccCHHHHHHHHHHhhcChhhCc
Confidence 11110 0 00000 0 01123488999999999999998
No 244
>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok
Probab=100.00 E-value=1e-39 Score=301.24 Aligned_cols=198 Identities=23% Similarity=0.298 Sum_probs=168.9
Q ss_pred hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC------
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV------ 164 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 164 (361)
..++|.+.+.||+|+||.||++... .++.||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999864 68899999987532 33446778899999999999999999988543
Q ss_pred CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918 165 DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK 244 (361)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 244 (361)
...++||||++ ++|.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 95 ~~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 95 QDVYLVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred ceeEEEhhhhc-ccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 35789999996 477777753 2788999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 245 LLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 245 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
...... ......++..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred cCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 654322 123346899999999999888999999999999999999999999753
No 245
>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p
Probab=100.00 E-value=2.5e-39 Score=294.10 Aligned_cols=195 Identities=23% Similarity=0.292 Sum_probs=159.9
Q ss_pred CCccccCCceEEEEEEeC---CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeec--CCeeEEEEEecC
Q 037918 101 CNLLGKGSFGSVYKGILS---DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN--VDFKALVLEFMP 175 (361)
Q Consensus 101 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~ 175 (361)
.++||+|+||.||+|... +++.+|+|.+..... ...+.+|++++++++||||+++++++.. ....+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999854 467899999865432 2356789999999999999999998854 456789999984
Q ss_pred CCCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE----cCCCcEEEEeccCc
Q 037918 176 NGSLEKWLYSH--------NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL----DENMVAHVSDFGIS 243 (361)
Q Consensus 176 ~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~a 243 (361)
++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5898887532 124889999999999999999999 8899999999999999 45678999999999
Q ss_pred cccCCCCc-ceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 244 KLLGDGEN-FETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 244 ~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
+....... ........+|+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 87643321 112234568999999998866 45899999999999999999999999643
No 246
>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development
Probab=100.00 E-value=7e-39 Score=283.86 Aligned_cols=202 Identities=28% Similarity=0.391 Sum_probs=172.1
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh-----hHHHHHHHHHHHHHHHhcCCCceeeeeeeeec--CCee
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ-----LERAFRSFDSECEVLRSIRHRNLVKILSSCSN--VDFK 167 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 167 (361)
.+|+..+.||+|+||.||+|... ++..|++|.+... ..+....+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47899999999999999999964 5899999988633 12344678899999999999999999998865 3577
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918 168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG 247 (361)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 247 (361)
+++|||+++++|.+++..... +++...+.++.|++.||+||| +.+++||||+|+||+++.++.++|+|||++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 899999999999999986543 789999999999999999999 8899999999999999999999999999987653
Q ss_pred CCCcc-eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 248 DGENF-ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 248 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
..... .......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 22111 1112345788999999998888999999999999999999999999754
No 247
>PTZ00266 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=1.2e-39 Score=322.47 Aligned_cols=248 Identities=22% Similarity=0.310 Sum_probs=190.1
Q ss_pred HHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeec--CCe
Q 037918 92 QRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSN--VDF 166 (361)
Q Consensus 92 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~ 166 (361)
....++|.+.+.||+|+||.||++... ++..+|+|.+... .......+..|+.++++++||||++++++|.+ ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 345578999999999999999999965 5778999988643 23445678899999999999999999998854 456
Q ss_pred eEEEEEecCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCeeeCCCCCCCEEEcC--------
Q 037918 167 KALVLEFMPNGSLEKWLYSH---NYFLDIQERLNVMIDVGSALEYLHHGY----SPSVVHCDLKPSNILLDE-------- 231 (361)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~----~~~ivH~dlk~~Nill~~-------- 231 (361)
.++||||+++|+|.+++... ...+++..++.|+.||+.||+|||... ..+|+||||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999999752 234899999999999999999999421 146999999999999964
Q ss_pred ---------CCcEEEEeccCccccCCCCcceeeecccccccccCccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918 232 ---------NMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSE--GIVSSKCDVYSYGVLLMETFTRKKPTDE 300 (361)
Q Consensus 232 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~~ 300 (361)
.+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||+||||+||+.||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 2358999999998764322 1233468999999998754 4588999999999999999999999964
Q ss_pred cccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 301 FFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
... ........... +.+... .....+.+|+..||+.+|++||
T Consensus 246 ~~~----~~qli~~lk~~-------p~lpi~--------~~S~eL~dLI~~~L~~dPeeRP 287 (1021)
T PTZ00266 246 ANN----FSQLISELKRG-------PDLPIK--------GKSKELNILIKNLLNLSAKERP 287 (1021)
T ss_pred CCc----HHHHHHHHhcC-------CCCCcC--------CCCHHHHHHHHHHhcCChhHCc
Confidence 321 11111111000 000000 1123478999999999999998
No 248
>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase. Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1
Probab=100.00 E-value=2.3e-39 Score=286.76 Aligned_cols=249 Identities=27% Similarity=0.361 Sum_probs=197.3
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
++|++.+.||.|++|.||+|... ++..+++|++.... ....+.+.+|+++++.++|+|++++++.+...+..+++||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46889999999999999999954 68899999986433 23557789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 174 MPNGSLEKWLYSH--NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 174 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
+++++|.+++... ...+++..+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999999754 235899999999999999999999 88999999999999999999999999999987654332
Q ss_pred ce--eeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918 252 FE--TRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL 328 (361)
Q Consensus 252 ~~--~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l 328 (361)
.. ......++..|+|||.+... .++.++|+||||+++|+|++|+.||...... .......... +..+.
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~-~~~~~------- 228 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQND-PPSLE------- 228 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhcCC-CCCcC-------
Confidence 21 22334588899999988776 7899999999999999999999999754321 1111111110 00000
Q ss_pred cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
... .....+..+.+++.+||+.||++||
T Consensus 229 -~~~----~~~~~~~~~~~li~~~l~~~p~~Rp 256 (267)
T cd06610 229 -TGA----DYKKYSKSFRKMISLCLQKDPSKRP 256 (267)
T ss_pred -Ccc----ccccccHHHHHHHHHHcCCChhhCc
Confidence 000 0012234578999999999999998
No 249
>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=2.2e-39 Score=289.92 Aligned_cols=246 Identities=23% Similarity=0.304 Sum_probs=195.4
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
++|++.+.||+|+||+||++... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56788899999999999999964 68899999886543 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
+++++|.+++...+ .+++..+..++.+++.+|.|||+ ..+++|+||+|+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--- 158 (284)
T cd06620 85 MDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--- 158 (284)
T ss_pred CCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence 99999999987654 38999999999999999999993 2589999999999999999999999999987542211
Q ss_pred eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccc------cHHHHHhhhcCCCcccccccc
Q 037918 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEM------SLKNWVKESLPHGLTNVVDEN 327 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~------~~~~~~~~~~~~~l~~~~~~~ 327 (361)
.....++..|+|||++.+..++.++|+||||+++|+|+||+.||........ ....+...........
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 232 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPR----- 232 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCC-----
Confidence 1234688999999998888899999999999999999999999975432210 1112222211111000
Q ss_pred ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+ ...+.+..+.+++.+|++.||++||
T Consensus 233 ~--------~~~~~~~~~~~li~~~l~~dp~~Rp 258 (284)
T cd06620 233 L--------PSSDFPEDLRDFVDACLLKDPTERP 258 (284)
T ss_pred C--------CchhcCHHHHHHHHHHhcCCcccCc
Confidence 0 0011334578999999999999998
No 250
>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=1.6e-39 Score=297.47 Aligned_cols=244 Identities=25% Similarity=0.446 Sum_probs=191.1
Q ss_pred CCCCCCCccccCCceEEEEEEeC--------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCC
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS--------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVD 165 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 165 (361)
.+|++.+.||+|+||.||++... .+..||+|.+.... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46889999999999999999742 12368999887543 34457789999999999 8999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc
Q 037918 166 FKALVLEFMPNGSLEKWLYSHN---------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD 230 (361)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~ 230 (361)
..+++|||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence 9999999999999999997532 23788899999999999999999 88999999999999999
Q ss_pred CCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHH
Q 037918 231 ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLK 309 (361)
Q Consensus 231 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~ 309 (361)
.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||..... .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~ 243 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-----E 243 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-----H
Confidence 999999999999987644322222222334567999999988889999999999999999998 8888865321 1
Q ss_pred HHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 310 NWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 310 ~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+........ .....+ ..+...+.+++.+||+.+|++||
T Consensus 244 ~~~~~~~~~---------~~~~~~-----~~~~~~l~~li~~cl~~~p~~Rp 281 (334)
T cd05100 244 ELFKLLKEG---------HRMDKP-----ANCTHELYMIMRECWHAVPSQRP 281 (334)
T ss_pred HHHHHHHcC---------CCCCCC-----CCCCHHHHHHHHHHcccChhhCc
Confidence 111111000 000000 01233588999999999999998
No 251
>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess
Probab=100.00 E-value=2.1e-39 Score=291.02 Aligned_cols=203 Identities=24% Similarity=0.370 Sum_probs=170.5
Q ss_pred hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH-HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE-RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
++++|.+.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999864 688999999865432 22235678999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
||+. ++|.+++......+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||+++.......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9995 6888777655555788889999999999999999 88999999999999999999999999999876433211
Q ss_pred ceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccc
Q 037918 252 FETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFF 302 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~ 302 (361)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 159 --TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred --CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 1223357889999998765 347889999999999999999999997543
No 252
>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4. Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin
Probab=100.00 E-value=1.3e-39 Score=294.14 Aligned_cols=243 Identities=29% Similarity=0.477 Sum_probs=190.6
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCc----EEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGA----EVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL 169 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (361)
++|+..+.||+|+||.||+|.+. +|. .+|+|.+.... ......+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 46788899999999999999853 444 47889886543 23334688999999999999999999998754 4679
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918 170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 249 (361)
++||+++|+|.+++......+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 99999999999999876656899999999999999999999 889999999999999999999999999999876433
Q ss_pred CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL 328 (361)
Q Consensus 250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l 328 (361)
..........++..|+|||.+.+..++.++||||||+++|||++ |..||..... ....++...... .
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~----------~ 230 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLEKGER----------L 230 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCCCC----------C
Confidence 32222223345678999999988889999999999999999997 9999865321 122222221100 0
Q ss_pred cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..+ ..+...+.+++.+||..+|++||
T Consensus 231 --~~~-----~~~~~~~~~li~~c~~~~p~~Rp 256 (303)
T cd05110 231 --PQP-----PICTIDVYMVMVKCWMIDADSRP 256 (303)
T ss_pred --CCC-----CCCCHHHHHHHHHHcCCChhhCc
Confidence 000 01223478999999999999998
No 253
>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki
Probab=100.00 E-value=3.4e-39 Score=284.48 Aligned_cols=228 Identities=25% Similarity=0.452 Sum_probs=181.7
Q ss_pred CccccCCceEEEEEEeCCCc-----------EEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918 102 NLLGKGSFGSVYKGILSDGA-----------EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV 170 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (361)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999975432 5788877655433 5778899999999999999999999988 778999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC-------cEEEEeccCc
Q 037918 171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM-------VAHVSDFGIS 243 (361)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-------~~kl~Dfg~a 243 (361)
|||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .++|+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999999876656899999999999999999999 88999999999999999887 7999999999
Q ss_pred cccCCCCcceeeecccccccccCccccCCC--CCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCc
Q 037918 244 KLLGDGENFETRTMTMATVGYMAPEYGSEG--IVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGL 320 (361)
Q Consensus 244 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l 320 (361)
..... .....++..|+|||++.+. .++.++||||||+++|||++ |..||...... ....+.... ..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~~~~~~~~--~~- 224 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EKERFYQDQ--HR- 224 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hHHHHHhcC--CC-
Confidence 87543 1223467789999998776 78999999999999999999 57777654211 111111100 00
Q ss_pred cccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 321 TNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 321 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+ ..+. ...+.+++.+||..+|++||
T Consensus 225 -------~--~~~~-------~~~~~~li~~~l~~~p~~Rp 249 (259)
T cd05037 225 -------L--PMPD-------CAELANLINQCWTYDPTKRP 249 (259)
T ss_pred -------C--CCCC-------chHHHHHHHHHhccChhhCC
Confidence 0 0000 03478999999999999998
No 254
>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea
Probab=100.00 E-value=1.8e-39 Score=290.02 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=196.3
Q ss_pred cCHHHHHHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeec
Q 037918 86 ISYLEIQRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSN 163 (361)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 163 (361)
.+..++....+.|++.+.||+|+||.||+|... +++.+|+|++..... ....+..|+.+++++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 455666677889999999999999999999964 688999999875532 335678899999998 79999999999853
Q ss_pred ------CCeeEEEEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEE
Q 037918 164 ------VDFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAH 236 (361)
Q Consensus 164 ------~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 236 (361)
.+..+++|||+++|+|.+++... ...+++..+..++.|++.||+||| +.+++|+||+|+||++++++.++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence 45789999999999999999754 334788889999999999999999 88999999999999999999999
Q ss_pred EEeccCccccCCCCcceeeecccccccccCccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHH
Q 037918 237 VSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS-----EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNW 311 (361)
Q Consensus 237 l~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~ 311 (361)
|+|||++........ ......++..|+|||.+. +..++.++|+||||+++|||++|..||.......... .
T Consensus 162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-~- 237 (282)
T cd06636 162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-L- 237 (282)
T ss_pred EeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-h-
Confidence 999999876532211 223346888999999875 3457889999999999999999999996542211100 0
Q ss_pred HhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 312 VKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 312 ~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.... ....... .+.+..+.+++.+||+.||.+||
T Consensus 238 ~~~~--------~~~~~~~--------~~~~~~~~~li~~cl~~~p~~Rp 271 (282)
T cd06636 238 IPRN--------PPPKLKS--------KKWSKKFIDFIEGCLVKNYLSRP 271 (282)
T ss_pred HhhC--------CCCCCcc--------cccCHHHHHHHHHHhCCChhhCc
Confidence 0000 0000000 01233589999999999999998
No 255
>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte
Probab=100.00 E-value=8.6e-39 Score=284.17 Aligned_cols=247 Identities=27% Similarity=0.407 Sum_probs=191.5
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh----------HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL----------ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD 165 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 165 (361)
+|...+.||+|++|.||+|... +|+.+|+|.+.... ....+.+..|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999854 68999999875321 112356788999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918 166 FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL 245 (361)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 245 (361)
..++||||+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 9999999999999999998764 4889999999999999999999 88999999999999999999999999999976
Q ss_pred cCCCCcceeeecccccccccCccccCCCC--CCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccc
Q 037918 246 LGDGENFETRTMTMATVGYMAPEYGSEGI--VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNV 323 (361)
Q Consensus 246 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~ 323 (361)
..............++..|+|||...... ++.++|+||||+++|++++|..||..... ...... .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~-~~~~~~~~~ 232 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----IAAMFK-LGNKRSAPP 232 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----HHHHHH-hhccccCCc
Confidence 54322111223345788999999876654 78999999999999999999999864221 111111 000000000
Q ss_pred ccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 324 VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 324 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
...... .+....+.+++.+||+.+|++||
T Consensus 233 ~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp 261 (272)
T cd06629 233 IPPDVS---------MNLSPVALDFLNACFTINPDNRP 261 (272)
T ss_pred CCcccc---------ccCCHHHHHHHHHHhcCChhhCC
Confidence 111110 11234588999999999999998
No 256
>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.
Probab=100.00 E-value=8.8e-39 Score=281.60 Aligned_cols=241 Identities=25% Similarity=0.349 Sum_probs=192.5
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeec-CCeeEEEEE
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSN-VDFKALVLE 172 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 172 (361)
+|++.+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999965 57889999987543 3445678899999999999999999998764 446789999
Q ss_pred ecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 173 FMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 173 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
|+++++|.+++... ...+++.+++.++.+++.||++|| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999999864 345899999999999999999999 88999999999999999999999999999987643222
Q ss_pred ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918 252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
......+++.|+|||+..+..++.++|+||||+++|+|++|+.||..... ...........+.. ...
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~-----~~~- 224 (257)
T cd08223 158 --MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSLVYRIIEGKLPP-----MPK- 224 (257)
T ss_pred --ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhcCCCC-----Ccc-
Confidence 22234578899999999988899999999999999999999999864321 11111111111100 000
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+|++.||++||
T Consensus 225 --------~~~~~~~~li~~~l~~~p~~Rp 246 (257)
T cd08223 225 --------DYSPELGELIATMLSKRPEKRP 246 (257)
T ss_pred --------ccCHHHHHHHHHHhccCcccCC
Confidence 1223478999999999999998
No 257
>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron. Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca
Probab=100.00 E-value=2.7e-39 Score=285.73 Aligned_cols=238 Identities=28% Similarity=0.464 Sum_probs=182.1
Q ss_pred CccccCCceEEEEEEeC----CCcEEEEEEeehh-hHHHHHHHHHHHHHHHhcCCCceeeeeeeee-cCCeeEEEEEecC
Q 037918 102 NLLGKGSFGSVYKGILS----DGAEVAIKIFNLQ-LERAFRSFDSECEVLRSIRHRNLVKILSSCS-NVDFKALVLEFMP 175 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~ 175 (361)
+.||+|+||.||+|... ++..+|+|.+... .....+.+.+|+.+++.++||||+++++++. .++..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999988543 2344567889999999999999999999775 4556889999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc--e
Q 037918 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF--E 253 (361)
Q Consensus 176 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~ 253 (361)
+++|.+++.......++..+..++.|+++||+||| +.+++||||||+||++++++.+||+|||+++........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999876555788888999999999999999 889999999999999999999999999999765432211 1
Q ss_pred eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhC-CCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 332 (361)
......++..|+|||...+..++.++||||||+++|||++| .+||..... ......+.... .. ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~~~~----------~~--~~ 223 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVYLLQGR----------RL--LQ 223 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHhcCC----------CC--CC
Confidence 11223456789999998888899999999999999999995 556654221 11111111100 00 00
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+. ..+..+.+++.+||+.+|++||
T Consensus 224 ~~-----~~~~~~~~li~~cl~~~p~~Rp 247 (262)
T cd05058 224 PE-----YCPDPLYEVMLSCWHPKPEMRP 247 (262)
T ss_pred CC-----cCCHHHHHHHHHHcCCChhhCC
Confidence 00 1133588999999999999998
No 258
>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express
Probab=100.00 E-value=8.1e-40 Score=293.80 Aligned_cols=240 Identities=24% Similarity=0.324 Sum_probs=191.3
Q ss_pred CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918 98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPN 176 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (361)
|.....||+|+||.||++... ++..||||.+........+.+.+|+.+++.++||||+++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 333467999999999999864 6889999998765555567788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918 177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256 (361)
Q Consensus 177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 256 (361)
++|.+++.... +++..+..++.|++.||+||| +.+++||||+|+||++++++.++|+|||++........ ...
T Consensus 104 ~~L~~~~~~~~--l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~ 176 (292)
T cd06658 104 GALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRK 176 (292)
T ss_pred CcHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCc
Confidence 99999886543 889999999999999999999 88999999999999999999999999999876533221 122
Q ss_pred cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918 257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA 336 (361)
Q Consensus 257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~ 336 (361)
...++..|+|||...+..++.++|+||||+++|||++|+.||...... ..........+. ......
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~~~~--------~~~~~~---- 242 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAMRRIRDNLPP--------RVKDSH---- 242 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCCC--------cccccc----
Confidence 345888999999998888999999999999999999999998643211 111111111111 110000
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 337 AKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 337 ~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+|+..||++||
T Consensus 243 ---~~~~~~~~li~~~l~~~P~~Rp 264 (292)
T cd06658 243 ---KVSSVLRGFLDLMLVREPSQRA 264 (292)
T ss_pred ---ccCHHHHHHHHHHccCChhHCc
Confidence 1122478889999999999998
No 259
>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase. Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea
Probab=100.00 E-value=3.3e-39 Score=288.85 Aligned_cols=199 Identities=24% Similarity=0.338 Sum_probs=172.9
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
+|++.+.||+|++|.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999964 68999999987543 33346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
+ +++|.+++......+++..++.++.|+++||+||| +.+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R 155 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence 9 99999999866666899999999999999999999 88999999999999999999999999999987654321 1
Q ss_pred eeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918 254 TRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDE 300 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~ 300 (361)
......++..|+|||.+.+ ..++.++||||+|+++|||+||.+||..
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 203 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG 203 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence 1223468889999998755 4468999999999999999999888764
No 260
>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros. Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male
Probab=100.00 E-value=2e-39 Score=287.72 Aligned_cols=238 Identities=28% Similarity=0.508 Sum_probs=186.6
Q ss_pred CccccCCceEEEEEEeCC-------CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 102 NLLGKGSFGSVYKGILSD-------GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
+.||+|+||.||+|...+ ++.+|+|.+.... ......+.+|+.+++.++||||+++++++...+..+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998642 2578999876543 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC-----cEEEEeccC
Q 037918 174 MPNGSLEKWLYSH------NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM-----VAHVSDFGI 242 (361)
Q Consensus 174 ~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-----~~kl~Dfg~ 242 (361)
+++++|.+++... ...+++..++.++.|++.||+||| +.+++|+||+|+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999742 234788999999999999999999 88999999999999999877 899999999
Q ss_pred ccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcc
Q 037918 243 SKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLT 321 (361)
Q Consensus 243 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~ 321 (361)
+................++..|+|||.+.+..++.++||||||+++|||+| |+.||..... .......... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~--~--- 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQHVTAG--G--- 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHHHhcC--C---
Confidence 976643322222223345678999999998889999999999999999998 9999864322 1111111100 0
Q ss_pred ccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 322 NVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 322 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
....+ ...+..+.+++.+||..+|++||
T Consensus 231 -------~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp 258 (269)
T cd05044 231 -------RLQKP-----ENCPDKIYQLMTNCWAQDPSERP 258 (269)
T ss_pred -------ccCCc-----ccchHHHHHHHHHHcCCCcccCC
Confidence 00000 01234578999999999999998
No 261
>PTZ00284 protein kinase; Provisional
Probab=100.00 E-value=2.8e-39 Score=308.45 Aligned_cols=201 Identities=26% Similarity=0.364 Sum_probs=165.5
Q ss_pred HHHHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCC------Cceeeeeeeee
Q 037918 90 EIQRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRH------RNLVKILSSCS 162 (361)
Q Consensus 90 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~~~~~~~ 162 (361)
++...+++|.+.+.||+|+||.||+|... .++.||||+++... .....+..|+.+++.++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34445688999999999999999999964 57889999986432 223445667777777654 45888999887
Q ss_pred cC-CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCEEEcCCC-------
Q 037918 163 NV-DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS-PSVVHCDLKPSNILLDENM------- 233 (361)
Q Consensus 163 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~~------- 233 (361)
.. +..++|||++ +++|.+++...+ .+++..+..++.|++.||+||| + .+|+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCccccccc
Confidence 64 5788999988 789999887654 3899999999999999999999 6 5999999999999998765
Q ss_pred ---------cEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 234 ---------VAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 234 ---------~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred ccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 499999998764322 223457899999999999999999999999999999999999999753
No 262
>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.6e-40 Score=302.97 Aligned_cols=247 Identities=27% Similarity=0.438 Sum_probs=205.2
Q ss_pred HHHhhCCCCCCCccccCCceEEEEEEeCC-CcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918 91 IQRATNGFDECNLLGKGSFGSVYKGILSD-GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL 169 (361)
Q Consensus 91 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (361)
++-...+...-++||-|.||.||.|.|+. .-.||||.++.+. -..++|++|..+|+.++|||+|+++|+|..+...|+
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 33344456667899999999999999864 5679999987654 345789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918 170 VLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD 248 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 248 (361)
|+|||..|+|.+||...+ ..++.-..+.++.||.+|+.||. .+++|||||..+|+|+.++..+|++|||+++++..
T Consensus 341 iTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred EEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 999999999999998543 33666777889999999999999 99999999999999999999999999999999865
Q ss_pred CCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccccccc
Q 037918 249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN 327 (361)
Q Consensus 249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 327 (361)
+.. ..+....-...|.|||-+....++.|+|||+||++|||+.| |..||....- .+ ...+++..
T Consensus 418 DTY-TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-----Sq---------VY~LLEkg 482 (1157)
T KOG4278|consen 418 DTY-TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQ---------VYGLLEKG 482 (1157)
T ss_pred Cce-ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-----HH---------HHHHHhcc
Confidence 432 23333445778999999999999999999999999999988 8888876421 11 13344444
Q ss_pred ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+..+.|+ .|+..+.+|+.+||+++|++||
T Consensus 483 yRM~~Pe-----GCPpkVYeLMraCW~WsPsDRP 511 (1157)
T KOG4278|consen 483 YRMDGPE-----GCPPKVYELMRACWNWSPSDRP 511 (1157)
T ss_pred ccccCCC-----CCCHHHHHHHHHHhcCCcccCc
Confidence 4444444 6888899999999999999998
No 263
>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also
Probab=100.00 E-value=1.6e-39 Score=290.69 Aligned_cols=198 Identities=25% Similarity=0.382 Sum_probs=168.5
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH--HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE--RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
+|++.+.||+|++|.||+|... +|+.+|+|.+..... .....+.+|++++++++||||+++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999965 689999999865321 1224577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
++ ++|.+++......+++..++.++.|+++||.||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-- 154 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-- 154 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence 96 5888888765556899999999999999999999 88999999999999999999999999999986543221
Q ss_pred eeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918 254 TRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDE 300 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~ 300 (361)
......++..|+|||.+.+. .++.++||||||+++|||+||..|+..
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~ 202 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 12234578899999987664 478999999999999999999998643
No 264
>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I
Probab=100.00 E-value=1.7e-39 Score=288.77 Aligned_cols=246 Identities=25% Similarity=0.341 Sum_probs=192.8
Q ss_pred HhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCC-----
Q 037918 93 RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVD----- 165 (361)
Q Consensus 93 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~----- 165 (361)
..+++|++.+.||+|++|.||+|... +++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35688999999999999999999975 578999999876543 336788999999999 7999999999996544
Q ss_pred -eeEEEEEecCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEecc
Q 037918 166 -FKALVLEFMPNGSLEKWLYSH---NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFG 241 (361)
Q Consensus 166 -~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 241 (361)
..++||||+++++|.+++... +..+++..+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence 489999999999999998742 345899999999999999999999 8999999999999999999999999999
Q ss_pred CccccCCCCcceeeecccccccccCccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhc
Q 037918 242 ISKLLGDGENFETRTMTMATVGYMAPEYGSE-----GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESL 316 (361)
Q Consensus 242 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 316 (361)
++....... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||....... .......
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~--- 232 (275)
T cd06608 159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFKIPR--- 232 (275)
T ss_pred cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHHHhhc---
Confidence 987654322 12233468889999997643 346789999999999999999999997532211 1111110
Q ss_pred CCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 317 PHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 317 ~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..... +. . .......+.+++.+||..||++||
T Consensus 233 -~~~~~-----~~--~-----~~~~~~~~~~li~~~l~~dp~~Rp 264 (275)
T cd06608 233 -NPPPT-----LK--S-----PENWSKKFNDFISECLIKNYEQRP 264 (275)
T ss_pred -cCCCC-----CC--c-----hhhcCHHHHHHHHHHhhcChhhCc
Confidence 00000 00 0 112234578999999999999998
No 265
>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l
Probab=100.00 E-value=3.9e-39 Score=286.18 Aligned_cols=235 Identities=31% Similarity=0.512 Sum_probs=182.5
Q ss_pred CccccCCceEEEEEEeCC-Cc--EEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEEecCC
Q 037918 102 NLLGKGSFGSVYKGILSD-GA--EVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLEFMPN 176 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (361)
+.||+|+||.||+|...+ +. .+++|.+.... ....+.+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999753 43 46888887432 34456788999999999 899999999999999999999999999
Q ss_pred CCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEecc
Q 037918 177 GSLEKWLYSHN---------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFG 241 (361)
Q Consensus 177 g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 241 (361)
++|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 99999997532 23788999999999999999999 8899999999999999999999999999
Q ss_pred CccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCc
Q 037918 242 ISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGL 320 (361)
Q Consensus 242 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l 320 (361)
++...... ........+..|+|||++....++.++||||||+++|||++ |..||...... ...... +...
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~~~~~-~~~~ 228 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYEKL-PQGY 228 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----HHHHHH-hCCC
Confidence 98632211 11111234567999999888889999999999999999997 99998653211 111111 1100
Q ss_pred cccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 321 TNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 321 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..+.+. .+...+.+++.+||+.||.+||
T Consensus 229 --------~~~~~~-----~~~~~~~~li~~~l~~~p~~Rp 256 (270)
T cd05047 229 --------RLEKPL-----NCDDEVYDLMRQCWREKPYERP 256 (270)
T ss_pred --------CCCCCC-----cCCHHHHHHHHHHcccChhhCC
Confidence 000000 1223478999999999999998
No 266
>PHA03209 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=2.7e-39 Score=298.35 Aligned_cols=193 Identities=22% Similarity=0.306 Sum_probs=167.2
Q ss_pred HhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 93 RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 93 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
....+|.+.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||+++++++...+..++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34467999999999999999999965 5788999975432 2346899999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
|++ .++|.+++......+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 137 e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 137 PHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred Ecc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 999 56999998876666999999999999999999999 8899999999999999999999999999997543221
Q ss_pred ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCC
Q 037918 252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPT 298 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~ 298 (361)
......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 212 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 --AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 122346899999999999889999999999999999999866554
No 267
>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i
Probab=100.00 E-value=1e-39 Score=293.87 Aligned_cols=238 Identities=24% Similarity=0.331 Sum_probs=190.1
Q ss_pred CCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCC
Q 037918 100 ECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGS 178 (361)
Q Consensus 100 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 178 (361)
....||+|+||.||++... +++.||+|.+........+.+.+|+.++..++|||++++++++..++..+++|||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999964 689999999876544445678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecc
Q 037918 179 LEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258 (361)
Q Consensus 179 L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 258 (361)
|.+++.... +++..++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 105 L~~~~~~~~--~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~ 177 (297)
T cd06659 105 LTDIVSQTR--LNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSL 177 (297)
T ss_pred HHHHHhhcC--CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccccce
Confidence 999886533 899999999999999999999 8899999999999999999999999999987654322 122334
Q ss_pred cccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHH
Q 037918 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAK 338 (361)
Q Consensus 259 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 338 (361)
.++..|+|||++.+..++.++||||||+++|||++|+.||..... ...........+..+.. . .
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~-----~-~-------- 241 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRLRDSPPPKLKN-----A-H-------- 241 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhccCCCCccc-----c-C--------
Confidence 688999999999888899999999999999999999999864321 11111111111000000 0 0
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCC
Q 037918 339 MDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 339 ~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||+.+|++||
T Consensus 242 -~~~~~l~~~i~~~l~~~P~~Rp 263 (297)
T cd06659 242 -KISPVLRDFLERMLTREPQERA 263 (297)
T ss_pred -CCCHHHHHHHHHHhcCCcccCc
Confidence 1123478899999999999998
No 268
>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=2.2e-40 Score=303.50 Aligned_cols=236 Identities=25% Similarity=0.429 Sum_probs=190.7
Q ss_pred CCccccCCceEEEEEEeC-CCcEEEEEEeeh----hhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCe--eEEEEEe
Q 037918 101 CNLLGKGSFGSVYKGILS-DGAEVAIKIFNL----QLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF--KALVLEF 173 (361)
Q Consensus 101 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~lv~e~ 173 (361)
...||+|+|-+||+|.+. +|..||=-.++. ......++|..|+.+|+.|+||||+++|++|.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 458999999999999974 477776222211 124556889999999999999999999999987665 7799999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC-CCcEEEEeccCccccCCCCcc
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE-NMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
+..|+|..|+++.+. .+...+..|++||++||.|||+. .++|+|||||.+||||+. -|.+||+|+|+|.......
T Consensus 125 ~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-- 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-- 200 (632)
T ss_pred ccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc--
Confidence 999999999998766 89999999999999999999976 889999999999999974 5799999999999875533
Q ss_pred eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918 253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 332 (361)
.....|||.|||||+.. ..|+...||||||+.++||+|+..||........-+.....+.-|..+..+-|+
T Consensus 201 --aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dP------ 271 (632)
T KOG0584|consen 201 --AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDP------ 271 (632)
T ss_pred --cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCH------
Confidence 23368999999999877 678999999999999999999999998765443333333333333434433322
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+.++|.+|+.. .++||
T Consensus 272 -----------evr~fIekCl~~-~~~R~ 288 (632)
T KOG0584|consen 272 -----------EVREFIEKCLAT-KSERL 288 (632)
T ss_pred -----------HHHHHHHHHhcC-chhcc
Confidence 268899999998 88876
No 269
>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti
Probab=100.00 E-value=3.1e-39 Score=284.39 Aligned_cols=241 Identities=22% Similarity=0.329 Sum_probs=194.6
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
+|++.+.||+|+||.+|++... +|+.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999954 68999999987532 33446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 174 MPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 174 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
+++++|.+++... ...+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 9999999999754 334789999999999999999999 88999999999999999999999999999987643221
Q ss_pred eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918 253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 332 (361)
......+++.|+|||+..+..++.++|+||||+++|+|++|+.||..... .+.+.......... ..
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~-----~~--- 222 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----KNLVLKIIRGSYPP-----VS--- 222 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-----HHHHHHHhcCCCCC-----Cc---
Confidence 11233578889999999888899999999999999999999999864321 11211111111100 00
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
......+.+++.+||+.+|++||
T Consensus 223 ------~~~~~~~~~li~~~l~~~p~~Rp 245 (256)
T cd08218 223 ------SHYSYDLRNLVSQLFKRNPRDRP 245 (256)
T ss_pred ------ccCCHHHHHHHHHHhhCChhhCc
Confidence 01233478999999999999998
No 270
>smart00219 TyrKc Tyrosine kinase, catalytic domain. Phosphotransferases. Tyrosine-specific kinase subfamily.
Probab=100.00 E-value=3.7e-39 Score=283.92 Aligned_cols=241 Identities=32% Similarity=0.566 Sum_probs=193.1
Q ss_pred CCCCCccccCCceEEEEEEeCC-----CcEEEEEEeehhhHH-HHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 98 FDECNLLGKGSFGSVYKGILSD-----GAEVAIKIFNLQLER-AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
+++.+.||.|+||.||++...+ +..||+|.+...... ..+.+..|+++++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999999653 388999999765433 5578899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918 172 EFMPNGSLEKWLYSHNYF-LDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE 250 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 250 (361)
||+++++|.+++...... +++..+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999865444 899999999999999999999 8899999999999999999999999999998765442
Q ss_pred cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918 251 NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL 329 (361)
Q Consensus 251 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 329 (361)
.... ....++..|+|||...+..++.++|+||+|+++|+|++ |+.||..... ........... ..
T Consensus 158 ~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~~~---~~-------- 223 (258)
T smart00219 158 YYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLEYLKKGY---RL-------- 223 (258)
T ss_pred cccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCC---CC--------
Confidence 2211 12336789999999888889999999999999999998 7888865211 11111111100 00
Q ss_pred CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..+. ..+..+.+++.+|+..||++||
T Consensus 224 -~~~~-----~~~~~~~~~i~~~l~~~p~~Rp 249 (258)
T smart00219 224 -PKPE-----NCPPEIYKLMLQCWAEDPEDRP 249 (258)
T ss_pred -CCCC-----cCCHHHHHHHHHHCcCChhhCc
Confidence 0000 1234588999999999999998
No 271
>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=3.5e-40 Score=304.27 Aligned_cols=240 Identities=26% Similarity=0.416 Sum_probs=198.6
Q ss_pred CCCCccccCCceEEEEEEeC--CCc--EEEEEEeehhhHH-HHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 99 DECNLLGKGSFGSVYKGILS--DGA--EVAIKIFNLQLER-AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 99 ~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
...++||+|.||.|++|.|. +|+ .||||.+...... ...+|.+|+.+|.+|+|||++++||+..+ ....+|||.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 34578999999999999975 343 5899999876543 67899999999999999999999999987 667899999
Q ss_pred cCCCCHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 174 MPNGSLEKWLYS-HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 174 ~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
++.|+|.+.|.+ ....+-......++.|||.||+||. ++++|||||..+|+|+-..-.+||+|||+.+.++.++..
T Consensus 192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 999999999987 4455778888899999999999999 999999999999999999999999999999999876655
Q ss_pred eeeec-ccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918 253 ETRTM-TMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330 (361)
Q Consensus 253 ~~~~~-~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 330 (361)
..+.. ..-...|+|||.+....++.+||||+|||++|||+| |+.||-...... + .+.+|..-..
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q--I------------L~~iD~~erL 334 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ--I------------LKNIDAGERL 334 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH--H------------HHhccccccC
Confidence 44432 335677999999999999999999999999999999 788887643211 1 1222222222
Q ss_pred CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..+ ..|+..++++++.||.++|++||
T Consensus 335 pRP-----k~csedIY~imk~cWah~paDRp 360 (1039)
T KOG0199|consen 335 PRP-----KYCSEDIYQIMKNCWAHNPADRP 360 (1039)
T ss_pred CCC-----CCChHHHHHHHHHhccCCccccc
Confidence 222 26788899999999999999998
No 272
>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1. Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.
Probab=100.00 E-value=4.6e-39 Score=283.66 Aligned_cols=241 Identities=27% Similarity=0.343 Sum_probs=196.5
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE 172 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (361)
+|++.+.||.|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++.+.+.+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999975 58999999997543 2445788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
|+++++|.+++... ..+++..+..++.|+++||.||| +.+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999999866 34899999999999999999999 8899999999999999999999999999988764432
Q ss_pred eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918 253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 332 (361)
......++..|+|||...+..++.++|+||||+++|+|++|+.||...... ........... .......
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~-----~~~~~~~-- 223 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQIRAKQET-----ADVLYPA-- 223 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHHHHHHhcc-----ccccCcc--
Confidence 123345788999999988888999999999999999999999999764322 11111111100 0000000
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..+..+.+++.+||+.||.+||
T Consensus 224 -------~~~~~~~~~i~~~l~~~p~~R~ 245 (258)
T cd05578 224 -------TWSTEAIDAINKLLERDPQKRL 245 (258)
T ss_pred -------cCcHHHHHHHHHHccCChhHcC
Confidence 1124578999999999999997
No 273
>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou
Probab=100.00 E-value=4.7e-39 Score=288.04 Aligned_cols=246 Identities=25% Similarity=0.335 Sum_probs=198.9
Q ss_pred HhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 93 RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 93 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
..++.|+..+.||+|++|.||+|... +++.+++|++..... ..+.+.+|+++++.++|+|++++++.+...+..++++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45567888899999999999999976 688999999986544 4567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
||+++++|.+++......+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 999999999999876545899999999999999999999 89999999999999999999999999999876543221
Q ss_pred ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918 252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....... ........ ......
T Consensus 172 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-~~~~~~~~----~~~~~~------- 237 (286)
T cd06614 172 --KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-ALFLITTK----GIPPLK------- 237 (286)
T ss_pred --hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhc----CCCCCc-------
Confidence 1223347788999999888889999999999999999999999987532211 11111000 000000
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+..+.+++.+|++.+|.+||
T Consensus 238 -----~~~~~~~~l~~li~~~l~~~p~~Rp 262 (286)
T cd06614 238 -----NPEKWSPEFKDFLNKCLVKDPEKRP 262 (286)
T ss_pred -----chhhCCHHHHHHHHHHhccChhhCc
Confidence 0011234588999999999999998
No 274
>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity
Probab=100.00 E-value=1.4e-39 Score=287.09 Aligned_cols=230 Identities=25% Similarity=0.396 Sum_probs=181.6
Q ss_pred CccccCCceEEEEEEeCC--------CcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 102 NLLGKGSFGSVYKGILSD--------GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
+.||+|+||.||+|.... ...+++|.+........+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998532 234888888765555567888999999999999999999999998999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCc--------EEEEeccCccc
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV--------AHVSDFGISKL 245 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~kl~Dfg~a~~ 245 (361)
+++|+|.+++..++..+++..++.++.|++.||+||| +.+|+||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999876666899999999999999999999 899999999999999987765 69999998875
Q ss_pred cCCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCC-CCCCccccccccHHHHHhhhcCCCcccc
Q 037918 246 LGDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRK-KPTDEFFAGEMSLKNWVKESLPHGLTNV 323 (361)
Q Consensus 246 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~l~~~ 323 (361)
.... ....++..|+|||.+.+ ..++.++||||||+++|||++|. .|+....... .......
T Consensus 158 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~--------- 220 (258)
T cd05078 158 VLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--KLQFYED--------- 220 (258)
T ss_pred cCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--HHHHHHc---------
Confidence 5321 22457888999998876 45789999999999999999995 5554322111 0111110
Q ss_pred ccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 324 VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 324 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
......+ ....+.+++.+||+.||++||
T Consensus 221 ---~~~~~~~-------~~~~~~~li~~~l~~~p~~Rp 248 (258)
T cd05078 221 ---RHQLPAP-------KWTELANLINQCMDYEPDFRP 248 (258)
T ss_pred ---cccCCCC-------CcHHHHHHHHHHhccChhhCC
Confidence 0000000 113478999999999999998
No 275
>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4. Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s
Probab=100.00 E-value=9.4e-39 Score=284.37 Aligned_cols=244 Identities=24% Similarity=0.386 Sum_probs=192.8
Q ss_pred CCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhhHH-HHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQLER-AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (361)
++|++.+.||+|+||.||+|+.. +.+.+++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888999999999999999953 2467999988765433 4577899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEec
Q 037918 169 LVLEFMPNGSLEKWLYSHN--------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDF 240 (361)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 240 (361)
+||||+++++|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997544 14899999999999999999999 889999999999999999999999999
Q ss_pred cCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCC
Q 037918 241 GISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHG 319 (361)
Q Consensus 241 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (361)
|++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ........ ..
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~~~~~---~~ 235 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLNRLQA---GK 235 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHHHHHc---CC
Confidence 99875432221 12223346778999999888888999999999999999999 88888653221 11111110 00
Q ss_pred ccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 320 LTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 320 l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+... ... .++..+.+++.+||+.||++||
T Consensus 236 ~~~~----~~~---------~~~~~l~~~i~~~l~~~p~~Rp 264 (275)
T cd05046 236 LELP----VPE---------GCPSRLYKLMTRCWAVNPKDRP 264 (275)
T ss_pred cCCC----CCC---------CCCHHHHHHHHHHcCCCcccCC
Confidence 0000 000 1233589999999999999998
No 276
>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is
Probab=100.00 E-value=6.8e-39 Score=288.65 Aligned_cols=258 Identities=25% Similarity=0.304 Sum_probs=193.3
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH-----HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE-----RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV 170 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (361)
+|+..+.||+|++|.||+|... +|+.||+|.+..... .....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999965 689999999875432 2334577899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918 171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE 250 (361)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 250 (361)
|||+ +++|.+++......+++..++.++.|+++||+||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 89999999876545899999999999999999999 8899999999999999999999999999998765432
Q ss_pred cceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhh---cCCC------c
Q 037918 251 NFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKES---LPHG------L 320 (361)
Q Consensus 251 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~------l 320 (361)
. ......++..|+|||.+.+ ..++.++|+||||+++|||++|.+||...... ..+....... .... +
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 157 R--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred c--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCCCchhhhhhcccc
Confidence 1 1223356788999998754 45789999999999999999998877643221 1111111100 0000 0
Q ss_pred cccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 321 TNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 321 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
............+...........+.+++.+||+.||++||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 274 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRI 274 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCc
Confidence 01110000011111111112345688999999999999998
No 277
>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin
Probab=100.00 E-value=5.7e-39 Score=291.62 Aligned_cols=245 Identities=27% Similarity=0.330 Sum_probs=195.1
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
++|+..+.||+|++|.||+|... +++.+|+|.+.... ....+.+..|+++++.++||||+++++.+.+.+..+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999965 58999999987543 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918 172 EFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE 250 (361)
Q Consensus 172 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 250 (361)
||+.+++|.+++... ...+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999999754 345899999999999999999999 8899999999999999999999999999987653221
Q ss_pred cce---------------------------eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcccc
Q 037918 251 NFE---------------------------TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFA 303 (361)
Q Consensus 251 ~~~---------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~ 303 (361)
... ......|+..|+|||+..+..++.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 100 01123578889999999888899999999999999999999999975422
Q ss_pred ccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 304 GEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
. ..+.... ......... ......+.+++.+||+.||++||
T Consensus 238 ~-~~~~~~~------------~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~R~ 277 (316)
T cd05574 238 D-ETFSNIL------------KKEVTFPGS-----PPVSSSARDLIRKLLVKDPSKRL 277 (316)
T ss_pred H-HHHHHHh------------cCCccCCCc-----cccCHHHHHHHHHHccCCHhHCC
Confidence 1 1111111 111100000 01234589999999999999997
No 278
>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=6.4e-41 Score=306.21 Aligned_cols=242 Identities=26% Similarity=0.352 Sum_probs=201.6
Q ss_pred CCCCCccccCCceEEEEEEeCC-CcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918 98 FDECNLLGKGSFGSVYKGILSD-GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPN 176 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (361)
|.++..||.|+||.||+|..++ +-..|-|++........+++.-|+++|....||+|+++++.|...+.+++..|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 4556789999999999999764 445678988888888889999999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918 177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256 (361)
Q Consensus 177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 256 (361)
|-.+..+-.-+..+.+.++.-+++|++.||.||| +++|+|||||+.|||++-+|.++|+|||.+.... .......
T Consensus 114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qkRD 188 (1187)
T KOG0579|consen 114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQKRD 188 (1187)
T ss_pred chHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccch--hHHhhhc
Confidence 9999999887788999999999999999999999 9999999999999999999999999999886532 2233456
Q ss_pred cccccccccCcccc-----CCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918 257 MTMATVGYMAPEYG-----SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 257 ~~~g~~~y~aPE~~-----~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
...|||.|||||+. ...+|+.++||||||++|.||..+.+|..+..+.. ++-..-..+
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR-----------------VllKiaKSe 251 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-----------------VLLKIAKSE 251 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH-----------------HHHHHhhcC
Confidence 67899999999964 56789999999999999999999999976543211 111111222
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+|...........+.+++.+||..||..||
T Consensus 252 PPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp 281 (1187)
T KOG0579|consen 252 PPTLLQPSHWSRSFSDFLKRCLVKNPRNRP 281 (1187)
T ss_pred CCcccCcchhhhHHHHHHHHHHhcCCccCC
Confidence 333333334455689999999999999998
No 279
>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase. Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki
Probab=100.00 E-value=2.9e-39 Score=284.32 Aligned_cols=235 Identities=32% Similarity=0.517 Sum_probs=187.8
Q ss_pred CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918 96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 175 (361)
++|++.+.||+|+||.||++.. +++.||+|.+..... .+.+.+|+.++++++|||++++++++... ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~--~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcch--HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4588899999999999999975 678899999875432 35788999999999999999999998765 4799999999
Q ss_pred CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918 176 NGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET 254 (361)
Q Consensus 176 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 254 (361)
+++|.+++.... ..+++..++.++.|++.||.||| +.+++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----- 153 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----- 153 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence 999999997543 34789999999999999999999 889999999999999999999999999998764321
Q ss_pred eecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918 255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP 333 (361)
Q Consensus 255 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 333 (361)
......+..|+|||.+.+..++.++|+||||+++|||++ |+.||......+ ........ .....+
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~------------~~~~~~ 219 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--VKECVEKG------------YRMEPP 219 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHHhCC------------CCCCCC
Confidence 112234567999999988889999999999999999998 999987543211 11111110 000100
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 334 AFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
. ..+..+.+++.+||+.+|++||
T Consensus 220 ~-----~~~~~~~~li~~~l~~~p~~Rp 242 (254)
T cd05083 220 E-----GCPADVYVLMTSCWETEPKKRP 242 (254)
T ss_pred C-----cCCHHHHHHHHHHcCCChhhCc
Confidence 0 1234578999999999999998
No 280
>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases. Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core
Probab=100.00 E-value=8.7e-39 Score=280.18 Aligned_cols=242 Identities=30% Similarity=0.400 Sum_probs=197.9
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 175 (361)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++.+...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999975 688999999987655556788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee
Q 037918 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR 255 (361)
Q Consensus 176 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 255 (361)
+++|.+++......+++..+..++.|++.+|++|| +.+++||||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999999876455899999999999999999999 89999999999999999999999999999987654321 2
Q ss_pred ecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhH
Q 037918 256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF 335 (361)
Q Consensus 256 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~ 335 (361)
....++..|+|||.+.+..++.++|+||||+++|+|++|+.||........ ...... ........ .
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~---~~~~~~~~-----~---- 220 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA--LFKIAT---NGPPGLRN-----P---- 220 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHHh---cCCCCcCc-----c----
Confidence 334688899999998888889999999999999999999999875321111 111100 00011000 0
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 336 AAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 336 ~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
......+.+++.+||+.||++||
T Consensus 221 ---~~~~~~~~~~i~~~l~~~p~~R~ 243 (253)
T cd05122 221 ---EKWSDEFKDFLKKCLQKNPEKRP 243 (253)
T ss_pred ---cccCHHHHHHHHHHccCChhhCC
Confidence 01123488999999999999998
No 281
>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI
Probab=100.00 E-value=3.4e-39 Score=288.80 Aligned_cols=199 Identities=28% Similarity=0.372 Sum_probs=170.1
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE 172 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (361)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999975 58999999876432 2234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
|+++++|.++..... .+++..+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07846 81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 155 (286)
T ss_pred cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence 999988888776543 3899999999999999999999 88999999999999999999999999999987643321
Q ss_pred eeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918 253 ETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDE 300 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~ 300 (361)
......++..|+|||+..+ ..++.++||||||+++|||++|++||..
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~ 203 (286)
T cd07846 156 -VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG 203 (286)
T ss_pred -ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence 1223457889999998765 4478899999999999999999999864
No 282
>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of
Probab=100.00 E-value=2.4e-38 Score=279.79 Aligned_cols=245 Identities=26% Similarity=0.319 Sum_probs=198.6
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH-HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE-RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
++|++.+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++.+.+++|+|++++++++...+..+++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999976 589999999876543 4457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS-PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
+++++|.+++.... .+++..++.++.|+++||+||| + .+++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 81 MDGGSLADLLKKVG-KIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 99999999998653 4899999999999999999999 8 99999999999999999999999999999876443321
Q ss_pred eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918 253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 332 (361)
.....++..|+|||...+..++.++|+||||+++|+|+||+.||..... ....+........... .+...
T Consensus 157 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~-----~~~~~- 226 (264)
T cd06623 157 --CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAICDGPPP-----SLPAE- 226 (264)
T ss_pred --ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHHhcCCCC-----CCCcc-
Confidence 1234578899999999888899999999999999999999999976532 1111111111111000 00000
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..+..+.+++.+||+.+|++||
T Consensus 227 -------~~~~~l~~li~~~l~~~p~~R~ 248 (264)
T cd06623 227 -------EFSPEFRDFISACLQKDPKKRP 248 (264)
T ss_pred -------cCCHHHHHHHHHHccCChhhCC
Confidence 0234589999999999999998
No 283
>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the
Probab=100.00 E-value=5.5e-39 Score=288.27 Aligned_cols=200 Identities=25% Similarity=0.360 Sum_probs=170.4
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH-HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE-RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
++|++.+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999965 689999999865432 1223467899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
++ ++|.+++......+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||+++.......
T Consensus 85 ~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-- 158 (291)
T cd07844 85 LD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-- 158 (291)
T ss_pred CC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--
Confidence 97 5999998876556899999999999999999999 88999999999999999999999999999875432211
Q ss_pred eeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 254 TRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
......++..|+|||...+ ..++.++||||+|+++|+|++|+.||...
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1122346788999998765 45789999999999999999999999654
No 284
>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4
Probab=100.00 E-value=6.1e-39 Score=283.65 Aligned_cols=245 Identities=27% Similarity=0.378 Sum_probs=195.3
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH--HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE--RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
+|.+.+.||+|++|.||+|... +++.|++|.+..... ...+.+..|+++++.++|+||+++++.+.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4788899999999999999964 689999999876543 3667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
+++++|.+++.... .+++..+..++.+++.||+||| +.+++|+||+|+||++++++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 99999999998654 3789999999999999999999 8899999999999999999999999999998765433211
Q ss_pred e--eecccccccccCccccCCCC---CCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918 254 T--RTMTMATVGYMAPEYGSEGI---VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL 328 (361)
Q Consensus 254 ~--~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l 328 (361)
. .....++..|+|||++.+.. ++.++||||||+++|+|++|+.||...... ........... .+.+
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~--------~~~~ 227 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQIMFHVGAGH--------KPPI 227 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-HHHHHHHhcCC--------CCCC
Confidence 1 11245788999999987766 889999999999999999999999753211 11111111000 0000
Q ss_pred cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.. .......+.+++.+||+.||++||
T Consensus 228 ~~-------~~~~~~~~~~li~~~l~~~p~~R~ 253 (264)
T cd06626 228 PD-------SLQLSPEGKDFLDRCLESDPKKRP 253 (264)
T ss_pred Cc-------ccccCHHHHHHHHHHccCCcccCC
Confidence 00 011233478899999999999998
No 285
>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun
Probab=100.00 E-value=6.8e-39 Score=286.87 Aligned_cols=240 Identities=25% Similarity=0.327 Sum_probs=192.2
Q ss_pred CCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918 98 FDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPN 176 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (361)
|...+.||+|++|.||++.. .+++.+++|.+........+.+.+|+.+++.++|||++++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457999999999999995 46889999998765545556788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918 177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256 (361)
Q Consensus 177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 256 (361)
++|.+++... .+++..+..++.|++.||+||| +.+++||||+|+||+++.++.++|+|||.+........ ...
T Consensus 101 ~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~ 173 (285)
T cd06648 101 GALTDIVTHT--RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRK 173 (285)
T ss_pred CCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccc
Confidence 9999999873 3899999999999999999999 88999999999999999999999999998876543221 222
Q ss_pred cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918 257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA 336 (361)
Q Consensus 257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~ 336 (361)
...|+..|+|||...+..++.++||||||+++|||++|+.||...... ..........+. .....
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--~~~~~~~~~~~~--------~~~~~----- 238 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--QAMKRIRDNLPP--------KLKNL----- 238 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--HHHHHHHhcCCC--------CCccc-----
Confidence 345889999999998888999999999999999999999998642211 111111111100 00000
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 337 AKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 337 ~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
......+.+++.+||+.||++||
T Consensus 239 --~~~~~~l~~li~~~l~~~p~~Rp 261 (285)
T cd06648 239 --HKVSPRLRSFLDRMLVRDPAQRA 261 (285)
T ss_pred --ccCCHHHHHHHHHHcccChhhCc
Confidence 01223489999999999999998
No 286
>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage
Probab=100.00 E-value=1.9e-38 Score=281.40 Aligned_cols=242 Identities=21% Similarity=0.327 Sum_probs=178.5
Q ss_pred CccccCCceEEEEEEeCCC---cEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCC
Q 037918 102 NLLGKGSFGSVYKGILSDG---AEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNG 177 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 177 (361)
+.||+|+||.||+|...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975433 346677765433 344568899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918 178 SLEKWLYSHN---YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET 254 (361)
Q Consensus 178 ~L~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 254 (361)
+|.+++.... ...++..+..++.|++.||+||| +.+++||||||+|||++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999997542 23567778899999999999999 88999999999999999999999999999864322221122
Q ss_pred eecccccccccCccccCC-------CCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccc
Q 037918 255 RTMTMATVGYMAPEYGSE-------GIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE 326 (361)
Q Consensus 255 ~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 326 (361)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||...... ..+..... +......++
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~----~~~~~~~~~ 232 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-EVLNHVIK----DQQVKLFKP 232 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHh----hcccccCCC
Confidence 233457889999998643 235789999999999999997 56677543221 11111111 111222222
Q ss_pred cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+..... ..+.+++..|| .+|++||
T Consensus 233 ~~~~~~~---------~~~~~l~~~c~-~~P~~Rp 257 (268)
T cd05086 233 QLELPYS---------ERWYEVLQFCW-LSPEKRA 257 (268)
T ss_pred ccCCCCc---------HHHHHHHHHHh-hCcccCC
Confidence 2222221 23677888999 6799998
No 287
>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as
Probab=100.00 E-value=1.7e-38 Score=288.53 Aligned_cols=194 Identities=23% Similarity=0.300 Sum_probs=158.8
Q ss_pred CccccCCceEEEEEEeC---CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeee--cCCeeEEEEEecCC
Q 037918 102 NLLGKGSFGSVYKGILS---DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS--NVDFKALVLEFMPN 176 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~ 176 (361)
.+||+|+||.||+|... ++..||+|.+..... ...+.+|++++++++||||+++++++. .....+++|||++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 57999999999999964 357899998865432 245678999999999999999999884 3567889999985
Q ss_pred CCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE----cCCCcEEEEeccCcc
Q 037918 177 GSLEKWLYSH--------NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL----DENMVAHVSDFGISK 244 (361)
Q Consensus 177 g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~a~ 244 (361)
++|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||++ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 5888877521 224788999999999999999999 8899999999999999 566799999999998
Q ss_pred ccCCCCc-ceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 245 LLGDGEN-FETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 245 ~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
....... ........+|+.|+|||++.+ ..++.++||||||+++|||+||++||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 7644321 112233468899999998766 45799999999999999999999999743
No 288
>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-40 Score=302.64 Aligned_cols=236 Identities=28% Similarity=0.352 Sum_probs=196.2
Q ss_pred CCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 98 FDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
|..++.||.|+||.||-|+. .+.+.||||.+.... ...++++.+|++.|++++|||++.+-|+|..+...+|||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 55667899999999999995 467889999987543 45568899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
| -|+-.|++.-..+++-+..+..|..+.++||+||| +.+.||||||+.|||+++.|.+||+|||.|.....
T Consensus 108 C-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----- 178 (948)
T KOG0577|consen 108 C-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----- 178 (948)
T ss_pred H-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc-----
Confidence 9 67999999877778999999999999999999999 99999999999999999999999999999987643
Q ss_pred eeecccccccccCcccc---CCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918 254 TRTMTMATVGYMAPEYG---SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 330 (361)
....+|||.|||||++ ..+.|+-++||||||++..||.-+++|.-.+.. ...+.+..+..- +.+.
T Consensus 179 -AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-MSALYHIAQNes---------PtLq- 246 (948)
T KOG0577|consen 179 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNES---------PTLQ- 246 (948)
T ss_pred -hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-HHHHHHHHhcCC---------CCCC-
Confidence 3456899999999975 457799999999999999999999999765432 112222211111 1111
Q ss_pred CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..+....+..++..||+.-|.+||
T Consensus 247 -------s~eWS~~F~~Fvd~CLqKipqeRp 270 (948)
T KOG0577|consen 247 -------SNEWSDYFRNFVDSCLQKIPQERP 270 (948)
T ss_pred -------CchhHHHHHHHHHHHHhhCcccCC
Confidence 113445589999999999999998
No 289
>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.
Probab=100.00 E-value=2.5e-38 Score=280.74 Aligned_cols=242 Identities=22% Similarity=0.350 Sum_probs=190.2
Q ss_pred CCCCCCccccCCceEEEEEEeCC--CcEEEEEEeehh----------hHHHHHHHHHHHHHHHh-cCCCceeeeeeeeec
Q 037918 97 GFDECNLLGKGSFGSVYKGILSD--GAEVAIKIFNLQ----------LERAFRSFDSECEVLRS-IRHRNLVKILSSCSN 163 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~ 163 (361)
+|++.+.||+|+||.||+|.... ++.+|+|.+... .......+..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999754 688999987532 22344567788888875 799999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEec
Q 037918 164 VDFKALVLEFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDF 240 (361)
Q Consensus 164 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 240 (361)
.+..+++|||+++++|.+++.. ....+++..++.++.|++.+|.|||+ ..+++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999998853 34458999999999999999999992 258999999999999999999999999
Q ss_pred cCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCc
Q 037918 241 GISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGL 320 (361)
Q Consensus 241 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l 320 (361)
|.+....... ......++..|+|||...+..++.++|+||||+++|+|++|+.||..... ............
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-----~~~~~~~~~~~~ 230 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-----LSLATKIVEAVY 230 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-----HHHHHHHhhccC
Confidence 9998764432 22345688899999999888899999999999999999999999864321 111111110100
Q ss_pred cccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 321 TNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 321 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..... . .....+.+++.+||+.||++||
T Consensus 231 ~~~~~----~---------~~~~~l~~li~~cl~~~p~~Rp 258 (269)
T cd08528 231 EPLPE----G---------MYSEDVTDVITSCLTPDAEARP 258 (269)
T ss_pred CcCCc----c---------cCCHHHHHHHHHHCCCCCccCC
Confidence 00000 0 1123478999999999999998
No 290
>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their
Probab=100.00 E-value=2.3e-38 Score=280.69 Aligned_cols=246 Identities=22% Similarity=0.340 Sum_probs=192.9
Q ss_pred CCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh------HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918 97 GFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL------ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL 169 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (361)
+|+..+.||+|++|.||++.. .+++.+|+|.+.... ....+.+..|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999985 578999999986432 2245678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC-cEEEEeccCccccCC
Q 037918 170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM-VAHVSDFGISKLLGD 248 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~ 248 (361)
||||+++++|.+++...+ .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++ .++|+|||.+.....
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 999999999999997654 4889999999999999999999 88999999999999998776 599999999987643
Q ss_pred CCcc--eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccc
Q 037918 249 GENF--ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE 326 (361)
Q Consensus 249 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 326 (361)
.... .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... ............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~-------- 226 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--NHLALIFKIASA-------- 226 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc--chHHHHHHHhcc--------
Confidence 3111 1112235788999999988888999999999999999999999998643211 111111110000
Q ss_pred cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
......+. .....+.+++.+|+..+|++||
T Consensus 227 ~~~~~~~~-----~~~~~~~~~i~~~l~~~p~~R~ 256 (268)
T cd06630 227 TTAPSIPE-----HLSPGLRDVTLRCLELQPEDRP 256 (268)
T ss_pred CCCCCCch-----hhCHHHHHHHHHHcCCCcccCc
Confidence 00000110 1233478899999999999998
No 291
>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re
Probab=100.00 E-value=1.5e-38 Score=281.58 Aligned_cols=202 Identities=28% Similarity=0.384 Sum_probs=171.6
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh-----hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecC--Cee
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ-----LERAFRSFDSECEVLRSIRHRNLVKILSSCSNV--DFK 167 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 167 (361)
.+|++.+.||+|+||.||+|... +|+.||+|.+... .....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57888999999999999999964 5899999987532 123456788999999999999999999988663 467
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918 168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG 247 (361)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 247 (361)
+++|||+++++|.+++..... +++.....++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGA-LTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 899999999999999976543 788999999999999999999 8899999999999999999999999999988653
Q ss_pred CCCc-ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 248 DGEN-FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 248 ~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
.... ........++..|+|||...+..++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 2211 11122345888999999988888999999999999999999999998753
No 292
>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6. Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs
Probab=100.00 E-value=1.5e-38 Score=284.27 Aligned_cols=242 Identities=26% Similarity=0.342 Sum_probs=185.5
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHH-HHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEV-LRSIRHRNLVKILSSCSNVDFKALVLE 172 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (361)
++|++.+.||+|+||.||++... +|+.||+|+++... ......+..|+.. ++.++||||+++++++...+..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999965 69999999987543 2223445556665 566789999999999999999999999
Q ss_pred ecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918 173 FMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSP-SVVHCDLKPSNILLDENMVAHVSDFGISKLLGD 248 (361)
Q Consensus 173 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 248 (361)
|++ ++|.+++.. ....+++..++.++.|++.||+||| +. +++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 995 688888764 2345899999999999999999999 76 999999999999999999999999999986543
Q ss_pred CCcceeeecccccccccCccccCC----CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccc
Q 037918 249 GENFETRTMTMATVGYMAPEYGSE----GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVV 324 (361)
Q Consensus 249 ~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~ 324 (361)
.. ..+...++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.........+...... ....+.
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~ 229 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE----PSPQLP 229 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc----CCCCCC
Confidence 21 1223457889999998754 446889999999999999999999986432211111111110 000000
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 325 DENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 325 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.. ..+..+.+++.+||..+|++||
T Consensus 230 ~~-------------~~~~~l~~li~~~l~~~p~~Rp 253 (283)
T cd06617 230 AE-------------KFSPEFQDFVNKCLKKNYKERP 253 (283)
T ss_pred cc-------------ccCHHHHHHHHHHccCChhhCc
Confidence 00 1233478999999999999998
No 293
>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins. Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily
Probab=100.00 E-value=1.2e-38 Score=288.27 Aligned_cols=238 Identities=27% Similarity=0.324 Sum_probs=189.6
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
..|...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999965 68999999886432 334467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
||++ |+|.+++......+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 9996 6888887755556899999999999999999999 889999999999999999999999999998765322
Q ss_pred ceeeecccccccccCccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918 252 FETRTMTMATVGYMAPEYGS---EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL 328 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l 328 (361)
....++..|+|||.+. ...++.++||||||+++|||+||+.||....... .........+ . .+
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--~~~~~~~~~~---~-----~~ 234 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIAQNDS---P-----TL 234 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--HHHHHhcCCC---C-----CC
Confidence 2235788899999863 4568899999999999999999999986532111 0000000000 0 00
Q ss_pred cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
. ...+...+.+++.+||+.||++||
T Consensus 235 ---~-----~~~~~~~~~~li~~~l~~~p~~Rp 259 (307)
T cd06607 235 ---S-----SNDWSDYFRNFVDSCLQKIPQDRP 259 (307)
T ss_pred ---C-----chhhCHHHHHHHHHHhcCChhhCc
Confidence 0 012334589999999999999998
No 294
>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent
Probab=100.00 E-value=8.7e-39 Score=284.87 Aligned_cols=240 Identities=25% Similarity=0.382 Sum_probs=191.6
Q ss_pred CCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcC---CCceeeeeeeeecCCeeEEEE
Q 037918 97 GFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIR---HRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~ 171 (361)
.|+..+.||+|+||.||+|.. .+++.+|+|.+.... ......+.+|+.++++++ |||++++++++.+....+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999996 468999999986542 334467888999999996 999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
||+++++|.+++... .+++..++.++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 999999999998764 4899999999999999999999 88999999999999999999999999999987654331
Q ss_pred ceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918 252 FETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 330 (361)
......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||...... ..... . .....+.+..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~-~----~~~~~~~~~~ 224 (277)
T cd06917 157 --KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMML-I----PKSKPPRLED 224 (277)
T ss_pred --ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhc-c----ccCCCCCCCc
Confidence 2233468889999998765 44688999999999999999999999753211 11100 0 0000011111
Q ss_pred CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
. ..+..+.+++.+||+.||++||
T Consensus 225 ~--------~~~~~~~~~i~~~l~~~p~~R~ 247 (277)
T cd06917 225 N--------GYSKLLREFVAACLDEEPKERL 247 (277)
T ss_pred c--------cCCHHHHHHHHHHcCCCcccCc
Confidence 0 0233478999999999999998
No 295
>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=3.4e-38 Score=282.60 Aligned_cols=248 Identities=25% Similarity=0.259 Sum_probs=192.5
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC--CeeEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV--DFKALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 171 (361)
++|...+.||.|++|.||++... +++.+|+|.+.... ......+.+|++++++++||||+++++++.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36778899999999999999974 68899999987543 23456788999999999999999999988553 4689999
Q ss_pred EecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918 172 EFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD 248 (361)
Q Consensus 172 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 248 (361)
||+++++|.+++.. ....++...+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999998753 3344789999999999999999999 88999999999999999999999999999876533
Q ss_pred CCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccc---cccHHHHHhhhcCCCcccccc
Q 037918 249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAG---EMSLKNWVKESLPHGLTNVVD 325 (361)
Q Consensus 249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~l~~~~~ 325 (361)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ......+........+.
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 229 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK---- 229 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhc----
Confidence 21 12335788899999998888999999999999999999999999754221 11222222111100000
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 326 ENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 326 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
...... ......+.+++.+||+.||++||
T Consensus 230 ----~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp 258 (287)
T cd06621 230 ----DEPGNG---IKWSEEFKDFIKQCLEKDPTRRP 258 (287)
T ss_pred ----cCCCCC---CchHHHHHHHHHHHcCCCcccCC
Confidence 000000 01234578999999999999998
No 296
>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi
Probab=100.00 E-value=2.5e-38 Score=282.27 Aligned_cols=234 Identities=24% Similarity=0.283 Sum_probs=179.0
Q ss_pred ccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHH---HhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918 103 LLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVL---RSIRHRNLVKILSSCSNVDFKALVLEFMP 175 (361)
Q Consensus 103 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 175 (361)
.||+|+||.||++... +++.+|+|.+.... ......+.+|..++ ...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 68999999886432 11122334444333 33479999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee
Q 037918 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR 255 (361)
Q Consensus 176 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 255 (361)
+++|.+++..++. +++..+..++.|++.||+||| +.+++|+||||+||++++++.++|+|||++....... .
T Consensus 81 ~~~L~~~i~~~~~-l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~ 152 (279)
T cd05633 81 GGDLHYHLSQHGV-FSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 152 (279)
T ss_pred CCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----c
Confidence 9999999876544 899999999999999999999 8899999999999999999999999999987653321 1
Q ss_pred ecccccccccCccccC-CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918 256 TMTMATVGYMAPEYGS-EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334 (361)
Q Consensus 256 ~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 334 (361)
....|+..|+|||... +..++.++|+||||+++|+|++|..||......... ....... .....+..
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~-----~~~~~~~~---- 220 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTL-----TVNVELPD---- 220 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH---HHHHHhh-----cCCcCCcc----
Confidence 2346899999999876 456889999999999999999999999754322211 1111000 00001111
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 335 FAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||+.||++||
T Consensus 221 -----~~~~~~~~li~~~l~~~p~~R~ 242 (279)
T cd05633 221 -----SFSPELKSLLEGLLQRDVSKRL 242 (279)
T ss_pred -----ccCHHHHHHHHHHhcCCHHHhc
Confidence 1233478999999999999997
No 297
>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int
Probab=100.00 E-value=2.4e-38 Score=282.18 Aligned_cols=239 Identities=27% Similarity=0.374 Sum_probs=192.3
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
-|+..+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.++++++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3677889999999999999864 68899999886433 344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918 175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET 254 (361)
Q Consensus 175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 254 (361)
++++|.+++... .+++..+..++.|++.++.||| +.+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 85 ~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~ 157 (277)
T cd06641 85 GGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--K 157 (277)
T ss_pred CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh--h
Confidence 999999998754 3899999999999999999999 89999999999999999999999999999876643221 1
Q ss_pred eecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918 255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334 (361)
Q Consensus 255 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 334 (361)
.....++..|+|||...+..++.++|+||||+++|+|++|..||....... ........ . . +.+..
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~---~-~----~~~~~---- 223 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--VLFLIPKN---N-P----PTLEG---- 223 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--HHHHHhcC---C-C----CCCCc----
Confidence 223457888999999888888999999999999999999999987532211 11111100 0 0 00111
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 335 FAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..+..+.+++.+||+.+|++||
T Consensus 224 -----~~~~~~~~~i~~~l~~~p~~Rp 245 (277)
T cd06641 224 -----NYSKPLKEFVEACLNKEPSFRP 245 (277)
T ss_pred -----ccCHHHHHHHHHHccCChhhCc
Confidence 1233478999999999999998
No 298
>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi
Probab=100.00 E-value=4.5e-38 Score=277.95 Aligned_cols=244 Identities=25% Similarity=0.369 Sum_probs=193.7
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeec--CCeeEEEE
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSN--VDFKALVL 171 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 171 (361)
+|++.+.||.|+||.||++... +++.+|+|.+... .....+.+..|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999854 6889999988643 23445678899999999999999999998753 45678999
Q ss_pred EecCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918 172 EFMPNGSLEKWLYSH---NYFLDIQERLNVMIDVGSALEYLHHGY--SPSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246 (361)
Q Consensus 172 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 246 (361)
||+++++|.+++... ...+++..++.++.|++.||+|||..+ +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999753 345899999999999999999999543 568999999999999999999999999999877
Q ss_pred CCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccc
Q 037918 247 GDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE 326 (361)
Q Consensus 247 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 326 (361)
..... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ..+.+...... . +
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~---~-----~ 228 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLASKIKEGK---F-----R 228 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HHHHHHHhcCC---C-----C
Confidence 54332 12234688999999999888899999999999999999999999975431 11111111110 0 0
Q ss_pred cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+.. .....+.+++.+|++.+|++||
T Consensus 229 ~~~~---------~~~~~~~~l~~~~l~~~p~~Rp 254 (265)
T cd08217 229 RIPY---------RYSSELNEVIKSMLNVDPDKRP 254 (265)
T ss_pred CCcc---------ccCHHHHHHHHHHccCCcccCC
Confidence 0110 1233578999999999999998
No 299
>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with
Probab=100.00 E-value=4e-38 Score=277.14 Aligned_cols=240 Identities=25% Similarity=0.414 Sum_probs=192.9
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
+|+..+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|++++++++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999964 68899999987542 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC-CcEEEEeccCccccCCCCc
Q 037918 174 MPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN-MVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 174 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~~~~ 251 (361)
+++++|.+++... ...+++..+..++.+++.+|+||| +.+++|+||+|+||+++++ +.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999999864 344899999999999999999999 8899999999999999854 4689999999987654321
Q ss_pred ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918 252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .............+.+
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~------ 223 (256)
T cd08220 158 ---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-----ALVLKIMSGTFAPISD------ 223 (256)
T ss_pred ---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-----HHHHHHHhcCCCCCCC------
Confidence 12345788999999998888899999999999999999999998653221 1111111000000000
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||+.||++||
T Consensus 224 --------~~~~~l~~li~~~l~~~p~~Rp 245 (256)
T cd08220 224 --------RYSPDLRQLILSMLNLDPSKRP 245 (256)
T ss_pred --------CcCHHHHHHHHHHccCChhhCC
Confidence 1233478999999999999998
No 300
>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional
Probab=100.00 E-value=7e-38 Score=277.61 Aligned_cols=243 Identities=22% Similarity=0.279 Sum_probs=189.6
Q ss_pred HHHHHHhhCCCCCCCcc--ccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeec
Q 037918 88 YLEIQRATNGFDECNLL--GKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSN 163 (361)
Q Consensus 88 ~~~~~~~~~~~~~~~~l--g~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 163 (361)
..+.....++|++.+.+ |+|+||.||++... ++..+|+|.+....... .|......+ +|||++++++.+..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec
Confidence 34455556778887777 99999999999964 68889999987542111 122222222 79999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC-cEEEEeccC
Q 037918 164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM-VAHVSDFGI 242 (361)
Q Consensus 164 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~ 242 (361)
.+..++||||+++++|.+++..+. .+++..+..++.|+++||.||| +.+++||||+|+||+++.++ .++|+|||+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 999999999999999999998764 5899999999999999999999 88999999999999999988 999999999
Q ss_pred ccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccc
Q 037918 243 SKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTN 322 (361)
Q Consensus 243 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~ 322 (361)
+...... ....++..|+|||++.+..++.++||||||+++|||++|+.||............+.... .... .
T Consensus 157 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~-~ 228 (267)
T PHA03390 157 CKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKL-P 228 (267)
T ss_pred ceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccC-C
Confidence 8766432 123578899999999888899999999999999999999999985443333333332211 1000 0
Q ss_pred cccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 323 VVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 323 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
. .. .....+.+++.+||+.||.+||
T Consensus 229 ~----~~----------~~~~~~~~li~~~l~~~p~~R~ 253 (267)
T PHA03390 229 F----IK----------NVSKNANDFVQSMLKYNINYRL 253 (267)
T ss_pred c----cc----------ccCHHHHHHHHHHhccChhhCC
Confidence 0 00 1233478999999999999997
No 301
>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the
Probab=100.00 E-value=2.4e-38 Score=284.39 Aligned_cols=200 Identities=25% Similarity=0.343 Sum_probs=170.7
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH--HHHHHHHHHHHHHHhcCCCceeeeeeeeecC--CeeEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE--RAFRSFDSECEVLRSIRHRNLVKILSSCSNV--DFKALV 170 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv 170 (361)
++|++.+.||.|++|.||+|... +++.+++|.++.... .....+.+|+.++.+++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888999999999999999975 588999999875432 2223567899999999999999999998777 889999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918 171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE 250 (361)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 250 (361)
|||++ ++|.+++......+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99996 5999998876556899999999999999999999 8899999999999999999999999999998765432
Q ss_pred cceeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 251 NFETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 251 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
. ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...
T Consensus 161 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 161 K--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred c--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 12234578889999987654 4688999999999999999999999753
No 302
>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK
Probab=100.00 E-value=5.4e-38 Score=276.26 Aligned_cols=244 Identities=29% Similarity=0.375 Sum_probs=197.5
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC--CeeEEEE
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV--DFKALVL 171 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 171 (361)
+|...+.||+|++|.||+|... +++.|++|++.... ....+.+.+|++++++++||||+++++.+... +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777889999999999999976 68999999987654 24567889999999999999999999999888 8899999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
||+++++|.+++.+.. .+++..++.++.|++.+|+||| +.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999998765 5899999999999999999999 88999999999999999999999999999987755432
Q ss_pred ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918 252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
........++..|+|||...+...+.++||||||+++|+|++|..||............. ........
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~--------- 224 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKI---GSSGEPPE--------- 224 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhc---cccCCCcC---------
Confidence 111234568889999999888889999999999999999999999997643111000000 00000000
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+. .....+.+++.+|++.||++||
T Consensus 225 ~~~-----~~~~~l~~~i~~~l~~~p~~Rp 249 (260)
T cd06606 225 IPE-----HLSEEAKDFLRKCLRRDPKKRP 249 (260)
T ss_pred CCc-----ccCHHHHHHHHHhCcCChhhCC
Confidence 000 1134589999999999999998
No 303
>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi
Probab=100.00 E-value=4.8e-38 Score=277.82 Aligned_cols=235 Identities=27% Similarity=0.313 Sum_probs=189.4
Q ss_pred cccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCH
Q 037918 104 LGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSL 179 (361)
Q Consensus 104 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 179 (361)
||.|++|.||++... +++.+|+|++.... ....+.+.+|+.+++.++||||+++++.+.+++..+++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 48999999987543 23446788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeeccc
Q 037918 180 EKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM 259 (361)
Q Consensus 180 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 259 (361)
.+++..... +++..+..++.|+++||+||| +.+++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~~-l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~ 153 (262)
T cd05572 81 WTILRDRGL-FDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC 153 (262)
T ss_pred HHHHhhcCC-CCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence 999986543 889999999999999999999 8999999999999999999999999999998765432 122345
Q ss_pred ccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHH
Q 037918 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKM 339 (361)
Q Consensus 260 g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 339 (361)
++..|+|||.+.+..++.++|+||||+++|+|++|..||.....+. .+...... ........+.
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~--------~~~~~~~~~~----- 217 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYNDIL--------KGNGKLEFPN----- 217 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHHHHHHh--------ccCCCCCCCc-----
Confidence 7889999999888889999999999999999999999997643211 11111111 0000001111
Q ss_pred HHHHHHHHHHhhcCCCCCCCCC
Q 037918 340 DCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 340 ~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||+.||++||
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~ 239 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERL 239 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCc
Confidence 1133489999999999999997
No 304
>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning
Probab=100.00 E-value=2.7e-38 Score=283.20 Aligned_cols=201 Identities=28% Similarity=0.339 Sum_probs=172.1
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE 172 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (361)
++|++.+.||+|++|.||+|... +++.||+|.++... ....+.+.+|++++++++|+||+++++++...+..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999975 58899999886532 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
|++++.+..+.... ..+++..+..++.|++.||+||| ..+++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~- 155 (288)
T cd07833 81 YVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA- 155 (288)
T ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence 99886666655443 44899999999999999999999 88999999999999999999999999999987654332
Q ss_pred eeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 253 ETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
.......++..|+|||++.+. .++.++|+||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 112234578889999998877 7899999999999999999999998753
No 305
>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex
Probab=100.00 E-value=3.4e-38 Score=282.12 Aligned_cols=198 Identities=28% Similarity=0.415 Sum_probs=168.5
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
+|+..+.||.|++|.||+|... +|+.||||.+.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999965 68999999886543 22235688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 174 MPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 174 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
+. ++|.+++... ...+++..+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 95 6899988753 345899999999999999999999 88999999999999999999999999999876543221
Q ss_pred eeeecccccccccCccccCCCC-CCcccchHHHHHHHHHHHhCCCCCCc
Q 037918 253 ETRTMTMATVGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFTRKKPTDE 300 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~il~elltg~~p~~~ 300 (361)
......++..|+|||...+.. ++.++||||||+++|||+||+.||..
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~ 203 (284)
T cd07860 156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 203 (284)
T ss_pred -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 122334688899999876544 68899999999999999999999865
No 306
>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-39 Score=287.94 Aligned_cols=245 Identities=27% Similarity=0.342 Sum_probs=199.0
Q ss_pred hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV 170 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (361)
.+.|..-++||+|+||.||-+... +|+.+|.|.+.+.. ........+|-.+|++++.+.||.+--.|++.+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 356778889999999999999854 69999999886543 22334577899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918 171 LEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249 (361)
Q Consensus 171 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 249 (361)
+..|+||+|.-+|.+.+ ..+++..++.++.+|+.||++|| ..+||+||+||+|||+|+.|+++|+|+|+|..+...
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999999998654 34899999999999999999999 889999999999999999999999999999988665
Q ss_pred CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL 329 (361)
Q Consensus 250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 329 (361)
.. ....+||.+|||||++.+..|+...|.|||||+||||+.|+.||....... . .+-+|++..
T Consensus 341 ~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv-k-------------~eEvdrr~~ 403 (591)
T KOG0986|consen 341 KP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV-K-------------REEVDRRTL 403 (591)
T ss_pred Cc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh-h-------------HHHHHHHHh
Confidence 43 334489999999999999999999999999999999999999997642211 0 111222222
Q ss_pred CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+..... .....+..+|....|..||++|.
T Consensus 404 ~~~~ey~--~kFS~eakslc~~LL~Kdp~~RL 433 (591)
T KOG0986|consen 404 EDPEEYS--DKFSEEAKSLCEGLLTKDPEKRL 433 (591)
T ss_pred cchhhcc--cccCHHHHHHHHHHHccCHHHhc
Confidence 2211111 12233467888899999999984
No 307
>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They
Probab=100.00 E-value=7.1e-38 Score=279.66 Aligned_cols=256 Identities=24% Similarity=0.306 Sum_probs=194.9
Q ss_pred CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH--HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918 98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE--RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
|++.+.||+|++|.||++... +++.+++|.+..... .....+..|++++++++|+||+++++++...+..+++|||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999964 688999999875432 23467888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918 175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET 254 (361)
Q Consensus 175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 254 (361)
++ +|.+++......+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--P 154 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--c
Confidence 64 999988876556899999999999999999999 88999999999999999999999999999987754331 1
Q ss_pred eecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcC----CCcccccc----
Q 037918 255 RTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLP----HGLTNVVD---- 325 (361)
Q Consensus 255 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~l~~~~~---- 325 (361)
.....++..|+|||.+.+. .++.++|+||||+++|+|+||+.||......+ ........+. ..+....+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID--QLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCchHhcccchhhhhh
Confidence 2234578889999987766 78999999999999999999999986533211 1111111111 11111111
Q ss_pred --cccc--CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 326 --ENLL--LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 326 --~~l~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.... ..........+....+.+++.+||+.||.+||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp 272 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI 272 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCc
Confidence 0000 00000111223456789999999999999998
No 308
>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.3e-38 Score=285.18 Aligned_cols=241 Identities=23% Similarity=0.339 Sum_probs=201.0
Q ss_pred hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
.+-|+..+.||+|.|..|-+|++ -+|..||||++.+.. .-....+.+|++.|+.++|||||++|++......+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 35588889999999999999984 489999999998654 223356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE-cCCCcEEEEeccCccccCCCC
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL-DENMVAHVSDFGISKLLGDGE 250 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfg~a~~~~~~~ 250 (361)
|.-.+|+|.+|+.++...+.+....+++.||+.|+.|+| +..+|||||||+||.+ ..-|-+||+|||++-.+....
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 999999999999988888999999999999999999999 8899999999999876 567899999999998876655
Q ss_pred cceeeecccccccccCccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918 251 NFETRTMTMATVGYMAPEYGSEGIV-SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL 329 (361)
Q Consensus 251 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 329 (361)
.. +..+|+..|-|||++.+..| .++.||||||+|||.|+.|++||+...+.+ -+.-++|..+.
T Consensus 174 kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-------------TLTmImDCKYt 237 (864)
T KOG4717|consen 174 KL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-------------TLTMIMDCKYT 237 (864)
T ss_pred hh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-------------hhhhhhccccc
Confidence 43 34579999999999888776 468999999999999999999998654322 22344444443
Q ss_pred CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
... -...+..+||.+||..||.+|.
T Consensus 238 vPs-------hvS~eCrdLI~sMLvRdPkkRA 262 (864)
T KOG4717|consen 238 VPS-------HVSKECRDLIQSMLVRDPKKRA 262 (864)
T ss_pred Cch-------hhhHHHHHHHHHHHhcCchhhc
Confidence 222 1123358999999999999983
No 309
>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of
Probab=100.00 E-value=7.3e-38 Score=279.02 Aligned_cols=236 Identities=23% Similarity=0.287 Sum_probs=186.5
Q ss_pred cccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCH
Q 037918 104 LGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSL 179 (361)
Q Consensus 104 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 179 (361)
||+|+||+||++... +|+.+|+|.+.... ......+..|++++++++|||++++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 68999999987543 22344567899999999999999999999999999999999999999
Q ss_pred HHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecc
Q 037918 180 EKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258 (361)
Q Consensus 180 ~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 258 (361)
.+++.... ..+++..+..++.|++.||.||| +.+++||||+|+||++++++.++|+|||.+....... .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccc
Confidence 99997654 34899999999999999999999 8899999999999999999999999999987654321 12234
Q ss_pred cccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHH
Q 037918 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAK 338 (361)
Q Consensus 259 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~ 338 (361)
.++..|+|||...+..++.++|+||||+++|+|++|+.||...... ...... ....... ......
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~-~~~~~~~-----~~~~~~-------- 219 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-VEKEEL-KRRTLEM-----AVEYPD-------- 219 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-ccHHHH-Hhccccc-----cccCCc--------
Confidence 5788899999988888999999999999999999999999654321 111111 1110000 000000
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCC
Q 037918 339 MDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 339 ~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||+.||++||
T Consensus 220 -~~~~~~~~li~~~l~~~p~~R~ 241 (277)
T cd05577 220 -KFSPEAKDLCEALLQKDPEKRL 241 (277)
T ss_pred -cCCHHHHHHHHHHccCChhHcc
Confidence 1123478999999999999997
No 310
>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3. Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac
Probab=100.00 E-value=3.4e-38 Score=280.41 Aligned_cols=242 Identities=28% Similarity=0.498 Sum_probs=187.2
Q ss_pred CCCCCccccCCceEEEEEEeC----CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC------
Q 037918 98 FDECNLLGKGSFGSVYKGILS----DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD------ 165 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 165 (361)
|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999853 36889999987542 344567889999999999999999999885432
Q ss_pred eeEEEEEecCCCCHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEec
Q 037918 166 FKALVLEFMPNGSLEKWLYSH-----NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDF 240 (361)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 240 (361)
..++++||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 247889999999999887532 224788999999999999999999 889999999999999999999999999
Q ss_pred cCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCC
Q 037918 241 GISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHG 319 (361)
Q Consensus 241 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (361)
|+++...............++..|++||.+.+..++.++||||||+++|||++ |++||..... .....+..... .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~--~ 233 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIKGN--R 233 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHcCC--c
Confidence 99987644332222223345678999999988889999999999999999999 8899865322 12222211100 0
Q ss_pred ccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 320 LTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 320 l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+.. .+ ..+..+.+++.+||+.+|++||
T Consensus 234 --------~~~-~~------~~~~~~~~l~~~~l~~~p~~Rp 260 (273)
T cd05074 234 --------LKQ-PP------DCLEDVYELMCQCWSPEPKCRP 260 (273)
T ss_pred --------CCC-CC------CCCHHHHHHHHHHcCCChhhCc
Confidence 000 00 1233589999999999999998
No 311
>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the
Probab=100.00 E-value=6e-38 Score=284.75 Aligned_cols=202 Identities=24% Similarity=0.343 Sum_probs=168.3
Q ss_pred CCCCCCccccCCceEEEEEEeC---CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC--CeeE
Q 037918 97 GFDECNLLGKGSFGSVYKGILS---DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV--DFKA 168 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 168 (361)
+|++.+.||+|++|.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778899999999999999964 47899999998632 33345678899999999999999999999888 8899
Q ss_pred EEEEecCCCCHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC----CCcEEEEec
Q 037918 169 LVLEFMPNGSLEKWLYSH----NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE----NMVAHVSDF 240 (361)
Q Consensus 169 lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Df 240 (361)
+||||++ ++|.+++... ...+++..++.++.|++.||+||| +.+++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999996 4777776532 225789999999999999999999 889999999999999999 999999999
Q ss_pred cCccccCCCCc-ceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccc
Q 037918 241 GISKLLGDGEN-FETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFF 302 (361)
Q Consensus 241 g~a~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~ 302 (361)
|++........ ........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 99987644322 112223457889999997665 457899999999999999999999997543
No 312
>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase. Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.
Probab=100.00 E-value=8.4e-38 Score=279.14 Aligned_cols=254 Identities=21% Similarity=0.272 Sum_probs=187.4
Q ss_pred CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcC-CCceeeeeeeeecC--CeeEEEEE
Q 037918 98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIR-HRNLVKILSSCSNV--DFKALVLE 172 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e 172 (361)
|++.+.||+|+||.||+|... +++.+|+|.++... ........+|+..+.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567789999999999999964 68899999887542 112233457888888885 99999999999887 88999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
|++ ++|.+++......+++..++.++.|++.||+||| +.+++||||+|+||+++. +.+||+|||++.........
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 996 5888888765556899999999999999999999 889999999999999999 99999999999876433221
Q ss_pred eeeecccccccccCccccC-CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccc---cccc-
Q 037918 253 ETRTMTMATVGYMAPEYGS-EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNV---VDEN- 327 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~- 327 (361)
....++..|+|||... +..++.++|||||||++|||++|..||...... ....+...........+ ....
T Consensus 156 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 156 ---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL--DQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred ---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH--HHHHHHHHHcCCCCHHHHHhhcccc
Confidence 2235788999999654 455788999999999999999999999753221 11111111110000000 0000
Q ss_pred -ccCCchh------HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 328 -LLLEEPA------FAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 328 -l~~~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+. .......+..+.+++.+||+.||++||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 271 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERI 271 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCccccc
Confidence 0000000 001123356689999999999999998
No 313
>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo
Probab=100.00 E-value=2.4e-38 Score=284.20 Aligned_cols=236 Identities=25% Similarity=0.344 Sum_probs=189.9
Q ss_pred CccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCHH
Q 037918 102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLE 180 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 180 (361)
..||+|+||.||++... +++.||+|.+..........+.+|+.+++.++|+|++++++.+...+..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999864 68999999986555455567889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecccc
Q 037918 181 KWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA 260 (361)
Q Consensus 181 ~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 260 (361)
+++.... +++..+..++.|++.+|+||| +.+++|+||+|+||+++.++.++|+|||++........ ......+
T Consensus 106 ~~~~~~~--~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~ 178 (292)
T cd06657 106 DIVTHTR--MNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVG 178 (292)
T ss_pred HHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccccc
Confidence 9886543 789999999999999999999 88999999999999999999999999999876543221 2233457
Q ss_pred cccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHH
Q 037918 261 TVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMD 340 (361)
Q Consensus 261 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~ 340 (361)
+..|+|||...+..++.++|+||||+++|+|++|..||..... ...........+..+... . .
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~-----~----------~ 241 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPPKLKNL-----H----------K 241 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhCCcccCCc-----c----------c
Confidence 8899999998888889999999999999999999999864321 111111222222111110 0 1
Q ss_pred HHHHHHHHHhhcCCCCCCCCC
Q 037918 341 CMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 341 ~~~~l~~l~~~cl~~dP~~RP 361 (361)
....+.+++.+||+.||.+||
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~ 262 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRA 262 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCc
Confidence 123468899999999999997
No 314
>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1. Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron
Probab=100.00 E-value=1.8e-37 Score=281.92 Aligned_cols=236 Identities=28% Similarity=0.354 Sum_probs=188.1
Q ss_pred CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh---hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ---LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
|...+.||+|+||.||++... ++..+|+|.+... .......+.+|++++++++|||++++++++.+.+..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 667789999999999999964 6889999998643 234456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
++ |+|.+++......+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 96 5888888765566899999999999999999999 889999999999999999999999999998754321
Q ss_pred eeecccccccccCcccc---CCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918 254 TRTMTMATVGYMAPEYG---SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 330 (361)
....++..|+|||++ ..+.++.++||||||+++|||++|+.||...... .....+.....+ . .
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~~~~----~-----~-- 244 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESP----T-----L-- 244 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhccCC----C-----C--
Confidence 233578899999986 3456889999999999999999999998653211 111111111100 0 0
Q ss_pred CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.. ......+.+++.+||+.+|.+||
T Consensus 245 -~~-----~~~~~~l~~li~~~l~~~p~~Rp 269 (317)
T cd06635 245 -QS-----NEWSDYFRNFVDSCLQKIPQDRP 269 (317)
T ss_pred -CC-----ccccHHHHHHHHHHccCCcccCc
Confidence 00 01223478999999999999998
No 315
>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re
Probab=100.00 E-value=3.3e-38 Score=278.83 Aligned_cols=236 Identities=26% Similarity=0.329 Sum_probs=188.8
Q ss_pred cccCCceEEEEEEeC-CCcEEEEEEeehhhH---HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCH
Q 037918 104 LGKGSFGSVYKGILS-DGAEVAIKIFNLQLE---RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSL 179 (361)
Q Consensus 104 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 179 (361)
||+|+||.||++... +|+.+++|.+..... ...+.+.+|++++++++||||+++++.+...+..+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 489999999875432 4456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc------ce
Q 037918 180 EKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN------FE 253 (361)
Q Consensus 180 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~------~~ 253 (361)
.+++...+ .+++..+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99998655 4899999999999999999999 88999999999999999999999999999876533211 01
Q ss_pred eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP 333 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 333 (361)
......++..|+|||...+...+.++||||||+++|+|++|..||......+ ........... .+
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~----------~~ 221 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-----IFQNILNGKIE----------WP 221 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHhcCCcC----------CC
Confidence 2233457888999999888888999999999999999999999997543211 11111100000 00
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 334 AFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.. ......+.+++.+||+.+|++||
T Consensus 222 ~~---~~~~~~~~~~i~~~l~~~p~~Rp 246 (265)
T cd05579 222 ED---VEVSDEAIDLISKLLVPDPEKRL 246 (265)
T ss_pred cc---ccCCHHHHHHHHHHhcCCHhhcC
Confidence 00 00133478999999999999998
No 316
>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85. Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.
Probab=100.00 E-value=8.8e-38 Score=279.35 Aligned_cols=199 Identities=26% Similarity=0.412 Sum_probs=169.6
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH-HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE-RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
+|++.+.||.|++|.||+|+.. +|+.||+|.+..... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788999999999999999975 688999999875432 22356778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 175 PNGSLEKWLYSHN--YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 175 ~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
+ ++|.+++.... ..+++..+..++.|++.||+||| +.+++||||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 7 48999887543 45899999999999999999999 88999999999999999999999999999976543221
Q ss_pred eeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 253 ETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 204 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT 204 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1223356888999998755 45788999999999999999999999754
No 317
>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl
Probab=100.00 E-value=7.8e-38 Score=283.16 Aligned_cols=203 Identities=24% Similarity=0.362 Sum_probs=167.9
Q ss_pred hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC------
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD------ 165 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 165 (361)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 356899999999999999999965 68999999886432 122234567999999999999999999986654
Q ss_pred --eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCc
Q 037918 166 --FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGIS 243 (361)
Q Consensus 166 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 243 (361)
..++||||+. ++|.+++......+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 4599999995 5898888766556899999999999999999999 889999999999999999999999999999
Q ss_pred cccCCCCcc--eeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 244 KLLGDGENF--ETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 244 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
......... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 876432221 111234578889999987654 4788999999999999999999998653
No 318
>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do
Probab=100.00 E-value=6.6e-38 Score=276.59 Aligned_cols=234 Identities=21% Similarity=0.293 Sum_probs=181.9
Q ss_pred CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHH-HhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918 102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVL-RSIRHRNLVKILSSCSNVDFKALVLEFMPN 176 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (361)
+.||+|++|.||+|... +|+.||+|.+.... ......+..|..++ ...+|+|++++++++...+..+++|||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999964 68999999986542 12223344555444 445899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918 177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256 (361)
Q Consensus 177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 256 (361)
++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..... ..
T Consensus 82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~ 151 (260)
T cd05611 82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK 151 (260)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence 99999997654 3899999999999999999999 88999999999999999999999999999876432 12
Q ss_pred cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918 257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA 336 (361)
Q Consensus 257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~ 336 (361)
...++..|+|||...+..++.++||||||+++|+|++|..||........ ......... .... ...
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~--~~~~----~~~------- 217 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-FDNILSRRI--NWPE----EVK------- 217 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhccc--CCCC----ccc-------
Confidence 33578899999998888889999999999999999999999975322110 111100000 0000 000
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 337 AKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 337 ~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..+...+.+++.+||+.||++||
T Consensus 218 --~~~~~~~~~~i~~~l~~~p~~R~ 240 (260)
T cd05611 218 --EFCSPEAVDLINRLLCMDPAKRL 240 (260)
T ss_pred --ccCCHHHHHHHHHHccCCHHHcc
Confidence 01234589999999999999997
No 319
>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4. Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates
Probab=100.00 E-value=1.4e-37 Score=278.69 Aligned_cols=245 Identities=25% Similarity=0.306 Sum_probs=185.9
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcC-CCceeeeeeeeecCCeeEEEEEe
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIR-HRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
+|...+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556678999999999999964 68999999987543 234467889999999996 99999999999999999999999
Q ss_pred cCCCCHHHHHh---c-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918 174 MPNGSLEKWLY---S-HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249 (361)
Q Consensus 174 ~~~g~L~~~l~---~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 249 (361)
+. ++|.++.. . ....+++..+..++.+++.||+|||+ ..+++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 85 46655432 1 23458999999999999999999993 248999999999999999999999999999765432
Q ss_pred CcceeeecccccccccCccccCCC---CCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccc
Q 037918 250 ENFETRTMTMATVGYMAPEYGSEG---IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE 326 (361)
Q Consensus 250 ~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 326 (361)
. ......++..|+|||.+.+. .++.++||||||+++|||++|+.||.... .............. +
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~~~-----~ 229 (288)
T cd06616 162 I---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQVVKGDP-----P 229 (288)
T ss_pred C---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhhcCCCC-----C
Confidence 2 11233578899999988765 68999999999999999999999987532 11111111111110 0
Q ss_pred cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+....+ ......+.+++.+||+.||++||
T Consensus 230 ~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rp 259 (288)
T cd06616 230 ILSNSEE-----REFSPSFVNFINLCLIKDESKRP 259 (288)
T ss_pred cCCCcCC-----CccCHHHHHHHHHHccCChhhCc
Confidence 1111100 12334589999999999999998
No 320
>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co
Probab=100.00 E-value=2.5e-37 Score=275.67 Aligned_cols=234 Identities=23% Similarity=0.292 Sum_probs=178.7
Q ss_pred ccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHH---HHHhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918 103 LLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECE---VLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175 (361)
Q Consensus 103 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~---~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 175 (361)
.||+|+||.||++... +++.||+|.+.... ......+..|.. +++...||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 58899999886532 111122333433 4444579999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee
Q 037918 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR 255 (361)
Q Consensus 176 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 255 (361)
+++|.+++.... .+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||++....... .
T Consensus 81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~ 152 (278)
T cd05606 81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 152 (278)
T ss_pred CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----C
Confidence 999999987654 4899999999999999999999 8899999999999999999999999999987653321 1
Q ss_pred ecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918 256 TMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334 (361)
Q Consensus 256 ~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 334 (361)
....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||.................. ...+...
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~--- 221 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--------AVELPDS--- 221 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc--------CCCCCCc---
Confidence 234689999999988654 5889999999999999999999999764221111111100000 0111111
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 335 FAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
....+.+++.+|+..||++||
T Consensus 222 ------~s~~~~~li~~~l~~~p~~R~ 242 (278)
T cd05606 222 ------FSPELRSLLEGLLQRDVNRRL 242 (278)
T ss_pred ------CCHHHHHHHHHHhhcCHHhcc
Confidence 123478999999999999997
No 321
>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]
Probab=100.00 E-value=2.8e-39 Score=268.62 Aligned_cols=242 Identities=24% Similarity=0.278 Sum_probs=191.2
Q ss_pred CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEEec
Q 037918 98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
...+..||.|+.|.||+++.. .|...|||.+.... ....+++...++++..- .+|.||+.+|+|..+...++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 445678999999999999965 68999999997654 45567888888887766 4999999999999999999999998
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918 175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET 254 (361)
Q Consensus 175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 254 (361)
..-+..++..-..++++..+-++...+.+||.||.+ +.+|+|||+||+|||+|+.|++||+|||.+-.+.++. .
T Consensus 174 -s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---A 247 (391)
T KOG0983|consen 174 -STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---A 247 (391)
T ss_pred -HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc---c
Confidence 446667776656668999899999999999999986 6799999999999999999999999999998775543 3
Q ss_pred eecccccccccCccccCC---CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918 255 RTMTMATVGYMAPEYGSE---GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 255 ~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
++...|-+.|||||.+.- ..|+.++||||||++++||.||+.||.....+-..+...+. ..|..+ +...
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L----~~~~--- 319 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLL----PGHM--- 319 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCC----Cccc---
Confidence 344578999999998754 45888999999999999999999999875433222222222 111111 1111
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++..||..|+.+||
T Consensus 320 --------gFSp~F~~fv~~CL~kd~r~RP 341 (391)
T KOG0983|consen 320 --------GFSPDFQSFVKDCLTKDHRKRP 341 (391)
T ss_pred --------CcCHHHHHHHHHHhhcCcccCc
Confidence 1233478999999999999998
No 322
>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7. Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it
Probab=100.00 E-value=1.1e-37 Score=280.66 Aligned_cols=243 Identities=25% Similarity=0.279 Sum_probs=187.7
Q ss_pred CCCCCCCccccCCceEEEEEEeCC-CcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILSD-GAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLE 172 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 172 (361)
++|++.+.||+|++|.||+|...+ ++.||||.+.... ......+..|+.++.+. .||||+++++++.+....+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 568889999999999999999764 8999999987543 23345566777777666 49999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS-PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
|+ +++|.+++......+++..+..++.|++.||+||| + .+++||||+|+||++++++.++|+|||++..+.....
T Consensus 95 ~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 95 LM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred cc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 98 45888887765556899999999999999999999 5 5899999999999999999999999999876643221
Q ss_pred ceeeecccccccccCccccCCCC----CCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccc
Q 037918 252 FETRTMTMATVGYMAPEYGSEGI----VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN 327 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 327 (361)
.....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||.........+........ ..
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----~~----- 238 (296)
T cd06618 171 ---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP----PS----- 238 (296)
T ss_pred ---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC----CC-----
Confidence 12235778899999876543 788999999999999999999998653221111111111110 00
Q ss_pred ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+.... .....+.+++.+||+.||++||
T Consensus 239 ~~~~~-------~~~~~l~~li~~~l~~~p~~Rp 265 (296)
T cd06618 239 LPPNE-------GFSPDFCSFVDLCLTKDHRKRP 265 (296)
T ss_pred CCCCC-------CCCHHHHHHHHHHccCChhhCC
Confidence 00000 1233478999999999999998
No 323
>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely
Probab=100.00 E-value=7.2e-38 Score=282.45 Aligned_cols=263 Identities=25% Similarity=0.292 Sum_probs=192.9
Q ss_pred HhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC----
Q 037918 93 RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD---- 165 (361)
Q Consensus 93 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 165 (361)
...++|++.+.||+|+||.||+|... +|+.||+|.++... ......+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35578999999999999999999975 58899999987543 222346778999999999999999999987654
Q ss_pred ------eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEe
Q 037918 166 ------FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSD 239 (361)
Q Consensus 166 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 239 (361)
..++++||+++ ++.+++......+++..++.++.|++.||+||| +.+|+|+||+|+||++++++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999975 788888765556899999999999999999999 88999999999999999999999999
Q ss_pred ccCccccCCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHh---hh
Q 037918 240 FGISKLLGDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK---ES 315 (361)
Q Consensus 240 fg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~---~~ 315 (361)
||++........ .......++..|+|||.+.+ ..++.++||||||+++|||++|++||..... ...+..... ..
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~~~~~~ 237 (302)
T cd07864 160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISRLCGSP 237 (302)
T ss_pred ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCC
Confidence 999987644321 11122345778999997754 4578899999999999999999999975321 111111111 11
Q ss_pred cCCCcccccccc--------ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 316 LPHGLTNVVDEN--------LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 316 ~~~~l~~~~~~~--------l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+..+..+.... -.............+..+.+++.+||+.||++||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 291 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRC 291 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCC
Confidence 111111111100 0000000001111245689999999999999998
No 324
>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho
Probab=100.00 E-value=2.4e-37 Score=273.70 Aligned_cols=202 Identities=27% Similarity=0.382 Sum_probs=171.9
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh-----hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecC--Cee
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ-----LERAFRSFDSECEVLRSIRHRNLVKILSSCSNV--DFK 167 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 167 (361)
.+|.+.+.||+|++|.||+|... ++..||+|.+... .......+.+|++++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999964 6899999987532 233456788999999999999999999998664 467
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918 168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG 247 (361)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 247 (361)
++++||+++++|.+++..... +++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~-l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 899999999999999986544 789999999999999999999 8899999999999999999999999999998653
Q ss_pred CCCc-ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 248 DGEN-FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 248 ~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
.... ........++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 2111 01112345888999999998888899999999999999999999999753
No 325
>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po
Probab=100.00 E-value=1.1e-37 Score=278.86 Aligned_cols=199 Identities=26% Similarity=0.370 Sum_probs=170.5
Q ss_pred CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC--CeeEEEEE
Q 037918 98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV--DFKALVLE 172 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 172 (361)
|++.+.||+|++|.||+|... +++.+|+|.+.... ......+.+|++++++++|||++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999965 58899999998653 33345688899999999999999999999888 88999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
|++ ++|.+++......+++..++.++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~- 155 (287)
T cd07840 81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS- 155 (287)
T ss_pred ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence 996 5999998776556899999999999999999999 88999999999999999999999999999987654321
Q ss_pred eeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 253 ETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
.......++..|+|||.+.+ ..++.++||||||+++|||+||+.||...
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~ 205 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGS 205 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11233456788999997654 45789999999999999999999999754
No 326
>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase
Probab=100.00 E-value=5.4e-38 Score=287.58 Aligned_cols=200 Identities=26% Similarity=0.376 Sum_probs=167.2
Q ss_pred hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC-----Cee
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV-----DFK 167 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 167 (361)
+++|++.+.||+|++|.||+|... +|+.||+|.+.... ......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999854 68999999986432 23446678899999999999999999987544 357
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918 168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG 247 (361)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 247 (361)
++++||++ ++|.+++.... +++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~--l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQH--LSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEehhcc-cCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 99999995 58888886543 899999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCcce-eeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918 248 DGENFE-TRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDE 300 (361)
Q Consensus 248 ~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~ 300 (361)
...... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 322111 1123467889999997544 5689999999999999999999999965
No 327
>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10. Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing
Probab=100.00 E-value=6.6e-38 Score=283.75 Aligned_cols=201 Identities=26% Similarity=0.364 Sum_probs=169.0
Q ss_pred hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH--HHHHHHHHHHHHHHhcCCCceeeeeeeeecC--CeeEE
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE--RAFRSFDSECEVLRSIRHRNLVKILSSCSNV--DFKAL 169 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 169 (361)
.++|++.+.||+|+||.||+|... +|+.||+|.+..... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999965 689999999874431 1123456799999999999999999998654 56899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918 170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 249 (361)
||||+. ++|.+++......+++..++.++.|++.||+||| +.+++||||+|+||++++++.++|+|||++......
T Consensus 86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 999995 5899988865556899999999999999999999 889999999999999999999999999999876543
Q ss_pred CcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 250 ENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 250 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 162 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~ 212 (309)
T cd07845 162 AK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212 (309)
T ss_pred cC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 21 1222345788999998765 55789999999999999999999999753
No 328
>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.
Probab=100.00 E-value=1.1e-37 Score=274.48 Aligned_cols=241 Identities=24% Similarity=0.377 Sum_probs=193.1
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
+|++.+.||+|+||.||+|... +|..+|+|.+.... ....+.+.+|+++++.++|+||+++++.+...+..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778889999999999999965 58899999987542 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC-cEEEEeccCccccCCCCc
Q 037918 174 MPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM-VAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 174 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~ 251 (361)
+++++|.+++.... ..+++..+..++.|+++||+||| +.+++|+||+|+||++++++ .++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999997543 34789999999999999999999 88999999999999999886 469999999987643321
Q ss_pred ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918 252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
......|++.|+|||+..+..++.++|+||||+++|||++|..||.... ..++........+...
T Consensus 158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~-------- 222 (257)
T cd08225 158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQGYFAPI-------- 222 (257)
T ss_pred --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhcccCCCC--------
Confidence 1223458889999999888889999999999999999999999986432 1222222221111111
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+ .....+.+++.+||+.+|++||
T Consensus 223 ~~------~~~~~~~~~i~~~l~~~p~~Rp 246 (257)
T cd08225 223 SP------NFSRDLRSLISQLFKVSPRDRP 246 (257)
T ss_pred CC------CCCHHHHHHHHHHhccChhhCc
Confidence 11 1123478999999999999998
No 329
>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=100.00 E-value=1.2e-37 Score=279.47 Aligned_cols=244 Identities=25% Similarity=0.290 Sum_probs=190.2
Q ss_pred CCCCCCccccCCceEEEEEEe----CCCcEEEEEEeehhh----HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCee
Q 037918 97 GFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIFNLQL----ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFK 167 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 167 (361)
+|++.+.||+|+||.||++.. .+|..||+|++.... ....+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999985 368899999987532 12345678899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918 168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG 247 (361)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 247 (361)
++||||+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 99999999999999998654 3789999999999999999999 8999999999999999999999999999998764
Q ss_pred CCCcceeeecccccccccCccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccc
Q 037918 248 DGENFETRTMTMATVGYMAPEYGSE--GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVD 325 (361)
Q Consensus 248 ~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 325 (361)
.... .......++..|+|||...+ ..++.++||||||+++|+|++|..||..... ...............
T Consensus 157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~------ 228 (290)
T cd05613 157 EDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKSE------ 228 (290)
T ss_pred cccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhccC------
Confidence 3221 12223458889999998765 3467899999999999999999999864211 111222211111000
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 326 ENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 326 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+.... .....+.+++.+||+.||++||
T Consensus 229 ~~~~~---------~~~~~~~~ll~~~l~~~p~~R~ 255 (290)
T cd05613 229 PPYPQ---------EMSALAKDIIQRLLMKDPKKRL 255 (290)
T ss_pred CCCCc---------cCCHHHHHHHHHHhcCCHHHhc
Confidence 00000 1123478999999999999996
No 330
>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an
Probab=100.00 E-value=1.2e-37 Score=274.10 Aligned_cols=239 Identities=28% Similarity=0.362 Sum_probs=194.1
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
+|++.+.||+|++|.||++... +++.+++|.+.... ......+.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999854 68899999987543 33446778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918 174 MPNGSLEKWLYSH---NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE 250 (361)
Q Consensus 174 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 250 (361)
+++++|.+++... ...+++..++.++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 9999999998752 244899999999999999999999 8999999999999999999999999999998765431
Q ss_pred cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918 251 NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330 (361)
Q Consensus 251 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 330 (361)
.....++..|+|||...+..++.++|+||||+++|+|++|+.||...... .+...... .....+
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~---~~~~~~------- 221 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYKVQR---GKYPPI------- 221 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhc---CCCCCC-------
Confidence 12245788999999998888999999999999999999999999754321 11111110 000100
Q ss_pred CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+ ......+.+++.+|++.+|++||
T Consensus 222 --~-----~~~~~~~~~li~~~l~~~p~~Rp 245 (256)
T cd08530 222 --P-----PIYSQDLQNFIRSMLQVKPKLRP 245 (256)
T ss_pred --c-----hhhCHHHHHHHHHHcCCCcccCC
Confidence 0 02234489999999999999998
No 331
>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc
Probab=100.00 E-value=1.8e-37 Score=277.32 Aligned_cols=198 Identities=28% Similarity=0.410 Sum_probs=168.3
Q ss_pred CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918 98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
|++.+.||.|++|.||+|... +|+.||+|++.... ......+.+|++++++++|||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999964 79999999987543 222356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 175 PNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 175 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
+ ++|.+++.... ..+++..++.++.|++.||+||| +.+++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-- 154 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-- 154 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence 4 69999987654 34899999999999999999999 88999999999999999999999999999976543221
Q ss_pred eeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 254 TRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
......++..|+|||++.+. .++.++|+||||+++|+|++|+.||...
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11223468889999987654 5788999999999999999999998653
No 332
>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They
Probab=100.00 E-value=9.7e-38 Score=274.62 Aligned_cols=241 Identities=26% Similarity=0.375 Sum_probs=196.6
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
+|.+.+.||.|++|.||++... ++..+++|++.... ......+.+|+++++.++|||++++.+.+...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999965 68999999987643 24556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918 174 MPNGSLEKWLYSH---NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE 250 (361)
Q Consensus 174 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 250 (361)
+++++|.+++... ...+++..+..++.+++.||.||| +.+++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999864 356899999999999999999999 8899999999999999999999999999998765432
Q ss_pred cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918 251 NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330 (361)
Q Consensus 251 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 330 (361)
.......+++.|+|||...+..++.++|+||+|+++|+|++|+.||..... .............. +..
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~-----~~~ 225 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----LELALKILKGQYPP-----IPS 225 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----HHHHHHHhcCCCCC-----CCC
Confidence 122334688899999998888899999999999999999999999865321 11111111111111 100
Q ss_pred CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||..+|++||
T Consensus 226 ---------~~~~~~~~~i~~~l~~~p~~Rp 247 (258)
T cd08215 226 ---------QYSSELRNLVSSLLQKDPEERP 247 (258)
T ss_pred ---------CCCHHHHHHHHHHcCCChhhCc
Confidence 1123478999999999999998
No 333
>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast
Probab=100.00 E-value=3.8e-37 Score=270.42 Aligned_cols=240 Identities=27% Similarity=0.411 Sum_probs=195.5
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH--HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE--RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
+|++.+.||+|++|.||++... +++.|++|.+..... ...+.+.+|++++++++|||++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999865 678999999876543 4557889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
+++++|.+++.... .+++..++.++.|++.+|.||| +.+++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (254)
T cd06627 81 AENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-- 154 (254)
T ss_pred CCCCcHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--
Confidence 99999999998663 4899999999999999999999 88999999999999999999999999999987754332
Q ss_pred eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP 333 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 333 (361)
......++..|+|||...+..++.++|+||+|+++|+|++|+.||..... ........ .... ..+..
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~~-~~~~-----~~~~~--- 221 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRIV-QDDH-----PPLPE--- 221 (254)
T ss_pred cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHh-ccCC-----CCCCC---
Confidence 12234578899999998877789999999999999999999999875321 11111100 0000 00100
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 334 AFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||..+|++||
T Consensus 222 ------~~~~~~~~~i~~~l~~~p~~R~ 243 (254)
T cd06627 222 ------GISPELKDFLMQCFQKDPNLRP 243 (254)
T ss_pred ------CCCHHHHHHHHHHHhCChhhCc
Confidence 1123478999999999999998
No 334
>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK
Probab=100.00 E-value=1.4e-37 Score=286.81 Aligned_cols=198 Identities=23% Similarity=0.298 Sum_probs=169.1
Q ss_pred hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecC------
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSNV------ 164 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 164 (361)
..++|++.+.||+|+||.||+|... +|+.||+|.+... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999964 6899999998643 233345677899999999999999999988543
Q ss_pred CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918 165 DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK 244 (361)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 244 (361)
...++||||+. ++|.+.+... ++...+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 35799999995 5888888643 789999999999999999999 8899999999999999999999999999998
Q ss_pred ccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 245 LLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 245 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
....... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 167 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 167 TAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred eCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 7643221 22335788999999999889999999999999999999999999643
No 335
>PHA03210 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=9.2e-38 Score=299.44 Aligned_cols=200 Identities=20% Similarity=0.250 Sum_probs=160.2
Q ss_pred HhhCCCCCCCccccCCceEEEEEEeCC--CcEEEEE------------------EeehhhHHHHHHHHHHHHHHHhcCCC
Q 037918 93 RATNGFDECNLLGKGSFGSVYKGILSD--GAEVAIK------------------IFNLQLERAFRSFDSECEVLRSIRHR 152 (361)
Q Consensus 93 ~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~e~~~l~~l~h~ 152 (361)
...++|++++.||+|+||+||++..+. +...+.| .+. ........+.+|++++++++||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCC
Confidence 345789999999999999999987532 2222222 111 1122345678999999999999
Q ss_pred ceeeeeeeeecCCeeEEEEEecCCCCHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEE
Q 037918 153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHN----YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNIL 228 (361)
Q Consensus 153 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nil 228 (361)
||+++++++...+..++++|++ +++|.+++.... .......+..++.|++.||+||| +.+|+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEE
Confidence 9999999999999999999999 568888776432 12345677889999999999999 889999999999999
Q ss_pred EcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCC
Q 037918 229 LDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPT 298 (361)
Q Consensus 229 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~ 298 (361)
++.++.+||+|||++..+..... .......|+..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999999987654322 1222356899999999999989999999999999999999988543
No 336
>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=5.4e-38 Score=287.51 Aligned_cols=242 Identities=28% Similarity=0.369 Sum_probs=198.6
Q ss_pred HhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918 93 RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL 169 (361)
Q Consensus 93 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (361)
.....|.+.+.||+|.|+.|.+|+.. ++..||||.+++.. ....+.+.+|+++++.++||||++++.+......+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 34567999999999999999999954 69999999998654 3334558899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918 170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 249 (361)
||||+.+|.+.+|+.+++. +.+..+..++.|+.+|++||| ++.|+|||||++|||++.+.++||+|||++..+...
T Consensus 133 V~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeeccc
Confidence 9999999999999998876 556889999999999999999 999999999999999999999999999999988654
Q ss_pred CcceeeecccccccccCccccCCCC-CCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918 250 ENFETRTMTMATVGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL 328 (361)
Q Consensus 250 ~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l 328 (361)
.. ....+|++.|.|||+..+.. .++.+|+||+|+++|.|+.|..||++..-.+.. ..++...+
T Consensus 209 ~~---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-------------~rvl~gk~ 272 (596)
T KOG0586|consen 209 LM---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-------------PRVLRGKY 272 (596)
T ss_pred cc---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-------------chheeeee
Confidence 33 34568999999999988766 478999999999999999999999864321111 12222222
Q ss_pred cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
...+... .+ ..+++.+++-.+|.+|+
T Consensus 273 rIp~~ms---~d----ce~lLrk~lvl~Pskr~ 298 (596)
T KOG0586|consen 273 RIPFYMS---CD----CEDLLRKFLVLNPSKRG 298 (596)
T ss_pred cccceee---ch----hHHHHHHhhccCccccC
Confidence 2222211 12 47778888888888885
No 337
>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul
Probab=100.00 E-value=2e-37 Score=283.97 Aligned_cols=202 Identities=29% Similarity=0.353 Sum_probs=168.6
Q ss_pred hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh--hHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecC--Cee
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ--LERAFRSFDSECEVLRSI-RHRNLVKILSSCSNV--DFK 167 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~~ 167 (361)
..++|++.+.||+|+||.||+|... +|+.+|+|++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888999999999999999965 5889999988542 223345677899999999 999999999998653 468
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918 168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG 247 (361)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 247 (361)
++||||++ ++|.+++... .+++..+..++.|++.||+||| +.+|+|+||+|+||+++.++.++|+|||++....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 99999996 5999998765 4889999999999999999999 8899999999999999999999999999998764
Q ss_pred CCCcc---eeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 248 DGENF---ETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 248 ~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
..... .......++..|+|||.+.+ ..++.++|+||||+++|+|+||+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 43221 12223458889999997654 55788999999999999999999999653
No 338
>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase. Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm
Probab=100.00 E-value=1.8e-37 Score=278.87 Aligned_cols=199 Identities=23% Similarity=0.346 Sum_probs=165.5
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH--HHHHHHHHHHHHHHhcC-CCceeeeeeeeecCCe-----
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE--RAFRSFDSECEVLRSIR-HRNLVKILSSCSNVDF----- 166 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~----- 166 (361)
++|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999965 689999998765432 12356788999999995 6999999999877665
Q ss_pred eEEEEEecCCCCHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC-CCcEEEEecc
Q 037918 167 KALVLEFMPNGSLEKWLYSH----NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE-NMVAHVSDFG 241 (361)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg 241 (361)
.+++|||+++ +|.+++... ...+++..++.++.|++.||+||| +.+++||||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 898888643 234799999999999999999999 889999999999999998 8899999999
Q ss_pred CccccCCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918 242 ISKLLGDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDE 300 (361)
Q Consensus 242 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~ 300 (361)
++........ ......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||..
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 214 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG 214 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Confidence 9886533211 1122346788999997754 4578999999999999999999999865
No 339
>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=5.5e-39 Score=272.92 Aligned_cols=202 Identities=28% Similarity=0.328 Sum_probs=179.7
Q ss_pred hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL 169 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (361)
..++|+.+++||+|.||.|-+++-+ .|+.+|+|++++.. ......-..|-++|+..+||.+..+--.|+..+.+++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3467999999999999999999954 79999999998764 3445566789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918 170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 249 (361)
||||..||.|.-+|...+. +++...+.+..+|..||.||| +++||.||||.+|.|+|.+|++||+|||+++.--..
T Consensus 246 VMeyanGGeLf~HLsrer~-FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERV-FSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEEEccCceEeeehhhhhc-ccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 9999999999999986554 788888999999999999999 899999999999999999999999999999854222
Q ss_pred CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
.......+|||.|+|||++....|+.+.|.|.+|+++|||+.|+.||...
T Consensus 322 --g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 322 --GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred --cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 23455678999999999999999999999999999999999999999764
No 340
>PLN00009 cyclin-dependent kinase A; Provisional
Probab=100.00 E-value=3.9e-37 Score=276.66 Aligned_cols=200 Identities=25% Similarity=0.377 Sum_probs=166.9
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE 172 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (361)
++|++.+.||+|++|.||+|... +|+.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999965 68999999886432 2233567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC-CCcEEEEeccCccccCCCC
Q 037918 173 FMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE-NMVAHVSDFGISKLLGDGE 250 (361)
Q Consensus 173 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~ 250 (361)
|++ ++|.+++.... ...++..+..++.|++.||+||| +.+++|+||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 995 58888876543 23678888999999999999999 889999999999999985 5679999999997654321
Q ss_pred cceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 251 NFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 251 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
. ......+++.|+|||.+.+ ..++.++||||||+++|+|+||+.||...
T Consensus 158 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 158 R--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred c--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 1123356889999998765 45789999999999999999999999753
No 341
>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5. Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the
Probab=100.00 E-value=1.6e-37 Score=284.26 Aligned_cols=202 Identities=25% Similarity=0.355 Sum_probs=169.4
Q ss_pred hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeec----CCee
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSN----VDFK 167 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~ 167 (361)
.++|++.+.||+|++|.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367999999999999999999964 68999999987542 2334567789999999999999999998753 3568
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918 168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG 247 (361)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 247 (361)
++||||+. ++|.+++..... +++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||++....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQP-LTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEehhh-hhHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 99999995 699999876544 899999999999999999999 8899999999999999999999999999997654
Q ss_pred CCCcc--eeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 248 DGENF--ETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 248 ~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
..... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 32211 11123468889999998755 45889999999999999999999999653
No 342
>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1. Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto
Probab=100.00 E-value=3e-37 Score=275.16 Aligned_cols=242 Identities=26% Similarity=0.404 Sum_probs=195.2
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcC-CCceeeeeeeeecCCeeEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIR-HRNLVKILSSCSNVDFKALV 170 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 170 (361)
++|.+.+.||+|++|.||+|... +|+.||+|++.... ....+.+..|.+++++++ ||||+++++++.+.+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999965 68999999987532 233467888999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918 171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE 250 (361)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 250 (361)
|||+++++|.+++.+.+ .+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 99999999999998764 4899999999999999999999 8899999999999999999999999999998764432
Q ss_pred cc------------------eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHH
Q 037918 251 NF------------------ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWV 312 (361)
Q Consensus 251 ~~------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~ 312 (361)
.. .......++..|+|||......++.++|+||||++++++++|+.||..... ...+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~ 235 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-YLTFQKIL 235 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHH
Confidence 11 112233578899999998888899999999999999999999999975421 01111110
Q ss_pred hhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 313 KESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 313 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.. ...+... ....+.+++.+||+.||++||
T Consensus 236 ~~----------~~~~~~~---------~~~~~~~li~~~l~~~p~~R~ 265 (280)
T cd05581 236 KL----------EYSFPPN---------FPPDAKDLIEKLLVLDPQDRL 265 (280)
T ss_pred hc----------CCCCCCc---------cCHHHHHHHHHHhcCCHhhCC
Confidence 00 0000000 123478999999999999998
No 343
>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein. Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc
Probab=100.00 E-value=6.6e-37 Score=277.77 Aligned_cols=197 Identities=22% Similarity=0.234 Sum_probs=162.4
Q ss_pred CCccccCCceEEEEEEeCCCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCC
Q 037918 101 CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGS 178 (361)
Q Consensus 101 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 178 (361)
.+.+|.|+++.|+++.. +++.||+|++... .....+.+.+|+++++.++||||+++++++.+.+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455555555555554 6899999998754 34456789999999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc-----c
Q 037918 179 LEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN-----F 252 (361)
Q Consensus 179 L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-----~ 252 (361)
|.+++... ...+++..+..++.|+++||+||| +.+|+||||||+||+++.++.++|+|||.+........ .
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99999854 344889999999999999999999 88999999999999999999999999998875532211 0
Q ss_pred eeeecccccccccCccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 253 ETRTMTMATVGYMAPEYGSE--GIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
.......++..|+|||++.. ..++.++|+||||+++|||++|+.||...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 11123356778999998765 35789999999999999999999999764
No 344
>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]
Probab=100.00 E-value=3.5e-38 Score=306.81 Aligned_cols=249 Identities=29% Similarity=0.413 Sum_probs=190.0
Q ss_pred HHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeec------
Q 037918 92 QRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSN------ 163 (361)
Q Consensus 92 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------ 163 (361)
.+..++|+.++.||+||||.||+++.+ ||+.||||++.... ......+.+|+..+++|+|||||+++..|.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 456678899999999999999999966 89999999987653 4456778999999999999999999753210
Q ss_pred -----------------------------------------------------------C--------------------
Q 037918 164 -----------------------------------------------------------V-------------------- 164 (361)
Q Consensus 164 -----------------------------------------------------------~-------------------- 164 (361)
+
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0
Q ss_pred ----------------------------------CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 037918 165 ----------------------------------DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210 (361)
Q Consensus 165 ----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH 210 (361)
..+|+-||||+..+|.+++..+...-.....|+++++|+.||+|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 1246789999998888888766542357889999999999999999
Q ss_pred hcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC----------------CCCcceeeecccccccccCccccCCCC
Q 037918 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG----------------DGENFETRTMTMATVGYMAPEYGSEGI 274 (361)
Q Consensus 211 ~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~----------------~~~~~~~~~~~~g~~~y~aPE~~~~~~ 274 (361)
+.|||||||||.||+++++..+||+|||+|.... ........+...||.-|+|||++.+..
T Consensus 715 ---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 ---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred ---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 8899999999999999999999999999998721 011122445678999999999877654
Q ss_pred ---CCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhh
Q 037918 275 ---VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALD 351 (361)
Q Consensus 275 ---~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~ 351 (361)
|+.|+|+||||++++||+. ||.........+...-+..+|.. ..+.++. ...-.++|.+
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~~~--------------~~~e~slI~~ 853 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFDPE--------------HPEEASLIRW 853 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-ccccccc--------------chHHHHHHHH
Confidence 9999999999999999995 56553322222222223333333 2222211 1224788999
Q ss_pred cCCCCCCCCC
Q 037918 352 CSMYSPDQRI 361 (361)
Q Consensus 352 cl~~dP~~RP 361 (361)
+++.||++||
T Consensus 854 Ll~hdP~kRP 863 (1351)
T KOG1035|consen 854 LLSHDPSKRP 863 (1351)
T ss_pred HhcCCCccCC
Confidence 9999999999
No 345
>PHA02882 putative serine/threonine kinase; Provisional
Probab=100.00 E-value=2.3e-37 Score=278.19 Aligned_cols=250 Identities=20% Similarity=0.230 Sum_probs=177.1
Q ss_pred hCCCCCCCccccCCceEEEEEEeCC----CcEEEEEEeehhhHHH-----------HHHHHHHHHHHHhcCCCceeeeee
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILSD----GAEVAIKIFNLQLERA-----------FRSFDSECEVLRSIRHRNLVKILS 159 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~~~~ 159 (361)
.++|.+.+.||+|+||.||+|...+ +..+|+|+........ ......+...+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3679999999999999999999653 4566777543222110 011223334455678999999998
Q ss_pred eeecCC----eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcE
Q 037918 160 SCSNVD----FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235 (361)
Q Consensus 160 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 235 (361)
.+.... ..++++|++ ..++.+.+.... ..++..+..++.|++.||+||| +.+++||||||+|||++.++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKL-VENTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeeEecCCceEEEEEEehh-ccCHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcE
Confidence 765543 446788877 447777665432 2578889999999999999999 8899999999999999999999
Q ss_pred EEEeccCccccCCCCcc-----eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHH
Q 037918 236 HVSDFGISKLLGDGENF-----ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKN 310 (361)
Q Consensus 236 kl~Dfg~a~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~ 310 (361)
+|+|||+++.+...... .......||+.|+|||...+..++.++||||||+++|||++|+.||........ ...
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~-~~~ 244 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN-LIH 244 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH-HHH
Confidence 99999999876432211 112234699999999999999999999999999999999999999986532211 111
Q ss_pred HHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 311 WVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 311 ~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
...... +..+...... ...++..+.+++..|++.+|++||
T Consensus 245 ~~~~~~---~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~rp 284 (294)
T PHA02882 245 AAKCDF---IKRLHEGKIK--------IKNANKFIYDFIECVTKLSYEEKP 284 (294)
T ss_pred HhHHHH---HHHhhhhhhc--------cCCCCHHHHHHHHHHHhCCCCCCC
Confidence 111000 0011111110 012234589999999999999998
No 346
>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]
Probab=100.00 E-value=2.8e-38 Score=293.24 Aligned_cols=200 Identities=35% Similarity=0.511 Sum_probs=172.6
Q ss_pred CCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC------CeeEE
Q 037918 98 FDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV------DFKAL 169 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~l 169 (361)
+...+.||+|+||.||+|+. ..|+.||||.+.... ....+...+|++++++++|+|||+++++-++. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 44567899999999999995 479999999987643 33456788999999999999999999986554 36789
Q ss_pred EEEecCCCCHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc--CCC--cEEEEeccCc
Q 037918 170 VLEFMPNGSLEKWLYS--HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD--ENM--VAHVSDFGIS 243 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~--~~~--~~kl~Dfg~a 243 (361)
|||||.||||...+++ +...+++.+.+.++.++..||.||| ..+|+||||||.||++- .+| .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999984 3455999999999999999999999 88999999999999994 334 4799999999
Q ss_pred cccCCCCcceeeecccccccccCccccC-CCCCCcccchHHHHHHHHHHHhCCCCCCcccc
Q 037918 244 KLLGDGENFETRTMTMATVGYMAPEYGS-EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFA 303 (361)
Q Consensus 244 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~p~~~~~~ 303 (361)
+.+.++. ......||..|.+||+.. .+.|+..+|.|||||++|+..||..||.....
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 9987655 445678999999999988 48899999999999999999999999976543
No 347
>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both
Probab=100.00 E-value=1.1e-36 Score=272.62 Aligned_cols=256 Identities=25% Similarity=0.335 Sum_probs=188.9
Q ss_pred CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhc---CCCceeeeeeeeecCCe-----
Q 037918 98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSI---RHRNLVKILSSCSNVDF----- 166 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~----- 166 (361)
|++.+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999976 48999999987432 22234566788777666 59999999999988776
Q ss_pred eEEEEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918 167 KALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL 245 (361)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 245 (361)
.+++|||+. ++|.+++.... ..+++..++.++.|+++||+||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 899999996 58999887543 35899999999999999999999 88999999999999999999999999999987
Q ss_pred cCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhc-CCC--ccc
Q 037918 246 LGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESL-PHG--LTN 322 (361)
Q Consensus 246 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~--l~~ 322 (361)
...... .....++..|+|||.+.+..++.++|+||||+++|||++|++||..... ...+........ +.. +..
T Consensus 157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhcCC
Confidence 644322 1223478889999999888899999999999999999999999875332 112222221110 000 000
Q ss_pred cc---cccccCCchh--HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 323 VV---DENLLLEEPA--FAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 323 ~~---~~~l~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.. ........+. .....+....+.+++.+||+.||++||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 276 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI 276 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCC
Confidence 00 0000000000 111112345678999999999999998
No 348
>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3. Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co
Probab=100.00 E-value=1.2e-36 Score=275.85 Aligned_cols=236 Identities=27% Similarity=0.322 Sum_probs=186.5
Q ss_pred CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
|...+.||+|+||.||+|... +|+.|++|.+.... ......+.+|+++++.++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 556678999999999999964 68899999986432 33446788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
+. ++|.+++......+++..+..++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 95 6888888766566899999999999999999999 88999999999999999999999999999865322
Q ss_pred eeecccccccccCccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918 254 TRTMTMATVGYMAPEYGS---EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 330 (361)
.....++..|+|||++. ...++.++||||||+++|+|++|..||...... ........ .........
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~---~~~~~~~~~---- 243 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQ---NDSPTLQSN---- 243 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHh---cCCCCCCcc----
Confidence 12345788999999873 456888999999999999999999998653211 11111110 000110000
Q ss_pred CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.....+.+++.+||+.+|++||
T Consensus 244 ---------~~~~~l~~li~~~l~~~P~~Rp 265 (313)
T cd06633 244 ---------EWTDSFRGFVDYCLQKIPQERP 265 (313)
T ss_pred ---------ccCHHHHHHHHHHccCChhhCc
Confidence 1122478899999999999998
No 349
>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati
Probab=100.00 E-value=1.3e-37 Score=285.19 Aligned_cols=199 Identities=26% Similarity=0.341 Sum_probs=167.9
Q ss_pred hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecC-----Ce
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSNV-----DF 166 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 166 (361)
.++|.+.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457899999999999999999964 6899999988643 222345677899999999999999999988654 34
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918 167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246 (361)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 246 (361)
.++++||+. ++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||++...
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 799999995 79999887654 3899999999999999999999 889999999999999999999999999999876
Q ss_pred CCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918 247 GDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDE 300 (361)
Q Consensus 247 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~ 300 (361)
.... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..
T Consensus 159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 211 (337)
T cd07858 159 SEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG 211 (337)
T ss_pred CCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence 4322 11223457889999997654 4688999999999999999999999965
No 350
>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2. Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin
Probab=100.00 E-value=2.1e-37 Score=280.27 Aligned_cols=237 Identities=27% Similarity=0.336 Sum_probs=187.6
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh---hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ---LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE 172 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (361)
.|+..+.||+|++|.||+|... +++.+|+|.+... .....+++.+|+++++.++|+|++++++++...+..++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3667789999999999999964 6788999988642 23445678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
|+. |+|.+++......+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 996 6888888655555899999999999999999999 889999999999999999999999999998765432
Q ss_pred eeeecccccccccCccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918 253 ETRTMTMATVGYMAPEYGS---EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL 329 (361)
Q Consensus 253 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 329 (361)
....++..|+|||.+. ...++.++||||||+++|+|++|..||......+ ....+..... ....
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~----~~~~----- 235 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNES----PALQ----- 235 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHhhcCC----CCcC-----
Confidence 2235788999999863 3557889999999999999999999986532111 1111111100 0000
Q ss_pred CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.......+.+++.+||+.+|++||
T Consensus 236 --------~~~~~~~~~~li~~cl~~~P~~Rp 259 (308)
T cd06634 236 --------SGHWSEYFRNFVDSCLQKIPQDRP 259 (308)
T ss_pred --------cccccHHHHHHHHHHhhCCcccCC
Confidence 001233478999999999999998
No 351
>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14
Probab=100.00 E-value=6.2e-37 Score=281.48 Aligned_cols=203 Identities=24% Similarity=0.350 Sum_probs=171.7
Q ss_pred CHHHHHHhhCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeec
Q 037918 87 SYLEIQRATNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163 (361)
Q Consensus 87 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 163 (361)
...++...+++|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3456777889999999999999999999985 468999999987532 2234567889999999999999999998854
Q ss_pred C------CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEE
Q 037918 164 V------DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHV 237 (361)
Q Consensus 164 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 237 (361)
. ...+++++++ +++|.+++.... +++..+..++.|++.||+||| +.+++||||||+||++++++.++|
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~~--l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEE
Confidence 3 3467888887 789998887543 899999999999999999999 889999999999999999999999
Q ss_pred EeccCccccCCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918 238 SDFGISKLLGDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDE 300 (361)
Q Consensus 238 ~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~ 300 (361)
+|||++...... .....++..|+|||...+ ..++.++||||||+++|||++|+.||..
T Consensus 162 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 162 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred eccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999998765321 223457889999998765 5678899999999999999999999864
No 352
>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-37 Score=263.60 Aligned_cols=207 Identities=25% Similarity=0.410 Sum_probs=175.4
Q ss_pred HHHHHHhhCCCCCCCccccCCceEEEEEE-eCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCC
Q 037918 88 YLEIQRATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVD 165 (361)
Q Consensus 88 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 165 (361)
+.++-..|+ +.||+|+++.|-.+. ..+|.++|||++.+.......++.+|++++.+. .|+||+.++++|+++.
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 455555543 589999999999888 668999999999988777778899999999998 5999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC---cEEEEeccC
Q 037918 166 FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM---VAHVSDFGI 242 (361)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~ 242 (361)
..|||||-+.||+|..+++++.. +++.++.++..+|+.||.||| .+||.|||+||+|||..+.. -+||+||.+
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~~-F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRKH-FNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred eEEEEEecccCchHHHHHHHhhh-ccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeecccc
Confidence 99999999999999999998765 899999999999999999999 99999999999999997554 489999998
Q ss_pred ccccCCCCcc-----eeeecccccccccCcccc-----CCCCCCcccchHHHHHHHHHHHhCCCCCCcccc
Q 037918 243 SKLLGDGENF-----ETRTMTMATVGYMAPEYG-----SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFA 303 (361)
Q Consensus 243 a~~~~~~~~~-----~~~~~~~g~~~y~aPE~~-----~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~ 303 (361)
..-+...... ......+|+..|||||+. ....|+.+.|.||||++||-|++|.+||.+.-.
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 8654322211 122345788999999953 234589999999999999999999999987543
No 353
>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U
Probab=100.00 E-value=2.9e-37 Score=281.61 Aligned_cols=200 Identities=28% Similarity=0.364 Sum_probs=169.6
Q ss_pred HHHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeec-CCe
Q 037918 91 IQRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSN-VDF 166 (361)
Q Consensus 91 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~ 166 (361)
+...+++|++.+.||.|+||.||++... +++.||+|++.... ....+.+..|++++++++||||+++++++.. .+.
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 4457789999999999999999999855 78999999875422 2234667889999999999999999999865 567
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918 167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246 (361)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 246 (361)
.++++||+ +++|.+++.... ++...+..++.|+++||+||| +.+++|+||+|+||++++++.++|+|||.+...
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSRP--LEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEEEeehh-ccCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 89999998 679998887543 788888999999999999999 889999999999999999999999999998764
Q ss_pred CCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 247 GDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 247 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
... .....++..|+|||.+.+ ..++.++|+||||+++|+|+||+.||...
T Consensus 159 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~ 209 (328)
T cd07856 159 DPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209 (328)
T ss_pred CCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 321 122356888999998765 56899999999999999999999999654
No 354
>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12
Probab=100.00 E-value=4.4e-37 Score=282.22 Aligned_cols=200 Identities=25% Similarity=0.358 Sum_probs=169.8
Q ss_pred HHHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC--
Q 037918 91 IQRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD-- 165 (361)
Q Consensus 91 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-- 165 (361)
+....++|++.+.||+|++|.||++... +|..||+|++.... ......+.+|++++++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 4456788999999999999999999854 68999999985432 333456789999999999999999999986553
Q ss_pred ----eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEecc
Q 037918 166 ----FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFG 241 (361)
Q Consensus 166 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 241 (361)
..++||||+ +++|.+++... .+++..+..++.|++.||+||| +.+|+||||+|+||+++.++.++|+|||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999999 78999988754 3899999999999999999999 8899999999999999999999999999
Q ss_pred CccccCCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 242 ISKLLGDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 242 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
++...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99865432 123357889999998765 45789999999999999999999999753
No 355
>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta. Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig
Probab=100.00 E-value=1.1e-36 Score=277.95 Aligned_cols=198 Identities=21% Similarity=0.305 Sum_probs=162.8
Q ss_pred CccccC--CceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918 102 NLLGKG--SFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPN 176 (361)
Q Consensus 102 ~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (361)
..||+| +||+||++... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 99999999964 79999999987432 34457788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce--
Q 037918 177 GSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE-- 253 (361)
Q Consensus 177 g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-- 253 (361)
++|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999998854 234889999999999999999999 8899999999999999999999999998654332111100
Q ss_pred ---eeecccccccccCccccCCC--CCCcccchHHHHHHHHHHHhCCCCCCccc
Q 037918 254 ---TRTMTMATVGYMAPEYGSEG--IVSSKCDVYSYGVLLMETFTRKKPTDEFF 302 (361)
Q Consensus 254 ---~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~p~~~~~ 302 (361)
......++..|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 01112345679999988663 47899999999999999999999997643
No 356
>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and
Probab=100.00 E-value=4e-37 Score=281.16 Aligned_cols=201 Identities=28% Similarity=0.354 Sum_probs=172.4
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC-----eeE
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD-----FKA 168 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 168 (361)
+|++.+.||.|++|.||+|... +++.+|+|.+.... ....+.+.+|+.++++++||||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788899999999999999965 58999999987543 334567889999999999999999999997775 789
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918 169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD 248 (361)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 248 (361)
++|||++ ++|.+++.... .+++..++.++.|++.||+||| +.+++||||||+||+++.++.++|+|||++.....
T Consensus 81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 9999996 58999887654 5899999999999999999999 88999999999999999999999999999987654
Q ss_pred CCcc-eeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccc
Q 037918 249 GENF-ETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEFF 302 (361)
Q Consensus 249 ~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~ 302 (361)
.... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 3210 112234578889999998877 78999999999999999999999997643
No 357
>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili
Probab=100.00 E-value=8.5e-37 Score=272.84 Aligned_cols=197 Identities=26% Similarity=0.343 Sum_probs=167.2
Q ss_pred CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH-HHHHHHHHHHHHHHhcC-CCceeeeeeeeecCCeeEEEEEec
Q 037918 98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE-RAFRSFDSECEVLRSIR-HRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
|.+.+.||+|++|.||+|... +++.|++|.+..... .......+|+..+.+++ |||++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999975 578899998865432 12234457899999998 999999999999999999999999
Q ss_pred CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 175 PNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 175 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
+|+|.+++.... ..+++..+..++.|++.+|.||| +.+++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 889999887654 45899999999999999999999 88999999999999999999999999999987643222
Q ss_pred eeecccccccccCccccC-CCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 254 TRTMTMATVGYMAPEYGS-EGIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
.....++..|+|||.+. ...++.++|+||||+++|||++|+.||...
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 12345788899999764 455789999999999999999999998654
No 358
>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines
Probab=100.00 E-value=8.3e-37 Score=273.75 Aligned_cols=244 Identities=24% Similarity=0.304 Sum_probs=189.4
Q ss_pred CCCCCCccccCCceEEEEEEe----CCCcEEEEEEeehhh----HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCee
Q 037918 97 GFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIFNLQL----ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFK 167 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 167 (361)
+|++.+.||+|++|.||++.. .+++.||+|.+.... ....+.+..|+.++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477788999999999999984 257889999987532 22345678899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918 168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG 247 (361)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 247 (361)
++||||+++++|.+++.... .+++..+..++.|++++|.||| +.+++||||+|+||+++.++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 99999999999999987654 3889999999999999999999 8899999999999999999999999999987754
Q ss_pred CCCcceeeecccccccccCccccCCCC--CCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccc
Q 037918 248 DGENFETRTMTMATVGYMAPEYGSEGI--VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVD 325 (361)
Q Consensus 248 ~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 325 (361)
..... ......++..|+|||...+.. .+.++|+||||+++|||++|..||..... ........+..... .
T Consensus 157 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~------~ 228 (288)
T cd05583 157 AEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEISRRILKS------K 228 (288)
T ss_pred ccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc-cchHHHHHHHHHcc------C
Confidence 33221 122345788999999876654 78899999999999999999999864211 11111111111100 0
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 326 ENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 326 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
... +. .....+.+++.+||+.||++||
T Consensus 229 ~~~----~~-----~~~~~l~~li~~~l~~~p~~R~ 255 (288)
T cd05583 229 PPF----PK-----TMSAEARDFIQKLLEKDPKKRL 255 (288)
T ss_pred CCC----Cc-----ccCHHHHHHHHHHhcCCHhhcc
Confidence 000 00 1123478899999999999997
No 359
>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins. Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic
Probab=100.00 E-value=4e-37 Score=278.64 Aligned_cols=203 Identities=24% Similarity=0.342 Sum_probs=167.0
Q ss_pred hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH--HHHHHHHHHHHHHHhcCCCceeeeeeeeecCC------
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE--RAFRSFDSECEVLRSIRHRNLVKILSSCSNVD------ 165 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 165 (361)
.++|++.+.||+|++|.||+|... +++.+|+|++..... .....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999965 689999998864331 12235678999999999999999999875433
Q ss_pred --eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCc
Q 037918 166 --FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGIS 243 (361)
Q Consensus 166 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 243 (361)
..++||||+. ++|.+.+......+++..+..++.|+++||+||| +.+++|+||+|+||++++++.++|+|||++
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 4689999995 5788887765556999999999999999999999 889999999999999999999999999999
Q ss_pred cccCCCCcce---------eeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 244 KLLGDGENFE---------TRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 244 ~~~~~~~~~~---------~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
.......... ..+...+++.|+|||.+.+ ..++.++||||||+++|||++|++||...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~ 230 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence 8654322111 1122356788999997654 45789999999999999999999998753
No 360
>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=2.3e-37 Score=301.26 Aligned_cols=247 Identities=28% Similarity=0.481 Sum_probs=198.1
Q ss_pred hhCCCCCCCccccCCceEEEEEEeC----C----CcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeec
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILS----D----GAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSN 163 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 163 (361)
..++..+.+.||+|.||.|++|... . ...||||.++... ....+.+..|+++++.+ +|+||+.++|+|..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 3344556679999999999999842 1 4569999987543 34567899999999999 69999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEE
Q 037918 164 VDFKALVLEFMPNGSLEKWLYSHN---------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNIL 228 (361)
Q Consensus 164 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nil 228 (361)
.+..++|+||+..|+|.+++..++ ..++....+.++.|||.|++||+ +.+++||||.++|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEE
Confidence 999999999999999999999776 34889999999999999999999 899999999999999
Q ss_pred EcCCCcEEEEeccCccccCCCCcceeee-cccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccc
Q 037918 229 LDENMVAHVSDFGISKLLGDGENFETRT-MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEM 306 (361)
Q Consensus 229 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~ 306 (361)
++++..+||+|||+|+............ ...-+..|||||.+....++.+|||||||++|||++| |..||.+... ..
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-~~ 529 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-TE 529 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-HH
Confidence 9999999999999999765544433221 1114566999999999999999999999999999999 8888876321 11
Q ss_pred cHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 307 SLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 307 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
++.++++ +....+.|. .|..++.++++.||+.+|++||
T Consensus 530 ~l~~~l~------------~G~r~~~P~-----~c~~eiY~iM~~CW~~~p~~RP 567 (609)
T KOG0200|consen 530 ELLEFLK------------EGNRMEQPE-----HCSDEIYDLMKSCWNADPEDRP 567 (609)
T ss_pred HHHHHHh------------cCCCCCCCC-----CCCHHHHHHHHHHhCCCcccCC
Confidence 2222222 112222222 3456689999999999999998
No 361
>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=3.1e-39 Score=315.66 Aligned_cols=244 Identities=26% Similarity=0.360 Sum_probs=192.2
Q ss_pred hCCCCCCCccccCCceEEEEEE-eCCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 95 TNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
+-++.-...||.|.||.||.|. .++|...|+|.+.... .+....+.+|+.++..++|||+|+++|+-.+.+..++.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 4456777899999999999999 4578999999876443 344567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
|||++|+|.+.+...+. .++.....+..|++.|++||| +.|||||||||.||+++.+|.+|++|||.|..+.....
T Consensus 1314 EyC~~GsLa~ll~~gri-~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRI-EDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHhccCcHHHHHHhcch-hhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 99999999999986543 667777778999999999999 88999999999999999999999999999998865421
Q ss_pred c--eeeecccccccccCccccCCCC---CCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccc
Q 037918 252 F--ETRTMTMATVGYMAPEYGSEGI---VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE 326 (361)
Q Consensus 252 ~--~~~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 326 (361)
. .......||+.|||||++.+.. -.-+.||||+||++.||+||+.||..+..+= .+-..
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~-aIMy~--------------- 1453 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW-AIMYH--------------- 1453 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh-HHHhH---------------
Confidence 1 1122457999999999887633 4568999999999999999999998754311 11000
Q ss_pred cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCC
Q 037918 327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360 (361)
Q Consensus 327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 360 (361)
.-.+..|..++. ...+-.+++.+||..||++|
T Consensus 1454 V~~gh~Pq~P~~--ls~~g~dFle~Cl~~dP~~R 1485 (1509)
T KOG4645|consen 1454 VAAGHKPQIPER--LSSEGRDFLEHCLEQDPKMR 1485 (1509)
T ss_pred HhccCCCCCchh--hhHhHHHHHHHHHhcCchhh
Confidence 001111111111 23345788999999999998
No 362
>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the
Probab=100.00 E-value=9.6e-37 Score=272.22 Aligned_cols=197 Identities=30% Similarity=0.407 Sum_probs=169.9
Q ss_pred CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918 98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
|+..+.||+|++|.||+|... +++.+|+|.+.... ....+.+..|+.++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999965 58999999987653 333456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918 175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET 254 (361)
Q Consensus 175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 254 (361)
+ ++|.+++......+++..+..++.|++.||+||| +.+++||||+|+||++++++.++|+|||++........ .
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~ 154 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T 154 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence 7 5999999876445899999999999999999999 88999999999999999999999999999987643321 1
Q ss_pred eecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918 255 RTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDE 300 (361)
Q Consensus 255 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~ 300 (361)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 201 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPG 201 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 2223457789999987666 789999999999999999999999865
No 363
>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi
Probab=100.00 E-value=4.5e-37 Score=282.12 Aligned_cols=201 Identities=24% Similarity=0.353 Sum_probs=166.3
Q ss_pred hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecC---------
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNV--------- 164 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------- 164 (361)
.++|.+.+.||.|+||.||+|... +|+.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367899999999999999999964 6899999998766555557788999999999999999999876543
Q ss_pred -----CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc-CCCcEEEE
Q 037918 165 -----DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVS 238 (361)
Q Consensus 165 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~ 238 (361)
...++||||++ ++|.+++.... +++..+..++.|++.||.||| +.+++||||||+||+++ +++.++|+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~--l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQGP--LSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999996 59998886543 889999999999999999999 88999999999999997 45678999
Q ss_pred eccCccccCCCCcce-eeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 239 DFGISKLLGDGENFE-TRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 239 Dfg~a~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
|||++.......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 222 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999997653221111 1122357888999997544 56788999999999999999999999654
No 364
>PTZ00024 cyclin-dependent protein kinase; Provisional
Probab=100.00 E-value=2.1e-36 Score=277.00 Aligned_cols=201 Identities=24% Similarity=0.338 Sum_probs=166.4
Q ss_pred CCCCC-CCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHH--------------HHHHHHHHHHHHhcCCCceeeeee
Q 037918 96 NGFDE-CNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERA--------------FRSFDSECEVLRSIRHRNLVKILS 159 (361)
Q Consensus 96 ~~~~~-~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~~~~ 159 (361)
++|.. .+.||.|+||.||+|... +++.||+|.+....... ...+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 467999999999999965 68999999886432111 124678999999999999999999
Q ss_pred eeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEe
Q 037918 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSD 239 (361)
Q Consensus 160 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 239 (361)
++...+..+++|||+. ++|.+++..... +++.....++.|++.||+||| +.+++|+||+|+||+++.++.++|+|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIR-LTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECC
Confidence 9999999999999996 699999876543 899999999999999999999 88999999999999999999999999
Q ss_pred ccCccccCCCCc------------ceeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 240 FGISKLLGDGEN------------FETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 240 fg~a~~~~~~~~------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
||++........ ........++..|+|||.+.+. .++.++|+||||+++|||++|+.||...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999987641110 0111223467889999987654 4688999999999999999999999754
No 365
>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the
Probab=100.00 E-value=3.2e-36 Score=264.07 Aligned_cols=232 Identities=28% Similarity=0.308 Sum_probs=188.6
Q ss_pred cccCCceEEEEEEeC-CCcEEEEEEeehhhH---HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCH
Q 037918 104 LGKGSFGSVYKGILS-DGAEVAIKIFNLQLE---RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSL 179 (361)
Q Consensus 104 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 179 (361)
||+|++|.||++... +++.+|+|.+..... .....+..|++++++++||||+++++.+..++..+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999965 589999999876532 2456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeeccc
Q 037918 180 EKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM 259 (361)
Q Consensus 180 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 259 (361)
.+++..... +++..+..++.|+++||.||| +.+++|+||+|+||+++.++.++|+|||++....... .......
T Consensus 81 ~~~l~~~~~-l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEGR-FSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC 154 (250)
T ss_pred HHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence 999986643 899999999999999999999 8899999999999999999999999999998764432 1223446
Q ss_pred ccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHH
Q 037918 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKM 339 (361)
Q Consensus 260 g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 339 (361)
++..|+|||...+...+.++|+||||+++|+|++|+.||..... ....... .... ..+...
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~---~~~~------~~~~~~-------- 215 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEKI---LKDP------LRFPEF-------- 215 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHH---hcCC------CCCCCC--------
Confidence 78899999998888889999999999999999999999965322 1111111 1000 000001
Q ss_pred HHHHHHHHHHhhcCCCCCCCCC
Q 037918 340 DCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 340 ~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+..+.+++.+||..||++||
T Consensus 216 -~~~~l~~~i~~~l~~~p~~R~ 236 (250)
T cd05123 216 -LSPEARDLISGLLQKDPTKRL 236 (250)
T ss_pred -CCHHHHHHHHHHhcCCHhhCC
Confidence 123478999999999999998
No 366
>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13
Probab=100.00 E-value=1.6e-36 Score=278.48 Aligned_cols=194 Identities=25% Similarity=0.366 Sum_probs=163.6
Q ss_pred hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC------
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD------ 165 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 165 (361)
.++|.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999964 68999999986432 223356788999999999999999999986543
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918 166 FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL 245 (361)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 245 (361)
..++|+||+. .+|.++.. ..+++..+..++.|++.||+||| +.+++||||+|+||+++.++.++|+|||+++.
T Consensus 94 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred eEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 4689999995 47777653 23889999999999999999999 88999999999999999999999999999876
Q ss_pred cCCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918 246 LGDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDE 300 (361)
Q Consensus 246 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~ 300 (361)
.... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 167 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~ 217 (342)
T cd07879 167 ADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217 (342)
T ss_pred CCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 5321 123357888999998765 4588999999999999999999999975
No 367
>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK
Probab=100.00 E-value=1e-36 Score=279.90 Aligned_cols=198 Identities=25% Similarity=0.362 Sum_probs=168.9
Q ss_pred HhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCe---
Q 037918 93 RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF--- 166 (361)
Q Consensus 93 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--- 166 (361)
...++|++.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.++++++|||++++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999975 58899999886432 2334567789999999999999999998866554
Q ss_pred ---eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCc
Q 037918 167 ---KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGIS 243 (361)
Q Consensus 167 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 243 (361)
.++|+||+ +++|.+++... .+++..++.++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999999 67999998764 3899999999999999999999 889999999999999999999999999999
Q ss_pred cccCCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 244 KLLGDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 244 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
...... .....++..|+|||...+ ..++.++||||||+++|||++|+.||...
T Consensus 166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~ 219 (343)
T cd07851 166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219 (343)
T ss_pred cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 876432 223357888999998754 46788999999999999999999999653
No 368
>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.2e-37 Score=300.93 Aligned_cols=207 Identities=25% Similarity=0.361 Sum_probs=183.3
Q ss_pred HHHHHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC
Q 037918 89 LEIQRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV 164 (361)
Q Consensus 89 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 164 (361)
.++.-..++|.++++||+|+||.|..++.+ +++.||+|++.+-. ......|..|-.+|..-+.+-|+.++-.|+++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 455566789999999999999999999965 68899999987632 22335688899999988999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918 165 DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK 244 (361)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 244 (361)
.++|+||||++||+|..++.+.. .+++..++.++..|.-||.-|| +.|+|||||||+|||+|..|++||+|||.+-
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHH
Confidence 99999999999999999999877 6999999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCcceeeecccccccccCccccC----C-CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918 245 LLGDGENFETRTMTMATVGYMAPEYGS----E-GIVSSKCDVYSYGVLLMETFTRKKPTDE 300 (361)
Q Consensus 245 ~~~~~~~~~~~~~~~g~~~y~aPE~~~----~-~~~~~~~Dv~slG~il~elltg~~p~~~ 300 (361)
.+..+.. ......+|||.|.+||++. + +.|++.+|.||+||++|||+.|..||..
T Consensus 224 km~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 224 KMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred hcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 8875544 3445678999999999753 3 5689999999999999999999999964
No 369
>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-37 Score=271.82 Aligned_cols=241 Identities=24% Similarity=0.292 Sum_probs=191.7
Q ss_pred hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEE
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKAL 169 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 169 (361)
..+|..+.+||+|+||.|-+|..+ +.+.+|||+++++. ....+--+.|-++|... +-|.++.++.+|+.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 346888999999999999999865 46779999998654 22233445677777655 57889999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918 170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 249 (361)
||||+.||+|--++++-++ +.+..+..++.+||-||-+|| +++|++||||.+||+++.+|++||+|||+++.---.
T Consensus 428 VMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred EEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence 9999999999999987765 678888999999999999999 999999999999999999999999999999753222
Q ss_pred CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL 329 (361)
Q Consensus 250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 329 (361)
. .+....+||+.|+|||++...+|+.++|.||||++||||+.|++||+....++ +- ..+.+.+..
T Consensus 504 ~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e--lF-----------~aI~ehnvs 568 (683)
T KOG0696|consen 504 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--LF-----------QAIMEHNVS 568 (683)
T ss_pred C--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH--HH-----------HHHHHccCc
Confidence 2 23445789999999999999999999999999999999999999998743222 11 122222221
Q ss_pred CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+|. ....+...+....+...|.+|.
T Consensus 569 --yPK-----slSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 569 --YPK-----SLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred --Ccc-----cccHHHHHHHHHHhhcCCcccc
Confidence 111 1122356778888888998884
No 370
>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co
Probab=100.00 E-value=4.9e-36 Score=274.19 Aligned_cols=200 Identities=25% Similarity=0.306 Sum_probs=163.8
Q ss_pred CCCCCCccccCCceEEEEEEeC-C--CcEEEEEEeehhh--HHHHHHHHHHHHHHHhc-CCCceeeeeeeeec----CCe
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-D--GAEVAIKIFNLQL--ERAFRSFDSECEVLRSI-RHRNLVKILSSCSN----VDF 166 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~ 166 (361)
+|++.+.||+|+||.||++... + +..||+|.+.... ....+.+.+|+++++++ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777889999999999999964 3 7789999886432 22345678899999999 59999999987533 245
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918 167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246 (361)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 246 (361)
.++++||+. ++|.+++.... .+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++...
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 788899985 69999987544 3899999999999999999999 889999999999999999999999999999866
Q ss_pred CCCCcc--eeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 247 GDGENF--ETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 247 ~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
...... .......|+..|+|||...+ ..++.++|+||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 432211 11123468899999997655 56899999999999999999999998753
No 371
>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check
Probab=100.00 E-value=2.6e-36 Score=266.39 Aligned_cols=240 Identities=23% Similarity=0.252 Sum_probs=184.9
Q ss_pred CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh-----hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918 97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ-----LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV 170 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (361)
+|.+.+.||+|+||.||++... .+..+++|.++.. .......+..|+.++++++||||+++++++.+.+..+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788899999999999999864 3445556655421 112234566789999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918 171 LEFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG 247 (361)
Q Consensus 171 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 247 (361)
|||+++++|.+++.. ....+++..++.++.|++.||.||| +.+++|+||+|+||++++ +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998863 3345899999999999999999999 889999999999999975 569999999987764
Q ss_pred CCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccc
Q 037918 248 DGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN 327 (361)
Q Consensus 248 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 327 (361)
.... ......++..|+|||...+..++.++|+||||+++|+|++|..||..... ........... .+.
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~~~~~~-----~~~ 224 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----LSVVLRIVEGP-----TPS 224 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHHcCC-----CCC
Confidence 3222 22234578899999998888889999999999999999999999864221 11111111110 000
Q ss_pred ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+. ......+.+++.+||+.||++||
T Consensus 225 ~~---------~~~~~~~~~li~~~l~~~p~~Rp 249 (260)
T cd08222 225 LP---------ETYSRQLNSIMQSMLNKDPSLRP 249 (260)
T ss_pred Cc---------chhcHHHHHHHHHHhcCChhhCc
Confidence 10 12234578999999999999998
No 372
>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins. Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha
Probab=100.00 E-value=5.1e-36 Score=261.00 Aligned_cols=217 Identities=21% Similarity=0.211 Sum_probs=173.3
Q ss_pred CCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCHHHHHhc
Q 037918 107 GSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYS 185 (361)
Q Consensus 107 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 185 (361)
|.+|.||++... +++.+|+|.+.... .+..|...+....||||+++++++.+.+..+++|||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999964 68999999987643 233455555666799999999999999999999999999999999976
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeeccccccccc
Q 037918 186 HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYM 265 (361)
Q Consensus 186 ~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~ 265 (361)
... +++..+..++.|++.||+||| +.+++||||||+||+++.++.++++|||.+...... .....++..|+
T Consensus 79 ~~~-l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~ 149 (237)
T cd05576 79 FLN-IPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYC 149 (237)
T ss_pred hcC-CCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcccc
Confidence 543 899999999999999999999 889999999999999999999999999988765432 12234567799
Q ss_pred CccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHH
Q 037918 266 APEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSI 345 (361)
Q Consensus 266 aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l 345 (361)
|||...+..++.++|+||+|+++|||++|+.|+....... ..... ...+. .....+
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------~~~~~----~~~~~-----~~~~~~ 205 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------NTHTT----LNIPE-----WVSEEA 205 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------ccccc----cCCcc-----cCCHHH
Confidence 9999888888999999999999999999998875321100 00000 00000 112347
Q ss_pred HHHHhhcCCCCCCCCC
Q 037918 346 MHLALDCSMYSPDQRI 361 (361)
Q Consensus 346 ~~l~~~cl~~dP~~RP 361 (361)
.+++.+|++.||++||
T Consensus 206 ~~li~~~l~~dp~~R~ 221 (237)
T cd05576 206 RSLLQQLLQFNPTERL 221 (237)
T ss_pred HHHHHHHccCCHHHhc
Confidence 8899999999999997
No 373
>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]
Probab=100.00 E-value=3e-37 Score=260.79 Aligned_cols=202 Identities=24% Similarity=0.350 Sum_probs=168.6
Q ss_pred hCCCCCCCccccCCceEEEEEEeC---C--CcEEEEEEeehhhH--HHHHHHHHHHHHHHhcCCCceeeeeeeeec-CCe
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS---D--GAEVAIKIFNLQLE--RAFRSFDSECEVLRSIRHRNLVKILSSCSN-VDF 166 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~ 166 (361)
...|+.+..||+|.||.||+|... + ...+|+|.++.+.+ ......-+|+.+++.++|||++.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 346899999999999999999633 2 23789999876532 223456789999999999999999999977 778
Q ss_pred eEEEEEecCCCCHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC----CcEEEE
Q 037918 167 KALVLEFMPNGSLEKWLYSH----NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN----MVAHVS 238 (361)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~ 238 (361)
.++++||.+. +|.+.++-+ ...++...+..|+.||+.|+.||| ++-|+||||||.|||+..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEee
Confidence 8999999976 999988732 345889999999999999999999 8889999999999999877 899999
Q ss_pred eccCccccCCCCc-ceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918 239 DFGISKLLGDGEN-FETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDE 300 (361)
Q Consensus 239 Dfg~a~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~ 300 (361)
|||+++.+...-. .......+-|.+|.|||.+.+ ..||++.||||.|||+.||+|-++-|..
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999998865432 223344568999999998766 5599999999999999999999887764
No 374
>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481
Probab=100.00 E-value=8.1e-36 Score=294.54 Aligned_cols=145 Identities=26% Similarity=0.448 Sum_probs=131.3
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
++|.+.+.||+|+||.||+|... +++.||||++.... ......+..|+.++..++||||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999975 68999999987532 333467888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK 244 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 244 (361)
||+.+++|.+++...+. +++..++.++.||+.||+||| ..+|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~~-l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999976543 789999999999999999999 8899999999999999999999999999886
No 375
>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]
Probab=100.00 E-value=2e-36 Score=254.60 Aligned_cols=245 Identities=23% Similarity=0.295 Sum_probs=189.9
Q ss_pred hhCCCCCC-CccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeec----CCe
Q 037918 94 ATNGFDEC-NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSN----VDF 166 (361)
Q Consensus 94 ~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~ 166 (361)
.+++|.+. ++||-|-.|.|-.+..+ +|+.+|+|++... ....+|+++.-.. .|||||.+++++.+ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45667654 67999999999999865 6899999988644 3456788876554 69999999999854 356
Q ss_pred eEEEEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC---CCcEEEEeccC
Q 037918 167 KALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE---NMVAHVSDFGI 242 (361)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~ 242 (361)
+.+|||.++||.|.+.+++++ ..+++.++..|+.||+.|+.||| +.+|.||||||+|+|.+. |-.+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccccc
Confidence 789999999999999998764 35899999999999999999999 999999999999999964 55799999999
Q ss_pred ccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccc
Q 037918 243 SKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTN 322 (361)
Q Consensus 243 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~ 322 (361)
|+...... .....+-|+.|.|||++....|+...|+||+||++|-|+.|.+||.....-. +..-++. .
T Consensus 211 AK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a--ispgMk~-------r 278 (400)
T KOG0604|consen 211 AKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISPGMKR-------R 278 (400)
T ss_pred ccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc--CChhHHh-------H
Confidence 98765432 2344578999999999999999999999999999999999999997653211 1111111 1
Q ss_pred cccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 323 VVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 323 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+..... ++|. ++.........++|...|+.+|++|.
T Consensus 279 I~~gqy--~FP~-pEWs~VSe~aKdlIR~LLkt~PteRl 314 (400)
T KOG0604|consen 279 IRTGQY--EFPE-PEWSCVSEAAKDLIRKLLKTEPTERL 314 (400)
T ss_pred hhccCc--cCCC-hhHhHHHHHHHHHHHHHhcCCchhhe
Confidence 111111 1121 12334455678999999999999994
No 376
>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]
Probab=100.00 E-value=4.4e-37 Score=275.92 Aligned_cols=194 Identities=28% Similarity=0.456 Sum_probs=170.1
Q ss_pred CCccccCCceEEEEEEe-CCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCC
Q 037918 101 CNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNG 177 (361)
Q Consensus 101 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 177 (361)
.++||+|-||+||-|+. ++|+.||||++++.. .+....+.+|+.+|+++.||.||.+...|+..+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 47899999999999995 479999999997543 333467889999999999999999999999999999999999554
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC---CcEEEEeccCccccCCCCccee
Q 037918 178 SLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN---MVAHVSDFGISKLLGDGENFET 254 (361)
Q Consensus 178 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~a~~~~~~~~~~~ 254 (361)
-|.-.|.+....+++.....++.||+.||.||| -++|+|+||||+|||+.+. -++||+|||+|+.+++.. .
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---F 722 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---F 722 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh---h
Confidence 444455555666999999999999999999999 8999999999999999643 379999999999997654 3
Q ss_pred eecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918 255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDE 300 (361)
Q Consensus 255 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~ 300 (361)
+....||+.|+|||++.++.|...-|+||.|+++|.-++|..||.+
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 4556899999999999999999999999999999999999999975
No 377
>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]
Probab=100.00 E-value=3.1e-36 Score=261.79 Aligned_cols=251 Identities=24% Similarity=0.329 Sum_probs=202.1
Q ss_pred HHHHHhhCCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeee
Q 037918 89 LEIQRATNGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSC 161 (361)
Q Consensus 89 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 161 (361)
.++.....+++...++-+|.||.||.|.+. +.+.|-+|.++... .-....+..|.-++..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 445555667888889999999999999653 34556777665443 33456788899999999999999999988
Q ss_pred e-cCCeeEEEEEecCCCCHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC
Q 037918 162 S-NVDFKALVLEFMPNGSLEKWLYS-------HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM 233 (361)
Q Consensus 162 ~-~~~~~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~ 233 (361)
. +.+.+++++.+..-|+|..++.. ....++..+...++.|++.|++||| +.+++|.||..+|.+||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhe
Confidence 4 55678899999999999999982 1233677788899999999999999 89999999999999999999
Q ss_pred cEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHH
Q 037918 234 VAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWV 312 (361)
Q Consensus 234 ~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~ 312 (361)
++||+|=.+++.+-..+...-......+..||+||.+.+..|+.++||||||++||||+| |+.|+.+..+.++ ..++
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm--~~yl 511 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM--EHYL 511 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH--HHHH
Confidence 999999999998866665444444557888999999999999999999999999999998 9999887654433 1221
Q ss_pred hhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 313 KESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 313 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+ ..... .+..+|+.+|+.++.-||+.+|++||
T Consensus 512 k------------dGyRl-----aQP~NCPDeLf~vMacCWallpeeRP 543 (563)
T KOG1024|consen 512 K------------DGYRL-----AQPFNCPDELFTVMACCWALLPEERP 543 (563)
T ss_pred h------------cccee-----cCCCCCcHHHHHHHHHHHhcCcccCC
Confidence 1 11111 22337888899999999999999998
No 378
>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=4.6e-36 Score=274.43 Aligned_cols=208 Identities=23% Similarity=0.329 Sum_probs=177.4
Q ss_pred CCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
.-|..++.||-|+||+|.++.. ++...+|+|.+.+.. .........|-.||..-..+-||++|-.|++.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 4477889999999999999984 456789999887654 334456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC--
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG-- 249 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~-- 249 (361)
+|++||++-.+|-..+- +.+..++.++.++..|+++.| +.|+|||||||+|||||.+|++||+|||+++-+...
T Consensus 709 dYIPGGDmMSLLIrmgI-FeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGI-FEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred eccCCccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceeccc
Confidence 99999999999987765 788888999999999999999 999999999999999999999999999998643210
Q ss_pred -------C-----cc--------------------------eeeecccccccccCccccCCCCCCcccchHHHHHHHHHH
Q 037918 250 -------E-----NF--------------------------ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMET 291 (361)
Q Consensus 250 -------~-----~~--------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~el 291 (361)
. .. ......+||+.|+|||++....++..+|.||.|+|||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 0 00 001224699999999999999999999999999999999
Q ss_pred HhCCCCCCcccccccc
Q 037918 292 FTRKKPTDEFFAGEMS 307 (361)
Q Consensus 292 ltg~~p~~~~~~~~~~ 307 (361)
+.|++||....+.+..
T Consensus 865 ~~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQ 880 (1034)
T ss_pred hhCCCCccCCCCCcce
Confidence 9999999876665543
No 379
>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]
Probab=100.00 E-value=3.2e-36 Score=261.25 Aligned_cols=199 Identities=27% Similarity=0.334 Sum_probs=171.3
Q ss_pred hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC-C-C----ceeeeeeeeecCCe
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-H-R----NLVKILSSCSNVDF 166 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~----niv~~~~~~~~~~~ 166 (361)
.+++|.+...+|+|.||.|-.+... .+..||||+++.- ....+..+-|+++++++. + | -++.+.++|.-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 4789999999999999999999854 4789999998744 445567788999999993 2 2 37888899999999
Q ss_pred eEEEEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC--------------
Q 037918 167 KALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE-------------- 231 (361)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-------------- 231 (361)
.++|+|.+ |.|+.+++.+++ .+++...+..++.|++++++||| +.+++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccc
Confidence 99999998 779999999764 34789999999999999999999 999999999999999931
Q ss_pred ------CCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccc
Q 037918 232 ------NMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFF 302 (361)
Q Consensus 232 ------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~ 302 (361)
+..++++|||.|+...... +....|..|.|||++.+-.++..+||||+||||+||.||...|....
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 3468999999998865432 45578999999999999999999999999999999999999987643
No 380
>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.7e-37 Score=275.24 Aligned_cols=241 Identities=23% Similarity=0.308 Sum_probs=196.5
Q ss_pred CCCCCCCccccCCceEEEEEEeCCC-cEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 96 NGFDECNLLGKGSFGSVYKGILSDG-AEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
.++..+..||-|+||.|-++...+. ..+|+|++++.. .+..+.+..|-++|...+.|.||++|-.|.+....|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 4566677899999999999986543 348888887543 455677889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 251 (361)
|-|-||.|+..+..++. ++......++..+.+|++||| +++||+|||||+|.+++.+|-+||.|||+|+.++.+..
T Consensus 500 EaClGGElWTiLrdRg~-Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGS-FDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred HhhcCchhhhhhhhcCC-cccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 99999999999998776 788888899999999999999 99999999999999999999999999999999876543
Q ss_pred ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918 252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
....+||+.|.|||++.+...+.++|.||||+++|||++|.+||....+.. .+...++. +..+ +
T Consensus 576 ---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk-tYn~ILkG-----id~i-------~ 639 (732)
T KOG0614|consen 576 ---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK-TYNLILKG-----IDKI-------E 639 (732)
T ss_pred ---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHhh-----hhhh-------h
Confidence 345689999999999999999999999999999999999999998643211 11111111 1111 1
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.|. .......+|+++.++.+|.+|.
T Consensus 640 ~Pr-----~I~k~a~~Lik~LCr~~P~ERL 664 (732)
T KOG0614|consen 640 FPR-----RITKTATDLIKKLCRDNPTERL 664 (732)
T ss_pred ccc-----ccchhHHHHHHHHHhcCcHhhh
Confidence 111 1122357889999999999984
No 381
>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=1.5e-35 Score=232.29 Aligned_cols=198 Identities=26% Similarity=0.382 Sum_probs=170.9
Q ss_pred CCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 97 GFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
+|...++||+|.||+||+|+. .+++.||+|.+..+. +..-....+|+-+++.++|.||++++++...+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 466678999999999999995 468899999987554 22335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
| ..+|..+..+-+..++.+.+..++.|+++||.++| +.++.|||+||.|.+++.+|++|++|||+++.++-.- .
T Consensus 83 c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipv--r 156 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--R 156 (292)
T ss_pred h-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--E
Confidence 9 56999999887777999999999999999999999 8999999999999999999999999999999876432 2
Q ss_pred eeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHh-CCCCCCc
Q 037918 254 TRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFT-RKKPTDE 300 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt-g~~p~~~ 300 (361)
..+...-|..|.+|.++.+. -|+...|+||-||++.|+.. |++.|..
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg 205 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence 33445679999999987765 48999999999999999987 5555554
No 382
>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]
Probab=100.00 E-value=2.7e-37 Score=255.79 Aligned_cols=242 Identities=23% Similarity=0.292 Sum_probs=186.3
Q ss_pred CCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHh-cCCCceeeeeeeeecCCeeEEEEEecCCC
Q 037918 101 CNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRS-IRHRNLVKILSSCSNVDFKALVLEFMPNG 177 (361)
Q Consensus 101 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~g 177 (361)
+..||.|+||+|++-.++ .|+..|||++.... +...+++..|.+...+ -+.||||++||.+..++..++.||.| ..
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DI 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hh
Confidence 457999999999998865 69999999998655 3566788888876654 47999999999999999999999999 56
Q ss_pred CHHHHHh----cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 178 SLEKWLY----SHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 178 ~L~~~l~----~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
||..+-+ .+...+++...-.|......||.||.+ ...|+|||+||+|||++..|.+||+|||.+-.+.++ .
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S---i 222 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS---I 222 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHH---H
Confidence 7766543 123348888888999999999999986 568999999999999999999999999999776432 2
Q ss_pred eeecccccccccCccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918 254 TRTMTMATVGYMAPEYGSE--GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 331 (361)
..+...|-..|||||.+.. ..|+.+|||||||++|||+.||+.|+....+ .-+.+.....+....+...
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----vfeql~~Vv~gdpp~l~~~----- 293 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----VFEQLCQVVIGDPPILLFD----- 293 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----HHHHHHHHHcCCCCeecCc-----
Confidence 3455678889999997754 3488999999999999999999999876433 2222222222221111111
Q ss_pred chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
... .+....+..++.-|+..|-+.||
T Consensus 294 ~~~----~~~s~~~~~fintCl~Kd~~~Rp 319 (361)
T KOG1006|consen 294 KEC----VHYSFSMVRFINTCLIKDRSDRP 319 (361)
T ss_pred ccc----cccCHHHHHHHHHHhhcccccCc
Confidence 110 11234578999999999999998
No 383
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.5e-35 Score=272.85 Aligned_cols=233 Identities=26% Similarity=0.295 Sum_probs=187.6
Q ss_pred hhCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEE
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 171 (361)
.+..|.....+|.|+|+.|-.+.. .+++..++|++.... .+..+|+.++... +||||+++.+.+.+..+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 366788888999999999999985 468899999998662 2234577666555 7999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE-cCCCcEEEEeccCccccCCCC
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL-DENMVAHVSDFGISKLLGDGE 250 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfg~a~~~~~~~ 250 (361)
|.+.|+-|.+.+..... ....+..|+.+|+.|+.||| ++|++||||||+|||+ ++.++++|+|||.++.....
T Consensus 396 e~l~g~ell~ri~~~~~--~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPE--FCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hhccccHHHHHHHhcch--hHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999988888876653 33778889999999999999 8999999999999999 68999999999999877543
Q ss_pred cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918 251 NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330 (361)
Q Consensus 251 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 330 (361)
....+-|..|.|||++....|++++|+||||++||+|++|+.||.....+ ..+...+ ......
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i---~~~~~s--------- 532 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRI---QMPKFS--------- 532 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhh---cCCccc---------
Confidence 22346788999999999999999999999999999999999999864433 1111110 011111
Q ss_pred CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
........+|+.+||+.||.+||
T Consensus 533 --------~~vS~~AKdLl~~LL~~dP~~Rl 555 (612)
T KOG0603|consen 533 --------ECVSDEAKDLLQQLLQVDPALRL 555 (612)
T ss_pred --------cccCHHHHHHHHHhccCChhhCc
Confidence 11233468999999999999997
No 384
>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=2.6e-35 Score=278.71 Aligned_cols=251 Identities=23% Similarity=0.314 Sum_probs=203.7
Q ss_pred HHHHHHhhCCCCCCCccccCCceEEEEEE-eCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeee---
Q 037918 88 YLEIQRATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCS--- 162 (361)
Q Consensus 88 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~--- 162 (361)
+..+...++-|++.+.||.|.+|.||+++ .++++.+|+|+.....+. .+++..|.++++.. .|||++.++|++.
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 34444556778899999999999999999 457899999998766433 25678899999988 7999999999984
Q ss_pred --cCCeeEEEEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEe
Q 037918 163 --NVDFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSD 239 (361)
Q Consensus 163 --~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 239 (361)
.++.++||||||.+||.-|++++. +..+.|..+..|++.++.||.+|| ...++|||||-.|||++.++.+||+|
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEee
Confidence 357899999999999999999853 455899999999999999999999 88999999999999999999999999
Q ss_pred ccCccccCCCCcceeeecccccccccCccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhh
Q 037918 240 FGISKLLGDGENFETRTMTMATVGYMAPEYGSE-----GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKE 314 (361)
Q Consensus 240 fg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~ 314 (361)
||.+..+.... .......||+.|||||++.. ..|+.++|+||||++..||--|.+|+-++.+..
T Consensus 167 FGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr--------- 235 (953)
T KOG0587|consen 167 FGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR--------- 235 (953)
T ss_pred eeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---------
Confidence 99998775432 34455679999999998754 347789999999999999999999988765421
Q ss_pred hcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 315 SLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 315 ~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.+-..-.+.+|..........++.++|..||..|-++||
T Consensus 236 --------aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP 274 (953)
T KOG0587|consen 236 --------ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRP 274 (953)
T ss_pred --------hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCc
Confidence 111222223333333445567799999999999999998
No 385
>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.5e-36 Score=266.25 Aligned_cols=205 Identities=30% Similarity=0.480 Sum_probs=172.3
Q ss_pred CCCCCCCccccCCceEEEEEE-eCCCcEEEEEEeehhh-------HHHHHHHHHHHHHHHhcCCCceeeeeeeee-cCCe
Q 037918 96 NGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL-------ERAFRSFDSECEVLRSIRHRNLVKILSSCS-NVDF 166 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~ 166 (361)
++|-.+++||+|||+.||+|. +...+.||+|+-.... ....+...+|.++.+.|.||.||++|+++. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 457778899999999999999 4568899999875432 223456778999999999999999999995 5577
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc---CCCcEEEEeccCc
Q 037918 167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD---ENMVAHVSDFGIS 243 (361)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~a 243 (361)
.+-|+|||+|.+|+-||+.+.. +++.+++.|+.||+.||.||.+- +.+|+|-||||.|||+. .-|.+||+|||++
T Consensus 543 FCTVLEYceGNDLDFYLKQhkl-mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKL-MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhh-hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 8899999999999999987654 89999999999999999999965 88999999999999995 4578999999999
Q ss_pred cccCCCCcc-----eeeecccccccccCccccC----CCCCCcccchHHHHHHHHHHHhCCCCCCccc
Q 037918 244 KLLGDGENF-----ETRTMTMATVGYMAPEYGS----EGIVSSKCDVYSYGVLLMETFTRKKPTDEFF 302 (361)
Q Consensus 244 ~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~----~~~~~~~~Dv~slG~il~elltg~~p~~~~~ 302 (361)
+.++.+... ...+...||.+|++||.+- ...++.+.||||.||++|..+.|+.||....
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq 688 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ 688 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence 998655432 2344567999999999543 2347889999999999999999999998643
No 386
>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.1e-35 Score=252.25 Aligned_cols=247 Identities=21% Similarity=0.293 Sum_probs=198.7
Q ss_pred hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEE
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKAL 169 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 169 (361)
.++|..+++||+|+|..|..+++. +.+.+|+|++++.. .+..+-.+.|-.++.+- +||.+|.+..+|+.+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 357999999999999999999964 67889999987653 33344566777777776 79999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918 170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 249 (361)
|.||++||+|--+++.+++ ++++.++.+..+|.-||.||| ++||+.||||.+|+|+|..|++||+|+|+++.--..
T Consensus 329 vieyv~ggdlmfhmqrqrk-lpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEEecCcceeeehhhhhc-CcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 9999999999988887665 999999999999999999999 999999999999999999999999999999864322
Q ss_pred CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc--ccccccHHHHHhhhcCCCcccccccc
Q 037918 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF--FAGEMSLKNWVKESLPHGLTNVVDEN 327 (361)
Q Consensus 250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~--~~~~~~~~~~~~~~~~~~l~~~~~~~ 327 (361)
. ...+..+||+.|.|||++.+..|....|.|+||++++||+.|+.||+-. ...+.+..+++-+.+- ++.
T Consensus 405 g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil-------ekq 475 (593)
T KOG0695|consen 405 G--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL-------EKQ 475 (593)
T ss_pred C--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh-------hhc
Confidence 2 3455678999999999999999999999999999999999999999743 3334444555433321 111
Q ss_pred ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
+..... .......+++..|+.||.+|.
T Consensus 476 iriprs-------lsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 476 IRIPRS-------LSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ccccce-------eehhhHHHHHHhhcCCcHHhc
Confidence 111110 112246677888999998883
No 387
>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain. Phosphotransferases. Serine or threonine-specific kinase subfamily.
Probab=100.00 E-value=3.7e-34 Score=249.13 Aligned_cols=231 Identities=31% Similarity=0.381 Sum_probs=186.0
Q ss_pred CceEEEEEEeC-CCcEEEEEEeehhhHHH-HHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCHHHHHhc
Q 037918 108 SFGSVYKGILS-DGAEVAIKIFNLQLERA-FRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYS 185 (361)
Q Consensus 108 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 185 (361)
+||.||+|... +|+.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999997655433 57889999999999999999999999999999999999999999999986
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeeccccccccc
Q 037918 186 HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYM 265 (361)
Q Consensus 186 ~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~ 265 (361)
... +++..++.++.+++.++.+|| +.+++|+||+|+||++++++.++|+|||.+....... ......++..|+
T Consensus 81 ~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR-LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM 153 (244)
T ss_pred ccC-CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence 554 889999999999999999999 8899999999999999999999999999998765432 223345788999
Q ss_pred CccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHH
Q 037918 266 APEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSI 345 (361)
Q Consensus 266 aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l 345 (361)
+||...+..++.++|+||||+++|+|++|..||...... ....+........ .. ... ......+
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~~~~~~~~~~----~~-----~~~------~~~~~~~ 217 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LELFKKIGKPKPP----FP-----PPE------WKISPEA 217 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhccCCC----Cc-----ccc------ccCCHHH
Confidence 999988888899999999999999999999998653211 1111111111000 00 000 0023358
Q ss_pred HHHHhhcCCCCCCCCC
Q 037918 346 MHLALDCSMYSPDQRI 361 (361)
Q Consensus 346 ~~l~~~cl~~dP~~RP 361 (361)
.+++.+|+..+|++||
T Consensus 218 ~~~i~~~l~~~p~~Rp 233 (244)
T smart00220 218 KDLIRKLLVKDPEKRL 233 (244)
T ss_pred HHHHHHHccCCchhcc
Confidence 8999999999999998
No 388
>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=2.7e-36 Score=248.20 Aligned_cols=262 Identities=22% Similarity=0.335 Sum_probs=191.5
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeec--------C
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSN--------V 164 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~ 164 (361)
+.|.-..+||+|.||.||+|+.+ +|+.||+|+.-.+. ...-....+|+.+|..++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34566678999999999999954 57888988654332 2222456789999999999999999998843 2
Q ss_pred CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918 165 DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK 244 (361)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 244 (361)
...|+||.+|+. +|..++.+....++..++.+++.++..||.|+| ...|+|||+||.|+||+.+|.+||+|||+++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 358999999965 999999887666999999999999999999999 8899999999999999999999999999998
Q ss_pred ccCCCCcce--eeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcccc-ccccHHHHHhhhc-CCC
Q 037918 245 LLGDGENFE--TRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFFA-GEMSLKNWVKESL-PHG 319 (361)
Q Consensus 245 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~-~~~~~~~~~~~~~-~~~ 319 (361)
.+....+.. ..+...-|..|.+||.+.+ ..|+++.|||+-||++.||+||.+-+..... ....+...+.+++ ++-
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 765433321 2334556999999997655 6699999999999999999999998765321 1112222222222 222
Q ss_pred ccccccc----cccCC---chhHHHHHHHHH------HHHHHHhhcCCCCCCCCC
Q 037918 320 LTNVVDE----NLLLE---EPAFAAKMDCML------SIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 320 l~~~~~~----~l~~~---~~~~~~~~~~~~------~l~~l~~~cl~~dP~~RP 361 (361)
|.++.+- .+..+ ....+...+.+. ...+|+..++..||.+||
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~ 307 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRI 307 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCc
Confidence 2222111 11000 011111122222 467899999999999997
No 389
>PLN03225 Serine/threonine-protein kinase SNT7; Provisional
Probab=100.00 E-value=3e-34 Score=277.00 Aligned_cols=198 Identities=23% Similarity=0.285 Sum_probs=142.4
Q ss_pred hhCCCCCCCccccCCceEEEEEEeC-C----CcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeee------ee
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILS-D----GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSS------CS 162 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~------~~ 162 (361)
..++|.+.+.||+|+||.||+|.+. + +..||+|++...... +....+ .+....+.++..+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678999999999999999999965 4 689999987643221 111111 1122222233322221 24
Q ss_pred cCCeeEEEEEecCCCCHHHHHhcCCCCC-------------------CHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCC
Q 037918 163 NVDFKALVLEFMPNGSLEKWLYSHNYFL-------------------DIQERLNVMIDVGSALEYLHHGYSPSVVHCDLK 223 (361)
Q Consensus 163 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------------------~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk 223 (361)
.....++||||+++++|.+++....... ....+..++.|++.||+||| +.+|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence 5667899999999999999987543211 12345679999999999999 8899999999
Q ss_pred CCCEEEcC-CCcEEEEeccCccccCCCCcceeeecccccccccCccccCCC----------------------CCCcccc
Q 037918 224 PSNILLDE-NMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG----------------------IVSSKCD 280 (361)
Q Consensus 224 ~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~~D 280 (361)
|+|||++. ++.+||+|||+++.+..... .......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 67999999999986643322 122345689999999954321 2344679
Q ss_pred hHHHHHHHHHHHhCCCCCC
Q 037918 281 VYSYGVLLMETFTRKKPTD 299 (361)
Q Consensus 281 v~slG~il~elltg~~p~~ 299 (361)
||||||+||||+++..|++
T Consensus 362 VwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred cHHHHHHHHHHHhCcCCCc
Confidence 9999999999999877654
No 390
>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]
Probab=100.00 E-value=4.1e-34 Score=228.77 Aligned_cols=207 Identities=26% Similarity=0.336 Sum_probs=170.1
Q ss_pred HHhhCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeE
Q 037918 92 QRATNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKA 168 (361)
Q Consensus 92 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 168 (361)
+...+....+..||+|++|.|-+-++ .+|+..|+|.+.... .+..++...|+.+..+- .+|.+|.++|........+
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 33444455567899999999988875 479999999987654 34456778888876654 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918 169 LVLEFMPNGSLEKWLY---SHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL 245 (361)
Q Consensus 169 lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 245 (361)
+.||.| ..||+.+-. ..+..+++..+-+|+..+..||.|||+ +..++|||+||+|||++.+|++|+||||.+-.
T Consensus 122 IcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 122 ICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEccccccee
Confidence 999999 568877654 345568999999999999999999997 67899999999999999999999999999987
Q ss_pred cCCCCcceeeecccccccccCccccC----CCCCCcccchHHHHHHHHHHHhCCCCCCccccc
Q 037918 246 LGDGENFETRTMTMATVGYMAPEYGS----EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAG 304 (361)
Q Consensus 246 ~~~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~ 304 (361)
+.++- ..+...|-..|||||.+. ...|+-+|||||||+++.||.+++.||+.-...
T Consensus 199 L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 199 LVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred ehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 75432 233356888899999754 346899999999999999999999999865443
No 391
>PLN03224 probable serine/threonine protein kinase; Provisional
Probab=100.00 E-value=5.4e-33 Score=262.14 Aligned_cols=203 Identities=25% Similarity=0.322 Sum_probs=153.4
Q ss_pred hhCCCCCCCccccCCceEEEEEEe-----------------CCCcEEEEEEeehhhHHHHHH--------------HHHH
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGIL-----------------SDGAEVAIKIFNLQLERAFRS--------------FDSE 142 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~e 142 (361)
..++|++.++||+|+||.||+|.. .+++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999963 235679999987543222222 3346
Q ss_pred HHHHHhcCCCce-----eeeeeeeec--------CCeeEEEEEecCCCCHHHHHhcCC----------------------
Q 037918 143 CEVLRSIRHRNL-----VKILSSCSN--------VDFKALVLEFMPNGSLEKWLYSHN---------------------- 187 (361)
Q Consensus 143 ~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~---------------------- 187 (361)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.+++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 677777766554 677777643 356899999999999999987421
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecccccccccC
Q 037918 188 -YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMA 266 (361)
Q Consensus 188 -~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~a 266 (361)
..+++..+..++.|++.+|.||| +.+|+||||||+||+++.++.+||+|||++......... ......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 12456788899999999999999 889999999999999999999999999999765432211 1122345789999
Q ss_pred ccccCCCCC----------------------CcccchHHHHHHHHHHHhCCC-CCCc
Q 037918 267 PEYGSEGIV----------------------SSKCDVYSYGVLLMETFTRKK-PTDE 300 (361)
Q Consensus 267 PE~~~~~~~----------------------~~~~Dv~slG~il~elltg~~-p~~~ 300 (361)
||.+..... ..+.||||+||++++|++|.. ||..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 997653221 124799999999999999986 6653
No 392
>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]
Probab=100.00 E-value=6.4e-34 Score=268.08 Aligned_cols=237 Identities=28% Similarity=0.420 Sum_probs=182.8
Q ss_pred CCCCCccccCCceE-EEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEEecC
Q 037918 98 FDECNLLGKGSFGS-VYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLEFMP 175 (361)
Q Consensus 98 ~~~~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 175 (361)
|...+.+|.|+.|+ ||+|.. +|+.||||++-.. ......+|+..|+.- +||||+++++.-.+....|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 44456788888864 799998 6899999987543 334667899999887 6999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCC---CHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC---C--CcEEEEeccCccccC
Q 037918 176 NGSLEKWLYSHNYFL---DIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE---N--MVAHVSDFGISKLLG 247 (361)
Q Consensus 176 ~g~L~~~l~~~~~~~---~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~--~~~kl~Dfg~a~~~~ 247 (361)
..+|.+++....... .-...+..+.|+++||++|| +.+||||||||.||||+. + ..++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 569999998741111 11345778999999999999 899999999999999975 3 479999999999987
Q ss_pred CCCcc-eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhC-CCCCCccccccccHHHHHhhhcCCCcccccc
Q 037918 248 DGENF-ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVD 325 (361)
Q Consensus 248 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 325 (361)
.+... .......||-+|+|||++....-+.++||||+||++|+.++| ..||.+....+.++. .
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl---------------~ 727 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL---------------T 727 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh---------------c
Confidence 65432 234556799999999999988888899999999999999996 899987543332211 1
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 326 ENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 326 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
....... .....++ ...+||.+|++++|..||
T Consensus 728 ~~~~L~~--L~~~~d~--eA~dLI~~ml~~dP~~RP 759 (903)
T KOG1027|consen 728 GNYTLVH--LEPLPDC--EAKDLISRMLNPDPQLRP 759 (903)
T ss_pred Cccceee--eccCchH--HHHHHHHHhcCCCcccCC
Confidence 1100000 0001122 368999999999999998
No 393
>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]
Probab=100.00 E-value=2.1e-33 Score=254.75 Aligned_cols=196 Identities=25% Similarity=0.390 Sum_probs=169.7
Q ss_pred CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---H-----HHHHHHHHHHHHHHhcC---CCceeeeeeeeec
Q 037918 96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---E-----RAFRSFDSECEVLRSIR---HRNLVKILSSCSN 163 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~-----~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~ 163 (361)
.+|+.++.+|+|+||.|+.|.++ +...|+||.+.+.. + +..-.+..|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45899999999999999999976 56789999887653 1 11223567999999997 9999999999999
Q ss_pred CCeeEEEEEec-CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccC
Q 037918 164 VDFKALVLEFM-PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGI 242 (361)
Q Consensus 164 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 242 (361)
++++||+||-. ++.+|.+++.-+.. +++.++..|+.|++-|+++|| +.+|+|||||-+|+.++.+|-+||+|||.
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~-m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPR-MDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCc-cchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccc
Confidence 99999999975 45699999986654 899999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCcceeeecccccccccCccccCCCCC-CcccchHHHHHHHHHHHhCCCCCC
Q 037918 243 SKLLGDGENFETRTMTMATVGYMAPEYGSEGIV-SSKCDVYSYGVLLMETFTRKKPTD 299 (361)
Q Consensus 243 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~ 299 (361)
+....... -...+||..|.|||++.+..| +..-|||++|++||.++....||.
T Consensus 717 aa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 98765433 234679999999999988765 667999999999999999999985
No 394
>smart00221 STYKc Protein kinase; unclassified specificity. Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.
Probab=99.98 E-value=4.8e-31 Score=227.16 Aligned_cols=199 Identities=29% Similarity=0.431 Sum_probs=173.1
Q ss_pred CCCCCccccCCceEEEEEEeCC-CcEEEEEEeehhhHH-HHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918 98 FDECNLLGKGSFGSVYKGILSD-GAEVAIKIFNLQLER-AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 175 (361)
|.+.+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+.+++|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999999764 899999999866544 56788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee
Q 037918 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR 255 (361)
Q Consensus 176 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 255 (361)
+++|.+++......+++..+..++.+++.++.+|| +.+++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALL 156 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccc
Confidence 99999999865433789999999999999999999 88999999999999999999999999999987754320 012
Q ss_pred ecccccccccCcccc-CCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918 256 TMTMATVGYMAPEYG-SEGIVSSKCDVYSYGVLLMETFTRKKPTDE 300 (361)
Q Consensus 256 ~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slG~il~elltg~~p~~~ 300 (361)
....++..|++||.. ....++.++|+|+||+++++|++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 234577889999987 667788899999999999999999999965
No 395
>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]
Probab=99.98 E-value=1.4e-32 Score=223.39 Aligned_cols=197 Identities=21% Similarity=0.448 Sum_probs=166.7
Q ss_pred HhhCCCCCCCccccCCceEEEEEE-eCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC-CCceeeeeeeeecCC--eeE
Q 037918 93 RATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-HRNLVKILSSCSNVD--FKA 168 (361)
Q Consensus 93 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~~~ 168 (361)
...++|++.+++|+|.++.||.|. ..+++.++||+++.-.. +.+.+|+.+|+.+. ||||+++++...+.. .+.
T Consensus 35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 356789999999999999999999 45788999999986543 46788999999996 999999999987654 577
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC-CcEEEEeccCccccC
Q 037918 169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN-MVAHVSDFGISKLLG 247 (361)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~~ 247 (361)
||+||+++.+...+... ++...+..++.++++||.|+| +.||+|||+||.|+++|.. -.++|+|+|+|.+..
T Consensus 112 LiFE~v~n~Dfk~ly~t----l~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYPT----LTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hHhhhhccccHHHHhhh----hchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 99999999887776543 677788899999999999999 9999999999999999854 469999999999987
Q ss_pred CCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccc
Q 037918 248 DGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFF 302 (361)
Q Consensus 248 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~ 302 (361)
..... .....+..|.-||.+-. ..|+..-|+|||||++..|+..+.||-...
T Consensus 185 p~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~ 237 (338)
T KOG0668|consen 185 PGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 237 (338)
T ss_pred CCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC
Confidence 65433 23356778899997655 558899999999999999999999986433
No 396
>cd00180 PKc Catalytic domain of Protein Kinases. Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which
Probab=99.98 E-value=1.3e-30 Score=221.60 Aligned_cols=202 Identities=35% Similarity=0.527 Sum_probs=176.6
Q ss_pred cccCCceEEEEEEeCC-CcEEEEEEeehhhHH-HHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCHHH
Q 037918 104 LGKGSFGSVYKGILSD-GAEVAIKIFNLQLER-AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEK 181 (361)
Q Consensus 104 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~ 181 (361)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999999866432 34678899999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC-CCcEEEEeccCccccCCCCcceeeecccc
Q 037918 182 WLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE-NMVAHVSDFGISKLLGDGENFETRTMTMA 260 (361)
Q Consensus 182 ~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 260 (361)
++......+++..++.++.++++++++|| +.+++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~ 155 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG 155 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence 99876344899999999999999999999 889999999999999999 89999999999987644321 1233457
Q ss_pred cccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHH
Q 037918 261 TVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKM 339 (361)
Q Consensus 261 ~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 339 (361)
...|++||..... ..+.++|+|++|+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 8889999988776 788999999999999999
Q ss_pred HHHHHHHHHHhhcCCCCCCCCC
Q 037918 340 DCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 340 ~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..+.+++..|++.||++||
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~ 206 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRP 206 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCc
Confidence 2378899999999999997
No 397
>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]
Probab=99.97 E-value=3.6e-32 Score=226.15 Aligned_cols=243 Identities=20% Similarity=0.282 Sum_probs=182.9
Q ss_pred hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeee-eecCCeeEEEE
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSS-CSNVDFKALVL 171 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~-~~~~~~~~lv~ 171 (361)
.+.|++.+.||+|.||.+-++.++ ..+.+++|.+..... ...+|.+|..---.| .|.||+.-|++ |+..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 456899999999999999999975 578899998876543 346788888765555 58999998875 67778888999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc--CCCcEEEEeccCccccCCC
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD--ENMVAHVSDFGISKLLGDG 249 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~a~~~~~~ 249 (361)
||++.|+|.+-+...+ +.+....+++.|+++|+.|+| ++++||||||.+||||- +...+||+|||+.+..+..
T Consensus 102 E~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred ccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 9999999999887755 788889999999999999999 99999999999999993 4458999999999865432
Q ss_pred CcceeeecccccccccCccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccc
Q 037918 250 ENFETRTMTMATVGYMAPEYGSE-----GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVV 324 (361)
Q Consensus 250 ~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~ 324 (361)
.....-+..|.+||.... -...+.+|+|.||+++|..+||..||+.....+..+.+|.+-.- +..
T Consensus 177 -----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~--rk~--- 246 (378)
T KOG1345|consen 177 -----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLK--RKN--- 246 (378)
T ss_pred -----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhc--ccC---
Confidence 122335667899995432 22577899999999999999999999865555555555543211 111
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCC
Q 037918 325 DENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360 (361)
Q Consensus 325 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 360 (361)
+++......+ ...++++.++-+.++|++|
T Consensus 247 -~~~P~~F~~f------s~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 247 -PALPKKFNPF------SEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred -ccCchhhccc------CHHHHHHHHHhcCCccccc
Confidence 1111111111 1235677778888888877
No 398
>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.97 E-value=1.4e-32 Score=228.97 Aligned_cols=197 Identities=24% Similarity=0.365 Sum_probs=164.6
Q ss_pred CCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC-----eeEEE
Q 037918 99 DECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD-----FKALV 170 (361)
Q Consensus 99 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv 170 (361)
+..+.||-|+||.||.+++. +|+.||+|++..-. -...+++.+|+.+|..++|.|++..++..+... ..|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 33578999999999999964 79999999886533 223467889999999999999999998875543 56788
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918 171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE 250 (361)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 250 (361)
+|.+ ..+|...+-+... ++.+.+.-++.||++||.||| +.+|.||||||.|.|++.|-.+||+|||+++..+.++
T Consensus 136 TELm-QSDLHKIIVSPQ~-Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVSPQA-LTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHH-HhhhhheeccCCC-CCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 8888 4588887765543 888899999999999999999 9999999999999999999999999999999875443
Q ss_pred cceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 251 NFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 251 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
. ..++...-|..|.|||++.+ ..|+.+.||||.||++.||+.++..|...
T Consensus 211 ~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq 261 (449)
T KOG0664|consen 211 R-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA 261 (449)
T ss_pred h-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc
Confidence 3 23444567889999998876 45999999999999999999999888653
No 399
>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]
Probab=99.97 E-value=1.8e-31 Score=239.50 Aligned_cols=200 Identities=25% Similarity=0.282 Sum_probs=170.7
Q ss_pred hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC------CCceeeeeeeeecCCe
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIR------HRNLVKILSSCSNVDF 166 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~~~~ 166 (361)
...+|.+....|+|-|++|.+|... .|+.||||++.... --.+.=+.|+++|++|+ --|+++++..|...++
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 3468999999999999999999964 48899999998653 22344567999999995 3489999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC-cEEEEeccCc
Q 037918 167 KALVLEFMPNGSLEKWLYSHN--YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM-VAHVSDFGIS 243 (361)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a 243 (361)
+|||+|-+ ..+|.+.|++-+ ..+....+..++.|+.-||..|- ..+|+|.||||+|||+++.- .+||||||.|
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCccc
Confidence 99999998 679999998643 34788999999999999999999 88999999999999998654 6899999999
Q ss_pred cccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccc
Q 037918 244 KLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFF 302 (361)
Q Consensus 244 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~ 302 (361)
...+.+.- +.+.-+..|.|||++.+.+|+...|+||.||+||||.||+..|.+..
T Consensus 585 ~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 585 SFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred cccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 88765432 33345667999999999999999999999999999999999887643
No 400
>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.97 E-value=9e-30 Score=227.22 Aligned_cols=131 Identities=24% Similarity=0.367 Sum_probs=111.5
Q ss_pred hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC-----C---Cceeeeeeeeec--
Q 037918 95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-----H---RNLVKILSSCSN-- 163 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~~~~~~~~-- 163 (361)
.++|.+.++||.|.|++||++.+ .+.+.||+|+.+.. ....+....|+++|++++ | .+||++++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 36788999999999999999995 46788999998755 334467788999999983 3 469999999954
Q ss_pred --CCeeEEEEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 037918 164 --VDFKALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL 229 (361)
Q Consensus 164 --~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill 229 (361)
+.+.++|+|+. |.+|..+|.... ..++...+.+|+.||+.||.|||..| +|+|-||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 45899999999 779999887543 34899999999999999999999855 99999999999998
No 401
>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]
Probab=99.97 E-value=8.8e-32 Score=247.91 Aligned_cols=246 Identities=24% Similarity=0.342 Sum_probs=197.9
Q ss_pred hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
.++|+.+..+|+|.+|.||+++.. .++..|+|+++........-+.+|+-+++..+||||+.++|.+...+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 357888999999999999999964 6899999999988777777888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 253 (361)
|.+|+|.+.-+-.+ .+++.++....++.++||+||| +.+-+|||||-.||++++.|.+|+.|||.+-.+... ..
T Consensus 94 cgggslQdiy~~Tg-plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i~ 167 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IA 167 (829)
T ss_pred cCCCcccceeeecc-cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhh--hh
Confidence 99999999776544 3899999999999999999999 899999999999999999999999999998776532 22
Q ss_pred eeecccccccccCccc---cCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918 254 TRTMTMATVGYMAPEY---GSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330 (361)
Q Consensus 254 ~~~~~~g~~~y~aPE~---~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 330 (361)
.+....||+.|||||+ -..+.|...+|||++|++..|+---++|-.+..+.. ..........
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr--~l~LmTkS~~------------- 232 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR--ALFLMTKSGF------------- 232 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH--HHHHhhccCC-------------
Confidence 4456789999999995 456778999999999999999998888854332211 1111111110
Q ss_pred CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..+...+.......+.++++.|+-.+|.+||
T Consensus 233 qpp~lkDk~kws~~fh~fvK~altknpKkRp 263 (829)
T KOG0576|consen 233 QPPTLKDKTKWSEFFHNFVKGALTKNPKKRP 263 (829)
T ss_pred CCCcccCCccchHHHHHHHHHHhcCCCccCC
Confidence 1111111112233488999999999999998
No 402
>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]
Probab=99.97 E-value=1.4e-30 Score=221.39 Aligned_cols=195 Identities=22% Similarity=0.303 Sum_probs=164.2
Q ss_pred hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC------C
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV------D 165 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 165 (361)
..+|..++.+|.|.- .|..+.+. .++.||+|...... ....++..+|..++..++|+||++++.++... .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 346777888999987 56555543 58999999875432 23346778899999999999999999998644 3
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918 166 FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL 245 (361)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 245 (361)
..|+|||++ ..+|.+.+... ++-..+..++.|++.|++||| +.+|+||||||+||++..+..+||.|||+|+.
T Consensus 95 e~y~v~e~m-~~nl~~vi~~e---lDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILME---LDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHHh---cchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcc
Confidence 578999999 67999988732 788889999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918 246 LGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDE 300 (361)
Q Consensus 246 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~ 300 (361)
-+.. ...+....+..|.|||++.+..+.+.+||||+||++.||++|+.-|.+
T Consensus 168 e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g 219 (369)
T KOG0665|consen 168 EDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG 219 (369)
T ss_pred cCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC
Confidence 5443 245566789999999999888899999999999999999999988763
No 403
>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]
Probab=99.95 E-value=2.5e-28 Score=214.94 Aligned_cols=209 Identities=27% Similarity=0.348 Sum_probs=171.1
Q ss_pred HHHhhCCCCCCCccccCCceEEEEEEeC----CCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCC
Q 037918 91 IQRATNGFDECNLLGKGSFGSVYKGILS----DGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVD 165 (361)
Q Consensus 91 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 165 (361)
+....+.|..+++||+|.|++||++.+. ..+.||+|.+...... .++..|+++|..+ -+.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445567999999999999999999843 4678999998765433 5688999999999 5999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC-CCcEEEEeccCcc
Q 037918 166 FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE-NMVAHVSDFGISK 244 (361)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~ 244 (361)
...+|+||++..+..++... ++...+..+++.++.||+++| ..|||||||||+|+|.+. .+.-.|+|||+|.
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred eeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHH
Confidence 99999999999999998865 778999999999999999999 999999999999999974 5678999999997
Q ss_pred ccCCCC------------------------------------------cceeeecccccccccCccccCC-CCCCcccch
Q 037918 245 LLGDGE------------------------------------------NFETRTMTMATVGYMAPEYGSE-GIVSSKCDV 281 (361)
Q Consensus 245 ~~~~~~------------------------------------------~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv 281 (361)
...... .........||++|.|||++.. ..-+++.||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 211000 0001122469999999998765 446889999
Q ss_pred HHHHHHHHHHHhCCCCCCccccccccH
Q 037918 282 YSYGVLLMETFTRKKPTDEFFAGEMSL 308 (361)
Q Consensus 282 ~slG~il~elltg~~p~~~~~~~~~~~ 308 (361)
||.|+++..+++++.||-....+-..+
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al 288 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADAL 288 (418)
T ss_pred eeccceeehhhccccccccCccccchH
Confidence 999999999999999987654444433
No 404
>PLN00181 protein SPA1-RELATED; Provisional
Probab=99.95 E-value=1e-28 Score=249.68 Aligned_cols=188 Identities=21% Similarity=0.241 Sum_probs=131.9
Q ss_pred cCC-Cceeeeeeee-------ecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeC
Q 037918 149 IRH-RNLVKILSSC-------SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHC 220 (361)
Q Consensus 149 l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~ 220 (361)
++| +||.+++++| ...+..++++||+ +++|.+++......+++.+++.++.||++||+||| +++|+||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvHr 104 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVVH 104 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence 345 5788888877 2334567788987 67999999866556899999999999999999999 8999999
Q ss_pred CCCCCCEEEcCCC-------------------cEEEEeccCccccCCCCc--------------ceeeecccccccccCc
Q 037918 221 DLKPSNILLDENM-------------------VAHVSDFGISKLLGDGEN--------------FETRTMTMATVGYMAP 267 (361)
Q Consensus 221 dlk~~Nill~~~~-------------------~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~g~~~y~aP 267 (361)
||||+|||++..+ .+|++|||+++....... ........||+.|+||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 9999999996544 455566666543211000 0001123578889999
Q ss_pred cccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHH
Q 037918 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMH 347 (361)
Q Consensus 268 E~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~ 347 (361)
|++.+..++.++|||||||+||||++|.+|+..... ..........+ +.. .........
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~~~~--------~~~----------~~~~~~~~~ 243 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHRVLP--------PQI----------LLNWPKEAS 243 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHhhcC--------hhh----------hhcCHHHHH
Confidence 999999999999999999999999999988653211 11111111010 000 011122467
Q ss_pred HHhhcCCCCCCCCC
Q 037918 348 LALDCSMYSPDQRI 361 (361)
Q Consensus 348 l~~~cl~~dP~~RP 361 (361)
++.+||++||.+||
T Consensus 244 ~~~~~L~~~P~~Rp 257 (793)
T PLN00181 244 FCLWLLHPEPSCRP 257 (793)
T ss_pred HHHHhCCCChhhCc
Confidence 78899999999998
No 405
>smart00750 KIND kinase non-catalytic C-lobe domain. It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features
Probab=99.95 E-value=1.9e-27 Score=197.26 Aligned_cols=157 Identities=22% Similarity=0.208 Sum_probs=117.0
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918 177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256 (361)
Q Consensus 177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 256 (361)
|+|.+++..++..+++..++.++.|++.||+||| +.+ ||+||+++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc------
Confidence 6899999876666999999999999999999999 555 999999999999999 99998754321
Q ss_pred cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918 257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA 336 (361)
Q Consensus 257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~ 336 (361)
..|++.|+|||++.+..++.++|||||||++|||+||+.||.........+..+.....+... ......
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~- 132 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDP---------RDRSNL- 132 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCc---------cccccH-
Confidence 258899999999999999999999999999999999999986543222222222111110000 000000
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 337 AKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 337 ~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
........+.+++.+||+.||++||
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp 157 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRRE 157 (176)
T ss_pred HHHHhhhhHHHHHHHHHhccccccc
Confidence 0111112589999999999999998
No 406
>PRK09188 serine/threonine protein kinase; Provisional
Probab=99.95 E-value=8e-27 Score=211.53 Aligned_cols=166 Identities=21% Similarity=0.245 Sum_probs=129.6
Q ss_pred HHhhCCCCCCCccccCCceEEEEEEeC--CCcEEEEEEeehh-----hHHHHHHHHHHHHHHHhcCCCceee-eeeeeec
Q 037918 92 QRATNGFDECNLLGKGSFGSVYKGILS--DGAEVAIKIFNLQ-----LERAFRSFDSECEVLRSIRHRNLVK-ILSSCSN 163 (361)
Q Consensus 92 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~ 163 (361)
....++|.+.+.||+|+||+||+|... +++.+|||++... .......+.+|++++++++|+|++. ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 345678999999999999999999864 5778899986532 1233467899999999999999985 4432
Q ss_pred CCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC-CCCCEEEcCCCcEEEEeccC
Q 037918 164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL-KPSNILLDENMVAHVSDFGI 242 (361)
Q Consensus 164 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfg~ 242 (361)
+..++||||++|++|.. +... . ...++.+++++|.||| +.+|+|||| ||+|||++.++.+||+|||+
T Consensus 91 -~~~~LVmE~~~G~~L~~-~~~~----~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHL-ARPH----G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred -CCcEEEEEccCCCCHHH-hCcc----c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 45799999999999963 2111 1 1467899999999999 899999999 99999999999999999999
Q ss_pred ccccCCCCccee------eecccccccccCccccCC
Q 037918 243 SKLLGDGENFET------RTMTMATVGYMAPEYGSE 272 (361)
Q Consensus 243 a~~~~~~~~~~~------~~~~~g~~~y~aPE~~~~ 272 (361)
|+.+........ -+...+++.|+|||.+..
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 997754332111 134467888999997654
No 407
>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.93 E-value=8.6e-25 Score=198.48 Aligned_cols=202 Identities=22% Similarity=0.275 Sum_probs=166.8
Q ss_pred CCCCCCccccCCceEEEEEEeCCC--cEEEEEEeehhhHHHHHHHHHHHHHHHhcCC----Cceeeeeeee-ecCCeeEE
Q 037918 97 GFDECNLLGKGSFGSVYKGILSDG--AEVAIKIFNLQLERAFRSFDSECEVLRSIRH----RNLVKILSSC-SNVDFKAL 169 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~-~~~~~~~l 169 (361)
+|.+.+.||+|+||.||.+...+. ..+|+|............+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996543 5789998765433222257778888888863 6899999998 57888999
Q ss_pred EEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC-----CcEEEEeccCc
Q 037918 170 VLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN-----MVAHVSDFGIS 243 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Dfg~a 243 (361)
||+.+ |.+|.++..... ..++..++..++.|++.+|.+|| +.|++||||||+|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99998 889999886554 56999999999999999999999 9999999999999999755 46999999999
Q ss_pred c--ccCCCCcc------eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccc
Q 037918 244 K--LLGDGENF------ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFF 302 (361)
Q Consensus 244 ~--~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~ 302 (361)
+ .+...... .......||..|+++....+...+.+.|+||++.++.|++.|..||....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 8 33222110 11234569999999999999999999999999999999999999996543
No 408
>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]
Probab=99.92 E-value=4.6e-26 Score=190.06 Aligned_cols=236 Identities=22% Similarity=0.364 Sum_probs=176.3
Q ss_pred CCCCccccCCceEEEEEEeCCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918 99 DECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPN 176 (361)
Q Consensus 99 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (361)
....+|.+...|+.|+|+++ |..+++|++.... .+..++|..|.-.|+-+.||||+.++|.|....++.++..|++.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 34567889999999999995 5566778776432 33446788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee
Q 037918 177 GSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR 255 (361)
Q Consensus 177 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 255 (361)
|+|...+.... ...+..++.+++.++++|++|||+- .+-|.---|.+..+++|++.+++|+- +-+++. ...
T Consensus 272 gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfs------fqe 343 (448)
T KOG0195|consen 272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFS------FQE 343 (448)
T ss_pred hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceee------eec
Confidence 99999998653 3468889999999999999999954 44455667899999999999888752 111110 111
Q ss_pred ecccccccccCccccCCCCC---CcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918 256 TMTMATVGYMAPEYGSEGIV---SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332 (361)
Q Consensus 256 ~~~~g~~~y~aPE~~~~~~~---~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 332 (361)
....-.+.|++||.+...+- -.++|+|||++++|||.|+..||.+..+.+....--+ +.+..-+.+.
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial-----eglrv~ippg----- 413 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL-----EGLRVHIPPG----- 413 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-----ccccccCCCC-----
Confidence 22346788999998877653 3479999999999999999999987655433221110 1111111111
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
....+.+|+.-|+..||.+||
T Consensus 414 --------is~hm~klm~icmnedpgkrp 434 (448)
T KOG0195|consen 414 --------ISRHMNKLMNICMNEDPGKRP 434 (448)
T ss_pred --------ccHHHHHHHHHHhcCCCCcCC
Confidence 122367889999999999998
No 409
>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]
Probab=99.92 E-value=1.2e-23 Score=191.00 Aligned_cols=199 Identities=37% Similarity=0.516 Sum_probs=170.3
Q ss_pred CCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHH---HHHHHHHHHHHHHhcCCC-ceeeeeeeeecCCeeEEEEEe
Q 037918 98 FDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLER---AFRSFDSECEVLRSIRHR-NLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~ 173 (361)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|..++..+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 567788999999999999976 78899988765432 467889999999999988 799999999877778999999
Q ss_pred cCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC-cEEEEeccCccccCCCC
Q 037918 174 MPNGSLEKWLYSHN--YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM-VAHVSDFGISKLLGDGE 250 (361)
Q Consensus 174 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~ 250 (361)
+.++++.+++.... ..+.......++.|++.++.|+| ..+++|||+||+||+++..+ .++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997777654 25889999999999999999999 88999999999999999988 79999999998654433
Q ss_pred cce----eeecccccccccCccccCC---CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918 251 NFE----TRTMTMATVGYMAPEYGSE---GIVSSKCDVYSYGVLLMETFTRKKPTDEF 301 (361)
Q Consensus 251 ~~~----~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~p~~~~ 301 (361)
... ......|+..|+|||...+ ..++...|+||+|++++++++|..||...
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~ 214 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE 214 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 211 2345679999999998877 57889999999999999999999997654
No 410
>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.92 E-value=1.8e-24 Score=185.25 Aligned_cols=203 Identities=21% Similarity=0.310 Sum_probs=172.9
Q ss_pred CCCCCCCccccCCceEEEEEE-eCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEEe
Q 037918 96 NGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
-.|.+.++||+|+||.++.|+ +-+++.||||.-...++ ...+..|.+..+.| ..+.|..+|-+...+-+..||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 469999999999999999999 45899999997654432 24566788888888 578999999998888889999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC-----CcEEEEeccCccccCC
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN-----MVAHVSDFGISKLLGD 248 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Dfg~a~~~~~ 248 (361)
. |.||.|++.-.+..++..++..++.|++.-++|+| ++.+|.|||||+|+||..- ..+.++|||+|+.+.+
T Consensus 106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 9 89999999866666999999999999999999999 8999999999999999643 3589999999998765
Q ss_pred CCc-----ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccc
Q 037918 249 GEN-----FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAG 304 (361)
Q Consensus 249 ~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~ 304 (361)
... ...+....||.+||+--...+..-+.+.|+=|||-+++..+-|..||.....+
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 432 22334457999999998888888899999999999999999999999876543
No 411
>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.92 E-value=3.2e-25 Score=181.89 Aligned_cols=204 Identities=25% Similarity=0.324 Sum_probs=170.1
Q ss_pred hhCCCCCCCccccCCceEEEEEE-eCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC-CCceeeeeeeeecCCeeEEEE
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-HRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 171 (361)
..++|.++++||+|+||.+|.|. ..+|..||||+-...... ..+..|..+...++ ...|..+.-+..+.+...+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 34679999999999999999999 568999999987654322 45677899999996 467888888888999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC---CCcEEEEeccCccccCC
Q 037918 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE---NMVAHVSDFGISKLLGD 248 (361)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~~~~~ 248 (361)
+.. |.||.++++--...++..+++-++-|++.-++|+| .++++||||||+|+|..- ...+.++|||+|+.+.+
T Consensus 91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 998 89999999855555899999999999999999999 889999999999999964 34689999999988754
Q ss_pred CCc-----ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcccc
Q 037918 249 GEN-----FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFA 303 (361)
Q Consensus 249 ~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~ 303 (361)
... ........||.+|.+--...+..-+.+.|+-|+|.+|....-|..||++...
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 322 1222345699999987766666678899999999999999999999998654
No 412
>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional
Probab=99.91 E-value=1.1e-24 Score=184.23 Aligned_cols=171 Identities=13% Similarity=0.150 Sum_probs=133.5
Q ss_pred hhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhH---HHHHH------HHHHHHHHHhcCCCceeeeeeeeecC
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLE---RAFRS------FDSECEVLRSIRHRNLVKILSSCSNV 164 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~------~~~e~~~l~~l~h~niv~~~~~~~~~ 164 (361)
..++|...+++|.|+||.||.... ++..+|+|++..... ..... +.+|++.+.++.|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 468899999999999999999766 577899999975432 22222 67899999999999999999886543
Q ss_pred --------CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEE
Q 037918 165 --------DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAH 236 (361)
Q Consensus 165 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 236 (361)
+..+++|||++|.+|.++.. ++. ....+++.+|..+| ..|++|||++|+||+++.++ ++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EE
Confidence 35789999999999988742 232 24569999999999 89999999999999999988 99
Q ss_pred EEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHH
Q 037918 237 VSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETF 292 (361)
Q Consensus 237 l~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ell 292 (361)
|+|||............ .+.....+..++|+||||+++..+.
T Consensus 175 liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHH
Confidence 99999887553211100 0333444667899999999987654
No 413
>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c
Probab=99.91 E-value=7.3e-24 Score=177.05 Aligned_cols=139 Identities=19% Similarity=0.180 Sum_probs=108.8
Q ss_pred CCccccCCceEEEEEEeCCCcEEEEEEeehhhHH--H------------------------HHHHHHHHHHHHhcCCCce
Q 037918 101 CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLER--A------------------------FRSFDSECEVLRSIRHRNL 154 (361)
Q Consensus 101 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~ni 154 (361)
...||+|++|.||+|...+|+.||||+++..... . ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999878999999998754210 0 0122459999999987776
Q ss_pred eeeeeeeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeeCCCCCCCEEEcCCC
Q 037918 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL-HHGYSPSVVHCDLKPSNILLDENM 233 (361)
Q Consensus 155 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~dlk~~Nill~~~~ 233 (361)
.....+... ..++||||++++++....... ..++...+..++.|++.+|.++ | +.+|+||||||+||+++ ++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence 443333222 238999999988776554333 3488999999999999999999 7 77999999999999998 47
Q ss_pred cEEEEeccCcccc
Q 037918 234 VAHVSDFGISKLL 246 (361)
Q Consensus 234 ~~kl~Dfg~a~~~ 246 (361)
.++|+|||+|...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999999754
No 414
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.90 E-value=1.9e-24 Score=208.54 Aligned_cols=246 Identities=22% Similarity=0.237 Sum_probs=180.5
Q ss_pred CCCccccCCceEEEEEEeC-CCcEEEEEEee-----hhhHHH-HHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918 100 ECNLLGKGSFGSVYKGILS-DGAEVAIKIFN-----LQLERA-FRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE 172 (361)
Q Consensus 100 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~-----~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (361)
....+|.|++|.|+..... .....+.|.+. ...... ...+..|+-+-..++|||++..+..+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4578999999977777632 33333444322 111221 2226677777788899999998888877776666699
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
||++ +|..++.... .+...++-.++.|++.|++|+| +.||.|||+|++|++++.+|.+||+|||.+.........
T Consensus 402 ~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred cccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 9999 9999998763 3888889999999999999999 999999999999999999999999999999876443332
Q ss_pred --eeeecccccccccCccccCCCCCCc-ccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918 253 --ETRTMTMATVGYMAPEYGSEGIVSS-KCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL 329 (361)
Q Consensus 253 --~~~~~~~g~~~y~aPE~~~~~~~~~-~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 329 (361)
.......|+..|+|||.+.+..|.+ ..||||.|+++..|.+|+.||......+..+. ..... ....
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~---~~~~~--------~~~~ 545 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK---TNNYS--------DQRN 545 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh---hhccc--------cccc
Confidence 3445678999999999999888766 69999999999999999999975433322210 00000 0011
Q ss_pred CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
..........+.+..-..++.++|+.||.+|.
T Consensus 546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ 577 (601)
T KOG0590|consen 546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRI 577 (601)
T ss_pred cccChHHHHHhchhhHHHHHHHHccCChhhee
Confidence 11112223334455678899999999999994
No 415
>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro
Probab=99.90 E-value=1.3e-22 Score=170.09 Aligned_cols=139 Identities=22% Similarity=0.234 Sum_probs=111.0
Q ss_pred CCccccCCceEEEEEEeCCCcEEEEEEeehhhHH--------------------------HHHHHHHHHHHHHhcCCCce
Q 037918 101 CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLER--------------------------AFRSFDSECEVLRSIRHRNL 154 (361)
Q Consensus 101 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~ni 154 (361)
...||+|++|.||+|...+|+.||||++...... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5689999999999999778999999998754210 01234578999999999987
Q ss_pred eeeeeeeecCCeeEEEEEecCCCCHHHH-HhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCEEEcCC
Q 037918 155 VKILSSCSNVDFKALVLEFMPNGSLEKW-LYSHNYFLDIQERLNVMIDVGSALEYLHHGYS-PSVVHCDLKPSNILLDEN 232 (361)
Q Consensus 155 v~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~ 232 (361)
.....+.... .++||||++|+++... +.. ..++......++.|++.++.++| . .||+||||||+||+++ +
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-C
Confidence 5544443332 4899999988865443 332 23788899999999999999999 7 8999999999999999 8
Q ss_pred CcEEEEeccCccccC
Q 037918 233 MVAHVSDFGISKLLG 247 (361)
Q Consensus 233 ~~~kl~Dfg~a~~~~ 247 (361)
+.++|+|||++....
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 899999999998764
No 416
>PRK12274 serine/threonine protein kinase; Provisional
Probab=99.89 E-value=4e-22 Score=165.04 Aligned_cols=186 Identities=17% Similarity=0.108 Sum_probs=139.4
Q ss_pred CCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHH----HHHHHHHHHHHHHhcC-CCceeeeeeeeecCCeeEEEEEe
Q 037918 99 DECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLER----AFRSFDSECEVLRSIR-HRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 99 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
.+...|++|+||+||.+.. .+.+++.+.+.....- ....+.+|+++|+++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999997776 6788887777644321 1235789999999995 5889999886 346999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC-CCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL-KPSNILLDENMVAHVSDFGISKLLGDGENF 252 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 252 (361)
+.|.+|.+.+.. ....++.|++.+|.++| +.||+|||| ||+|||++.++.++|+|||++.........
T Consensus 80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred ecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 999998754321 11357889999999999 899999999 799999999999999999999865433210
Q ss_pred ----ee-------eecccccccccCccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918 253 ----ET-------RTMTMATVGYMAPEYGSE--GIVSSKCDVYSYGVLLMETFTRKKPTDE 300 (361)
Q Consensus 253 ----~~-------~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~~ 300 (361)
.. ......++.|++|+...- ..--.+.+.++-|.-+|.++||..|+-+
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 00 111235777888873221 2222578999999999999999998654
No 417
>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]
Probab=99.88 E-value=1.5e-22 Score=186.99 Aligned_cols=202 Identities=27% Similarity=0.366 Sum_probs=153.3
Q ss_pred HHhcCCCceeeeeeeeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-eeCCCCC
Q 037918 146 LRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSV-VHCDLKP 224 (361)
Q Consensus 146 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i-vH~dlk~ 224 (361)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+......+++.....++++++.||+|||+ .+| .|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeeeecc
Confidence 356789999999999999999999999999999999999877779999999999999999999994 344 9999999
Q ss_pred CCEEEcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCC-------CCCcccchHHHHHHHHHHHhCCCC
Q 037918 225 SNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG-------IVSSKCDVYSYGVLLMETFTRKKP 297 (361)
Q Consensus 225 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-------~~~~~~Dv~slG~il~elltg~~p 297 (361)
.|.+++....+||+|||+.................-..-|.|||.+... ..+.++|+||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998876431111222223355669999987653 147789999999999999999999
Q ss_pred CCcccccccc--HHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 298 TDEFFAGEMS--LKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 298 ~~~~~~~~~~--~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
|+........ +..+++.. ......+.+... .+....+..++.+||..+|++||
T Consensus 158 ~~~~~~~~~~~eii~~~~~~----~~~~~rP~i~~~-------~e~~~~l~~l~~~cw~e~P~~rP 212 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKG----GSNPFRPSIELL-------NELPPELLLLVARCWEEIPEKRP 212 (484)
T ss_pred cccccccCChHHHHHHHHhc----CCCCcCcchhhh-------hhcchHHHHHHHHhcccChhhCc
Confidence 9874433322 22222220 111111111111 12233589999999999999998
No 418
>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A.
Probab=99.88 E-value=1.1e-22 Score=176.95 Aligned_cols=229 Identities=20% Similarity=0.258 Sum_probs=146.2
Q ss_pred CCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCC----------Cceeeeeeee---
Q 037918 99 DECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRH----------RNLVKILSSC--- 161 (361)
Q Consensus 99 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~niv~~~~~~--- 161 (361)
...+.||.|+++.||.+++. +|+.+|+|++.... ....+.+.+|.-....+.+ -.++-.++..
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 34568999999999999976 58999999886432 3345666666654444322 1222222221
Q ss_pred ------ecC---C-----eeEEEEEecCCCCHHHHHhc---CC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCC
Q 037918 162 ------SNV---D-----FKALVLEFMPNGSLEKWLYS---HN---YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCD 221 (361)
Q Consensus 162 ------~~~---~-----~~~lv~e~~~~g~L~~~l~~---~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~d 221 (361)
... . +.+++|+-+ .++|.+++.. .. ..+....+..+..|+++.+++|| +.|++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEecc
Confidence 111 1 236778877 5688887652 21 12445556777899999999999 88999999
Q ss_pred CCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCC--------CCCCcccchHHHHHHHHHHHh
Q 037918 222 LKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSE--------GIVSSKCDVYSYGVLLMETFT 293 (361)
Q Consensus 222 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~ellt 293 (361)
|+|+|++++.+|.++|+||+.....+... .....+..|.+||.... ..++.+.|.|+||+++|.|++
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999999887654311 11345577999996533 347889999999999999999
Q ss_pred CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCC
Q 037918 294 RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360 (361)
Q Consensus 294 g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 360 (361)
|..||+.......... .+.. +. +.+..+..||..+|+.||++|
T Consensus 246 ~~lPf~~~~~~~~~~~-----------------~f~~------C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW-----------------DFSR------CR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG-----------------GGTT------SS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc-----------------cchh------cC-CcCHHHHHHHHHHccCCcccC
Confidence 9999986533221110 1111 11 335568999999999999998
No 419
>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=99.87 E-value=1.6e-22 Score=199.21 Aligned_cols=201 Identities=21% Similarity=0.223 Sum_probs=160.8
Q ss_pred HHHHhhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC---CCceeeeeeeeecCCe
Q 037918 90 EIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR---HRNLVKILSSCSNVDF 166 (361)
Q Consensus 90 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~ 166 (361)
+.+.....|.+.+.||+|+||+||+|...+|+.||+|+-+...... |.--.+++.+|+ -+.|..+...+.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 3444556788899999999999999998889999999877654321 111223333443 3455566666666677
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc-------CCCcEEEEe
Q 037918 167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD-------ENMVAHVSD 239 (361)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~-------~~~~~kl~D 239 (361)
-+||+||.+.|+|.++++..+ .+++..+..+..|++..++.|| ..+||||||||+|.||. ++.-++|+|
T Consensus 769 S~lv~ey~~~Gtlld~~N~~~-~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTNK-VMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred ceeeeeccccccHHHhhccCC-CCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEe
Confidence 789999999999999999544 4999999999999999999999 88999999999999994 344689999
Q ss_pred ccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCC
Q 037918 240 FGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297 (361)
Q Consensus 240 fg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p 297 (361)
||.+..+.--.....-....+|-.+-.+|+..+..+++..|.|.++.+++-|+.|+.-
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9999766433333344556789999999999999999999999999999999999864
No 420
>PRK10345 hypothetical protein; Provisional
Probab=99.86 E-value=4.5e-21 Score=161.68 Aligned_cols=136 Identities=18% Similarity=0.259 Sum_probs=106.4
Q ss_pred CCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-----CCCceeeeeeeeecCC---eeE-E
Q 037918 99 DECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI-----RHRNLVKILSSCSNVD---FKA-L 169 (361)
Q Consensus 99 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~~~-l 169 (361)
...+.||+|++|.||. .-.++.. +||++........+.+.+|+.+++++ .||||++++|+++++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4457899999999996 3223444 79988765434456789999999999 5799999999998874 333 7
Q ss_pred EEEe--cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeeeCCCCCCCEEEcC----CCcEEEEeccC
Q 037918 170 VLEF--MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSAL-EYLHHGYSPSVVHCDLKPSNILLDE----NMVAHVSDFGI 242 (361)
Q Consensus 170 v~e~--~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfg~ 242 (361)
|+|| +.+++|.+++.+.. +++. ..++.+++.++ +||| +.+|+||||||+|||++. ++.++|+||+.
T Consensus 83 I~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 8999 55799999997643 5555 35678888887 9999 899999999999999974 34799999544
Q ss_pred c
Q 037918 243 S 243 (361)
Q Consensus 243 a 243 (361)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 4
No 421
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=99.86 E-value=2.3e-23 Score=192.69 Aligned_cols=186 Identities=27% Similarity=0.300 Sum_probs=157.5
Q ss_pred ccccCCceEEEEEE----eCCCcEEEEEEeehhhH--HHHHHHHHHHHHHHhcC-CCceeeeeeeeecCCeeEEEEEecC
Q 037918 103 LLGKGSFGSVYKGI----LSDGAEVAIKIFNLQLE--RAFRSFDSECEVLRSIR-HRNLVKILSSCSNVDFKALVLEFMP 175 (361)
Q Consensus 103 ~lg~G~~g~V~~~~----~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 175 (361)
.+|+|.||.|+++. .+.|..+|+|+.+.... +.......|..++...+ ||.++++...++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999876 23477788888765431 11124556888888886 9999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee
Q 037918 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR 255 (361)
Q Consensus 176 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 255 (361)
+|.|...+.+... .++.....+...++-+++++| +.+++|||+|++||+++.+|++++.|||+++..-+...
T Consensus 81 gg~lft~l~~~~~-f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM-FDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---- 152 (612)
T ss_pred cchhhhccccCCc-hHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence 9999998887665 567777788899999999999 99999999999999999999999999999987644322
Q ss_pred ecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918 256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDE 300 (361)
Q Consensus 256 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~ 300 (361)
.+||..|||||++. ....++|.||||++++||+||..||..
T Consensus 153 --~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 --ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred --cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 17999999999988 457789999999999999999999976
No 422
>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]
Probab=99.85 E-value=2.8e-22 Score=194.81 Aligned_cols=239 Identities=20% Similarity=0.241 Sum_probs=168.8
Q ss_pred CCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhh-HHHHHHHH---HHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918 97 GFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL-ERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLE 172 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~---~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (361)
++...+.||++.|=+|.+|++++|. |+||++-+.. .-..+.+. .|++ ...++|||.+++.-+-......|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5677889999999999999998887 8899986554 11223333 3444 555699999999988888888889999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc--CCCC
Q 037918 173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL--GDGE 250 (361)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~--~~~~ 250 (361)
|.. -+|.|.+..+. ++..-+...|+.|++.||.-+| ..||+|||||.+||||+.-..+.|+||..-+.. ..+.
T Consensus 102 yvk-hnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 102 YVK-HNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHh-hhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 984 59999997665 4778888889999999999999 999999999999999999889999999865432 1111
Q ss_pred ccee---eecccccccccCccccCC----------CC-CCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhh
Q 037918 251 NFET---RTMTMATVGYMAPEYGSE----------GI-VSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKES 315 (361)
Q Consensus 251 ~~~~---~~~~~g~~~y~aPE~~~~----------~~-~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 315 (361)
.... -.....-..|.|||.+-. .. .+++.||||+||++.||++ |++||.-. ++..+....
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~~ 251 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSGN 251 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhccC
Confidence 1100 011123345999995432 12 6789999999999999988 78888642 111111110
Q ss_pred cCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 316 LPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 316 ~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
.......++. +. -..+.+++..|++.||++|.
T Consensus 252 -~~~~e~~Le~-Ie------------d~~~Rnlil~Mi~rdPs~Rl 283 (1431)
T KOG1240|consen 252 -ADDPEQLLEK-IE------------DVSLRNLILSMIQRDPSKRL 283 (1431)
T ss_pred -ccCHHHHHHh-Cc------------CccHHHHHHHHHccCchhcc
Confidence 0000111110 00 01378899999999999984
No 423
>smart00090 RIO RIO-like kinase.
Probab=99.84 E-value=2.6e-20 Score=160.81 Aligned_cols=147 Identities=20% Similarity=0.158 Sum_probs=113.8
Q ss_pred HHhhCCCCCCCccccCCceEEEEEE--eCCCcEEEEEEeehhhH------------------------HHHHHHHHHHHH
Q 037918 92 QRATNGFDECNLLGKGSFGSVYKGI--LSDGAEVAIKIFNLQLE------------------------RAFRSFDSECEV 145 (361)
Q Consensus 92 ~~~~~~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~------------------------~~~~~~~~e~~~ 145 (361)
......|.+.+.||+|++|.||+|. ..+|+.||+|++..... .....+..|++.
T Consensus 24 ~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 103 (237)
T smart00090 24 LNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN 103 (237)
T ss_pred HhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence 3333458888999999999999998 46899999999874321 011235689999
Q ss_pred HHhcCCC--ceeeeeeeeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eeeCCC
Q 037918 146 LRSIRHR--NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS-VVHCDL 222 (361)
Q Consensus 146 l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~dl 222 (361)
+.++.+. .+.+++++ ...++||||+++.+|........ .........++.|++.++++|| +.+ ++||||
T Consensus 104 L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Di 175 (237)
T smart00090 104 LQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLY---KEGELVHGDL 175 (237)
T ss_pred HHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCC
Confidence 9999753 34444543 23489999999988877653332 3566677899999999999999 889 999999
Q ss_pred CCCCEEEcCCCcEEEEeccCccccC
Q 037918 223 KPSNILLDENMVAHVSDFGISKLLG 247 (361)
Q Consensus 223 k~~Nill~~~~~~kl~Dfg~a~~~~ 247 (361)
||+||+++ ++.++|+|||.+...+
T Consensus 176 kp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 176 SEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred ChhhEEEE-CCCEEEEEChhhhccC
Confidence 99999999 8899999999987543
No 424
>PRK14879 serine/threonine protein kinase; Provisional
Probab=99.83 E-value=1.1e-19 Score=155.14 Aligned_cols=134 Identities=21% Similarity=0.332 Sum_probs=114.0
Q ss_pred CccccCCceEEEEEEeCCCcEEEEEEeehhh--------HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQL--------ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
+.||+|++|.||+|.. +|..+++|+..... ......+.+|++++..+.|+++.....++.+.+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 67889999765321 11224578899999999999988877777777788999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL 245 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 245 (361)
++|++|.+++.... . .+..++.+++.+|.++| +.+++|+|++|+||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999987532 2 78899999999999999 88999999999999999 78999999998865
No 425
>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]
Probab=99.83 E-value=4.6e-20 Score=161.88 Aligned_cols=188 Identities=23% Similarity=0.288 Sum_probs=135.5
Q ss_pred CCCceeeeeeeeec---------------------------CCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHH
Q 037918 150 RHRNLVKILSSCSN---------------------------VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDV 202 (361)
Q Consensus 150 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i 202 (361)
+|||||++.++|.+ +...|+||..++ .+|.+|+..+. .+.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC--CchHHHHHHHHHH
Confidence 59999999987643 235789999884 59999998766 6777788899999
Q ss_pred HHHHHHHHhcCCCCeeeCCCCCCCEEEc--CCC--cEEEEeccCccccCCCC----cceeeecccccccccCccccCCCC
Q 037918 203 GSALEYLHHGYSPSVVHCDLKPSNILLD--ENM--VAHVSDFGISKLLGDGE----NFETRTMTMATVGYMAPEYGSEGI 274 (361)
Q Consensus 203 ~~~L~~LH~~~~~~ivH~dlk~~Nill~--~~~--~~kl~Dfg~a~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~ 274 (361)
++|+.||| +.|+.|||+|++|||+. +|+ .+.++|||++-.-.... .....-...|....||||+....+
T Consensus 351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999 89999999999999993 444 57899999875432211 111112234677789999765432
Q ss_pred ------CCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHH
Q 037918 275 ------VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHL 348 (361)
Q Consensus 275 ------~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l 348 (361)
.-.++|.|+.|.+.||+++...||........+...+-+..+|. +.. .++..+.++
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPa---------lp~---------~vpp~~rql 489 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPA---------LPS---------RVPPVARQL 489 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCC---------Ccc---------cCChHHHHH
Confidence 23489999999999999999999976332223333332222221 111 223347889
Q ss_pred HhhcCCCCCCCCC
Q 037918 349 ALDCSMYSPDQRI 361 (361)
Q Consensus 349 ~~~cl~~dP~~RP 361 (361)
+...|+.||++|+
T Consensus 490 V~~lL~r~pskRv 502 (598)
T KOG4158|consen 490 VFDLLKRDPSKRV 502 (598)
T ss_pred HHHHhcCCccccC
Confidence 9999999999996
No 426
>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom
Probab=99.82 E-value=1.7e-19 Score=152.43 Aligned_cols=144 Identities=19% Similarity=0.203 Sum_probs=112.8
Q ss_pred HHHHhhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhH----------------------HHHHHHHHHHHHHH
Q 037918 90 EIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLE----------------------RAFRSFDSECEVLR 147 (361)
Q Consensus 90 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~ 147 (361)
++......|.+.+.||+|+||.||++...+|+.||||++..... ........|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 44444445888899999999999999988899999998754220 01123567888999
Q ss_pred hcCCC--ceeeeeeeeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCC
Q 037918 148 SIRHR--NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPS 225 (361)
Q Consensus 148 ~l~h~--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~ 225 (361)
++.|+ .+...++. ...+++|||++|++|.+.... .....++.+++.++.++| ..+++||||+|+
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~ 154 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEF 154 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcc
Confidence 98777 44444442 345899999999999775431 234678899999999999 889999999999
Q ss_pred CEEEcCCCcEEEEeccCccccC
Q 037918 226 NILLDENMVAHVSDFGISKLLG 247 (361)
Q Consensus 226 Nill~~~~~~kl~Dfg~a~~~~ 247 (361)
||++++++.++|+|||.+....
T Consensus 155 Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 155 NILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999997654
No 427
>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated
Probab=99.82 E-value=4.3e-19 Score=171.82 Aligned_cols=140 Identities=21% Similarity=0.260 Sum_probs=113.4
Q ss_pred HhhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehh--------hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecC
Q 037918 93 RATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQ--------LERAFRSFDSECEVLRSIRHRNLVKILSSCSNV 164 (361)
Q Consensus 93 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 164 (361)
.....|...+.||+|+||.||+|.+.+. .+++|+.... .....+.+.+|+++++.++|++++....++.+.
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 3345567789999999999999987543 3444432111 011235688999999999999999888887777
Q ss_pred CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918 165 DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK 244 (361)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 244 (361)
+..++||||+++++|.+++. ....++.+++.+|.+|| +.+++||||||+||++ +++.++|+|||+++
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 77899999999999999885 34678999999999999 8899999999999999 67799999999997
Q ss_pred cc
Q 037918 245 LL 246 (361)
Q Consensus 245 ~~ 246 (361)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 53
No 428
>TIGR03724 arch_bud32 Kae1-associated kinase Bud32. Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.
Probab=99.81 E-value=3.7e-19 Score=150.57 Aligned_cols=130 Identities=24% Similarity=0.332 Sum_probs=107.0
Q ss_pred ccccCCceEEEEEEeCCCcEEEEEEeehhh--------HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918 103 LLGKGSFGSVYKGILSDGAEVAIKIFNLQL--------ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174 (361)
Q Consensus 103 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (361)
.||+|++|.||+|.+ +|..+++|...... ......+.+|++++..++|+++.....++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 57889999864321 112356778999999998887665555555666779999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918 175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL 245 (361)
Q Consensus 175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 245 (361)
+|++|.+++..... .++.+++.+|.+|| +.+++|+|++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998764321 78999999999999 89999999999999999 88999999999865
No 429
>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]
Probab=99.79 E-value=2.8e-20 Score=169.21 Aligned_cols=168 Identities=24% Similarity=0.405 Sum_probs=128.9
Q ss_pred eeEEEEEecCCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCc
Q 037918 166 FKALVLEFMPNGSLEKWLYSH--NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGIS 243 (361)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 243 (361)
.+|+.|++|...+|.+++..+ ....++.....++.|++.|+.| ++.+|+|+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999743 3446788889999999999999 48999999999999999999999999999
Q ss_pred cccCCCC----cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCC
Q 037918 244 KLLGDGE----NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPH 318 (361)
Q Consensus 244 ~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 318 (361)
....... ....++...||..||+||.+.+..|+.++||||||++|+||++ =..++... ..+.+.-
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----~t~~d~r------ 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----ATLTDIR------ 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----Hhhhhhh------
Confidence 8775544 2334566789999999999999999999999999999999998 23332221 1111111
Q ss_pred CccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918 319 GLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361 (361)
Q Consensus 319 ~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 361 (361)
...+.+....++|. -..++.+++.+.|.+||
T Consensus 474 --~g~ip~~~~~d~p~----------e~~ll~~lls~~p~~RP 504 (516)
T KOG1033|consen 474 --DGIIPPEFLQDYPE----------EYTLLQQLLSPSPEERP 504 (516)
T ss_pred --cCCCChHHhhcCcH----------HHHHHHHhcCCCcccCc
Confidence 11122222233333 25778899999999998
No 430
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=99.76 E-value=2.8e-19 Score=173.89 Aligned_cols=168 Identities=26% Similarity=0.300 Sum_probs=122.4
Q ss_pred hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
..+|+.++.|..|++|.||..+++ ..+.+|+|+-+... +.+- ++.....|.+ |
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l------ilRn--ilt~a~npfv---------------v--- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL------ILRN--ILTFAGNPFV---------------V--- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccch------hhhc--cccccCCcce---------------e---
Confidence 467999999999999999999876 46778885432211 1110 2222223332 2
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc--
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN-- 251 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-- 251 (361)
|+-...++.-+. ++.+ ++.+++||| +.+|+|||+||+|.+|+.-|++|++|||+.+.......
T Consensus 136 ---gDc~tllk~~g~-lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGP-LPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ---chhhhhcccCCC-Ccch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 455555554332 3333 278999999 99999999999999999999999999999875321110
Q ss_pred -----------ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcccc
Q 037918 252 -----------FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFA 303 (361)
Q Consensus 252 -----------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~ 303 (361)
.......+||+.|.|||++....|+..+|+|++|+++||.+.|..||....+
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp 263 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 263 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH
Confidence 0011234799999999999999999999999999999999999999976433
No 431
>cd05119 RIO RIO kinase family, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct
Probab=99.75 E-value=1.3e-17 Score=139.62 Aligned_cols=136 Identities=21% Similarity=0.271 Sum_probs=98.1
Q ss_pred CCccccCCceEEEEEEeCCCcEEEEEEeehhhHH--HHHH----------------------HHHHHHHHHhcCCC--ce
Q 037918 101 CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLER--AFRS----------------------FDSECEVLRSIRHR--NL 154 (361)
Q Consensus 101 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~--ni 154 (361)
.+.||+|+||.||+|...+|+.||||++...... .... ...|.+.+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999878999999998753211 1011 13455666665433 24
Q ss_pred eeeeeeeecCCeeEEEEEecCCCCHHH-HHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCEEEcCC
Q 037918 155 VKILSSCSNVDFKALVLEFMPNGSLEK-WLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS-PSVVHCDLKPSNILLDEN 232 (361)
Q Consensus 155 v~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~ 232 (361)
.+.++. ...++||||++++++.. .+.... .. .....++.+++.++.++| . .+++|+||+|+||+++ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence 444443 23589999999854322 111111 11 567889999999999999 7 8999999999999999 8
Q ss_pred CcEEEEeccCccccC
Q 037918 233 MVAHVSDFGISKLLG 247 (361)
Q Consensus 233 ~~~kl~Dfg~a~~~~ 247 (361)
+.++|+|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 999999999997653
No 432
>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family. The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves
Probab=99.74 E-value=3.2e-17 Score=131.92 Aligned_cols=135 Identities=21% Similarity=0.288 Sum_probs=114.0
Q ss_pred CCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCC--CceeeeeeeeecCCeeEEEEEecCCC
Q 037918 100 ECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRH--RNLVKILSSCSNVDFKALVLEFMPNG 177 (361)
Q Consensus 100 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g 177 (361)
+++.||+|.++.||++...+ ..+++|....... ...+..|...+..++| .++++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999854 7899999866543 3568889999999976 58999999988888899999999888
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918 178 SLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL 245 (361)
Q Consensus 178 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 245 (361)
++..+ +......++.+++++|+++|.....+++|+|++|+||++++++.++++|||.+..
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77654 4566778899999999999944335799999999999999989999999998864
No 433
>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed
Probab=99.72 E-value=9.5e-17 Score=138.97 Aligned_cols=134 Identities=18% Similarity=0.220 Sum_probs=104.6
Q ss_pred Cccc-cCCceEEEEEEeCCCcEEEEEEeehhh------H-------HHHHHHHHHHHHHHhcCCCce--eeeeeeeecCC
Q 037918 102 NLLG-KGSFGSVYKGILSDGAEVAIKIFNLQL------E-------RAFRSFDSECEVLRSIRHRNL--VKILSSCSNVD 165 (361)
Q Consensus 102 ~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~------~-------~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~ 165 (361)
..|| .|+.|+||.+... +..++||.+.... . .....+.+|++++.+++|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 7889999998874 7789999885321 0 122457889999999988775 67777643322
Q ss_pred ----eeEEEEEecCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEec
Q 037918 166 ----FKALVLEFMPN-GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDF 240 (361)
Q Consensus 166 ----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 240 (361)
..++|||+++| .+|.+++.... ++.. .+.+++.+|.+|| +.||+|+||||.|||++.++.++|+||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~--l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAP--LSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCC--CCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEEC
Confidence 23599999997 69999886532 4443 3578999999999 899999999999999999999999999
Q ss_pred cCccc
Q 037918 241 GISKL 245 (361)
Q Consensus 241 g~a~~ 245 (361)
|.+..
T Consensus 187 g~~~~ 191 (239)
T PRK01723 187 DRGEL 191 (239)
T ss_pred CCccc
Confidence 98875
No 434
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.70 E-value=1.6e-18 Score=167.64 Aligned_cols=215 Identities=25% Similarity=0.324 Sum_probs=172.1
Q ss_pred hCCCCCCCccccCCceEEEEEEeCC--CcEEEEEEeehhh--HHHHHHHHHHHHHHHhcC-CCceeeeeeeeecCCeeEE
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILSD--GAEVAIKIFNLQL--ERAFRSFDSECEVLRSIR-HRNLVKILSSCSNVDFKAL 169 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l 169 (361)
...|.+.+.||+|+|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++.+++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3457778889999999998877533 3456666655432 333445566777777776 9999999999999999999
Q ss_pred EEEecCCCCHHHHH-hcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC-cEEEEeccCccccC
Q 037918 170 VLEFMPNGSLEKWL-YSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM-VAHVSDFGISKLLG 247 (361)
Q Consensus 170 v~e~~~~g~L~~~l-~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~ 247 (361)
+++|..++++.+-+ .......+....-.++.|+..++.|+|. ..++.|+|++|+|.+++..+ ..++.|||+|..+.
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999999988 4443246777788899999999999995 45899999999999999999 99999999999887
Q ss_pred C-CCcceeeecccc-cccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHH
Q 037918 248 D-GENFETRTMTMA-TVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNW 311 (361)
Q Consensus 248 ~-~~~~~~~~~~~g-~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~ 311 (361)
. ...........| ++.|+|||...+ ....+..|+||.|+++.-+++|..|+............|
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~ 243 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSW 243 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceee
Confidence 6 444445556678 999999998877 456778999999999999999999998755544443344
No 435
>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase. This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.
Probab=99.65 E-value=1.1e-15 Score=143.53 Aligned_cols=145 Identities=22% Similarity=0.294 Sum_probs=101.8
Q ss_pred CCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHH----------------------------------------
Q 037918 97 GFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAF---------------------------------------- 136 (361)
Q Consensus 97 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---------------------------------------- 136 (361)
.|+ .+.||+|++|.||+|++.+|+.||||+.........
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 344 368999999999999999999999999864321100
Q ss_pred HHHHHHHHHHHhc----CCCceeeeeeee-ecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHH-HHHHHH
Q 037918 137 RSFDSECEVLRSI----RHRNLVKILSSC-SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS-ALEYLH 210 (361)
Q Consensus 137 ~~~~~e~~~l~~l----~h~niv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~-~L~~LH 210 (361)
-++..|.+.+.++ +|.+-+.+-.++ ......++||||++|++|.++........+ ...++..++. .+..+|
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH
Confidence 0244455555554 233223332222 223456899999999999987753321122 3456666665 467888
Q ss_pred hcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD 248 (361)
Q Consensus 211 ~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 248 (361)
..|++|+|++|.||+++++++++++|||++..+..
T Consensus 275 ---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 ---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 88999999999999999999999999999987643
No 436
>KOG1243 consensus Protein kinase [General function prediction only]
Probab=99.56 E-value=4.7e-14 Score=132.46 Aligned_cols=167 Identities=17% Similarity=0.203 Sum_probs=130.2
Q ss_pred eCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHH
Q 037918 117 LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL 196 (361)
Q Consensus 117 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 196 (361)
..++.+|.|...+...........+-++.|+.++||||+++++.+...+..|+|+|.+ ..|..++++.+ ...+.
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~----~~~v~ 107 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG----KEEVC 107 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH----HHHHH
Confidence 3468888888887766544566778899999999999999999999999999999998 47888887643 55566
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCC
Q 037918 197 NVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276 (361)
Q Consensus 197 ~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 276 (361)
.-+.||+.||.|||+ +.+++|++|+.+.|+++..|+.||++|.++........ .......-..|..|+.+....
T Consensus 108 ~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 108 LGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--
Confidence 678999999999986 66999999999999999999999999998865432221 111122233466776543322
Q ss_pred cccchHHHHHHHHHHHhCC
Q 037918 277 SKCDVYSYGVLLMETFTRK 295 (361)
Q Consensus 277 ~~~Dv~slG~il~elltg~ 295 (361)
-..|.|.||++++|++.|.
T Consensus 182 ~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cchhhhhHHHHHHHHhCcc
Confidence 2469999999999999994
No 437
>KOG1266 consensus Protein kinase [Signal transduction mechanisms]
Probab=99.55 E-value=8.8e-15 Score=126.07 Aligned_cols=153 Identities=22% Similarity=0.335 Sum_probs=118.6
Q ss_pred HHHHHhcCCCceeeeeeeeecCC-----eeEEEEEecCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 037918 143 CEVLRSIRHRNLVKILSSCSNVD-----FKALVLEFMPNGSLEKWLYSH---NYFLDIQERLNVMIDVGSALEYLHHGYS 214 (361)
Q Consensus 143 ~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~ 214 (361)
..-+-++-|.||++++.|+.+.. ...++.||+..|++..+|+.. ...+......+|+-||++||.|||.. +
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 34455667999999999986543 467899999999999999843 34477888889999999999999965 8
Q ss_pred CCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC---cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHH
Q 037918 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE---NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMET 291 (361)
Q Consensus 215 ~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~el 291 (361)
+.|+|+++..+.|++..+|-+|++--.-.. ..... .........+.++|.|||.......+.++|||+||+...||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 999999999999999999988875322111 10000 01112234578899999988877788899999999999999
Q ss_pred HhCCCC
Q 037918 292 FTRKKP 297 (361)
Q Consensus 292 ltg~~p 297 (361)
..|..-
T Consensus 276 ailEiq 281 (458)
T KOG1266|consen 276 AILEIQ 281 (458)
T ss_pred HHheec
Confidence 988764
No 438
>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed
Probab=99.53 E-value=4.8e-14 Score=134.10 Aligned_cols=143 Identities=19% Similarity=0.224 Sum_probs=93.2
Q ss_pred hCCCCCCCccccCCceEEEEEEeCC-CcEEEEEEeehhhHH----------------------------------HHHH-
Q 037918 95 TNGFDECNLLGKGSFGSVYKGILSD-GAEVAIKIFNLQLER----------------------------------AFRS- 138 (361)
Q Consensus 95 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~~- 138 (361)
...|+. +.||+|++|+||+|++++ |+.||||+......+ ..+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 799999999999999877 999999998744211 0111
Q ss_pred -----HHHHHHHHHhc----CCCceeeeeeeeec-CCeeEEEEEecCCCCHHHHH--hcCCC---CCCHHHHHHHHHHHH
Q 037918 139 -----FDSECEVLRSI----RHRNLVKILSSCSN-VDFKALVLEFMPNGSLEKWL--YSHNY---FLDIQERLNVMIDVG 203 (361)
Q Consensus 139 -----~~~e~~~l~~l----~h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~---~~~~~~~~~i~~~i~ 203 (361)
+.+|+..+.++ .+.+.+.+-.++.+ ....+|||||++|+++.++- ...+. .+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 23344333333 13333333333322 34567999999999998753 22221 12222222233333
Q ss_pred HHHHHHHhcCCCCeeeCCCCCCCEEEcCCC----cEEEEeccCccccCC
Q 037918 204 SALEYLHHGYSPSVVHCDLKPSNILLDENM----VAHVSDFGISKLLGD 248 (361)
Q Consensus 204 ~~L~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~a~~~~~ 248 (361)
. ..|++|+|++|.||+++.++ .++++|||++..+..
T Consensus 277 ------f---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ------F---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------H---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3 56999999999999999888 999999999987654
No 439
>cd05151 ChoK Choline Kinase (ChoK). The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph
Probab=99.50 E-value=9.5e-14 Score=114.21 Aligned_cols=128 Identities=20% Similarity=0.218 Sum_probs=95.3
Q ss_pred CCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCce-eeeeeeeecCCeeEEEEEecCCCCH
Q 037918 101 CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNL-VKILSSCSNVDFKALVLEFMPNGSL 179 (361)
Q Consensus 101 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~L 179 (361)
++.|+.|.++.||++... +..+++|....... ....+..|+..++.+.+.++ .+++.+.. +..++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 357889999999999874 77899998765432 12345789999998865444 44554433 345799999999887
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918 180 EKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS-----VVHCDLKPSNILLDENMVAHVSDFGISKL 245 (361)
Q Consensus 180 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 245 (361)
.+.- . ....++.+++++|+.|| +.+ ++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~~------~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED------F---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc------c---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 6530 1 11345689999999999 555 59999999999999 66899999998753
No 440
>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.
Probab=99.49 E-value=1.3e-12 Score=108.41 Aligned_cols=137 Identities=20% Similarity=0.189 Sum_probs=99.8
Q ss_pred CCccccCCceEEEEEEeCC-------CcEEEEEEeehhh----------------------HHHHHH----HHHHHHHHH
Q 037918 101 CNLLGKGSFGSVYKGILSD-------GAEVAIKIFNLQL----------------------ERAFRS----FDSECEVLR 147 (361)
Q Consensus 101 ~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~----~~~e~~~l~ 147 (361)
...||.|.-+.||.|...+ +..+|||+.+... ....+. ..+|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998543 4789999874211 001122 238999999
Q ss_pred hcC--CCceeeeeeeeecCCeeEEEEEecCCCCHHH-HHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeeCCCC
Q 037918 148 SIR--HRNLVKILSSCSNVDFKALVLEFMPNGSLEK-WLYSHNYFLDIQERLNVMIDVGSALEYL-HHGYSPSVVHCDLK 223 (361)
Q Consensus 148 ~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~dlk 223 (361)
++. .-++.+++++ ...++||||+.+..+.. .+... .++......+..+++.+|..| | ..+++||||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 884 3566777765 45689999997654422 22221 245566677889999999998 7 7899999999
Q ss_pred CCCEEEcCCCcEEEEeccCccccC
Q 037918 224 PSNILLDENMVAHVSDFGISKLLG 247 (361)
Q Consensus 224 ~~Nill~~~~~~kl~Dfg~a~~~~ 247 (361)
+.||+++ ++.+.|+|||.+....
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCC
Confidence 9999997 4679999999887653
No 441
>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.48 E-value=5.1e-14 Score=130.92 Aligned_cols=199 Identities=24% Similarity=0.286 Sum_probs=159.6
Q ss_pred CCCCCCCcccc--CCceEEEEEEe---CCCcEEEEEEeehhhH--HHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCee
Q 037918 96 NGFDECNLLGK--GSFGSVYKGIL---SDGAEVAIKIFNLQLE--RAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFK 167 (361)
Q Consensus 96 ~~~~~~~~lg~--G~~g~V~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 167 (361)
..|.+.+.+|. |.+|.||.+.. .++..+|+|.-+.... ....+-.+|+.....+ .|+|.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34677889999 99999999986 3678899987433221 2122334566666666 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeeeCCCCCCCEEEcCC-CcEEEEeccC
Q 037918 168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS----ALEYLHHGYSPSVVHCDLKPSNILLDEN-MVAHVSDFGI 242 (361)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~ 242 (361)
++-+|++ +.+|.++.......++....+..+.+..+ ||.++| +.+++|-|++|.||+...+ ...+++|||+
T Consensus 194 fiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcce
Confidence 9999999 57999998877766888888999999999 999999 9999999999999999999 8899999999
Q ss_pred ccccCCCCcc---eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 037918 243 SKLLGDGENF---ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTD 299 (361)
Q Consensus 243 a~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~ 299 (361)
...++..... .......|...|++||...+ .++..+|+|++|.+..+..++..+..
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhccccc
Confidence 9988765421 11222367888999997654 46889999999999999999887654
No 442
>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.42 E-value=5.4e-12 Score=101.24 Aligned_cols=131 Identities=23% Similarity=0.318 Sum_probs=100.0
Q ss_pred CccccCCceEEEEEEeCCCcEEEEEEeehh------hH--HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918 102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQ------LE--RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~------~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (361)
..+++|+-+.+|.+.+. |..+++|.=... .+ -...+..+|++++.+++--.|....=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46889999999999774 445777743211 11 1234567899999998655555445455566777899999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918 174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL 245 (361)
Q Consensus 174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 245 (361)
++|..|.+++... ...++..+-.-+.-|| ..+|+||||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999998765 2457778888888999 89999999999999997765 99999999974
No 443
>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]
Probab=99.40 E-value=6.6e-12 Score=100.31 Aligned_cols=142 Identities=20% Similarity=0.258 Sum_probs=105.8
Q ss_pred CCCccccCCceEEEEEEeCCCcEEEEEEeehh--------hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918 100 ECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQ--------LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 100 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (361)
.+..+.+|+-+.|+++.+ .|+..+||.-... ..-...+..+|++++.+++--.|.-..=++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 467899999999999998 5788777743211 1112356788999999886545544444566666678999
Q ss_pred EecCC-CCHHHHHhcCCCCCCHHHH-HHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC---cEEEEeccCccc
Q 037918 172 EFMPN-GSLEKWLYSHNYFLDIQER-LNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM---VAHVSDFGISKL 245 (361)
Q Consensus 172 e~~~~-g~L~~~l~~~~~~~~~~~~-~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~a~~ 245 (361)
||++| .++.+++......-..+.. ..++..+-+.+.-|| ..+|+||||..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 4888888765332333333 788999999999999 89999999999999997655 458999999854
No 444
>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins. This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain
Probab=99.37 E-value=5.8e-12 Score=108.16 Aligned_cols=142 Identities=22% Similarity=0.258 Sum_probs=110.3
Q ss_pred CccccCCceEEEEEEeCCCcEEEEEEeehhhH-HHHHHHHHHHHHHHhcCC--CceeeeeeeeecC---CeeEEEEEecC
Q 037918 102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQLE-RAFRSFDSECEVLRSIRH--RNLVKILSSCSNV---DFKALVLEFMP 175 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~---~~~~lv~e~~~ 175 (361)
+.|+.|..+.+|++...+|+.+++|....... .....+..|.++++.+.+ .++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999987778999998765322 123567889999999965 4467777777654 35689999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 037918 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG------------------------------------------- 212 (361)
Q Consensus 176 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~------------------------------------------- 212 (361)
|.++.+.+.. ..++......++.+++++|..||+.
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9988776532 2367778888888999999888842
Q ss_pred ----------CCCCeeeCCCCCCCEEEcC--CCcEEEEeccCccc
Q 037918 213 ----------YSPSVVHCDLKPSNILLDE--NMVAHVSDFGISKL 245 (361)
Q Consensus 213 ----------~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~ 245 (361)
....++|+|+.|.||+++. ++.+.++||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 0245799999999999998 66789999998754
No 445
>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.33 E-value=1.1e-12 Score=122.17 Aligned_cols=197 Identities=25% Similarity=0.223 Sum_probs=151.3
Q ss_pred HHhhCCCCCCCccccCCceEEEEEEeC--CCcEEEEEEeehhhHHHHH--HHHHHHHHHHhc-CCCceeeeeeeeecCCe
Q 037918 92 QRATNGFDECNLLGKGSFGSVYKGILS--DGAEVAIKIFNLQLERAFR--SFDSECEVLRSI-RHRNLVKILSSCSNVDF 166 (361)
Q Consensus 92 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 166 (361)
.....+|..+..||.|.|+.|+....+ ++..+++|.+......... .-..|+.+...+ .|.++++.+..|.....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 334567889999999999999988743 6788999977654322212 223466666655 59999999998888888
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC-CcEEEEeccCccc
Q 037918 167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN-MVAHVSDFGISKL 245 (361)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~ 245 (361)
.|+--||++++++...+.... .+++..++++..|++.++.++| ++.++|+|++|+||++..+ +.-+++|||.+..
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~-~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQ-MLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred ccCchhhhcCcchhhhhHHHH-hcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccc
Confidence 889999999998877664222 2788889999999999999999 9999999999999999876 7889999999875
Q ss_pred cCCCCcceeeeccccccccc--CccccCCCCCCcccchHHHHHHHHHHHhCCCC
Q 037918 246 LGDGENFETRTMTMATVGYM--APEYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297 (361)
Q Consensus 246 ~~~~~~~~~~~~~~g~~~y~--aPE~~~~~~~~~~~Dv~slG~il~elltg~~p 297 (361)
+.-.. .......+++ +|+......+..+.|++|||..+.+..++..-
T Consensus 417 ~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 417 LAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred cceec-----ccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 32211 1112333344 56666677788999999999999999998864
No 446
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=99.30 E-value=3.2e-13 Score=132.32 Aligned_cols=205 Identities=24% Similarity=0.295 Sum_probs=148.4
Q ss_pred hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL 169 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (361)
..+.+.+.+.+.+|.++.++.+.-. .|...+.|...... ....+....+-.++-..++|.+++..-.+.-....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3456777888889999999987732 34333333332211 1112233333333333456767666655566678899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918 170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249 (361)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 249 (361)
+++|..+++|...+++.+. .+.+........+.+++++|| ...+.|+|++|.|.+...++..++.|||.....+.-
T Consensus 882 ~~~~~~~~~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGC-LSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred hhHHhccCCchhhhhcCCC-cccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccc
Confidence 9999999999999987653 566667778888999999999 777999999999999999999999999844322100
Q ss_pred ---------------------C--------cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918 250 ---------------------E--------NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDE 300 (361)
Q Consensus 250 ---------------------~--------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~ 300 (361)
. .........+|+.|.+||...+......+|.|++|++++|.++|.+||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0 00112334689999999999999999999999999999999999999986
Q ss_pred cc
Q 037918 301 FF 302 (361)
Q Consensus 301 ~~ 302 (361)
..
T Consensus 1038 ~t 1039 (1205)
T KOG0606|consen 1038 ET 1039 (1205)
T ss_pred cc
Confidence 44
No 447
>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.
Probab=99.27 E-value=6.9e-11 Score=97.74 Aligned_cols=125 Identities=25% Similarity=0.303 Sum_probs=84.1
Q ss_pred EEEEEEeCCCcEEEEEEeehhh--------------------------HHHHHHHHHHHHHHHhcCCC--ceeeeeeeee
Q 037918 111 SVYKGILSDGAEVAIKIFNLQL--------------------------ERAFRSFDSECEVLRSIRHR--NLVKILSSCS 162 (361)
Q Consensus 111 ~V~~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~ 162 (361)
.||.|...+|..+|||+..... .-......+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998899999999874210 01224567899999999654 567777552
Q ss_pred cCCeeEEEEEecC--CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeeeCCCCCCCEEEcCCCcEEEEe
Q 037918 163 NVDFKALVLEFMP--NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY-LHHGYSPSVVHCDLKPSNILLDENMVAHVSD 239 (361)
Q Consensus 163 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~-LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 239 (361)
...+||||++ |..+..+.... ++......++.+++..+.. +| ..||+|||+++.||+++++ .+.++|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence 3479999998 65565544322 1133445677778775555 67 8899999999999999988 999999
Q ss_pred ccCcccc
Q 037918 240 FGISKLL 246 (361)
Q Consensus 240 fg~a~~~ 246 (361)
||.+...
T Consensus 150 f~qav~~ 156 (188)
T PF01163_consen 150 FGQAVDS 156 (188)
T ss_dssp GTTEEET
T ss_pred cCcceec
Confidence 9988764
No 448
>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional
Probab=99.20 E-value=8.6e-10 Score=96.68 Aligned_cols=139 Identities=14% Similarity=0.107 Sum_probs=99.6
Q ss_pred ccccCCceEEEEEEeCCCcEEEEEEeehhhHH-HHH----------HHHHHHHHHHhcCCC--ceeeeeeeeec-----C
Q 037918 103 LLGKGSFGSVYKGILSDGAEVAIKIFNLQLER-AFR----------SFDSECEVLRSIRHR--NLVKILSSCSN-----V 164 (361)
Q Consensus 103 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~----------~~~~e~~~l~~l~h~--niv~~~~~~~~-----~ 164 (361)
.+-......|++... +|+.+.||........ ..+ .+.+|.+.+.++..- ..+.++++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344344445777766 6788999977543211 111 367899988888432 33344555432 2
Q ss_pred CeeEEEEEecCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC-------CCcE
Q 037918 165 DFKALVLEFMPNG-SLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE-------NMVA 235 (361)
Q Consensus 165 ~~~~lv~e~~~~g-~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-------~~~~ 235 (361)
...++|||++++. +|.+++... ....+......++.+++..+.-|| ..||+|+|++++|||++. ++.+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceE
Confidence 3468999999876 899998632 223566777899999999999999 899999999999999975 4689
Q ss_pred EEEeccCccc
Q 037918 236 HVSDFGISKL 245 (361)
Q Consensus 236 kl~Dfg~a~~ 245 (361)
.++||+.+..
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998854
No 449
>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]
Probab=99.14 E-value=5.6e-10 Score=95.11 Aligned_cols=136 Identities=22% Similarity=0.251 Sum_probs=100.1
Q ss_pred CCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhH----------------------HHHHHHHHHHHHHHhcCCC--c
Q 037918 98 FDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLE----------------------RAFRSFDSECEVLRSIRHR--N 153 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~--n 153 (361)
..+...||.|.-+.||.|..++|.++|||.-..... -......+|.++|++|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 455689999999999999999999999996532110 0123467899999998644 7
Q ss_pred eeeeeeeeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC
Q 037918 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM 233 (361)
Q Consensus 154 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~ 233 (361)
+.+.+++ +...+|||+++|-.|...- ++....-.++..|+.-+.-+- ..|+||||+++=||++++||
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCC
Confidence 7777765 5568999999887665533 123333445555555555555 56899999999999999999
Q ss_pred cEEEEeccCcccc
Q 037918 234 VAHVSDFGISKLL 246 (361)
Q Consensus 234 ~~kl~Dfg~a~~~ 246 (361)
.+.++||--+...
T Consensus 240 ~~~vIDwPQ~v~~ 252 (304)
T COG0478 240 DIVVIDWPQAVPI 252 (304)
T ss_pred CEEEEeCcccccC
Confidence 9999999776543
No 450
>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]
Probab=99.12 E-value=8.6e-10 Score=101.27 Aligned_cols=167 Identities=20% Similarity=0.228 Sum_probs=128.2
Q ss_pred ceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeee----cCCeeEEEEEecCC-CCHHHH
Q 037918 109 FGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS----NVDFKALVLEFMPN-GSLEKW 182 (361)
Q Consensus 109 ~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~-g~L~~~ 182 (361)
-.+.|++... ||..|++|+++............-++.++++.|+|+|++.+++. .+..+++|++|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 4678888844 89999999994332222223345688999999999999999886 34578899999875 578776
Q ss_pred HhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918 183 LYSH--------------NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD 248 (361)
Q Consensus 183 l~~~--------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 248 (361)
-... +...++..+|.++.|+..||.++| +.|+.-+-|.+.+|+++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 5422 233678999999999999999999 88999999999999999999999998887766543
Q ss_pred CCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCC
Q 037918 249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297 (361)
Q Consensus 249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p 297 (361)
+.. |-+.+ -.+-|.=.||.+++.|.||...
T Consensus 446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 320 11111 2367999999999999999654
No 451
>COG0661 AarF Predicted unusual protein kinase [General function prediction only]
Probab=99.09 E-value=1.1e-09 Score=103.91 Aligned_cols=147 Identities=18% Similarity=0.232 Sum_probs=97.0
Q ss_pred CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHH----------------------------------HH----
Q 037918 96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERA----------------------------------FR---- 137 (361)
Q Consensus 96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----------------------------------~~---- 137 (361)
..|+. +.|+.++-|.||+|++++|+.||||+......+. .+
T Consensus 126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 34553 6899999999999999999999999875432110 01
Q ss_pred --HHHHHHHHHHhcC-----CCceeeeeeeeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 037918 138 --SFDSECEVLRSIR-----HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210 (361)
Q Consensus 138 --~~~~e~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH 210 (361)
++..|..-+.+++ .+++.-..=+++-.+...|+|||++|..+.+.........+...+.....++.--.-+-|
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~d 284 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLRD 284 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHhc
Confidence 1334444444441 333322222333345668999999999998885432233664444333333332222334
Q ss_pred hcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD 248 (361)
Q Consensus 211 ~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 248 (361)
|+.|.|..|.||+++.+|++.+.|||+...+.+
T Consensus 285 -----gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 -----GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -----CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999877654
No 452
>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane
Probab=98.94 E-value=1.2e-08 Score=86.42 Aligned_cols=106 Identities=22% Similarity=0.272 Sum_probs=83.8
Q ss_pred HHHHHHHHHHHhcC--CCceeeeeeeeecCC----eeEEEEEecCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 037918 137 RSFDSECEVLRSIR--HRNLVKILSSCSNVD----FKALVLEFMPNG-SLEKWLYSHNYFLDIQERLNVMIDVGSALEYL 209 (361)
Q Consensus 137 ~~~~~e~~~l~~l~--h~niv~~~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~L 209 (361)
....+|...+..+. .-..++.+++..... ..++|+|++++. +|.+++..... .+......++.+++..++-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 35677888887774 334555666655432 457999999874 89999986433 56777889999999999999
Q ss_pred HhcCCCCeeeCCCCCCCEEEcCCC---cEEEEeccCcccc
Q 037918 210 HHGYSPSVVHCDLKPSNILLDENM---VAHVSDFGISKLL 246 (361)
Q Consensus 210 H~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~a~~~ 246 (361)
| ..||+|+|+++.|||++.++ .+.++||+.++..
T Consensus 135 H---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 H---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred H---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9 89999999999999999887 8999999987653
No 453
>PRK09902 hypothetical protein; Provisional
Probab=98.90 E-value=5.6e-08 Score=81.03 Aligned_cols=137 Identities=18% Similarity=0.104 Sum_probs=101.0
Q ss_pred cccCCceEEEEEEeCCCcEEEEEEeehhhH------HHHHHHHHHHHHHHhcC--CCceeeeeeeee-c----CCeeEEE
Q 037918 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLE------RAFRSFDSECEVLRSIR--HRNLVKILSSCS-N----VDFKALV 170 (361)
Q Consensus 104 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~~~~~~~-~----~~~~~lv 170 (361)
-|+||-+.|++.... |+.+-+|.-..... -....|.+|...+.++. .-.+.++. ++. . .-..+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 456888899997774 55788887652211 12357889999999884 23355555 332 1 1235799
Q ss_pred EEecCC-CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCc--EEEEeccCccc
Q 037918 171 LEFMPN-GSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV--AHVSDFGISKL 245 (361)
Q Consensus 171 ~e~~~~-g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~a~~ 245 (361)
+|-+++ -||.+++.+.. ...+......++.+++..+.-|| +.|+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997753 58999886542 23677888899999999999999 999999999999999986666 99999986654
No 454
>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]
Probab=98.89 E-value=3.6e-08 Score=88.72 Aligned_cols=192 Identities=13% Similarity=0.107 Sum_probs=126.6
Q ss_pred CCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeee------eecC-CeeEEEE
Q 037918 100 ECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSS------CSNV-DFKALVL 171 (361)
Q Consensus 100 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~------~~~~-~~~~lv~ 171 (361)
....||+|+.+.+|..- +-...+-|++.........+ -+..|... .||-+-.=+.+ .-+. ....+.|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 35679999999999543 21223457776543221111 22233333 45543331111 1112 2356788
Q ss_pred EecCCC-CHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918 172 EFMPNG-SLEKWLYSH-----NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL 245 (361)
Q Consensus 172 e~~~~g-~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 245 (361)
..+++. ....+.... -...+|+..++.++.++.+.+.|| ..|.+-||++++|+|+++++.+.|.|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceee
Confidence 887664 333333311 123689999999999999999999 88999999999999999999999998554333
Q ss_pred cCCCCcceeeecccccccccCcccc-----CCCCCCcccchHHHHHHHHHHHhC-CCCCCccc
Q 037918 246 LGDGENFETRTMTMATVGYMAPEYG-----SEGIVSSKCDVYSYGVLLMETFTR-KKPTDEFF 302 (361)
Q Consensus 246 ~~~~~~~~~~~~~~g~~~y~aPE~~-----~~~~~~~~~Dv~slG~il~elltg-~~p~~~~~ 302 (361)
... ........|...|.+||.- .+..-+...|-|.||+++++++.| +.||....
T Consensus 167 ~~n---g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 167 NAN---GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred ccC---CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 211 1123345689999999952 344457789999999999999887 99998653
No 455
>KOG2137 consensus Protein kinase [Signal transduction mechanisms]
Probab=98.84 E-value=9.8e-10 Score=104.23 Aligned_cols=97 Identities=24% Similarity=0.426 Sum_probs=76.5
Q ss_pred HHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee-------ecccccccccCccccC
Q 037918 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR-------TMTMATVGYMAPEYGS 271 (361)
Q Consensus 199 ~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~-------~~~~g~~~y~aPE~~~ 271 (361)
+.+++.||.|+|. +.++||++|.|++|.++.++..||+.|+.+............ ........|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3455599999996 789999999999999999999999999988765432111111 1123456799999999
Q ss_pred CCCCCcccchHHHHHHHHHHHhCCCC
Q 037918 272 EGIVSSKCDVYSYGVLLMETFTRKKP 297 (361)
Q Consensus 272 ~~~~~~~~Dv~slG~il~elltg~~p 297 (361)
+...+.++|+||+|+++|.+..|..+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~ 208 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKS 208 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcc
Confidence 98889999999999999999955544
No 456
>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]
Probab=98.81 E-value=5e-08 Score=92.41 Aligned_cols=139 Identities=17% Similarity=0.264 Sum_probs=92.4
Q ss_pred CccccCCceEEEEEEeCCCcEEEEEEeehhhHH-------------------------------HHH------HHHHHHH
Q 037918 102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQLER-------------------------------AFR------SFDSECE 144 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-------------------------------~~~------~~~~e~~ 144 (361)
+.||.-+.|.||+|++++|+.||||+-+...+. ..+ +|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 689999999999999999999999986543211 011 2334443
Q ss_pred HHHh----cCCCc------eeeeeeeeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 037918 145 VLRS----IRHRN------LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS 214 (361)
Q Consensus 145 ~l~~----l~h~n------iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~ 214 (361)
-..+ ++|-+ |.+++-. -.....|+|||++|..+.|.-.-....++...+..-+.+...-+-+-|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~---- 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKT---- 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhc----
Confidence 3332 23444 3333322 234568999999998776654322223666655554444443333344
Q ss_pred CCeeeCCCCCCCEEEcC----CCcEEEEeccCccccC
Q 037918 215 PSVVHCDLKPSNILLDE----NMVAHVSDFGISKLLG 247 (361)
Q Consensus 215 ~~ivH~dlk~~Nill~~----~~~~kl~Dfg~a~~~~ 247 (361)
|++|+|-.|.||+++. ++.+.+.|||+...+.
T Consensus 321 -GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 321 -GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred -CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 8999999999999983 6789999999987764
No 457
>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172. This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.
Probab=98.80 E-value=1.1e-07 Score=81.72 Aligned_cols=132 Identities=13% Similarity=0.170 Sum_probs=85.5
Q ss_pred CccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCC--ceeeeeeeeecCCeeEEEEEecCCCC-
Q 037918 102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHR--NLVKILSSCSNVDFKALVLEFMPNGS- 178 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~g~- 178 (361)
..||+|..+.||+. .|..+++|....... .....+|.++++.+..- .+.+.+++....+...++||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~--~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFD--KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCCC--HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 47899999999983 255678898765432 23467899999888533 35777888877778889999998863
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---------------------------------------h-cCCCCee
Q 037918 179 LEKWLYSHNYFLDIQERLNVMIDVGSALEYLH---------------------------------------H-GYSPSVV 218 (361)
Q Consensus 179 L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH---------------------------------------~-~~~~~iv 218 (361)
+...+.. +......++.++++.+.-|| . .....++
T Consensus 82 ~~~~~~~-----~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 82 FSRIISD-----NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred hhhhhcC-----CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 2222110 01111111122222222222 0 1134578
Q ss_pred eCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918 219 HCDLKPSNILLDENMVAHVSDFGISK 244 (361)
Q Consensus 219 H~dlk~~Nill~~~~~~kl~Dfg~a~ 244 (361)
|+|+.|.||++++++ +.++||+.+.
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcC
Confidence 999999999999888 9999999775
No 458
>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY). The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process
Probab=98.77 E-value=1.1e-07 Score=79.67 Aligned_cols=137 Identities=18% Similarity=0.178 Sum_probs=91.0
Q ss_pred hhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHH---------HHHHHHHHhcCC---Cceeeeeeee
Q 037918 94 ATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSF---------DSECEVLRSIRH---RNLVKILSSC 161 (361)
Q Consensus 94 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~e~~~l~~l~h---~niv~~~~~~ 161 (361)
..++|.+.+++-......|.+-.. +|..+++|..........+.| .+++..+.+++. .....++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 456788878887777777776666 678999998875543322222 233333344422 2222222222
Q ss_pred -----ecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEE
Q 037918 162 -----SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAH 236 (361)
Q Consensus 162 -----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 236 (361)
.-....+++|||++|..|.+... ++. .+...+.+++.-|| +.|+.|||..|.|+++++++ ++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i~ 174 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-IR 174 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-EE
Confidence 22234568999999988877543 222 24566778899999 89999999999999998654 89
Q ss_pred EEeccCcc
Q 037918 237 VSDFGISK 244 (361)
Q Consensus 237 l~Dfg~a~ 244 (361)
++||+..+
T Consensus 175 iID~~~k~ 182 (229)
T PF06176_consen 175 IIDTQGKR 182 (229)
T ss_pred EEECcccc
Confidence 99998665
No 459
>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]
Probab=98.76 E-value=2.1e-07 Score=78.79 Aligned_cols=155 Identities=21% Similarity=0.249 Sum_probs=104.4
Q ss_pred cccCHHHHHHhhCCCCCCCc---cccCCceEEEEEEeCCCcEEEEEEeehhhHH------------------------HH
Q 037918 84 RRISYLEIQRATNGFDECNL---LGKGSFGSVYKGILSDGAEVAIKIFNLQLER------------------------AF 136 (361)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~---lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------------------------~~ 136 (361)
...+...+....++..+... |++|.-+.||+|...++..+|+|++...... ..
T Consensus 33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~ 112 (268)
T COG1718 33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF 112 (268)
T ss_pred hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence 34556666666666665554 5578888999999888999999998643211 01
Q ss_pred HHHHHHHHHHHhc--CCCceeeeeeeeecCCeeEEEEEecCCCCH-HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 037918 137 RSFDSECEVLRSI--RHRNLVKILSSCSNVDFKALVLEFMPNGSL-EKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213 (361)
Q Consensus 137 ~~~~~e~~~l~~l--~h~niv~~~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~ 213 (361)
.-..+|..-|.++ .+-.+.+.+++.. ..|||||+..... .-.|.. ..+.......+..++++.+.-|-.
T Consensus 113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~-- 184 (268)
T COG1718 113 AWARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYK-- 184 (268)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHH--
Confidence 1134577777766 2455555555543 3699999854311 111111 113333567788888888888772
Q ss_pred CCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG 247 (361)
Q Consensus 214 ~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 247 (361)
..++||+||+.=|||+. ++.+.++|||-|....
T Consensus 185 ~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 185 EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 37999999999999999 8899999999987654
No 460
>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily.; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....
Probab=98.67 E-value=4.1e-07 Score=78.55 Aligned_cols=140 Identities=22% Similarity=0.287 Sum_probs=83.5
Q ss_pred CccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCC--Cceeeeeeee---ecCCeeEEEEEecCC
Q 037918 102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRH--RNLVKILSSC---SNVDFKALVLEFMPN 176 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~---~~~~~~~lv~e~~~~ 176 (361)
+.|+.|..+.||+....+ ..+++|..... .....+..|..+++.+.. ..+.+++... ......+++|++++|
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 578899999999999876 68999998665 344567788888888742 2356666644 233457899999999
Q ss_pred CCHHH----------------HHh---cC---CCCCCHHH---------HHHH------------HHHHHH-HHHHHHh-
Q 037918 177 GSLEK----------------WLY---SH---NYFLDIQE---------RLNV------------MIDVGS-ALEYLHH- 211 (361)
Q Consensus 177 g~L~~----------------~l~---~~---~~~~~~~~---------~~~i------------~~~i~~-~L~~LH~- 211 (361)
.++.. .+. .. ........ .... ...+.. .++.++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88877 111 11 00011100 0000 111222 2333331
Q ss_pred ---cCCCCeeeCCCCCCCEEEc-CCCcEEEEeccCcc
Q 037918 212 ---GYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISK 244 (361)
Q Consensus 212 ---~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~ 244 (361)
.....++|+|+.|+||+++ +++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1356799999999999999 66666899998764
No 461
>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH). The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio
Probab=98.60 E-value=9.4e-07 Score=77.08 Aligned_cols=138 Identities=17% Similarity=0.123 Sum_probs=86.0
Q ss_pred ccccCCc-eEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC-CCceeeeeeeeecCCeeEEEEEecCCCCHH
Q 037918 103 LLGKGSF-GSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-HRNLVKILSSCSNVDFKALVLEFMPNGSLE 180 (361)
Q Consensus 103 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 180 (361)
.|..|.. ..||+.... +..+++|+..... .....+|+++++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3445555 788998764 4788899876542 234667888888873 455677888877777789999999998876
Q ss_pred HHHh-------------------cCC---CCCC--HHHHHHHHH--------------------HHHHHHHHHHh----c
Q 037918 181 KWLY-------------------SHN---YFLD--IQERLNVMI--------------------DVGSALEYLHH----G 212 (361)
Q Consensus 181 ~~l~-------------------~~~---~~~~--~~~~~~i~~--------------------~i~~~L~~LH~----~ 212 (361)
+... .-. .... ......... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 5421 000 0000 000000000 01111222211 1
Q ss_pred CCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISK 244 (361)
Q Consensus 213 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 244 (361)
....++|+|+.|.||+++++....|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 13568999999999999998778899998774
No 462
>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP. PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].
Probab=98.59 E-value=2e-06 Score=71.80 Aligned_cols=128 Identities=20% Similarity=0.296 Sum_probs=92.9
Q ss_pred CCccccCCceEEEEEEeCCCcEEEEEEeehhh----------------HHHHHHHHHHHHHHHhcC------CCceeeee
Q 037918 101 CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL----------------ERAFRSFDSECEVLRSIR------HRNLVKIL 158 (361)
Q Consensus 101 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv~~~ 158 (361)
...||+|+.-.||. +++.....||+..... ....+...+|+.-...+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46899999999995 4556677889887654 122456667777666665 88999999
Q ss_pred eeeecCCeeEEEEEecCC------CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC
Q 037918 159 SSCSNVDFKALVLEFMPN------GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN 232 (361)
Q Consensus 159 ~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~ 232 (361)
|+.+++....+|+|.+.+ .+|.+++.... ++. ...+.+.++ ..||- +..|+.+|++|+||++..+
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~--~~~-~~~~~L~~f---~~~l~---~~~Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG--LTE-ELRQALDEF---KRYLL---DHHIVIRDLNPHNIVVQRR 154 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC--ccH-HHHHHHHHH---HHHHH---HcCCeecCCCcccEEEEec
Confidence 999999999999998643 47889986554 555 444444444 44555 6679999999999999532
Q ss_pred C----cEEEEe
Q 037918 233 M----VAHVSD 239 (361)
Q Consensus 233 ~----~~kl~D 239 (361)
. .+.|+|
T Consensus 155 ~~~~~~lvlID 165 (199)
T PF10707_consen 155 DSGEFRLVLID 165 (199)
T ss_pred CCCceEEEEEe
Confidence 2 577777
No 463
>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]
Probab=98.50 E-value=1.2e-08 Score=96.09 Aligned_cols=186 Identities=19% Similarity=0.142 Sum_probs=134.0
Q ss_pred CCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCc-eeeeeeeeecCCeeEEEEEecCC
Q 037918 98 FDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRN-LVKILSSCSNVDFKALVLEFMPN 176 (361)
Q Consensus 98 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~ 176 (361)
+...+-.++|+++.++|.+-.-.+....+.+... ....-++++|.+++||| .+..++-++.++...+.++++.+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 3334567889999999887433333445554433 33455899999999999 77777888888889999999977
Q ss_pred C-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee
Q 037918 177 G-SLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR 255 (361)
Q Consensus 177 g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 255 (361)
+ +-..........+...+...+.+.-+++++++| +..=+|+| ||+..+ +..+..||+....+.... ..
T Consensus 319 ~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~ 387 (829)
T KOG0576|consen 319 GRSSALEMTVSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KP 387 (829)
T ss_pred CccccccCChhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc---cc
Confidence 6 222222211122344445566777788999999 54457888 777765 678999999988775533 33
Q ss_pred ecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 037918 256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTD 299 (361)
Q Consensus 256 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~ 299 (361)
....+++.|+|||+.....+....|.|++|.-..++--|.+|-.
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 45579999999999999999999999999987778877777643
No 464
>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]
Probab=98.46 E-value=2.1e-06 Score=68.87 Aligned_cols=129 Identities=21% Similarity=0.284 Sum_probs=89.6
Q ss_pred CCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCcee-eeeeeeecCCeeEEEEEecCCC
Q 037918 99 DECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLV-KILSSCSNVDFKALVLEFMPNG 177 (361)
Q Consensus 99 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~g 177 (361)
...+.|++|++|.||+|.+. |..+|+|+-..++.. ..+..|+++|..+.-.++. +++.+..+ ++.|||+.|.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~r--~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSPR--RNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCCcch--hhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCc
Confidence 34578999999999999995 568999987665543 6788899999998766554 34444332 3559999988
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCC-CCCEEEcCCCcEEEEeccCccc
Q 037918 178 SLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLK-PSNILLDENMVAHVSDFGISKL 245 (361)
Q Consensus 178 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk-~~Nill~~~~~~kl~Dfg~a~~ 245 (361)
+|.+.-... +-. -...++..---|. ..||-|+.|+ |...++..+..+.|+||..|+.
T Consensus 98 ~L~~~~~~~----~rk----~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG----DRK----HLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc----cHH----HHHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 887765421 222 2334444433355 6688888886 4444554555999999998874
No 465
>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C). Proteins in this uncharacterised family are described as transmembrane proteins.
Probab=98.42 E-value=1.4e-06 Score=72.38 Aligned_cols=102 Identities=23% Similarity=0.305 Sum_probs=82.0
Q ss_pred HHHHHHHHhcCC-CceeeeeeeeecCCeeEEEEEecCCCCHHHH---HhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 037918 140 DSECEVLRSIRH-RNLVKILSSCSNVDFKALVLEFMPNGSLEKW---LYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215 (361)
Q Consensus 140 ~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~---l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~ 215 (361)
..|.-+++.+.+ +++++++|+|- .++++||...+++... +.. -...+|..+.+|+.++++.+.+|++....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 357888888865 69999999994 3689999987655421 111 01268999999999999999999976556
Q ss_pred CeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLL 246 (361)
Q Consensus 216 ~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 246 (361)
.+.-.|++++|+-+++++++|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 7899999999999999999999999877654
No 466
>PLN02876 acyl-CoA dehydrogenase
Probab=98.39 E-value=3.8e-06 Score=85.85 Aligned_cols=78 Identities=14% Similarity=0.309 Sum_probs=56.9
Q ss_pred CCccccCCceEEEEEEeCCC---cEEEEEEeehhh-HHHHHHHHHHHHHHHhcC-CCce--eeeeeeeecC---CeeEEE
Q 037918 101 CNLLGKGSFGSVYKGILSDG---AEVAIKIFNLQL-ERAFRSFDSECEVLRSIR-HRNL--VKILSSCSNV---DFKALV 170 (361)
Q Consensus 101 ~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv 170 (361)
++.++.|.+..+|+....++ ..+++|+..... ......+.+|.++++.+. |+++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46788999999999886553 467888765422 112246788999999995 6654 7888888764 467899
Q ss_pred EEecCCCC
Q 037918 171 LEFMPNGS 178 (361)
Q Consensus 171 ~e~~~~g~ 178 (361)
|||++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998764
No 467
>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members. The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista
Probab=98.36 E-value=5.3e-06 Score=71.91 Aligned_cols=73 Identities=8% Similarity=0.103 Sum_probs=46.6
Q ss_pred CccccCCce-EEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCC---ceeeeeeeeecC---CeeEEEEEec
Q 037918 102 NLLGKGSFG-SVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHR---NLVKILSSCSNV---DFKALVLEFM 174 (361)
Q Consensus 102 ~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e~~ 174 (361)
+.|+.|+.. .||+. +..+++|...... ....+..|.+.+..+... .+.++++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 467776665 58874 2457788765432 234678899999887532 345555544332 2458899999
Q ss_pred CCCCHH
Q 037918 175 PNGSLE 180 (361)
Q Consensus 175 ~~g~L~ 180 (361)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987764
No 468
>PRK10593 hypothetical protein; Provisional
Probab=98.31 E-value=1.7e-05 Score=71.23 Aligned_cols=77 Identities=10% Similarity=0.057 Sum_probs=56.5
Q ss_pred CCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCC---Cceeeeeeeeec---CCeeEEEEEe
Q 037918 100 ECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRH---RNLVKILSSCSN---VDFKALVLEF 173 (361)
Q Consensus 100 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~---~~~~~lv~e~ 173 (361)
..+.||.|..+.||.....++ .+++|..+... ....+..|.+.++.+.- ..+.++++++.. .+..++|||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 356799999999999886555 46677754311 12467889999998842 468888887754 3668999999
Q ss_pred cCCCCH
Q 037918 174 MPNGSL 179 (361)
Q Consensus 174 ~~~g~L 179 (361)
++++++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
No 469
>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2
Probab=98.21 E-value=4.1e-05 Score=63.52 Aligned_cols=125 Identities=28% Similarity=0.452 Sum_probs=90.5
Q ss_pred CCCCCCCccccCCc-eEEEEEEeCCCcEEEEEEeeh---hh--------H----------HHHHHHHHHHHHHHhcC---
Q 037918 96 NGFDECNLLGKGSF-GSVYKGILSDGAEVAIKIFNL---QL--------E----------RAFRSFDSECEVLRSIR--- 150 (361)
Q Consensus 96 ~~~~~~~~lg~G~~-g~V~~~~~~~~~~vavK~~~~---~~--------~----------~~~~~~~~e~~~l~~l~--- 150 (361)
.+++.++.||.|.. |.||++.. +|+.+|+|++.. .. . .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 77888999999999 99999999 578999999321 00 0 12346888999888874
Q ss_pred CCce--eeeeeeeecC------------------CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 037918 151 HRNL--VKILSSCSNV------------------DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210 (361)
Q Consensus 151 h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH 210 (361)
+.++ ++.+||..-. ....+|.||++... .+.. +-+.+|.+-+..+|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccch----hHHHHHHHHHHHHH
Confidence 4556 8999987322 12347888776533 1222 33456777788899
Q ss_pred hcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCc
Q 037918 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGIS 243 (361)
Q Consensus 211 ~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 243 (361)
..||+-+|+++.|.. + -+|+|||.+
T Consensus 182 ---k~gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 182 ---KLGIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred ---HCCeeeccCcccccc---C--CEEEecccC
Confidence 899999999999985 2 389999864
No 470
>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo
Probab=98.16 E-value=2.7e-05 Score=67.40 Aligned_cols=73 Identities=15% Similarity=0.252 Sum_probs=48.2
Q ss_pred CccccCCceEEEEEEeCC--CcEEEEEEeehhhHHHHHHHHHHHHHHHhcCC-CceeeeeeeeecCCeeEEEEEecCCCC
Q 037918 102 NLLGKGSFGSVYKGILSD--GAEVAIKIFNLQLERAFRSFDSECEVLRSIRH-RNLVKILSSCSNVDFKALVLEFMPNGS 178 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~g~ 178 (361)
+.|..|-...+|+....+ +..+++|+....... .-...+|+.+++.+.. .-.+++++.+. ..++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 467788888999998654 678999977643221 1223468888888843 33445544432 248999999876
Q ss_pred H
Q 037918 179 L 179 (361)
Q Consensus 179 L 179 (361)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
No 471
>TIGR02721 ycfN_thiK thiamine kinase. Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.
Probab=98.15 E-value=1.4e-05 Score=70.20 Aligned_cols=137 Identities=12% Similarity=0.116 Sum_probs=78.6
Q ss_pred ccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCce-eeeeeeeecCCeeEEEEEecCCCCHHH
Q 037918 103 LLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNL-VKILSSCSNVDFKALVLEFMPNGSLEK 181 (361)
Q Consensus 103 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~L~~ 181 (361)
.+..|-...+|+... ++..+++|..........-...+|.++++.+....+ .+++.... .++||||++|.++..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 456678889998874 567888997654322211134678888888853322 34444432 368999998876532
Q ss_pred H--------------Hh---cC---CCCCCHHH-HHHHHHHH---------HHHHHHHHh-----cCCCCeeeCCCCCCC
Q 037918 182 W--------------LY---SH---NYFLDIQE-RLNVMIDV---------GSALEYLHH-----GYSPSVVHCDLKPSN 226 (361)
Q Consensus 182 ~--------------l~---~~---~~~~~~~~-~~~i~~~i---------~~~L~~LH~-----~~~~~ivH~dlk~~N 226 (361)
. +. +. ...++... ...+..++ ...+..+-. .....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11 11 11122211 11111111 111222211 113468999999999
Q ss_pred EEEcCCCcEEEEeccCccc
Q 037918 227 ILLDENMVAHVSDFGISKL 245 (361)
Q Consensus 227 ill~~~~~~kl~Dfg~a~~ 245 (361)
|++++++ +.++||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998754
No 472
>PRK05231 homoserine kinase; Provisional
Probab=98.11 E-value=0.00022 Score=64.85 Aligned_cols=157 Identities=15% Similarity=0.143 Sum_probs=84.9
Q ss_pred ccCHHHHHHhhCCCCC-----CCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCC--Cceeee
Q 037918 85 RISYLEIQRATNGFDE-----CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRH--RNLVKI 157 (361)
Q Consensus 85 ~~~~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~ 157 (361)
.++..++......|.+ .+.|+.|....+|+....+| .+++|++..... +....|..++..+.. -.+.++
T Consensus 6 ~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~ 81 (319)
T PRK05231 6 DVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAP 81 (319)
T ss_pred cCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcc
Confidence 3444555554455544 34566777789999887655 688898752222 233345555555521 123333
Q ss_pred ee------eeecCCeeEEEEEecCCCCHH-----------HHHh---c--CC------C--CC-CHHHHHH---------
Q 037918 158 LS------SCSNVDFKALVLEFMPNGSLE-----------KWLY---S--HN------Y--FL-DIQERLN--------- 197 (361)
Q Consensus 158 ~~------~~~~~~~~~lv~e~~~~g~L~-----------~~l~---~--~~------~--~~-~~~~~~~--------- 197 (361)
+. +....+..+++++|++|..+. +.+. . .+ . .+ .+.....
T Consensus 82 i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (319)
T PRK05231 82 VARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADE 161 (319)
T ss_pred eeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChh
Confidence 32 123345678999999886431 1111 0 00 0 01 1111111
Q ss_pred ---HHHH-HHHHHHHHHh----cCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918 198 ---VMID-VGSALEYLHH----GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL 245 (361)
Q Consensus 198 ---i~~~-i~~~L~~LH~----~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 245 (361)
.+.+ +...++.+.. ....+++|+|+.|.||+++.+...-++||+.+..
T Consensus 162 ~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 162 QAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1111 1112222221 1246899999999999999776668999998753
No 473
>PRK09550 mtnK methylthioribose kinase; Reviewed
Probab=98.09 E-value=0.00012 Score=67.83 Aligned_cols=75 Identities=16% Similarity=0.179 Sum_probs=53.3
Q ss_pred CccccCCceEEEEEEeCCC-cEEEEEEeehhh-------HHHHHHHHHHHHHHHhcC---CCceeeeeeeeecCCeeEEE
Q 037918 102 NLLGKGSFGSVYKGILSDG-AEVAIKIFNLQL-------ERAFRSFDSECEVLRSIR---HRNLVKILSSCSNVDFKALV 170 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv 170 (361)
+.||.|.+..||++...+| +.++||.-.... .-..++...|.+.|..+. -.++++++.+. .+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEE
Confidence 5799999999999998776 589999753211 112356677888887762 34677777773 3557899
Q ss_pred EEecCCCC
Q 037918 171 LEFMPNGS 178 (361)
Q Consensus 171 ~e~~~~g~ 178 (361)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99997643
No 474
>cd05153 HomoserineK_II Homoserine Kinase, type II. Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.
Probab=98.03 E-value=7.3e-05 Score=67.17 Aligned_cols=141 Identities=16% Similarity=0.154 Sum_probs=84.2
Q ss_pred CCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCC--ceeeeeee------eecCCeeEEEEE
Q 037918 101 CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHR--NLVKILSS------CSNVDFKALVLE 172 (361)
Q Consensus 101 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~------~~~~~~~~lv~e 172 (361)
.+.+..|....+|+....+ ..+++|+..... ......|++++..+.+. .+.+++.. ....+..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKVS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCCCC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567778888999987644 468889876422 24466688888777432 24454432 123456689999
Q ss_pred ecCCCCHHH----HH----------hc--CC--------CCCCHHHHH----------HHHHHHHHHHHHHHh----cCC
Q 037918 173 FMPNGSLEK----WL----------YS--HN--------YFLDIQERL----------NVMIDVGSALEYLHH----GYS 214 (361)
Q Consensus 173 ~~~~g~L~~----~l----------~~--~~--------~~~~~~~~~----------~i~~~i~~~L~~LH~----~~~ 214 (361)
|++|.++.. .. +. .. ....|.... .....+..++.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998876532 00 00 00 001111110 011122334444442 123
Q ss_pred CCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKL 245 (361)
Q Consensus 215 ~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 245 (361)
.+++|+|+.|.||++++++.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 5799999999999999987788999987753
No 475
>TIGR00938 thrB_alt homoserine kinase, Neisseria type. Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.
Probab=97.91 E-value=0.0007 Score=61.18 Aligned_cols=141 Identities=18% Similarity=0.226 Sum_probs=81.6
Q ss_pred CCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCC--Cceeeeeeee------ecCCeeEEEEE
Q 037918 101 CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRH--RNLVKILSSC------SNVDFKALVLE 172 (361)
Q Consensus 101 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~------~~~~~~~lv~e 172 (361)
.+.++.|....+|+....+| .+++|+...... ......|.+++..|.. -.+.+++... ...+..+++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677777789999876555 577898754321 1234456677766632 2244444321 22456789999
Q ss_pred ecCCCCHH-----------HHH---hc--CCC---------CCCHHHHH------------HHHHHHHHHHHHHHh----
Q 037918 173 FMPNGSLE-----------KWL---YS--HNY---------FLDIQERL------------NVMIDVGSALEYLHH---- 211 (361)
Q Consensus 173 ~~~~g~L~-----------~~l---~~--~~~---------~~~~~~~~------------~i~~~i~~~L~~LH~---- 211 (361)
|++|.++. ..+ +. .+. ...|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99885432 111 10 000 00111100 001123334555532
Q ss_pred cCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISK 244 (361)
Q Consensus 212 ~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 244 (361)
....+++|+|+.+.||++++++...|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 225789999999999999988877899999874
No 476
>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]
Probab=97.88 E-value=2.8e-05 Score=68.54 Aligned_cols=147 Identities=18% Similarity=0.210 Sum_probs=99.3
Q ss_pred ccCHHHHHHhhCC---CCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhH--------H----------H----HHHH
Q 037918 85 RISYLEIQRATNG---FDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLE--------R----------A----FRSF 139 (361)
Q Consensus 85 ~~~~~~~~~~~~~---~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~----------~----~~~~ 139 (361)
-+.|..+....++ +.+.+.||-|.-+.||.+...+|++.++|.-..... + + .-..
T Consensus 78 GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa 157 (465)
T KOG2268|consen 78 GYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA 157 (465)
T ss_pred cchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence 3445555554443 677899999999999999999999999985432110 0 0 1134
Q ss_pred HHHHHHHHhcC-C-CceeeeeeeeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 037918 140 DSECEVLRSIR-H-RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSV 217 (361)
Q Consensus 140 ~~e~~~l~~l~-h-~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i 217 (361)
.+|...|+.+. | --+.+.+++ +..++|||++.+-+|...-+-. +..+ +...+..-+.-|. ..|+
T Consensus 158 ~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~----d~~~---ly~~lm~~Iv~la---~~Gl 223 (465)
T KOG2268|consen 158 TKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE----DPPT---LYDDLMGLIVRLA---NHGL 223 (465)
T ss_pred HHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeecC----ChHH---HHHHHHHHHHHHH---HcCc
Confidence 56888888773 2 234444544 4568999999888876644322 2222 3333333444455 6799
Q ss_pred eeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918 218 VHCDLKPSNILLDENMVAHVSDFGISKL 245 (361)
Q Consensus 218 vH~dlk~~Nill~~~~~~kl~Dfg~a~~ 245 (361)
||||..-=||++++++.++++||--...
T Consensus 224 IHgDFNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 224 IHGDFNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred eecccchheeEEecCCCEEEeechHhhc
Confidence 9999999999999999999999976543
No 477
>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]
Probab=97.88 E-value=0.00022 Score=64.14 Aligned_cols=142 Identities=18% Similarity=0.164 Sum_probs=95.7
Q ss_pred CCCCccccCCceEEEEEEeCCCcEEEEEEeehhh------------------------H-HHH-HHHHHHHHHHHhcCCC
Q 037918 99 DECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL------------------------E-RAF-RSFDSECEVLRSIRHR 152 (361)
Q Consensus 99 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------------~-~~~-~~~~~e~~~l~~l~h~ 152 (361)
.+...|..|.-+.||.+.-.+|..+|||+++... . +-. --...|++-|.+++..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 3456788999999999999899999999875221 0 011 1234677778877544
Q ss_pred ceeeeeeeeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC
Q 037918 153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN 232 (361)
Q Consensus 153 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~ 232 (361)
.|.-.--... ....|||+|+. .+=+-.-.-....++...+..+-.+++.-+.-|-+. .++||.||+-=|+|+- +
T Consensus 227 GIP~PePIlL--k~hVLVM~FlG-rdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~Lyh-d 300 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLG-RDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLYH-D 300 (520)
T ss_pred CCCCCCceee--ecceEeeeecc-CCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheEE-C
Confidence 3322111111 13379999984 322222111233377778888888999888888764 4899999999999984 5
Q ss_pred CcEEEEeccCcccc
Q 037918 233 MVAHVSDFGISKLL 246 (361)
Q Consensus 233 ~~~kl~Dfg~a~~~ 246 (361)
|.+.++|.+-+...
T Consensus 301 G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEH 314 (520)
T ss_pred CEEEEEEccccccC
Confidence 68999999877644
No 478
>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes. The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer
Probab=97.85 E-value=0.00011 Score=66.12 Aligned_cols=138 Identities=23% Similarity=0.256 Sum_probs=82.1
Q ss_pred CccccCCceEEEEEEeCC-------CcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCc-eeeeeeeeecCCeeEEEEEe
Q 037918 102 NLLGKGSFGSVYKGILSD-------GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRN-LVKILSSCSNVDFKALVLEF 173 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~ 173 (361)
+.+..|-...+|+....+ ++.+++|+...... .......|.+++..+.... ..++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 356667777999988654 57899999765432 2234567888888874322 3455555532 358999
Q ss_pred cCCCCHHHHH-----------------hcCCCC--------CC--HHHHHH--------------------------HHH
Q 037918 174 MPNGSLEKWL-----------------YSHNYF--------LD--IQERLN--------------------------VMI 200 (361)
Q Consensus 174 ~~~g~L~~~l-----------------~~~~~~--------~~--~~~~~~--------------------------i~~ 200 (361)
++|.++.... ++.... .+ +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 9887664311 000000 00 001100 111
Q ss_pred HHHHHHHHHHh------cCCCCeeeCCCCCCCEEEcCC----CcEEEEeccCcc
Q 037918 201 DVGSALEYLHH------GYSPSVVHCDLKPSNILLDEN----MVAHVSDFGISK 244 (361)
Q Consensus 201 ~i~~~L~~LH~------~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~a~ 244 (361)
.+...+..+.. .....++|+|+.+.||+++++ +.+.++||..|.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22222333431 135679999999999999985 889999998875
No 479
>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]
Probab=97.75 E-value=0.00018 Score=73.14 Aligned_cols=155 Identities=25% Similarity=0.234 Sum_probs=110.5
Q ss_pred HHHHHHHHHHHHhcCCCceeeeeeeeecCCee----EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 037918 136 FRSFDSECEVLRSIRHRNLVKILSSCSNVDFK----ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211 (361)
Q Consensus 136 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~ 211 (361)
......|...+.++.|+|++.++.|....... .+..+++..-++...++.-.. ++....+.+..++..||.|+|
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~-i~~~~~r~~~~~~~~GL~~~h- 303 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS-IPLETLRILHQKLLEGLAYLH- 303 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc-cCHHHHHHHHHHHhhhHHHHH-
Confidence 34455677788888999999999987554332 345678888888888876544 788999999999999999999
Q ss_pred cCCCCeeeCCCCCC---CEEEcCCCcEEEE--eccCccccCCCCcceeeecccccccccCccccCCCCCCc--ccchHHH
Q 037918 212 GYSPSVVHCDLKPS---NILLDENMVAHVS--DFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS--KCDVYSY 284 (361)
Q Consensus 212 ~~~~~ivH~dlk~~---Nill~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~--~~Dv~sl 284 (361)
+....|.-+..+ +-..+.++....+ ||+....+..... ......+..+.+||......... ..|+|.+
T Consensus 304 --~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 304 --SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred --HhccceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHH
Confidence 554555444444 3444556666666 8888776654332 12223455678888776655544 4799999
Q ss_pred HHHHHHHHhCCCC
Q 037918 285 GVLLMETFTRKKP 297 (361)
Q Consensus 285 G~il~elltg~~p 297 (361)
|.....+..|..+
T Consensus 379 gll~~~~~~~~~i 391 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDI 391 (1351)
T ss_pred HHHHhhhhhcCcc
Confidence 9999999998876
No 480
>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]
Probab=97.71 E-value=0.00055 Score=61.31 Aligned_cols=138 Identities=15% Similarity=0.181 Sum_probs=87.1
Q ss_pred CCccccCCceEEEEEEeCCCcEEEEEEeeh--hhHHHHHHHHHHHHHHHhcCC--CceeeeeeeeecCC--eeEEEEEec
Q 037918 101 CNLLGKGSFGSVYKGILSDGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRH--RNLVKILSSCSNVD--FKALVLEFM 174 (361)
Q Consensus 101 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~e~~ 174 (361)
++.+..|..-.+|..... ++.++++ ... ..........+|.++++.+.- .-+.+.++.|.++. ..+.||+|+
T Consensus 30 v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 30 VEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 344444544555555543 7888888 331 223344566778888888742 34556677776665 789999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHH-HHHHHHHHHHHhc-----------------------------------------
Q 037918 175 PNGSLEKWLYSHNYFLDIQERLNVM-IDVGSALEYLHHG----------------------------------------- 212 (361)
Q Consensus 175 ~~g~L~~~l~~~~~~~~~~~~~~i~-~~i~~~L~~LH~~----------------------------------------- 212 (361)
+|..+.+.+.... .. .+++ ..+++.|+-||+-
T Consensus 108 eGe~~~~~~~~~~----~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~ 181 (321)
T COG3173 108 EGEVVWSALPPES----LG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD 181 (321)
T ss_pred cceeccCcCCccc----ch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence 8854433322111 11 1222 2555555555521
Q ss_pred --------------CCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918 213 --------------YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246 (361)
Q Consensus 213 --------------~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 246 (361)
....++|||+.+.|++++.++.+-+.||+++..-
T Consensus 182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 1346999999999999999988999999998754
No 481
>PLN02236 choline kinase
Probab=97.62 E-value=0.00058 Score=62.64 Aligned_cols=139 Identities=19% Similarity=0.229 Sum_probs=80.4
Q ss_pred CccccCCceEEEEEEeCC-----CcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCce-eeeeeeeecCCeeEEEEEecC
Q 037918 102 NLLGKGSFGSVYKGILSD-----GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNL-VKILSSCSNVDFKALVLEFMP 175 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~ 175 (361)
+.+..|-.-.+|+....+ ++.|++|+.........+ -.+|..+++.+..-++ .++++.+... .|++|++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 345557778899987532 367899988654422222 3668888888843333 3455655332 5899998
Q ss_pred CCCHHHH-------H----------hcCC----C-CCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 037918 176 NGSLEKW-------L----------YSHN----Y-FLDIQERLNVMIDV-----------------GSALEYL----HH- 211 (361)
Q Consensus 176 ~g~L~~~-------l----------~~~~----~-~~~~~~~~~i~~~i-----------------~~~L~~L----H~- 211 (361)
+.+|..- + ++.. . ...+..+..+..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7766421 0 1111 0 11122232332211 1112222 11
Q ss_pred cCCCCeeeCCCCCCCEEEcC-CCcEEEEeccCccc
Q 037918 212 GYSPSVVHCDLKPSNILLDE-NMVAHVSDFGISKL 245 (361)
Q Consensus 212 ~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~ 245 (361)
.....++|+|+++.||++++ ++.+.++||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 12457899999999999986 46899999988764
No 482
>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []. Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.
Probab=97.52 E-value=0.0011 Score=59.04 Aligned_cols=73 Identities=22% Similarity=0.284 Sum_probs=48.0
Q ss_pred CCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC---CCceeeeeeeeecCCeeEEEEEecCCC
Q 037918 101 CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR---HRNLVKILSSCSNVDFKALVLEFMPNG 177 (361)
Q Consensus 101 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g 177 (361)
.+.++.|....+|+.. .+++.+.||+-.... ...|..|.+-|+.|. --.+++++++....+..+|+|||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~---~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSESG---RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEEGGG---CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecChhh---HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4578889999999987 578889999877332 245777888888873 456888899888777789999998776
No 483
>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported
Probab=97.52 E-value=0.0015 Score=58.02 Aligned_cols=31 Identities=35% Similarity=0.594 Sum_probs=25.7
Q ss_pred CCeeeCCCCCCCEEEcCCCc-EEEEeccCccc
Q 037918 215 PSVVHCDLKPSNILLDENMV-AHVSDFGISKL 245 (361)
Q Consensus 215 ~~ivH~dlk~~Nill~~~~~-~kl~Dfg~a~~ 245 (361)
..++|+|++|.||++++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 56999998754
No 484
>TIGR01767 MTRK 5-methylthioribose kinase. This enzyme is involved in the methionine salvage pathway in certain bacteria.
Probab=97.38 E-value=0.0028 Score=57.69 Aligned_cols=80 Identities=15% Similarity=0.133 Sum_probs=49.9
Q ss_pred ccccCCceEEEEEEeCCC-cEEEEEEeehhhH-------HHHHHHHHHHHHHHhcC--CC-ceeeeeeeeecCCeeEEEE
Q 037918 103 LLGKGSFGSVYKGILSDG-AEVAIKIFNLQLE-------RAFRSFDSECEVLRSIR--HR-NLVKILSSCSNVDFKALVL 171 (361)
Q Consensus 103 ~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~lv~ 171 (361)
.||.|....||++..++| +.|+||.-..... -..++..-|.+.|+... -| .+++++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999997654 5899997542211 11234556777776652 34 45555544 445567999
Q ss_pred EecCCC-CHHHHHh
Q 037918 172 EFMPNG-SLEKWLY 184 (361)
Q Consensus 172 e~~~~g-~L~~~l~ 184 (361)
|+++.. .|.+.|.
T Consensus 80 EdL~~~~ilR~~Li 93 (370)
T TIGR01767 80 EDLSHHKIARKGLI 93 (370)
T ss_pred hhCccchHHHHHHH
Confidence 998543 3434443
No 485
>PLN02756 S-methyl-5-thioribose kinase
Probab=97.29 E-value=0.007 Score=56.15 Aligned_cols=80 Identities=18% Similarity=0.135 Sum_probs=52.8
Q ss_pred CCccccCCceEEEEEEeCCCcEEEEEEeehhh----H---HHHHHHHHHHHHHHhcC---CCceeeeeeeeecCCeeEEE
Q 037918 101 CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL----E---RAFRSFDSECEVLRSIR---HRNLVKILSSCSNVDFKALV 170 (361)
Q Consensus 101 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~---~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv 170 (361)
.+.||.|....||+.... +..++||.-.... . -...+-..|.+.|+.+. ..++.+++.++.+. .+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEEE
Confidence 467899999999998864 5568999765211 0 12233444566666553 35788889888744 5789
Q ss_pred EEecCC--CCHHHHH
Q 037918 171 LEFMPN--GSLEKWL 183 (361)
Q Consensus 171 ~e~~~~--g~L~~~l 183 (361)
||++++ ..+.+-+
T Consensus 114 ME~L~~~~~ilr~~L 128 (418)
T PLN02756 114 MRYLEPPHIILRKGL 128 (418)
T ss_pred EeecCCcceehhhhh
Confidence 999976 3444444
No 486
>TIGR02904 spore_ysxE spore coat protein YsxE. Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.
Probab=97.27 E-value=0.0043 Score=56.12 Aligned_cols=32 Identities=25% Similarity=0.300 Sum_probs=28.7
Q ss_pred CCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKL 245 (361)
Q Consensus 214 ~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 245 (361)
..+++|+|+.++|+++++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 55899999999999999999999999988754
No 487
>TIGR02906 spore_CotS spore coat protein, CotS family. Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.
Probab=97.09 E-value=0.018 Score=52.03 Aligned_cols=30 Identities=30% Similarity=0.314 Sum_probs=26.0
Q ss_pred CCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISK 244 (361)
Q Consensus 214 ~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 244 (361)
..+++|||+.+.||+++. +.+.|+||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 468999999999999987 578999998764
No 488
>PLN02421 phosphotransferase, alcohol group as acceptor/kinase
Probab=97.03 E-value=0.0044 Score=56.56 Aligned_cols=139 Identities=13% Similarity=0.162 Sum_probs=78.4
Q ss_pred CccccCCceEEEEEEeCC----CcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCce-eeeeeeeecCCeeEEEEEecCC
Q 037918 102 NLLGKGSFGSVYKGILSD----GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNL-VKILSSCSNVDFKALVLEFMPN 176 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~ 176 (361)
+.|..|-...+|+....+ +..|++|+....... .-.-.+|..+++.+..-++ .++++++. .+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 455557777889887543 237899987654322 1223568888888854444 35555553 22 58999877
Q ss_pred CCHHH-------HH----------hcCC----C-CCCHHHHHHHHHHH----------------------HHHHHHHHh-
Q 037918 177 GSLEK-------WL----------YSHN----Y-FLDIQERLNVMIDV----------------------GSALEYLHH- 211 (361)
Q Consensus 177 g~L~~-------~l----------~~~~----~-~~~~~~~~~i~~~i----------------------~~~L~~LH~- 211 (361)
.+|.. .+ ++.. . +.-+..+.++..++ ..-+..+..
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 66522 01 1111 0 11122222222221 111111111
Q ss_pred ----cCCCCeeeCCCCCCCEEEcC-CCcEEEEeccCccc
Q 037918 212 ----GYSPSVVHCDLKPSNILLDE-NMVAHVSDFGISKL 245 (361)
Q Consensus 212 ----~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~ 245 (361)
....-++|+|+.+.||++++ ++.++++||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11234799999999999974 57899999998854
No 489
>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]
Probab=96.83 E-value=0.015 Score=52.65 Aligned_cols=134 Identities=20% Similarity=0.238 Sum_probs=78.6
Q ss_pred CceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC---CCc---eeeeeeee--ecCC--eeEEEEEecCCC
Q 037918 108 SFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR---HRN---LVKILSSC--SNVD--FKALVLEFMPNG 177 (361)
Q Consensus 108 ~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~n---iv~~~~~~--~~~~--~~~lv~e~~~~g 177 (361)
.-..+|+....+|+. ++|+.... .....+..|...+..+. .+= +...=|-. .-.+ ..+-+++|++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 456789988877776 89988775 22245667788887773 111 22222211 1223 677899999988
Q ss_pred CHHH-----H-------H---h--cCC---------CCCCHHH-------------HHHHHHHHHHHHHHHHh----cCC
Q 037918 178 SLEK-----W-------L---Y--SHN---------YFLDIQE-------------RLNVMIDVGSALEYLHH----GYS 214 (361)
Q Consensus 178 ~L~~-----~-------l---~--~~~---------~~~~~~~-------------~~~i~~~i~~~L~~LH~----~~~ 214 (361)
.+.. . + + ..+ ....|.. ......++...+..+.. ...
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 7772 1 1 0 000 0122220 01123333444444442 112
Q ss_pred CC---eeeCCCCCCCEEEcCCCc-EEEEeccCcc
Q 037918 215 PS---VVHCDLKPSNILLDENMV-AHVSDFGISK 244 (361)
Q Consensus 215 ~~---ivH~dlk~~Nill~~~~~-~kl~Dfg~a~ 244 (361)
.. +||+|+.|.||+++.+.. ..++||+-+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 23 999999999999998875 8999999875
No 490
>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2.7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....
Probab=96.83 E-value=0.0023 Score=54.42 Aligned_cols=31 Identities=29% Similarity=0.476 Sum_probs=21.9
Q ss_pred CCeeeCCCCCCCEEE-cCCCcEEEEeccCccc
Q 037918 215 PSVVHCDLKPSNILL-DENMVAHVSDFGISKL 245 (361)
Q Consensus 215 ~~ivH~dlk~~Nill-~~~~~~kl~Dfg~a~~ 245 (361)
..++|+|+.+.||++ +.++.++++||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 468999999999999 8899999999988753
No 491
>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length. The function of this family is unknown.
Probab=96.82 E-value=0.0062 Score=51.17 Aligned_cols=151 Identities=13% Similarity=0.075 Sum_probs=88.0
Q ss_pred CceEEEEEEeCCCcEEEEEEeehhhHH-HHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCHHHHHhcC
Q 037918 108 SFGSVYKGILSDGAEVAIKIFNLQLER-AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH 186 (361)
Q Consensus 108 ~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 186 (361)
+.++.-.+..+-| +..+|++..-.-. ...-|..+.+++.++. .|+++..- +.-...++.|+|.....
T Consensus 74 gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------- 141 (308)
T PF07387_consen 74 GNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------- 141 (308)
T ss_pred CceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------
Confidence 3344444443333 3345554432211 2245677888888774 46666622 33345688999843111
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecccccccccC
Q 037918 187 NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMA 266 (361)
Q Consensus 187 ~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~a 266 (361)
. .. .++..=+++|.-.|++ ..+.+|||-.|+||+-|..|.+||.|-+.... .+..|.-
T Consensus 142 ---~---~~-N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~vN 199 (308)
T PF07387_consen 142 ---N---FS-NFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNMVN 199 (308)
T ss_pred ---c---hh-HHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh--------------heeeEEe
Confidence 1 11 1222224667778865 77899999999999999999999999775421 1111222
Q ss_pred ccccCCCCCCcccchHHHHHHHHHHHhCC
Q 037918 267 PEYGSEGIVSSKCDVYSYGVLLMETFTRK 295 (361)
Q Consensus 267 PE~~~~~~~~~~~Dv~slG~il~elltg~ 295 (361)
-| ....|+++.+-+|=.-++++....
T Consensus 200 ~~---Y~~lT~~aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 200 IE---YESLTQEAEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred ee---ccccChHHHHHHHHHHHHHHHHHH
Confidence 11 123466777777777777776644
No 492
>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]
Probab=96.77 E-value=0.0034 Score=59.06 Aligned_cols=50 Identities=26% Similarity=0.287 Sum_probs=39.2
Q ss_pred HHHHHHHHHHHhcCCCceeeeeeeeecC-CeeEEEEEecCCCCHHHHHhcCC
Q 037918 137 RSFDSECEVLRSIRHRNLVKILSSCSNV-DFKALVLEFMPNGSLEKWLYSHN 187 (361)
Q Consensus 137 ~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~ 187 (361)
..+.....+++.+.|+|...++++-... ....+|||++ +.+|.+++..+.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~ 77 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN 77 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence 3456678889999999999999887543 4567899999 679999887554
No 493
>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]
Probab=96.76 E-value=0.00077 Score=70.65 Aligned_cols=159 Identities=12% Similarity=-0.041 Sum_probs=112.4
Q ss_pred HHHHHHHHHhcCCCceeeeeeeeec--CCeeEEEEEecCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh--
Q 037918 139 FDSECEVLRSIRHRNLVKILSSCSN--VDFKALVLEFMPNGSLEKWLYSHN---YFLDIQERLNVMIDVGSALEYLHH-- 211 (361)
Q Consensus 139 ~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~-- 211 (361)
...|...++...|+++.....-... ....+..++|+.+|.+.+.+-+.. ..++...+.....+...+..-.|.
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3345555566789988877665533 345678999999999999987542 223444444334443555555442
Q ss_pred cCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHH
Q 037918 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMET 291 (361)
Q Consensus 212 ~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~el 291 (361)
..+.--+|+++++-|.+|..+..++++++|+.+..... ........+++-|++|++...-.++.++|+|..|+-+|++
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 22445789999999999999999999999999832211 1122334577789999988887888889999999999999
Q ss_pred HhCCCCCC
Q 037918 292 FTRKKPTD 299 (361)
Q Consensus 292 ltg~~p~~ 299 (361)
--|..+|-
T Consensus 1434 s~~n~~fi 1441 (2724)
T KOG1826|consen 1434 SDGNAYFI 1441 (2724)
T ss_pred hcccHHHH
Confidence 98888764
No 494
>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]
Probab=96.59 E-value=0.11 Score=44.13 Aligned_cols=75 Identities=19% Similarity=0.314 Sum_probs=53.1
Q ss_pred CccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhc---CCCceeeeeeeeecCCeeEEEEEecCCCC
Q 037918 102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI---RHRNLVKILSSCSNVDFKALVLEFMPNGS 178 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 178 (361)
+.+..|..-..|.... +..++.||+-.. .....|..|+.-|..+ +.-++.+++.+..+.++.|+||||.+-+.
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 3455555555555544 467788886543 3345677787777666 44678889999999999999999998876
Q ss_pred HH
Q 037918 179 LE 180 (361)
Q Consensus 179 L~ 180 (361)
+.
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 65
No 495
>PRK12396 5-methylribose kinase; Reviewed
Probab=96.52 E-value=0.016 Score=53.55 Aligned_cols=81 Identities=17% Similarity=0.195 Sum_probs=51.1
Q ss_pred CCccccCCceEEEEEEeCC-CcEEEEEEeehhh------HHHHHHHHHHHHHHHhcC--CC-ceeeeeeeeecCCeeEEE
Q 037918 101 CNLLGKGSFGSVYKGILSD-GAEVAIKIFNLQL------ERAFRSFDSECEVLRSIR--HR-NLVKILSSCSNVDFKALV 170 (361)
Q Consensus 101 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~lv 170 (361)
.+.||.|.-..||++...+ ++.|+||.-..-. .-..++..-|.+.|+... -| .+++++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4578999999999999743 5679999653221 112345566777777652 34 45556654 44455789
Q ss_pred EEecCCC-CHHHHH
Q 037918 171 LEFMPNG-SLEKWL 183 (361)
Q Consensus 171 ~e~~~~g-~L~~~l 183 (361)
||+++.. .|.+.|
T Consensus 112 MEdL~~~~ilR~~L 125 (409)
T PRK12396 112 MEDLSDHTILRTAL 125 (409)
T ss_pred HHhCcccHHHHHHH
Confidence 9998542 344444
No 496
>PRK11768 serine/threonine protein kinase; Provisional
Probab=96.50 E-value=0.12 Score=47.04 Aligned_cols=71 Identities=14% Similarity=0.065 Sum_probs=43.4
Q ss_pred CCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCC--ceeeee---e--eeecCCeeEEEEEecCCCC
Q 037918 107 GSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHR--NLVKIL---S--SCSNVDFKALVLEFMPNGS 178 (361)
Q Consensus 107 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~---~--~~~~~~~~~lv~e~~~~g~ 178 (361)
+.-..||+....+|..+++|+..... .....+..|.+.+..+... .++... | ....++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 34567999988788899999875332 1224566677777766311 122212 1 1223456778999987754
No 497
>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]
Probab=96.36 E-value=0.011 Score=53.39 Aligned_cols=73 Identities=22% Similarity=0.220 Sum_probs=57.6
Q ss_pred CCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCc
Q 037918 164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGIS 243 (361)
Q Consensus 164 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 243 (361)
....|++|++. |++|.- +. ...+++...++++.+..+.-+.. +-+.-|||+.-.||+|+ +|++.|+||-++
T Consensus 298 ~~y~yl~~kdh-gt~is~-ik----~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI-IK----ADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred ceEEEEEEecC-Cceeee-ee----cccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeee
Confidence 34567778876 555532 22 24688899999999888888874 55789999999999999 999999999999
Q ss_pred cc
Q 037918 244 KL 245 (361)
Q Consensus 244 ~~ 245 (361)
+.
T Consensus 369 Rl 370 (488)
T COG5072 369 RL 370 (488)
T ss_pred ec
Confidence 84
No 498
>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]
Probab=96.36 E-value=0.016 Score=53.23 Aligned_cols=60 Identities=22% Similarity=0.145 Sum_probs=43.8
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc
Q 037918 167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD 230 (361)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~ 230 (361)
..++-+|.+|-++..++.... .++....+++.-.++|+--+-. -.+++|.|+.|.||++.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~--~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS--QPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhccc--ChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEE
Confidence 346778888999999998655 4455666666666666554332 44899999999999994
No 499
>PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ]. This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis [].
Probab=96.31 E-value=0.0016 Score=38.24 Aligned_cols=33 Identities=27% Similarity=0.394 Sum_probs=21.4
Q ss_pred ccceehhhhhhhHHHHHHHHHHHHHHHHhhhcc
Q 037918 33 KKAIVALFLKYVLPPIVSILLIMTVVVFMRRRN 65 (361)
Q Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~r~ 65 (361)
.+..+.+..++++|+.+++++++.++++++||+
T Consensus 7 ~~~~vaIa~~VvVPV~vI~~vl~~~l~~~~rR~ 39 (40)
T PF08693_consen 7 NSNTVAIAVGVVVPVGVIIIVLGAFLFFWYRRK 39 (40)
T ss_pred CCceEEEEEEEEechHHHHHHHHHHhheEEecc
Confidence 344556667778887777777666666555554
No 500
>PRK06148 hypothetical protein; Provisional
Probab=96.27 E-value=0.058 Score=56.72 Aligned_cols=140 Identities=24% Similarity=0.233 Sum_probs=77.8
Q ss_pred CccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-------CCCceeeeee-----eeec-CC--e
Q 037918 102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI-------RHRNLVKILS-----SCSN-VD--F 166 (361)
Q Consensus 102 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-------~h~niv~~~~-----~~~~-~~--~ 166 (361)
+.|+ |..-.+|+....+|..+++|+....... .....|...+..| .-|.+++-.+ .... .+ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 3454 4457789888878889999999754322 2333455555544 2233333221 1111 22 4
Q ss_pred eEEEEEecCCCCHHHHH-----------------hc------C---CCCCCHHH-----------------HHHHHHHHH
Q 037918 167 KALVLEFMPNGSLEKWL-----------------YS------H---NYFLDIQE-----------------RLNVMIDVG 203 (361)
Q Consensus 167 ~~lv~e~~~~g~L~~~l-----------------~~------~---~~~~~~~~-----------------~~~i~~~i~ 203 (361)
.+-+++|++|..+.+.. .. . ...+.|.. ...++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 56789999997776510 00 0 01112211 112222332
Q ss_pred HHHH-----HHHhcCCCCeeeCCCCCCCEEEcCCC--cEE-EEeccCccc
Q 037918 204 SALE-----YLHHGYSPSVVHCDLKPSNILLDENM--VAH-VSDFGISKL 245 (361)
Q Consensus 204 ~~L~-----~LH~~~~~~ivH~dlk~~Nill~~~~--~~k-l~Dfg~a~~ 245 (361)
.... .+. ....++||+|+.+.||+++.++ ++. |+|||.+..
T Consensus 188 ~~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 2222 122 2256899999999999999775 454 999998753
Done!